introduct
healthi
bowel
function
import
factor
judg
advis
earli
enter
nutrit
critic
ill
patient
longterm
observ
object
evalu
gastrointestin
motil
diffi
cult
develop
noninvas
monitor
system
capabl
quantifi
visual
gastrointestin
motil
real
time
studi
gastrointestin
motil
perform
patient
sever
sepsi
use
develop
bowel
sound
analysi
system
correl
bowel
sound
chang
time
blood
concentr
associ
sepsi
sever
evalu
method
studi
prospect
observ
pilot
studi
conduct
hospit
consecut
adult
patient
sever
sepsi
mechan
ventil
blood
concentr
pgml
acut
phase
defi
ned
day
ill
icu
enter
studi
june
decemb
subject
divid
treat
steroid
steroid
treatment
group
nosteroid
group
target
period
steroid
strongli
aff
ect
blood
level
result
subject
fi
adult
patient
acut
phase
sever
sepsi
mechan
ventil
gastrointestin
motil
measur
total
minut
minut
three
subject
nosteroid
group
minut
two
subject
steroid
treatment
group
nosteroid
group
bowel
sound
count
neg
correl
blood
concentr
r
p
suggest
gastrointestin
motil
suppress
blood
concentr
increas
howev
steroid
treatment
group
gastrointestin
motil
show
correl
blood
concentr
r
p
blood
concentr
appear
decreas
steroid
treatment
irrespect
chang
state
sepsi
wherea
bowel
sound
count
monitor
system
refl
ect
chang
state
sepsi
result
correl
conclus
new
realtim
bowel
sound
analysi
system
provid
use
method
continu
quantit
noninvas
evalu
gastrointestin
motil
sever
patient
furthermor
analysi
may
predict
diseas
sever
septic
patient
introduct
sever
sepsi
result
uk
death
year
prior
studi
demonstr
benefi
earli
recognit
treatment
sepsi
reduc
mortal
sepsi
six
bundl
aim
optimis
fi
rst
hour
sepsi
manag
assess
proport
emerg
depart
ed
patient
sever
sepsi
receiv
sepsi
six
bundl
whether
improv
combin
staff
educ
use
sepsi
six
manag
sticker
patient
note
method
close
loop
audit
complet
ed
ipswich
hospit
uk
cycl
day
intervent
made
period
two
cycl
intervent
consist
sepsi
six
manag
sticker
poster
place
ed
two
train
session
ed
nurs
sepsi
recognit
manag
teach
session
middlegrad
doctor
trolley
ed
equip
requir
sepsi
six
note
patient
lactat
mmoll
retrospect
review
system
infl
ammatori
respons
syndrom
criteria
document
suspicion
infect
deem
sever
sepsi
time
patient
sepsi
six
complet
record
fi
nal
diagnosi
day
mortal
result
cycl
patient
met
criteria
sever
sepsi
compar
cycl
deliveri
sepsi
six
intervent
highli
variabl
cycl
lactat
level
iv
access
highest
complet
rate
respect
blood
cultur
iv
fl
uid
resuscit
complet
patient
within
minut
septic
patient
given
iv
antibiot
within
minut
total
patient
receiv
antibiot
accord
trust
guidelin
high
fl
ow
oxygen
cathet
fl
uid
balanc
chart
lowest
complet
rate
respect
cycl
post
intervent
signifi
cant
chang
percentag
patient
receiv
sepsi
six
bundl
conclus
low
rate
sepsi
six
complet
requir
improv
meet
target
set
colleg
emerg
medicin
result
suggest
simpl
intervent
ineff
ectiv
increas
sepsi
six
complet
thu
lend
support
case
integr
intervent
electron
record
alert
system
refer
wound
infect
follow
preoper
characterist
periop
paramet
age
femal
gender
diabet
mellitu
dm
insulin
depend
bodi
mass
index
bmi
current
smoker
copd
cardiopulmonari
bypass
time
cbp
minut
use
steroid
emerg
oper
prolong
mechan
ventil
hour
reintub
transfus
unit
red
blood
cell
postop
use
noninvas
ventil
niv
chisquar
test
use
statist
analysi
result
total
patient
complic
deep
sternal
wound
infect
statist
correl
found
age
gender
dm
bmi
steroid
emerg
oper
prolong
ventil
cbp
time
minut
reintub
niv
factor
statist
signifi
cant
correl
present
tabl
conclus
postop
deep
sternal
wound
infect
statist
signifi
cant
correl
follow
paramet
transfus
red
blood
cell
unit
histori
copd
insulin
depend
patient
current
smoker
also
tendenc
correl
cbp
time
minut
p
introduct
blood
cultur
critic
procedur
detect
potenti
lifethreaten
bloodstream
infect
bsi
time
earli
diagnosi
appropri
treatment
bsi
key
factor
order
improv
prognosi
purpos
current
analysi
identifi
risk
factor
bacteremia
adult
febril
patient
emerg
set
method
conduct
retrospect
casecontrol
studi
within
popul
adult
patient
visit
emerg
depart
commun
hospit
st
luke
intern
hospit
tokyo
japan
underw
two
set
blood
cultur
test
among
total
patient
detect
bacteremia
includ
studi
randomli
select
patient
bacteremia
group
randomli
select
patient
neg
blood
cultur
group
serv
comparison
group
multivari
logist
regress
use
evalu
relationship
clinic
characterist
factor
bacteremia
introduct
aim
studi
evalu
eff
ect
surviv
sepsi
campaign
mortal
rate
second
surviv
sepsi
public
assess
whether
patient
sepsi
admit
icu
lower
apach
ii
score
admiss
patient
sepsi
requir
icu
care
extrem
poor
prognosi
shown
mortal
rate
rang
sever
sepsi
septic
shock
surviv
sepsi
campaign
initi
fi
rst
second
third
public
publish
respect
method
retrospect
case
note
review
perform
look
sampl
patient
year
older
admit
east
surrey
hospit
esh
icu
januari
octob
total
number
patient
sepsi
compar
result
second
public
surviv
sepsi
campaign
look
mortal
rate
age
patient
admiss
length
prior
icu
transfer
apach
ii
score
length
stay
icu
result
begin
end
mortal
rate
septic
patient
compar
begin
end
octob
fisher
twotail
test
show
signifi
cant
diff
erenc
p
mortal
second
public
median
age
year
time
hospit
admiss
icu
greater
day
compar
day
signifi
cant
diff
erenc
mannwhitney
test
apach
ii
score
mean
median
score
group
mean
length
stay
day
longer
day
compar
day
conclus
patient
sepsi
admit
esh
icu
rel
decreas
mortal
second
public
surviv
sepsi
guidelin
origin
aim
campaign
reduc
mortal
sepsi
year
decreas
due
signifi
cant
diff
erenc
set
patient
decreas
time
admitt
icu
may
due
improv
recognit
need
icu
care
overal
surviv
sepsi
campaign
signifi
cantli
benefi
cial
eff
ect
mortal
rate
patient
sepsi
introduct
survivor
sepsi
report
persist
problem
last
year
hospit
discharg
main
aim
studi
investig
longterm
healthrel
qualiti
life
survivor
sir
sepsi
compar
welsh
norm
data
control
age
length
stay
preexist
condit
second
aim
investig
diff
erenc
longterm
healthrel
qualiti
life
specifi
calli
patient
categoris
three
group
sir
uncompl
sepsi
sever
sepsissept
shock
method
prospect
studi
design
use
order
investig
sepsi
patient
either
present
emerg
depart
admit
icu
region
trauma
centr
total
patient
recruit
patient
consid
elig
per
sir
sepsi
criteria
sepsisrel
organ
failur
assess
score
determin
fi
rst
hour
assess
organ
function
patient
assign
group
follow
steril
sir
uncompl
sepsi
sever
sepsi
septic
shock
per
criteria
assign
group
blind
perform
intens
care
specialist
independ
studi
baselin
demograph
clinic
characterist
outcom
collect
surviv
patient
sent
survey
month
year
post
hospit
discharg
result
total
patient
includ
studi
mortal
rate
record
lead
fi
nal
respons
rate
end
data
collect
period
qualiti
life
signifi
cantli
reduc
patient
compar
local
norm
data
p
reduct
physic
compon
healthrel
qualiti
life
pronounc
sever
sepsissept
shock
patient
compar
uncompl
sepsi
sir
patient
conclus
fi
rst
observ
studi
specifi
calli
focu
diff
erent
group
sir
sepsi
patient
assess
longterm
qualiti
life
local
popul
norm
use
comparison
rather
wide
geograph
norm
fail
refl
ect
intricaci
countri
popul
signifi
cant
reduct
qualiti
life
found
sever
sepsissept
shock
patient
compar
uncompl
sepsi
sir
patient
control
age
preexist
condit
hospit
icu
length
stay
refer
introduct
sepsi
highpreval
diseas
icu
associ
high
mortal
high
cost
mainli
develop
countri
aim
studi
demonstr
icu
cost
privat
hospit
patient
admit
sever
sepsi
septic
shock
method
retrospect
observ
singlecent
studi
patient
admit
novemb
march
sever
sepsi
septic
shock
record
data
taken
softwar
epim
mv
system
ibm
spss
statist
classifi
cation
base
surviv
sepsi
campaign
includ
bed
adult
icu
clinic
surgic
patient
older
year
sever
sepsi
septic
shock
includ
evalu
cost
patient
icu
stay
relat
clinic
present
sever
sepsi
septic
shock
antibiot
start
time
perman
icu
stay
mortal
fi
rst
episod
per
patient
record
result
novemb
march
includ
patient
criteria
sever
sepsi
septic
shock
mean
age
patient
year
divid
equal
genr
overal
mortal
rate
sap
death
probabl
set
latin
america
patient
sever
sepsi
mortal
septic
shock
mortal
rate
averag
total
cost
icu
admiss
per
patient
us
averag
daili
cost
us
daili
cost
patient
sever
sepsi
septic
shock
us
us
p
respect
survivor
nonsurvivor
us
us
p
length
stay
patient
icu
day
day
patient
sever
sepsi
day
patient
septic
shock
p
begin
antibiot
nonsurvivor
minut
survivor
minut
p
earliest
onset
patient
septic
shock
patient
sever
sepsi
vs
minut
p
conclus
sever
sepsi
septic
shock
condit
consum
larg
amount
resourc
nonsurvivor
higher
averag
spend
survivor
patient
admit
septic
shock
higher
mortal
patient
sever
sepsi
high
mortal
relat
prognost
indic
adopt
begin
antibiot
longer
nonsurvivor
adopt
measur
aim
recogn
earlier
treatment
sepsi
improv
treatment
especi
septic
shock
prevent
death
decrement
cost
introduct
object
studi
compar
number
roll
adher
leukocyt
patient
sever
sepsissept
shock
noninfect
control
microcirculatori
fl
ow
alter
endotheli
cell
dysfunct
element
sepsi
pathophysiolog
tradit
microcirculatori
emphasi
red
blood
cell
vessel
perfus
howev
assess
interact
white
blood
cell
endotheli
cell
may
anoth
earli
diagnost
modal
includ
adult
age
year
ed
patient
present
sever
sepsissept
shock
sepsi
elev
lactat
mmoll
hypotens
prospect
clinic
process
trial
studi
subset
patient
microcirculatori
video
obtain
along
noninfect
control
patient
use
sidestream
darkfi
eld
videomicroscop
obtain
imag
sequenc
sublingu
mucosa
use
video
stabil
frame
averag
techniqu
visual
slowlymov
leukocyt
quantifi
ed
number
roll
adher
leukocyt
present
per
mm
mm
visual
fi
eld
standard
clip
furthermor
extract
total
length
vessel
candid
count
rollingadh
leukocyt
vessel
adequ
focu
report
sampl
mean
standard
deviat
compar
student
test
result
includ
total
patient
sever
sepsissept
shock
noninfect
control
mean
number
adher
leukocyt
per
fi
eld
sepsi
group
sd
compar
sd
noninfect
group
p
correspond
mean
number
adher
leukocyt
per
unit
vessel
length
sd
sd
sepsi
noninfect
group
respect
p
roll
leukocyt
observ
mean
number
sd
sepsi
group
sd
noninfect
group
p
per
fi
eld
correspond
mean
number
roll
leukocyt
per
unit
vessel
length
sd
sd
respect
p
conclus
result
show
higher
number
roll
adher
leukocyt
patient
sever
sepsissept
shock
compar
noninfect
control
also
appli
take
total
vessel
length
fi
eld
view
consider
may
hold
potenti
use
tool
sepsi
assess
introduct
platelet
consid
immun
infl
ammatori
agent
well
key
cell
coagul
implic
pathophysiolog
sepsi
thrombocytopenia
associ
sepsi
sever
poor
prognosi
hyperactiv
platelet
probabl
contribut
microvascular
thrombosi
organ
failur
present
studi
evalu
platelet
activ
marker
potenti
predict
marker
sepsi
mortal
among
four
commonli
encount
popul
patient
admit
icu
method
ninetynin
noninfect
icu
patient
prospect
screen
day
day
admiss
elect
cardiac
surgeri
trauma
acut
neurolog
dysfunct
prolong
ventil
hour
third
sampl
drawn
infect
diagnos
tx
evalu
platelet
activ
measur
express
pselectin
fi
brinogen
bind
cell
surfac
stimul
major
platelet
agonist
adp
collagen
trap
fl
ow
cytometri
clinic
score
obtain
admiss
result
patient
develop
sepsi
n
present
signifi
cantli
higher
platelet
fi
brinogen
bind
compar
patient
get
infect
basal
p
upon
stimul
p
roc
auc
associ
basal
fi
brinogen
bind
occurr
sepsi
ci
elev
basal
express
level
associ
increas
mortal
p
roc
auc
kaplanmei
surviv
curv
illustr
mortal
signifi
cantli
higher
stratifi
cation
base
basal
level
cutoff
mfi
hr
p
multivari
logist
regress
analysi
use
clinic
score
sofa
apach
ii
sap
ii
sap
iii
indic
addit
level
bound
fi
brinogen
level
signifi
cantli
improv
predict
mortal
odd
ratio
p
sepsi
odd
ratio
p
respect
conclus
predisposit
sever
infect
select
critic
ill
medicosurg
adult
identifi
ed
day
admiss
base
circul
basal
activ
platelet
level
activ
platelet
may
add
increment
prognost
inform
clinic
score
refer
introduct
inhibitor
belong
superfamili
serin
proteas
inhibitor
regul
complement
system
also
plasma
kallikreinkinin
system
fi
brinolyt
system
coagul
system
biolog
activ
divid
regul
vascular
permeabl
antiinfl
ammatori
function
recent
year
hereditari
angioedema
hae
caus
inherit
defi
cienci
focus
hae
attack
vascular
permeabl
markedli
increas
lead
angioedema
sepsi
signifi
cant
endotheli
hyperperm
similarli
observ
system
role
clarifi
ed
pathogenesi
serial
chang
patient
sepsi
clear
object
studi
clarifi
serial
chang
patient
sepsi
evalu
impact
clinic
cours
method
serial
examin
activ
valu
normal
rang
quantit
valu
normal
rang
patient
sepsi
period
decemb
februari
also
analyz
clinic
cours
prognosi
volum
infus
bodi
weight
urin
volum
catecholamin
administr
steroid
administr
result
serial
chang
evalu
fi
patient
sepsi
three
male
two
femal
four
survivor
one
nonsurvivor
mean
age
year
nonsurvivor
activ
admiss
valu
normal
rang
quantit
valu
normal
patient
sever
sepsi
requir
fl
uid
resuscit
catecholamin
steroid
administr
maintain
hemodynam
activ
valu
admiss
normal
rang
quantit
valu
normal
rang
gener
condit
improv
day
activ
valu
quantit
valu
increas
normal
rang
normal
rang
three
patient
sepsi
requir
steroid
administr
activ
valu
admiss
normal
rang
quantit
valu
normal
rang
conclus
nonsurvivor
sever
patient
sepsi
requir
steroid
administr
enhanc
activ
observ
quantit
valu
low
evalu
serial
chang
valid
replac
therapi
patient
septic
shock
may
lead
new
strategi
manag
sepsi
infl
ammatori
respons
sepsi
develop
two
phase
infl
ammatori
phase
sir
phase
variabl
frequenc
intens
car
balanc
import
eff
ect
morbid
mortal
lymphopenia
aff
ect
particularli
cell
correl
invers
outcom
aim
studi
identifi
phenotyp
function
earli
marker
cell
nk
cell
relat
prognosi
septic
patient
popul
method
collect
peripher
blood
mononuclear
cell
patient
sever
sepsi
septic
shock
icu
admiss
healthi
control
subject
evalu
frequenc
absolut
number
cell
nk
b
lymphocyt
rate
regulatori
cell
treg
cytotox
potenti
cell
nk
cell
evalu
perforin
per
granzym
gra
express
product
eff
ector
cytokin
name
cell
nk
cell
upon
polyclon
stimul
marker
compar
patient
diff
erent
outcom
result
septic
patient
compar
healthi
donor
character
global
lymphopenia
found
increas
frequenc
cell
produc
p
increas
percentag
cell
produc
p
reduc
proport
cell
p
nk
cell
p
produc
also
notic
increas
frequenc
cell
express
per
p
gra
p
moreov
proport
nk
cell
express
gra
also
signifi
cantli
increas
p
establish
prognost
valu
biolog
marker
compar
cytokin
express
lymphocyt
septic
patient
surviv
die
found
cell
signifi
cantli
increas
p
p
respect
similarli
percentag
cell
produc
elev
p
observ
product
cell
p
contrari
observ
tendenc
reduct
circul
treg
p
conclus
septic
patient
character
peculiar
immunophenotyp
includ
global
lymphopenia
specifi
c
pattern
cytokin
evalu
marker
seem
individu
wors
outcom
particular
group
show
infl
ammatori
phenotyp
higher
express
tendenc
reduct
treg
introduct
critic
ill
patient
show
sign
immun
suppress
consid
increas
vulner
nosocomi
infect
whole
blood
stimul
frequent
use
function
test
immun
suppress
aim
assess
associ
whole
blood
leukocyt
respons
lipopolysaccharid
lp
subsequ
occurr
nosocomi
infect
critic
ill
patient
admit
icu
method
consecut
critic
ill
patient
admit
icu
april
june
two
system
infl
ammatori
respons
syndrom
criteria
expect
length
icu
stay
hour
enrol
agematch
gendermatch
healthi
individu
includ
control
blood
drawn
fi
rst
morn
icu
admiss
stimul
ex
vivo
ngml
ultrapur
lp
hour
tumor
necrosi
factor
tnf
interleukin
il
measur
supernat
result
seventythre
critic
ill
patient
includ
develop
icuacquir
infect
compar
healthi
subject
whole
blood
leukocyt
patient
less
respons
ex
vivo
stimul
lp
refl
ect
strongli
reduc
level
cultur
supernat
howev
result
diff
erent
patient
develop
icuacquir
infect
figur
conclus
extent
reduc
lp
respons
blood
leukocyt
critic
ill
patient
fi
rst
day
icu
admiss
relat
subsequ
develop
icuacquir
infect
introduct
index
immun
suppress
heat
shock
protein
hsp
regul
cell
respons
oxid
stress
evalu
relationship
patient
sir
sever
sepsi
versu
healthi
volunt
method
evalu
patient
sir
sever
sepsi
group
sexmatch
healthi
volunt
demograph
data
obtain
patient
apach
score
calcul
upon
admiss
blood
sampl
collect
upon
diagnosi
sir
sever
sepsi
evalu
hladr
express
monocyt
fresh
whole
blood
stain
antihladrp
stain
allow
evalu
mfi
express
hsp
monocyt
cell
analyz
use
fl
ow
cytometri
anova
post
hoc
test
use
compar
cell
count
level
among
three
group
result
nineteen
control
six
sir
patient
sever
sepsi
patient
studi
percent
express
hladr
monocyt
signifi
cantli
diff
erent
three
group
show
progress
decreas
control
mean
sir
mean
sever
sepsi
mean
patient
control
vs
sever
sepsi
p
control
vs
sir
p
sir
vs
sever
sepsi
p
mfi
signifi
cantli
diff
erent
control
mean
respect
sir
mean
respect
sever
sepsi
patient
mean
respect
p
comparison
notabl
hsp
level
rose
control
sir
fell
sir
sever
sepsi
patient
apach
score
increas
signifi
cantli
p
septic
patient
compar
sir
conclus
signifi
cant
diff
erenc
marker
immun
paralysi
control
patient
sir
sever
sepsi
show
initi
stimul
follow
exhaust
sepsi
progress
introduct
decreas
monocyt
surfac
hladr
mhladr
measur
fl
ow
cytometri
fcm
independ
marker
immunosuppress
sepsi
previou
report
demonstr
septic
patient
display
strong
correl
mhladr
mrnalevel
hladra
whole
blood
mrnabas
hladr
monitor
pcr
would
improv
clinic
usag
facilit
conduct
multicentr
studi
primari
focu
studi
evalu
correl
mhladr
hladra
diff
erent
time
point
sepsi
addit
assess
dynam
express
mhladr
hladra
relat
sepsi
sever
method
studi
patient
n
includ
day
hospit
admiss
blood
cultur
turn
posit
repeat
sampl
day
perform
mhladr
monitor
fcm
hladra
quantit
rtpcr
mix
model
longitudin
data
use
logarithm
transform
calcul
interact
eff
ect
time
sever
hladr
express
introduct
idea
use
eosinophil
count
ec
diagnost
marker
clarifi
natur
system
infl
ammatori
respons
syndrom
sir
belong
k
abidi
show
ec
could
use
diagnost
criterion
sepsi
publish
data
defi
ne
role
dynam
control
ec
process
intens
therapi
prognost
marker
indic
sever
condit
critic
ill
patient
aim
determin
inform
valu
ec
develop
sir
biomark
sepsi
indic
sever
condit
prognosi
outcom
patholog
process
method
total
patient
enrol
studi
admit
icu
sir
patient
divid
septic
group
patient
communityacquir
pneumonia
complic
sepsi
two
sir
group
noninfecti
genesi
patient
acut
cerebrovascular
accid
cva
acut
myocardi
infarct
ami
absolut
ec
measur
admiss
dynam
day
stay
result
median
ec
cellsmm
septic
patient
admiss
signifi
cantli
lower
patient
cva
cellsmm
ami
cellsmm
comparison
ec
septic
patient
survivor
die
show
signifi
cant
diff
erenc
tabl
receiv
oper
characterist
roc
analysi
determin
valu
less
cellsmm
optim
diagnost
cutoff
valu
high
level
confi
denc
comparison
septic
noninfecti
group
area
roc
curv
sensit
specifi
citi
p
signifi
cant
increas
ec
survivor
ec
chang
signifi
cantli
among
die
dynam
roc
analysi
determin
cutoff
valu
ec
indic
high
risk
advers
outcom
septic
patient
tabl
introduct
purpos
studi
evalu
diagnost
prognost
valu
endotoxin
activ
assay
eaa
sepsi
patient
system
infl
ammatori
respons
syndrom
sir
organ
failur
icu
set
method
total
patient
sir
organ
failur
suspect
sepsi
critic
care
includ
accord
level
eaa
patient
classifi
ed
three
group
group
l
eaa
group
eaa
eaa
group
h
eaa
order
evalu
sever
ill
acut
physiolog
chronic
health
evalu
ii
apach
ii
score
sequenti
organ
failur
assess
sofa
score
catecholamin
ca
index
record
blood
sampl
obtain
measur
eaa
level
infl
ammatori
marker
procalcitonin
creactiv
protein
white
blood
cell
serum
lactat
level
indic
tissu
hypoxia
blood
cultur
patient
follow
month
apach
ii
score
sofa
score
ca
index
infl
ammatori
marker
serum
lactat
level
blood
cultur
result
examin
diagnosi
sepsi
sever
sepsi
septic
shock
prognosi
mortal
valu
also
compar
eaa
level
result
patient
age
year
male
n
femal
n
total
number
sampl
group
lgroup
mgroup
h
twentyseven
specimen
obtain
nonsept
patient
specimen
obtain
septic
patient
apach
ii
score
highli
correl
sofa
score
p
group
h
apach
ii
score
signifi
cantli
higher
group
p
sofa
score
group
h
signifi
cantli
higher
group
group
l
p
eaa
level
signifi
cantli
increas
septic
patient
septic
patient
nonsept
patient
p
posit
blood
cultur
group
posit
group
neg
group
p
relationship
eaa
level
infl
ammat
marker
mortal
conclus
patient
suspect
sepsi
posit
blood
cultur
eaa
level
signifi
cantli
increas
strong
correl
sever
diseas
result
suggest
eaa
indic
state
sepsi
regardless
possibl
infect
patient
sir
organ
failur
introduct
sepsi
common
reason
admiss
icu
throughout
world
past
two
decad
incid
sepsi
usa
tripl
lead
caus
death
sepsi
continu
impact
neg
critic
ill
patient
clear
earli
diagnosi
eff
ectiv
manag
could
improv
patient
morbid
mortal
numer
studi
attempt
examin
biomark
abil
diagnos
prognost
septic
patient
despit
multipl
eff
ort
current
reliabl
marker
eff
ectiv
improv
clinic
eff
ectiv
diagnos
manag
septic
patient
purpos
systemat
review
evalu
diagnost
prognost
valu
variou
biomark
use
septic
patient
method
systemat
search
literatur
perform
medlin
embas
cochran
central
regist
control
trial
databas
use
terminolog
select
biomark
includ
novemb
articl
involv
neonat
english
exclud
inclus
agre
two
independ
review
abstract
full
text
assess
base
biomark
abil
diagnos
septic
patient
abil
predict
mortal
result
articl
identifi
ed
abstract
screen
fulltext
articl
select
review
includ
primarili
random
control
trial
cohort
studi
postmortem
studi
biomark
examin
studi
examin
procalcitonin
compar
serum
septic
patient
control
biomark
elev
septic
patient
even
though
high
sensit
high
specifi
citi
often
introduct
earli
diagnosi
system
infl
ammat
generalis
respons
noxiou
stimuli
fundament
import
eff
ectiv
goaldirect
therapi
variou
infl
ammat
biomark
use
clinic
experiment
practic
howev
defi
nitiv
diagnost
tool
earli
detect
system
infl
ammat
remain
identifi
ed
acetylcholin
ach
shown
play
import
role
infl
ammatori
respons
serum
cholinesteras
butyrylcholinesteras
bche
major
ach
hydrolyz
enzym
plasma
role
enzym
infl
ammat
yet
fulli
understood
describ
correl
bche
activ
earli
system
infl
ammatori
respons
upon
traumat
injuri
method
measur
bche
activ
patient
traumat
injuri
admit
emerg
room
use
pointofcaretest
poct
system
addit
measur
level
routin
infl
ammat
biomark
initi
treatment
period
use
injuri
sever
score
assess
trauma
sever
data
statist
analyz
use
friedman
test
correl
analysi
perform
use
spearman
rank
correl
test
p
consid
statist
signifi
cant
result
reduc
bche
activ
correl
trauma
sever
result
system
infl
ammat
compar
serum
level
routin
measur
infl
ammatori
biomark
chang
bche
activ
detect
signifi
cantli
earlier
suggest
bche
activ
might
serv
earli
indic
system
infl
ammat
conclus
result
suggest
bche
activ
measur
use
poct
system
might
play
import
role
earli
diagnosi
traumainduc
system
infl
ammat
introduct
apoptot
process
cell
activ
elimin
program
pathway
increas
sepsi
extrins
intrins
apoptot
death
cell
pathway
activ
lead
cell
apoptosi
cytokeratin
protein
present
epitheli
parenchym
cell
cleav
action
caspas
releas
blood
caspasecleav
ck
ccck
apoptot
death
novel
object
studi
determin
whether
associ
serum
level
serum
level
mortal
septic
patient
method
prospect
multicent
observ
studi
six
spanish
icu
includ
patient
sever
sepsi
collect
blood
sampl
sever
sepsi
diagnosi
moment
determin
serum
level
assess
main
executor
apoptosi
assess
apoptosi
level
endpoint
mortal
result
found
nonsurvivor
n
comparison
survivor
n
septic
patient
show
higher
serum
level
ngml
vs
ngml
p
vs
p
multipl
logist
regress
show
serum
level
ngml
associ
mortal
day
odd
ratio
confi
denc
interv
p
control
sofa
score
age
kaplanmei
surviv
analysi
show
higher
risk
death
septic
patient
serum
level
ngml
patient
lower
level
hazard
ratio
ci
p
found
posit
associ
serum
level
p
conclus
novel
fi
nding
studi
associ
serum
level
serum
level
mortal
septic
patient
report
decreas
apoptosi
increas
surviv
septic
rat
administr
caspas
inhibitor
thu
may
interest
explor
agent
septic
patient
introduct
low
awar
late
recognit
delay
treatment
sepsi
still
common
marker
innat
immun
respons
upregul
sepsi
primari
goal
prospect
doubleblind
studi
compar
diagnost
accuraci
neutrophil
cellular
marker
along
creactiv
protein
crp
procalcitonin
pct
level
earli
sepsi
method
adult
icu
patient
elig
eightcolor
fl
ow
cytometr
biomark
panel
includ
hla
dr
other
diagnost
test
result
compar
infect
refer
standard
sepsi
target
condit
use
receiv
oper
characterist
curv
analys
multivari
logist
regress
use
assess
relationship
set
marker
probabl
sepsi
adjust
patient
characterist
result
total
patient
enrol
sepsi
serv
control
apach
iv
median
vs
sofa
vs
icu
vs
hospit
length
stay
vs
higher
sepsi
group
mortal
diff
erent
adjust
apach
iv
crp
pct
moleculesneutrophil
measur
remain
signifi
cant
predictor
sepsi
oneunit
increas
log
scale
ci
p
auc
see
tabl
conclus
neutrophil
express
accur
predictor
earli
sepsi
introduct
procalcitonin
pct
increasingli
standard
emerg
depart
ed
diagnost
prognost
workup
patient
suspect
infect
recent
pct
direct
new
highsensit
pointofcar
test
develop
fast
pct
measur
capillari
venou
blood
sampl
measur
rang
method
prospect
compar
intern
studi
conduct
three
european
ed
consecut
patient
suspicion
bacteri
infect
includ
duplic
determin
pct
perform
two
distinct
pct
direct
test
devic
capillari
fi
ngertip
venou
whole
blood
edta
compar
refer
method
pct
sensit
kryptor
elecsi
pct
respect
diagnost
accuraci
evalu
correl
concord
analys
result
total
patient
includ
period
male
median
age
year
correl
capillari
venou
whole
blood
refer
method
excel
r
sensit
specifi
citi
concord
respect
threshold
signifi
cant
bia
observ
capillari
venou
whole
blood
although
outlier
respect
pct
direct
shorter
time
result
compar
refer
method
vs
minut
diff
erenc
minut
ci
minut
p
conclus
studi
found
high
diagnost
accuraci
faster
time
result
pct
direct
ed
set
pct
direct
may
allow
widespread
use
pct
test
outpati
clinic
smaller
institut
involv
develop
septic
shock
procalcitonin
pct
serum
concentr
strongli
associ
sever
sepsi
eff
ect
elev
endotoxin
activ
ea
pct
serum
level
organ
function
mortal
patient
septic
shock
evalu
day
admiss
icu
method
icu
patient
diagnosi
septic
shock
consecut
ad
studi
group
within
fi
rst
hour
serum
pct
level
whole
blood
ea
immedi
measur
patient
admiss
n
endotoxemia
defi
ned
ea
eau
result
endotoxemia
present
patient
group
n
age
patient
ea
low
group
n
age
median
ea
eau
group
eau
group
p
pct
level
six
time
higher
group
group
ngml
vs
ngml
p
correl
ea
p
r
median
apach
ii
score
point
group
group
observ
diff
erenc
signifi
cant
sever
clinic
statu
estim
sofa
score
similar
group
group
group
ns
fortysix
percent
patient
group
group
requir
renal
replac
therapi
p
icu
mortal
patient
mortal
rate
higher
group
compar
group
kaplanmei
surviv
analysi
time
death
show
statist
signifi
canc
two
group
p
logrank
test
gramneg
pathogen
primari
sourc
infect
identifi
ed
patient
group
group
p
bacteremia
detect
case
group
group
p
conclus
septic
shock
endotoxemia
associ
biochem
clinic
consequ
includ
higher
pct
level
higher
frequenc
bacteremia
kidney
failur
death
evalu
util
procalcitonin
pct
marker
outcom
sever
sepsi
abdomin
origin
ssao
ssao
one
preval
patholog
surgic
icu
sicu
mortal
report
biomark
basic
tool
diagnosi
followup
outcom
sepsi
one
studi
last
decad
pct
level
kinet
could
use
evalu
outcom
septic
patient
pct
day
best
identifi
ed
outcom
auc
roc
pct
ngml
predict
mortal
sensit
specifi
citi
conclus
pct
day
pct
kinet
use
predict
outcom
ssao
pct
higher
communityacquir
sepsi
surgic
cultur
posit
gramneg
isol
male
introduct
blood
lactat
level
routin
use
biomark
manag
patient
septic
condit
icu
lack
clinic
research
data
compar
lactat
novel
sepsi
biomark
procalcitonin
regard
diagnost
prognost
potenti
herein
investig
diagnost
prognost
valu
initi
lactat
procalcitonin
level
kinet
within
icu
stay
predict
posit
blood
cultur
fatal
outcom
well
character
cohort
sepsi
patient
us
critic
care
set
method
retrospect
observ
cohort
studi
adult
patient
confi
rmed
sever
sepsi
septic
shock
least
one
procalcitonin
lactat
measur
admiss
icu
morton
plant
hospit
clearwat
fl
usa
logist
regress
model
calcul
assess
associ
biomark
blood
cultur
posit
fatal
icu
outcom
area
curv
auc
measur
discrimin
result
inhospit
mortal
rate
includ
patient
age
year
ci
patient
posit
cultur
regard
diagnost
valu
bacterem
diseas
initi
procalcitonin
higher
discriminatori
valu
auc
compar
initi
lactat
level
auc
regard
prognosi
initi
lactat
level
better
mortal
predictor
auc
compar
procalcitonin
auc
although
initi
level
signifi
cantli
lower
compar
apach
iii
p
comparison
look
biomark
kinet
procalcitonin
decreas
strongli
associ
fatal
outcom
compar
initi
level
alon
auc
still
lower
compar
lactat
kinet
auc
conclus
biomark
procalcitonin
lactat
provid
diagnost
prognost
inform
icu
patient
sepsi
particularli
look
biomark
kinet
evidencebas
protocol
incorpor
marker
may
improv
manag
septic
patient
conclus
pct
level
patient
undergo
lvad
implant
rise
signifi
cantli
fi
rst
day
surgeri
interestingli
elev
much
higher
routin
cardiac
surgeri
cpb
recent
work
suggest
pct
concentr
aff
ect
sir
caus
contact
nonphysiolog
surfac
case
lvad
immunolog
stimul
long
last
even
potent
addit
rvad
arf
treat
renal
replac
therapi
accord
hypothesi
data
show
abil
pct
detect
infecti
complic
lvad
patient
limit
concentr
probabl
correl
postop
complic
gener
potenti
envisag
action
intraven
immunoglobulin
ivig
sever
infecti
diseas
includ
viru
toxin
neutral
action
opson
eff
ect
complement
bacteriolyt
activ
enhanc
sensit
antibiot
case
sever
infecti
diseas
antibiot
often
supplement
administr
ivig
method
chang
sepsi
marker
procalcitonin
presepsin
creactiv
protein
follow
ivig
administr
investig
sever
sepsi
septic
shock
patient
subject
patient
admit
icu
diagnosi
sever
sepsi
septic
shock
inform
consent
obtain
present
studi
ivig
administ
intraven
day
g
day
measur
undertaken
administr
day
day
complet
administr
day
day
item
measur
procalcitonin
presepsin
crp
eff
ect
ivig
administr
marker
studi
ivig
studi
polyethylen
glycoltr
human
immunoglobulin
inject
fl
uid
g
ml
one
vial
patient
apach
ii
score
sofa
score
surviv
rate
day
valu
ivig
administr
procalcitonin
median
ngml
presepsin
median
pgml
crp
median
mgdl
median
pgml
valu
thu
elev
day
complet
ivig
administr
day
level
almost
mediat
procalcitonin
presepsin
crp
decreas
signifi
cantli
patient
suspect
sever
sepsi
septic
shock
presepsin
reveal
valuabl
diagnost
capac
diff
erenti
sepsi
sever
compar
procalcitonin
crp
wbc
addit
presepsin
reveal
prognost
valu
respect
day
month
allcaus
mortal
throughout
fi
rst
week
icu
treatment
result
present
studi
found
signifi
cant
decreas
procalcitonin
presepsin
result
day
immunoglobulin
administr
evid
still
limit
need
confi
rmed
larger
studi
introduct
presepsin
serv
mediat
respons
infecti
agent
first
evid
suggest
presepsin
may
util
sepsi
marker
method
presepsin
determin
present
hour
individu
admit
sign
sir
infect
primari
endpoint
death
within
day
presepsin
determin
use
poc
assay
pathfast
presepsin
mitsubishi
chemic
japan
result
mean
presepsin
concentr
patient
group
present
control
group
pgml
respect
p
baselin
presepsin
diff
ere
highli
signifi
cant
patient
sir
sepsi
sever
sepsi
septic
shock
twentyfour
patient
die
day
mortal
total
rang
fi
rst
fourth
quartil
presepsin
concentr
nonsurvivor
show
high
presepsin
valu
increas
tendenc
cours
diseas
surviv
patient
tendenc
decreas
see
tabl
conclus
presepsin
demonstr
strong
relationship
diseas
sever
outcom
presepsin
provid
reliabl
discrimin
sir
sepsi
well
prognosi
earli
predict
mortal
alreadi
admiss
presepsin
show
close
associ
cours
diseas
introduct
whether
infl
ammatori
biomark
procalcitonin
pct
provid
prognost
inform
across
clinic
set
diff
erent
acut
respiratori
tract
infect
ari
poorli
understood
herein
investig
prognost
valu
admiss
pct
level
predict
advers
clinic
outcom
larg
ari
popul
method
analyz
data
trial
ari
patient
studi
associ
admiss
pct
level
set
specifi
c
treatment
failur
mortal
alon
day
use
multivari
hierarch
logist
regress
conduct
sensit
analys
stratifi
ed
clinic
set
ari
diagnos
assess
result
consist
introduct
purpos
studi
assess
prognosi
valu
proadrenomedullin
padm
creactiv
protein
crp
procalcitonin
pct
lactat
lt
albumin
alb
cholesterol
chol
white
blood
cell
wbc
sever
score
patient
sever
sepsi
septic
shock
method
prospect
observ
studi
adult
patient
sever
sepsi
septic
shock
polyval
icu
demograph
sever
score
apach
ii
sofa
biomark
studi
within
hour
septic
shock
onset
descript
compar
statist
analysi
perform
use
statist
softwar
packag
spss
v
introduct
earli
diff
erenti
bacteri
candid
bloodstream
infect
bsi
presenc
sepsi
septic
shock
crucial
need
appropri
treatment
initi
clinic
data
although
limit
suggest
role
procalcitonin
pct
aim
studi
investig
possibl
associ
etiolog
bsi
serum
pct
level
method
icu
patient
clinic
laboratori
sign
sepsi
septic
shock
document
bsi
serum
pct
crp
measur
day
posit
blood
sampl
day
includ
ill
sever
assess
sofa
score
admiss
bsi
day
demograph
clinic
laboratori
data
includ
pct
crp
level
well
white
blood
cell
wbc
count
day
bsi
record
pct
measur
electrochemiluminesc
analyz
crp
tholosimetr
method
roch
switzerland
result
total
icu
patient
mean
age
year
male
bsi
includ
sofa
sore
icu
admiss
day
bsi
patient
candida
spp
isol
blood
cultur
candidemia
group
wherea
remain
bacteri
etiolog
bsi
bacteremia
group
serum
pct
concentr
remain
within
normal
rang
patient
candidemia
wherea
wide
rang
observ
patient
bacteremia
mean
valu
pct
crp
level
higher
bacteri
candidemia
bsi
group
versu
ngml
p
versu
mgdl
p
respect
signifi
cant
diff
erenc
wbc
count
two
group
versu
p
bacteremia
candidemia
bsi
group
respect
roc
curv
analysi
predict
abil
pct
show
auc
p
cutoff
point
ngml
select
use
youden
j
statist
low
valu
pct
sampl
neg
predict
valu
likelihood
ratio
neg
conclus
low
serum
pct
valu
could
consid
diagnost
marker
distinguish
bsi
candid
bacteri
origin
icu
patient
vari
sever
sepsi
follow
dialysi
surgeri
pancreat
receipt
corticosteroid
immunosuppress
agent
parenter
nutrit
diff
erent
origin
descript
score
consid
fi
rst
day
icu
stay
select
patient
fulfi
lled
criteria
time
icu
stay
patient
fulfi
lled
criteria
aft
anidulafungin
mg
follow
mg
daili
initi
provid
patient
also
present
follow
fever
hypothermia
hypotens
leukocytosi
acidosi
elev
creactiv
protein
blood
cultur
day
baselin
serum
bdg
day
perform
patient
candidemia
treat
day
without
candidemia
posit
bdg
pgml
receiv
aft
day
patient
neg
blood
cultur
neg
bdg
discontinu
anidulafungin
result
total
patient
screen
fulfi
lled
entri
criteria
incid
candidemia
patient
compar
remain
patient
rel
risk
confi
denc
interv
ci
baselin
bdg
posit
patient
median
number
posit
test
rang
median
valu
pgml
rang
seven
patient
candidemia
posit
baselin
bdg
median
valu
pgml
rang
best
cutoff
baselin
bdg
diagnosi
candidemia
pgml
area
roc
curv
ci
sensit
specifi
citi
respect
cutoff
valu
pgml
sensit
specifi
citi
respect
conclus
dynam
predict
rule
abl
diff
erenti
group
icu
patient
high
risk
develop
candidemia
rel
risk
bdg
frequent
posit
icu
patient
cutoff
valu
pgml
abl
discrimin
candidem
noncandidem
patient
revis
cutoff
valu
bdg
icu
need
introduct
bloodstream
infect
icu
major
trigger
morbid
mortal
sever
risk
factor
bacteremia
previous
identifi
ed
presenc
central
venou
cathet
invas
ventil
iron
key
element
bacteria
growth
metabol
extens
alter
infl
ammat
aim
determin
whether
iron
defi
cienci
risk
protect
factor
bacteremia
icu
method
perform
retrospect
analysi
patient
includ
mimicii
databas
icu
databas
collect
data
patient
admit
medic
surgic
coronari
cardiac
surgeri
icu
boston
beth
israel
deaco
medic
center
period
year
perform
logist
regress
model
assess
associ
iron
bloodstream
infect
result
includ
patient
low
serum
iron
ng
ml
normalhigh
serum
iron
ngml
fi
rst
stay
icu
patient
develop
bloodstream
infect
low
serum
iron
associ
increas
odd
bloodstream
infect
ci
adjust
age
gender
simplifi
ed
acut
physiolog
score
presenc
central
venou
cathet
icu
type
transfus
perform
iron
measur
neoplast
diseas
diabet
mellitu
hepat
diseas
congest
heart
failur
ferritin
level
low
level
iron
still
associ
increas
odd
bacteremia
ci
contrast
low
serum
iron
associ
decreas
risk
death
hospit
adj
ci
conclus
low
serum
iron
increas
risk
bloodstream
infect
icu
consid
risk
factor
stratifi
patient
risk
bacteremia
icu
stay
introduct
aim
studi
investig
whether
clinician
estim
time
insert
length
time
central
venou
cathet
cvc
remain
place
identifi
clinic
variabl
may
predict
cvc
durat
cvcrelat
bloodstream
infect
known
complic
among
critic
ill
patient
infect
rate
may
increas
durat
catheter
expens
antimicrobialco
cathet
may
use
patient
anticip
long
durat
cvc
use
method
conduct
singlecent
prospect
studi
januari
novemb
clinician
prospect
estim
anticip
durat
cvc
time
line
placement
electron
procedur
note
collect
demograph
past
medic
histori
type
icu
vital
sign
laboratori
valu
sofa
score
mechan
ventil
use
vasopressor
time
placement
continu
variabl
compar
wilcoxon
ranksum
test
categor
variabl
fisher
exact
test
pearson
correl
coeffi
cient
use
assess
correl
estim
cvc
time
actual
time
durat
cvc
use
dichotom
long
day
short
day
base
previou
literatur
sensit
specifi
citi
predict
long
durat
calcul
perform
logist
regress
analysi
identifi
variabl
associ
long
cvc
durat
calcul
area
roc
curv
auc
result
enrol
patient
median
age
iqr
femal
mortal
median
time
cvc
placement
remov
iqr
day
correl
estim
cvc
time
actual
time
low
r
p
fortyeight
patient
long
cvc
durat
clinician
estim
sensit
specifi
citi
predict
long
durat
cvc
variabl
test
temperatur
time
insert
signifi
cantli
associ
long
durat
ci
p
auc
model
ci
conclus
result
suggest
low
correl
clinician
predict
time
insert
actual
durat
cvc
fi
nd
good
predictor
long
durat
cvc
given
rel
low
sampl
size
may
underpow
may
feasibl
identifi
patient
time
insert
may
benefi
antimicrobialco
cathet
method
ethic
committe
approv
patient
admit
icu
older
year
thought
central
venou
cathet
cvc
hour
whose
fi
rst
cathet
insert
icu
includ
studi
staff
educ
studi
period
studi
cathet
care
insert
appli
accord
guidelin
studi
plan
three
sequenc
fi
rst
group
cathet
care
made
steril
gauz
pad
second
third
group
cathet
care
made
chlorhexidin
glucon
impregn
dress
also
third
group
silverco
needleless
connector
insert
tip
venou
cathet
result
total
patient
includ
studi
everi
group
includ
patient
diff
erenc
group
evalu
reason
cathet
insert
statist
signifi
cant
diff
erenc
accord
emerg
elect
catheter
tri
time
cathet
insert
side
p
crbsi
determin
two
patient
group
one
patient
group
patient
group
group
observ
day
group
observ
day
catheter
studi
statist
signifi
cant
decreas
determin
crbsi
ratio
educ
catheterday
p
accord
group
statist
meaning
decreas
assign
crbsi
ratio
group
catheterday
p
p
p
conclus
continu
educ
import
prevent
crbsi
maximum
precaut
must
taken
usag
antisept
solut
clorhexidin
chlorhexidin
glucon
impregn
dress
decreas
insert
side
infect
usag
silverco
needleless
connector
reduc
microorgan
entri
cathet
lumen
provid
sever
decreas
infect
ratio
introduct
current
cdc
guidelin
prevent
intravascular
catheterrel
infect
recommend
skin
prepar
greater
chlorhexidin
alcohol
solut
central
venou
cathet
cvc
peripher
arteri
cathet
ac
placement
howev
studi
investig
superior
alcohol
chlorhexidin
glucon
chg
either
alcohol
chlorhexidin
glucon
chg
aqueou
povidon
iodin
pvi
prevent
cathet
colon
aim
studi
compar
eff
ectiv
three
skin
antisept
solut
prevent
intravascular
cathet
colon
method
multicent
prospect
random
control
trial
conduct
japanes
icu
decemb
march
patient
year
age
undergo
cvc
ac
placement
icu
random
one
three
skin
antisept
prepar
cathet
insert
remov
cathet
distal
tip
cultur
use
semiquantit
quantit
techniqu
incid
cathet
colon
catheterrel
bloodstream
infect
crbsi
compar
three
group
result
total
cathet
place
includ
cathet
use
chg
use
chg
use
pvi
median
durat
cathet
indwel
entir
popul
day
interquartil
rang
day
signifi
cant
diff
erenc
group
p
thirteen
cathet
pvi
group
posit
cathetertip
colon
wherea
six
cathet
chg
group
fi
cathet
chg
group
posit
p
probabl
cathet
colon
signifi
cantli
higher
pvi
group
chg
group
p
logrank
test
incid
cathet
colon
crbsi
compar
three
group
conclus
random
control
trial
compar
eff
ectiv
three
cutan
antisept
solut
prevent
cathet
colon
either
chg
superior
pvi
main
pathogen
clabsi
cn
staphylococci
staphylococcu
aureu
enterobacteriacea
studi
densiti
clabsi
lower
previou
studi
inicc
report
higher
cdc
nhsn
report
conclus
implement
infect
control
program
prevent
intervent
patient
central
venou
cathet
improv
safeti
qualiti
healthcar
icu
reduc
clabsi
rate
refer
easi
avoid
import
know
happen
neutropen
patient
admit
icu
sepsi
sourc
cathet
infect
exclud
method
retrospect
cohort
descript
studi
carri
januari
novemb
epidemiolog
data
collect
neutropen
patient
admit
icu
came
hematooncolog
servic
implant
central
venou
cathet
microbiolog
result
data
relat
cathet
remov
describ
result
total
patient
includ
mean
age
year
old
male
implant
cathet
remov
patient
platelet
transfus
need
patient
cathet
remov
complic
observ
cathet
remov
insert
new
one
patient
cathet
infect
confi
rmed
posteriori
conclus
remov
implant
central
venou
cathet
neutropen
patient
admit
icu
due
sepsi
sourc
benefi
cial
kind
patient
found
patient
cathet
infect
confi
rmed
posteriori
introduct
femor
jugular
subclavian
central
venou
catheter
cvc
routin
perform
care
critic
ill
invas
procedur
contribut
addit
morbid
mortal
cost
deriv
interact
traumat
infecti
complic
aim
studi
determin
whether
subclavian
jugular
femor
central
venou
access
cva
rout
eff
ect
incid
clabsi
critic
ill
patient
compar
rout
regard
major
complic
icu
mortal
method
retrospect
observ
studi
medic
surgic
icu
tertiari
care
hospit
adult
patient
admit
januari
decemb
studi
enrol
patient
divid
intern
jugular
cvc
ijc
subclavian
cvc
scc
femor
cvc
fc
cathet
insert
icu
experienc
physician
least
previous
success
trial
central
line
insert
use
cvc
bundl
checklist
icu
length
stay
incid
complic
apach
ii
score
adjust
sever
mortal
calcul
group
result
patient
cathet
characterist
includ
durat
catheter
similar
group
rate
clabsi
ijc
scc
fc
group
versu
versu
per
catheterday
respect
p
icu
mortal
case
ijc
group
case
scc
group
case
fc
group
signifi
cant
diff
erenc
three
group
cvc
incid
clabsi
rate
critic
ill
patient
slight
increas
icu
mortal
ijc
group
compar
two
group
pneumothorax
occur
six
case
scc
case
ijc
signifi
cant
diff
erenc
two
group
p
valu
conclus
site
insert
cvc
appear
aff
ect
rate
clabsi
among
critic
ill
patient
pneumothorax
record
scc
ijc
group
statist
prefer
either
group
introduct
neutrophil
work
frontlin
defens
infect
neutrophil
extracellular
trap
net
one
immun
system
suppress
dissemin
infect
net
chromatin
decor
antibacteri
molecul
report
net
play
import
role
variou
kind
infect
pneumonia
howev
report
net
patient
soft
tissu
infect
studi
evalu
net
product
pu
clarifi
ed
role
net
host
defens
patient
soft
tissu
infect
method
studi
conduct
icu
trauma
acut
critic
care
center
osaka
univers
hospit
collect
pu
patient
soft
tissu
infect
time
drainag
debrid
perform
clinic
improv
observ
smear
pu
specimen
examin
immunohistochemistri
visual
major
net
compon
dna
neutrophil
elastas
histon
concurr
patient
clinic
data
laboratori
data
blood
record
analyz
relationship
net
product
result
total
fi
patient
includ
studi
drainag
abscess
debrid
infect
site
perform
case
four
patient
diagnos
necrot
soft
tissu
infect
clostridium
spp
n
bacteroid
spp
n
diagnos
cervic
abscess
streptococcu
spp
case
net
neutrophil
identifi
ed
fi
rst
pu
howev
net
appear
later
smear
patient
condit
get
better
conclus
result
suggest
net
also
work
immun
system
soft
tissu
infect
drainag
debrid
infect
focu
might
promot
net
product
introduct
studi
aim
compar
applic
benzalkonium
chlorid
bc
nanotechnologybas
product
period
didecyl
dimethyl
ammonium
chlorid
ddac
period
regard
effi
cienci
applic
surfac
antisept
icu
method
two
diff
erent
area
eight
bed
side
common
corridor
icu
name
area
b
bc
appli
area
period
ddca
appli
area
b
period
surfac
clean
sampl
taken
total
diff
erent
surfac
includ
nursest
desk
phone
keyboard
bed
bedsid
monitor
ventil
infect
control
nurs
everi
hour
area
everi
hour
area
b
day
swab
sampl
cultur
sheep
bloodi
agar
mcconkey
agar
laboratori
cultur
medium
incub
aerob
environ
hour
statist
softwar
ut
usa
program
use
statist
analysi
result
statist
diff
erenc
two
group
tabl
introduct
urinari
cathet
insert
common
procedur
icu
import
caus
infect
hospit
environ
aim
analyz
eff
ect
chlorhexidin
longterm
urinari
cathet
insert
urinari
tract
infect
uti
period
patient
admit
coronari
icu
method
analysi
patient
admit
coronari
icu
mediums
hospit
brazil
januari
may
institut
protocol
periprocedur
antisepsi
chang
iodinebas
antisept
chlorhexidin
uti
diagnosi
base
urin
cultur
colonyform
unit
per
ml
urin
associ
least
one
clinicallaboratori
abnorm
fever
urin
urgenc
increas
urinari
frequenc
dysuria
suprapub
lumbar
pain
uti
rate
repres
urinari
tract
infect
associ
longterm
urinari
cathet
patient
uti
associ
longterm
urinari
cathet
divid
patient
longterm
urinari
cathet
urinari
tract
infect
rate
year
n
longterm
urinari
n
devic
usag
rate
year
n
longterm
urinari
n
devic
usag
rate
year
n
longterm
urinari
n
devic
usag
rate
year
n
longterm
urinari
n
devic
usag
rate
year
n
longterm
urinari
n
devic
usag
rate
conclus
use
chlorhexidin
periprocedur
antisepsi
urinari
catheter
contribut
decreas
urinari
tract
infect
associ
longterm
urinari
cathet
patient
admit
coronari
icu
refer
introduct
wholebodi
skin
decolon
chlorhexidin
critic
ill
patient
reduc
multidrugresist
bacteri
colon
catheterrel
bloodstream
infect
bsi
perform
metaanalysi
random
control
trial
determin
whether
daili
bath
chlorhexidin
decreas
hospitalacquir
bsi
critic
ill
patient
method
search
medlin
embas
cochran
central
regist
control
trial
databas
identifi
random
control
trial
compar
daili
bath
chlorhexidin
control
daili
bath
soap
water
nonantimicrobi
washcloth
implement
mrsa
screen
isol
critic
ill
patient
primari
outcom
hospitalacquir
bsi
secondari
outcom
advers
eff
ect
chlorhexidin
incid
identifi
ed
pathogen
result
metaanalysi
includ
four
studi
overal
incid
hospitalacquir
bsi
signifi
cantli
lower
chlorhexidin
group
compar
control
ci
p
gramposit
rr
ci
p
mrsainduc
pool
rr
ci
p
bacteremia
signifi
cantli
less
common
chlorhexidin
group
chlorhexidin
aff
ect
gramneg
bacteremia
fungemia
overal
incid
advers
event
skin
rash
similar
group
introduct
good
hand
hygien
hh
critic
infect
control
icu
electron
hh
surveil
system
purport
improv
hh
practic
system
recent
trial
icu
system
base
radiofrequ
transpond
three
locat
bracelet
worn
icu
personnel
hh
product
dispens
patient
bed
correl
input
three
sourc
system
detect
whether
hh
perform
patient
contact
event
hh
perform
bracelet
alert
user
vibrat
real
time
studi
repres
clinic
valid
system
method
icu
staff
nurs
physician
follow
train
observ
period
movement
contact
period
document
hh
opportun
determin
accord
criteria
actual
hh
perform
record
observ
electron
data
compar
number
opportun
hh
perform
complianc
satisfact
questionnair
distribut
user
pair
student
test
use
comparison
observ
electron
data
result
observ
made
time
period
includ
hh
opportun
occas
hh
perform
observ
record
hh
opportunitieshour
compar
electron
system
p
hh
perform
occur
occasionshour
versu
occasionshour
record
electron
system
p
overal
hh
complianc
versu
respect
p
comparison
specifi
c
observ
period
poor
correl
complianc
record
observ
electron
system
r
p
satisfact
questionnair
complet
personnel
satisfact
system
low
low
system
inaccuraci
either
bracelet
alert
without
caus
lack
bracelet
alert
hh
requir
common
reason
dissatisfact
follow
physic
discomfort
bracelet
conclus
electron
hh
system
consist
underestim
hh
opportun
hh
perform
main
reason
dissatisfact
system
inaccuraci
bracelet
alert
data
suggest
electron
system
accept
icu
staff
highli
accur
comfort
user
use
close
system
transfer
devic
cstd
evalu
microbi
tight
cstd
develop
two
method
simul
bioburden
ambient
air
oper
room
icu
method
method
simul
airborn
touch
contamin
test
microbi
tight
integr
safefl
valv
use
drug
admixtur
airborn
contamin
done
exposur
chamber
nebul
distribut
defi
ned
b
subtili
spore
aerosol
insert
vial
sodium
chlorid
solut
nacl
nebul
suspens
cfu
spore
b
subtili
per
ml
use
gener
aerosol
minut
volum
b
subtili
suspens
nebul
per
minut
ml
correspond
aerosol
spore
exposur
chamber
volum
cfu
per
air
use
concentr
time
higher
microbi
burden
found
hospit
nebul
valv
disinfect
nacl
withdrawn
syring
certain
time
interv
nacl
incub
tryptic
soy
agar
hour
result
document
cfu
touch
contamin
attach
vial
nacl
valv
contamin
cfu
staphylococcu
aureu
subsequ
procedur
done
describ
result
nine
test
valv
none
show
transmiss
b
subtili
spore
airborn
contamin
three
nine
test
valv
contamin
aureu
touch
contamin
conclus
studi
show
method
suitabl
evalu
microbi
tight
cstd
introduct
conduct
survey
assess
clinician
knowledg
person
protect
equip
ppe
requir
infecti
diseas
biochem
warfar
agent
safe
level
ppe
essenti
treat
patient
highli
infecti
diseas
contamin
hazard
substanc
recent
ebola
viru
diseas
evd
outbreak
west
africa
highlight
although
uncommon
contagi
diseas
high
mortal
rate
threat
healthcar
system
local
nation
intern
level
chemic
biolog
radiolog
nuclear
cbrn
contamin
present
similar
risk
method
valid
handdeliv
multiplechoic
questionnair
use
assess
intens
care
emerg
medicin
anesthet
specialist
registrar
knowledg
respiratori
skin
protect
need
resuscit
scenario
advanc
life
support
particip
select
ppe
requir
biolog
hazard
evd
sever
acut
respiratori
syndrom
sar
inhal
anthrax
plagu
smallpox
biochem
hazard
sarin
hydrogen
cyanid
phosgen
mustard
ga
dichlordiethyl
sulfi
de
respons
compar
uk
nation
recommend
previou
survey
result
ninetyeight
clinician
anesthet
n
emerg
medicin
n
intens
care
medicin
n
complet
survey
best
knowledg
correct
sar
less
knowledg
anthrax
plagu
evd
smallpox
found
limit
knowledg
chemic
warfar
agent
sixti
incorrect
respons
overr
diff
erenc
knowledg
compar
previou
publish
result
conclus
despit
nation
region
train
sinc
previou
survey
result
indic
train
ppe
requir
clinician
treat
patient
expos
infecti
diseas
cbrn
agent
ideal
simul
set
also
combin
therapi
also
reduct
sensit
group
betalactam
antibiot
fl
uoroquinolon
conclus
number
patient
sepsi
increas
mortal
sepsi
decreas
frequenc
aureu
isol
still
high
mrsa
frequenc
gramneg
fl
ora
isol
increas
especi
k
pneumonia
acinetobact
spp
resist
microorgan
betalactam
fl
uoroquinolon
rise
sensit
aminoglycosid
glycopeptid
carbapenem
still
maintain
gramposit
bacteria
n
staphylococcu
aureu
n
enterococcu
faecali
n
staphylococcu
epidermidi
n
gramneg
n
klebsiella
sp
n
pseudomona
aeruginosa
n
escherichia
coli
n
fungi
n
candida
sp
n
candida
albican
n
candida
dubliniensi
n
commonli
prescrib
antimicrobi
piperacillintazobactam
n
vancomycin
n
polymyxin
b
n
cefepim
n
meropenem
n
cefuroxim
n
ciprofl
oxacin
n
tigecyclin
n
ampicillin
n
clindamycin
n
chloramphenicol
n
oxacillin
n
other
n
n
infect
hospit
unit
approxim
infect
caus
multidrugresist
pathogen
although
effi
cienci
proper
use
initi
antimicrobi
introduct
ventilatorassoci
pneumonia
vap
common
seriou
problem
icu
sever
studi
conduct
determin
eff
ectiv
gram
stain
tracheal
aspir
diagnos
vap
howev
eff
ectiv
predict
caus
microorgan
guid
appropri
initi
antibiot
therapi
evalu
purpos
studi
determin
whether
gram
stain
tracheal
aspir
guid
appropri
initi
antibiot
therapi
vap
method
retrospect
assess
two
hypothet
empir
antibiot
treatment
algorithm
vap
icu
data
consecut
episod
microbiolog
confi
rmed
vap
collect
period
month
divid
deriv
februari
novemb
valid
decemb
novemb
cohort
construct
two
algorithm
deriv
cohort
one
local
ecologybas
algorithm
leba
accord
clinic
risk
factor
mdr
suscept
result
hospit
gram
stainbas
algorithm
gsba
select
antibiot
gsba
direct
pathogen
predict
result
bedsid
gram
stain
tracheal
aspir
collect
antibiot
therapi
subsequ
leba
gsba
retrospect
review
compar
actual
prescrib
antibiot
valid
cohort
fi
rst
vap
episod
made
deriv
cohort
subsequ
vap
episod
valid
cohort
antibiot
coverag
rate
appli
leba
gsba
ident
vs
gsba
propos
narrow
spectrum
therapi
compar
leba
p
gsba
recommend
carbapenem
signifi
cantli
less
episod
leba
p
episod
actual
prescrib
initi
therapi
p
howev
signifi
cant
increas
antibiot
coverag
rate
gsba
compar
actual
prescrib
initi
therapi
vs
p
conclus
antibiot
coverag
rate
gsba
compar
leba
use
gsba
would
result
signifi
cant
reduct
administr
broadspectrum
antibiot
bedsid
gram
stain
may
use
guid
appropri
initi
antibiot
therapi
vap
introduct
urinari
tract
infect
uti
one
common
bacteri
infect
human
gramneg
organ
common
caus
agent
rise
preval
resist
number
antibiot
importantli
product
extend
spectrum
betalactamas
esbl
organ
grow
concern
worldwid
scenario
better
commun
isol
choic
empir
antimicrobi
infect
becom
great
challeng
clinician
method
retrospect
observ
studi
aim
know
preval
esbl
product
organ
caus
uti
commun
studi
antibiogram
isol
urin
sampl
patient
suspect
uti
commun
cultur
uropathogen
routin
microbiolog
method
suscept
test
done
microscan
autoscan
siemen
isol
enterobactereacea
esbl
produc
commun
sampl
compar
hospit
sampl
escherichia
coli
commonli
isol
pathogen
enterobact
spp
show
highest
preval
esbl
product
commun
sampl
among
esbl
produc
strain
commun
sensit
ciprofl
oxacin
levofl
oxacin
nitrofurantoin
respect
nonesbl
produc
sensit
rate
respect
conclus
organ
produc
esbl
phenotyp
present
ad
possibl
resist
broadspectrum
antimicrobi
agent
commonli
prescrib
commun
empir
treat
infect
make
choic
empir
antibiot
much
challeng
commun
draw
error
judgment
possibl
frequent
overcorrect
lie
side
coin
studi
also
show
possibl
need
empir
institut
class
carbapenem
one
treatment
option
outpati
parenter
antimicrobi
therapi
possibl
predict
multidrugresist
organ
colon
andor
infect
icu
admiss
whether
viral
infect
associ
prolong
mechan
ventil
wors
outcom
remain
determin
earli
identifi
cation
sever
sepsi
septic
shock
earli
implement
ssc
bundl
associ
reduc
mortal
failur
initi
appropri
antimicrobi
therapi
increas
mortal
septic
shock
patient
hypothes
paramet
consensu
initi
antimicrobi
therapi
microbi
cultur
correl
outcom
septic
shock
patient
introduct
mdr
infect
icu
nosocomi
time
perceiv
commonli
perform
retrospect
studi
analyz
sourc
cultur
posit
medic
icu
identifi
type
infect
preval
method
data
medic
icu
analyz
novemb
octob
sourc
cultur
posit
divid
three
group
patient
admit
er
icu
refer
hospit
direct
admiss
second
group
patient
admit
within
hospit
outsid
icu
fi
rst
hour
third
group
icuacquir
infect
also
analyz
data
type
infect
whether
gramneg
gramposit
fungal
result
cultur
posit
period
total
n
cultur
alreadi
posit
admiss
denot
communityacquir
refer
patient
hospit
total
n
cultur
posit
patient
admit
gener
ward
hour
transfer
icu
twentytwo
percent
n
cultur
icuacquir
infect
data
show
communityacquir
hospitalacquir
infect
bulk
cultur
load
icu
could
attribut
increas
surveil
adher
infect
control
practic
icu
may
follow
stringent
part
hospit
overus
broadspectrum
antibiot
commun
primari
care
hospit
result
spurt
growth
resist
infect
reach
alarm
level
develop
countri
total
cultur
posit
n
gramneg
infect
includ
communitybas
nonicu
infect
conclus
antibiot
stewardship
strict
adher
infect
control
protocol
hospit
guidelin
gener
practition
signifi
cantli
reduc
load
resist
organ
icu
may
eventu
improv
patient
outcom
help
preserv
antibiot
futur
gener
introduct
earli
microbiolog
document
may
reduc
attribut
mortal
excess
use
broadspectrum
antibiot
ventilatorassoci
pneumonia
vap
use
bronchoalveolar
lavag
bal
endotrach
aspir
eta
studi
new
molecular
biologybas
approach
detect
quantifi
bacteria
less
hour
prospect
multicent
trial
aim
compar
microbiolog
result
obtain
use
molecular
protocol
system
semiquantit
cultur
suspect
vap
method
eta
bal
sampl
consecut
collect
month
adult
patient
four
icu
franc
molecular
method
includ
preprocess
liquefact
eta
dna
extract
dna
extract
use
system
realtim
pcr
qpcr
run
use
pcr
instrument
result
present
concern
staphylococcu
aureu
pseudomona
aeruginosa
enterobacteriacea
quantifi
cation
perform
use
qpcr
standard
curv
convert
cycl
threshold
cfu
ml
result
total
suspect
vap
includ
patient
total
bal
eta
collect
sex
ratio
mf
cpi
calcul
suspect
vap
patient
mean
ventil
durat
sampl
day
seventyeight
percent
bal
eta
cultur
posit
respect
correl
molecular
method
cultur
bal
eta
report
tabl
conclus
sensit
specifi
citi
new
molecular
approach
main
bacteria
found
vap
could
enabl
target
fi
rstline
antibiot
therapi
futur
develop
approach
aim
obtain
bedsid
diagnost
hour
use
cepheid
xpert
rapid
detect
carbapenemaseproduc
bacteria
critic
ill
abdomin
surgic
patient
fi
rst
report
observ
studi
cortegiani
v
russotto
p
capuano
g
tricoli
dm
geraci
ghodousi
l
saporito
g
graziano
giarratano
univers
palermo
itali
critic
care
suppl
doi
introduct
xpert
usa
pcrbase
assay
rapid
hour
detect
bacteria
carri
carbapenemresist
gene
kpc
ndm
vim
aim
studi
compar
pcr
microbiolog
cultur
critic
ill
abdomin
surgic
patient
method
perform
observ
studi
univers
hospit
p
giaccon
palermo
enrol
abdomin
surgic
patient
admit
icu
suspect
abdomin
sepsi
develop
sepsi
icu
stay
obtain
two
rectal
swab
specimen
two
drainag
sampl
perform
pcr
assay
classic
cultur
test
use
cohen
k
test
concord
result
consid
concord
result
posit
detect
carbapenemaseproduc
bacteria
method
even
polymicrobi
growth
observ
cultur
neg
result
method
concord
studi
rectal
swab
drainag
specimen
antibiot
suscept
test
perform
semiquantit
method
result
eight
complet
sampl
set
collect
seven
patient
seven
rectal
swab
specimen
neg
pcr
cultur
one
patient
posit
cultur
carbapenemresist
p
aeruginosa
detect
rectal
swab
result
neg
pcr
one
patient
posit
cultur
carbapenemresist
baumanii
detect
drainag
cultur
result
neg
pcr
two
case
posit
result
observ
pcr
cultur
rectal
swab
drainag
specimen
vim
kpc
gene
detect
one
case
baumanii
k
pneumonia
carbapenem
resist
isol
cultur
kpc
gene
detect
pcr
case
k
pneumonia
carbapenem
resist
isol
cultur
case
neg
result
observ
pcr
cultur
cohen
k
ci
observ
rectal
swab
drainag
specimen
conclus
need
data
evalu
perform
pcr
rapid
detect
carbapenemaseproduc
bacteria
rectal
swab
drainag
critic
ill
surgic
patient
even
though
concord
cultur
seem
good
introduct
antimicrobi
resist
constitut
grow
global
threat
driven
part
inappropri
antimicrobi
prescrib
hospit
implement
antibiot
polici
promot
antimicrobi
stewardship
audit
examin
royal
cornwal
hospit
trust
rcht
critic
care
depart
complianc
current
standard
defi
ned
local
antimicrobi
polici
state
antimicrobi
prescript
indic
review
date
record
sequenti
strategi
improv
complianc
introduc
prior
reaudit
eff
ect
method
rcht
critic
care
depart
util
phillip
care
vue
electron
patient
record
data
system
interrog
three
stage
assess
complianc
trust
antimicrobi
polici
fi
rst
data
interrog
perform
prior
intervent
refl
ect
baselin
antimicrobi
prescrib
habit
second
data
interrog
perform
period
activ
antibiot
stewardship
promot
third
data
interrog
perform
follow
addit
care
bundl
prescrib
modul
care
vue
daili
tickbox
prompt
remind
clinician
check
antimicrobi
prescript
indic
review
date
record
record
patient
admit
critic
care
depart
period
data
interrog
assess
antimicrobi
indic
review
date
transcript
result
fi
rst
data
interrog
antimicrobi
prescript
indic
review
date
transcript
case
respect
follow
awar
campaign
indic
review
date
transcript
rate
increas
respect
daili
electron
prompt
ad
care
bundl
list
fi
nal
data
interrog
perform
intervent
demonstr
transcript
rate
indic
review
date
increas
conclus
demonstr
use
daili
prompt
within
electron
patient
record
greatli
improv
complianc
record
indic
review
date
antimicrobi
data
support
widespread
implement
electron
prescrib
system
daili
remind
integr
eff
ort
improv
complianc
antimicrobi
stewardship
critic
care
volum
suppl
http
introduct
multidrugresist
mdr
bacteri
pneumonia
associ
signifi
cant
morbid
mortal
sever
ill
icu
patient
assess
factor
associ
onset
clinic
cours
mdr
pneumonia
may
improv
treatment
eff
ectiv
purpos
studi
identifi
factor
associ
outcom
mechan
ventil
patient
ventilatorassoci
pneumonia
vap
caus
mdr
bacteria
method
studi
retrospect
mechan
ventil
patient
treat
icu
kat
gener
hospit
athen
januari
decemb
show
ventilatorassoci
pneumonia
mdr
gramneg
bacteria
standard
demograph
clinic
data
caus
organ
outcom
record
statist
signifi
canc
chisquar
student
test
use
result
total
mechan
ventil
patient
men
women
includ
studi
patient
show
vap
caus
mdr
bacteria
stratifi
ed
outcom
survivor
nonsurvivor
icu
mortal
gender
caus
admiss
caus
microb
colon
bronchial
secret
secondari
bacteremia
correl
outcom
age
apach
ii
score
higher
nonsurvivor
p
p
respect
timeonset
pneumonia
admiss
longer
patient
vap
caus
klebsiella
pseudomona
vap
caus
acinetobact
p
patient
klebsiella
pseudomona
pneumonia
need
time
mechan
ventil
pneumonia
acinetobact
p
conclus
vap
caus
mdr
bacteria
lead
caus
icu
death
age
apach
ii
score
signifi
cant
risk
factor
death
introduct
prescript
antifung
treatment
aft
icu
case
suspect
confi
rmed
invas
candidiasi
sic
cic
challeng
diff
erent
guidelin
studi
aim
describ
epidemiolog
invas
candidiasi
ic
analyz
criteria
aft
initi
aft
type
chang
patient
followup
candida
albican
main
pathogen
c
glabrata
inclus
cic
treat
caspofungin
ca
fl
uconazol
flu
wherea
antifung
administ
sic
respect
patient
sic
sever
cic
two
main
criteria
initi
empir
aft
central
venou
cathet
sever
septic
shock
rate
chang
initi
aft
higher
cic
group
sic
group
p
cic
group
mostli
chang
antifung
agent
deescal
ca
flu
half
patient
base
mycolog
test
result
sic
group
aft
modifi
ed
almost
often
chang
drug
includ
deescal
ca
flu
stop
aft
mortal
candidaemia
case
c
glabrata
case
c
albican
case
c
parapsilosi
among
survivor
median
durat
treatment
day
accord
infect
site
case
cic
day
case
sic
conclus
french
icu
patient
treat
antifung
agent
select
accord
candidiasi
sever
contrari
escmid
guidelin
recommend
initi
echinocandin
regardless
sever
recommend
therapi
secondarili
adapt
microbiolog
result
introduct
micafungin
mcf
echinocandin
agent
broad
activ
candida
spp
frequent
isol
blood
eschar
cultur
burn
patient
present
diff
erent
pharmacokinet
pk
characterist
due
limit
inform
pk
investig
mcf
level
plasma
burn
eschar
tissu
popul
method
pk
studi
mcf
standard
dosag
mgday
cmax
end
infus
cmin
next
dose
plasma
level
mcf
obtain
fi
rst
dose
steadi
state
day
therapi
day
eschar
hour
infus
measur
hplc
spearman
rho
test
use
bivari
correl
mcf
exposur
patient
clinic
factor
result
patient
eight
men
age
year
patient
characterist
pk
shown
tabl
high
interindividu
variabl
observ
concentr
mcf
peak
plasma
concentr
fi
rst
repeat
dose
mcf
invers
correl
burn
tbsa
spearman
p
respect
time
burn
injuri
mcf
concentr
burn
eschar
correl
burn
tbsa
mcf
well
toler
one
patient
candidemia
crude
mortal
conclus
largest
pk
studi
mg
daili
mcf
sever
burn
critic
ill
patient
invers
correl
mcf
exposur
burn
tbsa
suggest
patient
larg
burn
tbsa
may
need
higher
dose
mcf
nevertheless
mcf
level
plasma
burn
eschar
tissu
fi
rst
multipl
dose
clinic
import
candida
speci
treatment
nosocomi
pneumonia
common
critic
ill
patient
acut
kidney
injuri
limit
data
tedizolid
disposit
continu
renal
replac
therapi
crrt
studi
purpos
assess
continu
hemofi
ltration
chf
continu
hemodialysi
chd
infl
uenc
tedizolid
clearanc
method
valid
bovin
bloodbas
vitro
chf
chd
model
use
six
new
hf
polysulfon
six
new
multifl
ow
hemodiafi
lter
tedizolid
transmembran
clearanc
cltm
chf
chd
assess
measur
siev
sc
satur
sa
coeffi
cient
variou
ultrafi
ltrate
quf
l
hour
dialys
fl
ow
rate
qd
lhour
use
blood
fl
ow
rate
qb
mlminut
tedizolid
adsorpt
test
l
recircul
chf
model
quf
lhour
qb
mlminut
hour
adsorpt
calcul
correct
dilut
chf
prime
volum
urea
ad
control
experi
result
urea
sc
sa
experi
chf
mean
tedizolid
sc
rang
cltm
diff
er
fi
lter
type
quf
lhour
chd
mean
tedizolid
sa
rang
tedizolid
cltm
higher
valu
qd
lhour
p
tedizolid
exhibit
irrevers
adsorpt
within
minut
see
figur
conclus
tedizolid
cltm
depend
hemodiafi
lter
type
qd
chd
quf
chf
convent
crrt
rate
tedizolid
cltm
appear
modest
rel
total
bodi
clearanc
unlik
requir
dose
adjust
crrt
adsorpt
clinic
set
like
less
observ
vitro
continu
recircul
blood
model
tedizolid
phosphat
novel
oxazolidinon
antibacteri
prodrug
recent
approv
us
food
drug
administr
treatment
acut
bacteri
skin
skin
structur
infect
avail
oral
tablet
intraven
formul
clinic
pharmacokinet
tedizolid
activ
moieti
tedizolid
phosphat
similar
oral
administ
tedizolid
phosphat
given
powder
capsul
tablet
suggest
crush
tablet
prior
administr
unlik
alter
tedizolid
pharmacokinet
provid
drug
lost
administr
determin
whether
expect
dose
tedizolid
phosphat
deliv
via
nasogastr
ng
tube
critic
ill
patient
diffi
culti
swallow
studi
evalu
stabil
recoveri
tedizolid
phosphat
mg
tablet
crush
dispers
water
passag
ng
tube
method
assay
run
triplic
one
mg
tablet
tedizolid
phosphat
crush
dispers
water
drain
graviti
one
two
type
ng
tube
type
kangaroo
nasogastr
feed
tube
fr
cm
type
salem
sump
dual
lumen
stomach
tube
frch
cm
collect
recoveri
analysi
highperform
liquid
chromatographi
uv
detect
analyz
chemic
stabil
crush
tablet
dispers
water
aqueou
prepar
assay
initi
dispers
hour
room
temperatur
without
ng
tube
passag
prespecifi
ed
limit
tedizolid
phosphat
recoveri
sampl
dose
limit
also
specifi
ed
level
certain
impur
result
averag
individu
recoveri
valu
tedizolid
phosphat
within
mg
dose
crush
tablet
dispers
water
room
temperatur
transfer
ng
tube
type
type
signifi
cant
chang
recoveri
valu
hour
storag
room
temperatur
initi
hour
result
degrad
product
impur
also
within
specifi
ed
limit
ng
recoveri
sampl
aqueou
prepar
conclus
stabil
recoveri
tedizolid
phosphat
infl
uenc
crush
tablet
pass
ng
tube
therefor
administr
crush
tedizolid
phosphat
tablet
patient
unlik
alter
pharmacokinet
tedizolid
compar
whole
tablet
introduct
vitro
studi
suggest
signifi
cant
adsorpt
amikacin
netilmicin
gentamicin
tobramycin
polyacrylonitril
haemofi
lter
occur
rapidli
potenti
substanti
reduc
peak
aminoglycosid
concentr
reduc
effi
caci
howev
whether
signifi
cant
adsorpt
occur
vivo
unknown
therefor
carri
control
vivo
studi
eff
ect
amikacin
adsorpt
polyacrylonitril
fi
lter
haemofi
ltration
use
porcin
model
acut
renal
failur
method
porcin
model
acut
renal
failur
creat
bilater
ligat
renal
arteri
vein
eight
pig
underw
haemofi
ltration
use
polyacrylonitril
fi
lter
blood
fl
ow
ml
minut
ultrafi
ltration
rate
mlhour
ultrafi
ltrate
return
pig
via
separ
venou
cathet
elimin
amikacin
haemofi
ltration
could
due
adsorpt
anoth
eight
pig
underw
sham
haemofi
ltration
blood
pump
around
haemofi
ltration
circuit
without
haemofi
lter
without
ultrafi
ltration
group
pig
given
intraven
amikacin
mgkg
bodi
weight
minut
blood
sampl
taken
arteri
limb
haemofi
lter
circuit
minut
start
amikacin
administr
assay
amikacin
concentr
result
postdistribut
peak
concentr
amikacin
slightli
signifi
cantli
lower
crrt
group
sham
group
vs
mgl
p
conclus
studi
show
eff
ect
adsorpt
polyacrylonitril
haemofi
lter
vivo
amikacin
peak
concentr
small
less
would
expect
vitro
data
tabl
compar
one
report
icu
introduct
direct
hemoperfus
polymyxin
b
immobil
column
pmxdhp
adsorb
endotoxin
use
treatment
septic
shock
howev
mechan
action
behind
pmxdhp
fulli
understood
therefor
purpos
studi
elucid
mechan
action
behind
pmxdhp
rat
model
cecal
ligat
punctur
method
spraguedawley
rat
anesthet
mechan
ventil
tracheostomi
right
intern
carotid
arteri
cannul
cathet
continu
measur
arteri
pressur
heart
rate
right
femor
vein
cannul
cathet
infus
salin
mlkghour
studi
period
rat
random
three
experiment
group
cecal
ligat
punctur
clp
dummi
column
dummydhp
group
n
clp
pmxdhp
group
n
sham
group
n
four
hour
clp
dummydhp
pmxdhp
perform
hour
blood
drawn
right
intern
carotid
arteri
perfus
pmx
column
dummi
column
return
right
femor
vein
heart
rate
mean
arteri
pressur
arteri
blood
gase
plasma
concentr
creatinin
lactat
potassium
cytokin
measur
baselin
hour
clp
complet
experi
rat
kill
overdos
pentobarbit
kidney
liver
lung
harvest
histopatholog
examin
organ
perform
result
hypotens
metabol
acidosi
occur
clp
dummydhp
group
wherea
hemodynam
acidbas
balanc
better
maintain
clp
pmxdhp
group
plasma
concentr
lactat
creatinin
potassium
cytokin
signifi
cantli
higher
clp
dummydhp
group
clp
pmxdhp
group
hour
renal
tubular
cell
death
observ
clp
dummydhp
group
clp
pmxdhp
group
conclus
pmxdhp
improv
hemodynam
acidbas
balanc
creatinin
level
reduc
cytokin
renal
tubular
cell
death
rat
model
cecal
ligat
punctur
fi
nding
suggest
prevent
role
pmxdhp
develop
sepsisrel
acut
kidney
injuri
refer
introduct
mortal
rate
sever
sepsi
septic
shock
vari
high
institut
indic
polymyxinb
immobil
fi
ber
direct
hemoperfus
pmxdhp
circulatori
failur
systol
blood
pressur
mmhg
requir
catecholamin
high
lactacidemia
continu
despit
follow
earli
goaldirect
therapi
surviv
sepsi
campaign
guidelin
method
studi
includ
patient
sever
sepsi
septic
shock
due
abdomin
infect
retrospect
subject
divid
two
group
wbc
count
lgroup
patient
wbc
count
hgroup
patient
mean
arteri
pressur
wbc
count
platelet
count
plasminogen
activ
measur
immedi
initi
complet
pmxdhp
statist
analysi
perform
use
chisquar
test
background
factor
wilcoxon
ranksum
test
comparison
within
group
mannwhitney
u
test
comparison
group
signifi
canc
level
set
p
mortal
rate
day
lgroup
hgroup
mean
arteri
pressur
increas
signifi
cantli
p
hgroup
compar
lgroup
wbc
count
lgroup
increas
hgroup
decreas
p
pmxdhp
treatment
platelet
count
group
decreas
signifi
cantli
p
signifi
cant
diff
erenc
pmxdhp
level
hand
decreas
signifi
cantli
pmxdhp
also
lgroup
signifi
cantli
higher
hgroup
start
pmxdhp
pct
valu
lgroup
increas
compar
hgroup
start
pmxdhp
p
pct
lgroup
increas
signifi
cantli
p
signifi
cant
chang
hgroup
show
signifi
cant
chang
pmxdhp
chang
group
start
pmxdhp
conclus
mortal
rate
lgroup
tend
higher
hgroup
infl
ammatori
antiinfl
ammatori
cytokin
lgroup
higher
hgroup
result
indic
leukopenia
wbc
sever
sepsi
patient
lead
sever
outcom
hypercytokinemia
leukocytosi
wbc
sever
sepsi
patient
exchang
therapi
may
improv
thrombot
microangiopathi
purpos
observ
cohort
studi
describ
whether
associ
use
plasma
exchang
therapi
outcom
turkish
tamof
network
method
perform
retrospect
cohort
analysi
patient
tamof
three
diff
erent
pediatr
icu
compar
receiv
plasma
exchang
plu
standard
therapi
receiv
plasma
exchang
receiv
standard
therapi
introduct
mortal
septic
shock
icu
remain
high
rang
particular
gramneg
bacilli
gnb
account
caus
bacteria
sever
sepsi
progress
multiorgan
failur
due
signifi
cant
infl
ammat
hemoperfus
polymyxin
bimmobil
fi
ber
pmx
adsorb
endotoxin
reduc
infl
ammatori
cascad
sepsi
due
gnb
howev
clinic
effi
caci
treatment
demonstr
aim
verifi
effi
caci
endotoxin
adsorpt
therapi
use
pmx
method
retrospect
evalu
patient
receiv
broadspectrum
antimicrobi
treatment
septic
shock
due
gnb
januari
decemb
icu
japanes
tertiari
hospit
align
treatment
time
phase
patient
divid
patient
two
group
accord
whether
pmx
treatment
perform
within
hour
icu
admiss
pmx
group
n
nonpmx
group
n
primari
endpoint
mortal
result
mean
sd
age
sofa
score
icu
admiss
year
respect
infect
site
intraabdomin
pulmonari
urinari
tract
twothird
patient
bacteremia
due
gnb
diff
erenc
mortal
observ
two
group
pmx
vs
nonpmx
p
cox
regress
analysi
adjust
age
sex
facil
pmx
treatment
hazard
ratio
confi
denc
interv
improv
outcom
conclus
diff
erenc
mortal
rate
observ
adjust
endotoxin
adsorpt
therapi
pmx
patient
septic
shock
due
gnb
evalu
impact
evolv
region
cardiac
catheteris
servic
region
intens
care
unit
ricu
serv
popul
million
method
retrospect
review
carri
patient
admit
region
cardiac
catheteris
laboratori
region
icu
septemb
septemb
identifi
ed
use
valid
ricu
admiss
record
clinic
data
extract
computeris
patient
record
previou
work
group
shown
incorpor
simulationbas
teach
element
basic
tte
cours
improv
candid
satisfact
assess
impact
introduc
iceblu
elearn
programm
prior
simulationbas
basic
tte
cours
method
prior
august
cours
candid
requir
complet
iceblu
elearn
modul
morn
cours
candid
complet
questionnair
assess
impact
elearn
modul
survey
includ
question
qualiti
content
user
friendli
whether
content
pitch
right
level
problem
face
whilst
access
elearn
modul
also
analys
candid
feedback
januari
august
cours
figur
respons
rate
survey
eighti
per
cent
candid
complet
elearn
modul
elearn
modul
rate
high
candid
howev
nearli
onehalf
candid
face
problem
access
modul
onlin
analysi
candid
feedback
januari
august
cours
reveal
candid
overal
impress
better
introduct
elearn
prior
cours
survey
shown
elearn
initi
welcom
candid
conclud
introduct
elearn
prior
simulationbas
basic
tte
cours
enhanc
candid
satisfact
feedback
deep
venou
thrombosi
dvt
increas
major
caus
mortal
morbid
need
quick
easi
cheap
conveni
reliabl
diagnost
tool
object
ascertain
diagnost
concord
emerg
doctorperform
ultrasound
edu
lower
extrem
specialist
doctorperform
radiologist
vascular
surgeon
echodoppl
sded
diagnosi
dvt
identifi
possibl
caus
nonconcord
method
prospect
multicentr
studi
adult
patient
year
old
clinic
suspicion
dvt
high
moder
risk
well
score
low
risk
increas
ddimer
level
elig
studi
emerg
doctor
perform
two
edu
femor
poplit
area
result
blind
echodoppl
perform
specialist
doctor
procedur
done
within
hour
fi
nal
result
consid
nonconcord
one
edu
match
sded
sded
use
refer
standard
clinic
practic
result
septemb
septemb
total
patient
enrol
fiftyon
investig
seven
hospit
perform
edu
patient
edu
femor
poplit
area
sded
also
femor
poplit
area
pair
us
studi
nonconcord
edu
sded
two
edu
incomplet
concord
analysi
perform
us
studi
discord
percentag
agreement
edu
sded
kappa
index
ci
mean
substanti
agreement
conclus
substanti
agreement
edu
sded
diagnosi
dvt
routin
clinic
practic
confi
rm
result
previou
paper
largest
nondiagnost
concord
thrombu
occur
earli
perform
emerg
doctor
introduct
sepsisinduc
myocardi
dysfunct
wellrecogn
condit
confer
wors
outcom
septic
patient
howev
diagnost
criteria
remain
poorli
describ
echocardiograph
assess
convent
paramet
left
ventricular
eject
fraction
lvef
often
aff
ect
ongo
chang
preload
afterload
condit
novel
echocardiograph
technolog
speckl
track
imag
evolv
direct
assess
myocardi
function
studi
investig
measur
myocardi
strain
speckl
track
imag
diagnosi
sepsisinduc
myocardi
dysfunct
method
prospect
casecontrol
studi
universityaffi
liat
tertiari
care
adult
medic
icu
consecut
patient
admit
diagnosi
septic
shock
meet
intern
consensu
criteria
includ
patient
caus
myocardi
dysfunct
exclud
compar
agematch
gendermatch
cardiovascular
risk
factormatch
control
admit
hospit
sepsi
develop
septic
shock
convent
echocardiograph
paramet
well
speckl
track
imag
myocardi
function
obtain
within
hour
diagnosi
offl
ine
analys
endocardi
trace
perform
two
independ
oper
result
januari
decemb
patient
septic
shock
studi
group
patient
sepsi
septic
shock
control
group
recruit
baselin
characterist
similar
convent
echocardiograph
measur
includ
lvef
vs
control
group
p
fraction
shorten
vs
p
diff
er
two
group
studi
group
greater
degre
myocardi
dysfunct
measur
left
ventricular
global
longitudin
strain
vs
p
less
neg
valu
impli
wors
myocardi
contractil
hemodynam
profi
le
cardiac
index
lminutem
vs
lminut
respect
p
statist
diff
erent
conclus
fi
rst
studi
adult
popul
show
use
speckl
track
imag
diagnos
signifi
cant
sepsisinduc
myocardi
dysfunct
otherwis
detect
convent
echocardiographi
compar
group
versu
group
ii
mortal
rate
statist
signifi
cant
diff
erenc
temperatur
p
hr
p
wbc
count
p
admiss
upon
compar
survivor
versu
nonsurvivor
group
statist
diff
erenc
hr
day
p
success
vasopressor
withdraw
p
pf
ratio
p
scvo
day
p
regard
troponin
statist
signifi
cant
diff
erenc
group
ii
crp
show
statist
signifi
cant
diff
erenc
admiss
pv
cs
probnp
show
statist
signifi
cant
diff
erenc
cs
sampl
septic
nonsept
group
regard
echo
upon
compar
survivor
versu
nonsurvivor
edt
day
show
statist
signifi
cant
diff
erenc
group
sap
ii
seventhday
sofa
good
predict
score
mortal
sepsi
conclus
diastol
dysfunct
seen
patient
fever
hr
wbc
count
still
good
earli
indic
diagnosi
sepsi
vasopressor
withdraw
seventh
day
good
predictor
surviv
admiss
serum
crp
pv
better
indic
sepsi
probnp
troponin
admiss
seventhday
level
highli
prognost
mortal
cs
sampl
prove
nt
probnp
good
indic
sepsi
diagnosi
good
predictor
surviv
cs
sampl
also
good
predictor
mortal
sap
ii
slower
edt
admiss
good
predictor
mortal
introduct
myocardi
depress
common
among
septic
patient
aim
studi
assess
whether
valu
cardiac
index
ci
velocitytim
integr
vti
calcul
echocardiographi
diff
er
survivor
nonsurvivor
sepsi
method
prospect
observ
studi
includ
adult
newli
admit
septic
patient
regardless
diseas
sever
exclus
criteria
concomit
pregnanc
obstetricgyneco
logic
sepsi
coexist
termin
diseas
may
limit
life
expect
moment
recruit
addit
exclus
criteria
includ
concomit
pulmonari
embol
trauma
acut
ischem
coronari
diseas
pericardi
tamponad
aortic
valv
diseas
tachyarrhythmia
absenc
adequ
echocardiograph
window
echocardiograph
evalu
made
within
fi
rst
minut
initi
fl
uid
therapi
emerg
room
measur
imag
obtain
mhz
phase
array
transduc
use
standard
cardiac
preset
ci
quotient
cardiac
output
co
divid
bodi
surfac
area
co
product
stroke
volum
heart
rate
stroke
volum
calcul
product
aortic
vti
measur
use
pulsedwav
doppler
aortic
crosssect
area
latter
calcul
long
axi
parastern
window
use
left
ventricular
outfl
ow
tract
diamet
measur
introduct
quantifi
cation
lung
ultrasound
lu
artifact
bline
use
assess
pulmonari
congest
emerg
medicin
cardiolog
investig
bline
relat
extravascular
lungwat
index
evlwi
invas
transpulmonari
thermodilut
septic
shock
patient
aim
evalu
role
lu
intens
care
set
method
twentyon
patient
admit
septic
shock
gener
icu
underw
lu
eight
zone
four
per
hemithorax
within
hour
icu
admiss
evlwi
calcul
simultan
transpulmonari
thermodilut
use
pulsecontour
continu
cardiac
output
system
ntprobnp
clinic
data
collect
two
physician
blind
data
independ
quantifi
ed
number
bline
spearman
rho
use
test
correl
bline
evlwi
clinic
data
linear
regress
blandaltman
analysi
use
assess
agreement
bline
evlwi
interobserv
variabl
test
use
blandaltman
analysi
intraclass
correl
coeffi
cient
icc
result
fourteen
patient
male
median
age
year
iqr
eight
patient
cardiac
comorbid
median
sap
iqr
icu
length
stay
day
iqr
seven
patient
die
within
day
icu
admiss
patient
mechan
ventil
treat
accord
guidelin
median
number
bline
iqr
median
iqr
ntprobnp
evlwi
oxygen
index
oi
ngl
mlkg
iqr
respect
none
characterist
diff
ere
signifi
cantli
survivor
nonsurvivor
number
bline
correl
evlwi
p
r
p
ntprobnp
p
oi
p
icu
length
stay
p
blandaltman
analysi
mean
diff
erenc
limit
agreement
bline
evlwi
assess
observ
agreement
icc
method
ci
ci
observ
conclus
lu
noninvas
userindepend
quantifi
es
lung
water
concord
replac
invas
measur
studi
need
establish
role
lu
monitor
diagnost
tool
septic
shock
patient
introduct
nearinfrar
spectroscopi
nir
vascular
occlus
test
vot
use
extrapol
inform
regard
tissu
oxygen
extract
rate
explor
mean
variat
tissu
oxygen
satur
downslop
sto
vot
critic
ill
patient
method
prospect
observ
studi
nir
thenar
emin
appli
everi
day
patient
admit
icu
vot
perform
use
sto
target
slope
desatur
curv
assess
separ
fi
rst
part
sto
last
part
sto
curv
diff
erenc
calcul
result
signifi
cant
diff
erenc
seen
sto
icu
survivor
n
icu
nonsurvivor
n
fi
rst
day
icu
higher
icu
nonsurvivor
figur
patient
upper
quartil
mean
show
highest
mortal
p
conclus
icu
nonsurvivor
tend
show
fl
atten
last
part
desatur
curv
vot
suggest
reduc
tissu
oxygen
extract
may
depend
microvascular
dysfunct
andor
cellular
hypometabol
statu
introduct
well
known
oxygen
act
vasoconstrictor
evalu
impact
normobar
hyperoxia
sublingu
microcircul
critic
ill
patient
method
forti
mechan
ventil
fio
patient
hemodynam
stabil
enrol
prospect
observ
studi
fi
rst
patient
underw
period
hyperoxia
fio
patient
studi
control
fio
variat
sublingu
microcircul
three
site
evalu
sidestream
darkfi
eld
imag
baselin
hour
hyperoxia
hour
return
baselin
continu
video
record
also
perform
fio
variat
one
area
video
chang
mean
arteri
pressur
observ
perfus
small
vessel
densiti
tend
decreas
normal
figur
hyperoxia
group
variat
appear
earli
minut
fio
chang
signifi
cant
increas
lactat
level
time
mmoll
p
seen
hyperoxia
group
conclus
hyperoxia
induc
earli
decreas
microvascular
perfus
appear
go
back
normal
return
normoxia
healthi
volunt
n
studi
control
slope
desatur
curv
assess
separ
fi
rst
sto
last
part
sto
curv
diff
erenc
calcul
result
sto
lower
healthi
volunt
compar
septic
patient
p
diff
erenc
seen
icu
survivor
n
nonsurvivor
n
sto
similar
healthi
volunt
icu
survivor
higher
nonsurvivor
p
vs
healthi
icu
nonsurvivor
show
higher
compar
icu
survivor
p
figur
conclus
tissu
oxygen
extract
reduc
septic
patient
nonsurvivor
show
fl
atten
last
part
desatur
curv
vot
fi
rst
part
sto
downslop
show
diff
erenc
survivor
nonsurvivor
may
refl
ect
tissu
hypometabol
statu
may
better
elicit
fi
nal
part
ischem
challeng
prospect
nonrandom
observ
studi
use
imped
threshold
devic
patient
spontan
respir
hemodynam
instabl
c
pantazopoulo
indic
endorgan
hypoperfus
hypothes
lactat
lac
normal
prognost
valu
cohort
patient
perform
retrospect
observ
studi
patient
admit
icu
refractori
cs
januari
novemb
patient
postcardiotomi
andor
posttranspl
cs
exclud
demograph
clinic
hemodynam
biochem
valu
collect
lac
measur
arteri
blood
ecmo
institut
hour
lactat
clearanc
calcul
follow
data
analyz
compar
statist
sensibl
specifi
citi
test
roc
result
twentythre
patient
underw
va
ecmo
refractori
cs
studi
period
etiolog
cs
acut
myocard
fi
acut
myocardi
infarct
seven
acut
decompens
chronic
cardiomyopathi
median
time
ecmo
day
thirteen
patient
die
hospit
stay
surviv
three
patient
bridg
lvad
two
heart
transplant
eight
bridg
recoveri
main
caus
icu
death
multipl
organ
dysfunct
nonsurvivor
show
signifi
cantli
higher
vs
p
lactat
clearanc
hour
signifi
cantli
diff
erent
survivor
nonsurvivor
ci
vs
ci
p
howev
predict
icu
mortal
auc
ci
p
roc
curv
analysi
identifi
ed
accuraci
highest
set
lactat
mmoll
patient
normal
lactat
lac
mmoll
hour
despit
hemodynam
restor
poorer
outcom
day
shown
kaplanmei
curv
logrank
p
figur
conclus
fail
normal
patient
lac
fi
rst
hour
va
ecmo
assist
cs
predictor
icu
mortal
target
lac
level
mmoll
hour
post
ecmo
institut
might
reason
goal
patient
inotrop
score
predictor
mortal
morbid
children
septic
shock
introduct
inotrop
vasoact
drug
septic
shock
commonli
use
maintain
cardiac
output
tissu
perfus
oxygen
undertook
studi
purpos
evalu
inotrop
score
predictor
mortal
morbid
among
children
diagnos
septic
shock
method
multicent
retrospect
chart
review
perform
two
pediatr
icu
total
children
septic
shock
recruit
hourli
dose
follow
inotrop
record
fi
rst
hour
admiss
dopamin
dobutamin
adrenalin
noradrenalin
inotrop
score
everi
hour
minimum
maximum
mean
valu
fi
rst
hour
subsequ
hour
calcul
analysi
inotrop
score
calcul
describ
wernovski
expand
formula
includ
norephinephrin
follow
wernovski
inotrop
score
dopamin
dose
dobutamin
dose
epinephrin
dose
minut
adjust
inotrop
score
wernovski
inotrop
score
norepinephrin
dose
result
fortytwo
patient
die
age
sex
diff
erent
survivor
nonsurvivor
signifi
cantli
higher
mean
maximum
inotrop
score
fi
rst
hour
fi
rst
hour
found
nonsurvivor
survivor
p
use
cutoff
point
predict
mortal
sensit
specifi
citi
respect
associ
prism
score
minimum
mean
maximum
inotrop
score
statist
signifi
cant
hour
hour
hour
mean
hour
maximum
hour
inotrop
score
weakli
associ
prolong
icu
stay
p
p
respect
signifi
cant
relationship
inotrop
score
receiv
mechan
ventil
conclus
mean
maximum
inotrop
score
fi
rst
hour
hour
independ
predictor
mortal
critic
ill
children
septic
shock
shock
index
si
heart
ratesystol
blood
pressur
wide
report
tool
identifi
acut
ill
patient
risk
circulatori
collaps
emerg
depart
ed
old
age
diabet
essenti
hypertens
channelblock
might
reduc
compensatori
increas
heart
rate
mask
blood
pressur
reduct
shock
preshock
state
hypothes
factor
weaken
associ
si
mortal
reduc
util
si
identifi
patient
risk
method
cohort
studi
odens
univers
hospit
fi
rsttime
visit
ed
n
outcom
mortal
examin
whether
age
year
diabet
essenti
hypertens
use
channelblock
modifi
ed
associ
si
mortal
prognost
valu
si
evalu
diagnost
likelihood
ratio
observ
mortal
si
refer
si
associ
adjust
ci
mortal
adjust
si
ci
or
si
reduc
still
signifi
cant
patient
older
hypertens
channelblock
wherea
diabet
eff
ect
si
patient
year
ci
compar
ci
younger
patient
channelblock
patient
ci
versu
ci
nonus
hypertens
patient
ci
versu
ci
nonhypertens
patient
si
ci
diabet
diff
er
ci
nondiabet
patient
si
associ
or
signifi
cantli
greater
rang
evid
diff
erenc
within
subgroup
si
measur
associ
lower
posit
likelihood
ratio
patient
year
hypertens
diabet
use
channelblock
rang
compar
patient
expos
factor
rang
introduct
vasodilatori
shock
wellknown
complic
patient
undergo
cardiac
surgeri
cardiopulmonari
bypass
cpb
occurr
associ
higher
morbid
mortal
despit
clinic
characterist
vasopleg
shock
spectrum
sever
poorli
describ
aim
studi
compar
patient
develop
mild
moder
vasopleg
shock
patient
develop
sever
form
identifi
predict
factor
sever
form
vasopleg
shock
method
perform
observ
studi
patient
underw
cardiac
surgeri
cpb
present
within
fi
rst
hour
surgeri
refractori
hypotens
use
vasopressor
agent
sever
vasopleg
shock
defi
ned
requir
norepinephrin
higher
use
two
vasopressor
baselin
characterist
laboratori
clinic
intraop
data
amount
fl
uid
bleed
blood
transfus
inotrop
length
cpb
collect
icu
admiss
logist
regress
perform
use
sever
vasodilatori
shock
outcom
result
patient
develop
sever
form
vasodilatori
shock
within
hour
cardiac
surgeri
univari
analysi
patient
sever
form
like
older
receiv
blood
transfus
inotrop
agent
higher
level
serum
lactat
lower
hemoglobin
concentr
lower
svo
end
procedur
lower
cardiac
output
index
higher
heart
rate
higher
level
reactiv
c
protein
icu
admiss
patient
also
experienc
postop
organ
dysfunct
longer
length
icu
stay
higher
mortal
diff
erenc
patient
regard
amount
fl
uid
length
cpb
multivari
analysi
identifi
age
ci
p
intraop
use
epinephrin
ci
p
higher
serum
lactat
end
procedur
ci
p
intraop
blood
transfus
ci
p
conclus
studi
demonstr
older
patient
intraop
blood
transfus
util
epinephrin
independ
associ
sever
form
vasodilatori
shock
cardiac
surgeri
cpb
also
identifi
ed
higher
lactat
end
procedur
independ
predict
factor
sever
form
shock
refer
analyz
patient
use
levosimendan
compar
use
dobutamin
fi
rst
hour
cardiac
surgeri
discard
patient
neither
two
drug
use
surgic
case
arriv
icu
inotrop
analyz
demograph
variabl
well
clinic
complic
icu
overal
periop
mortal
patient
perform
second
analysi
use
propens
score
obtain
probabl
patient
treat
either
drug
pair
patient
receiv
levosimendan
nearest
neighbor
receiv
dobutamin
collect
patient
receiv
one
two
drug
receiv
drug
receiv
drug
icu
mortal
levosimendan
group
dobutamin
group
p
adjust
sever
type
surgeri
use
levosimendan
postop
period
protect
factor
icu
mortal
p
ci
match
sampl
mortal
levosimendan
group
dobutamin
p
logist
regress
adjust
sever
measur
euroscor
type
surgeri
levosimendan
protect
factor
icu
mortal
p
ci
conclus
environ
observ
diff
erenc
use
levosimendan
compar
dobutamin
higher
rate
men
undergo
cabg
diabet
wors
ef
homogen
sampl
patient
propens
score
eff
ect
mortal
discard
observ
signifi
cant
need
use
norepinephrin
nonsignifi
cant
trend
prolong
mechan
ventil
renal
failur
requir
renal
replac
therapi
probabl
relat
greatest
need
vasopressor
observ
introduct
levosimendan
origin
develop
treat
ment
decompens
heart
failur
situat
convent
therapi
suffi
cient
eff
ectiv
calciumsensitis
drug
vasodilatori
inotrop
eff
ect
improv
cardiac
contractil
trial
shown
posit
outcom
benefi
use
levosimendan
review
usag
levosimendan
institut
outcom
patient
review
use
levosimendan
harefi
eld
januari
decemb
patient
demograph
logist
euroscor
figur
diagnosi
surgic
intervent
detail
inotrop
support
dosag
durat
levosimendan
use
length
stay
icu
cost
tabl
patient
outcom
collect
result
levosimendan
use
patient
male
seven
femal
median
age
levosimendan
use
post
cardiac
surgeri
post
angioplasti
patient
ventricular
assist
devic
vad
extracorpor
membran
oxygen
ecmo
patient
receiv
standard
regimen
mg
administ
dose
hour
concurr
noradrenalin
use
patient
rang
median
length
stay
icu
nine
day
survivor
day
nonsurvivor
sixteen
patient
surviv
discharg
hospit
introduct
levosimendan
inotrop
seldom
use
emerg
depart
ed
shown
improv
mortal
patient
shock
advers
eff
ect
work
denot
experi
levosimendan
use
ed
hospit
universitario
mayor
method
present
retrospect
studi
analyz
eff
ect
hour
levosimendan
administr
perfus
paramet
ed
patient
patient
shock
diagnosi
caus
diff
erenc
initi
fi
nal
mean
valu
follow
paramet
evalu
lactat
central
venou
oxygen
satur
scvo
venoarteri
diff
erenc
co
dvaco
data
stratifi
ed
accord
levosimendan
categori
initi
rescu
addit
associ
diff
erent
variabl
mortal
sought
diff
erenc
consid
statist
signifi
cant
probabl
level
result
diff
erenc
apach
ii
valu
patient
receiv
levosimendan
initi
therapi
receiv
rescu
measur
total
patient
fulfi
lled
lactat
normal
requir
lactat
clearanc
tabl
fortyfour
patient
reach
normal
valu
svco
patient
davco
levosimendan
initi
associ
normal
lactat
svo
dvaco
diff
erent
type
shock
twentynin
patient
receiv
initi
therapi
levosimendan
normal
lactat
valu
receiv
rescu
therapi
p
sixtythre
patient
develop
hypotens
none
advers
eff
ect
requir
discontinu
drug
hospit
mortal
variabl
associ
mortal
studi
group
lactat
valu
admiss
ci
use
vasopressin
start
levosimendan
ci
use
norepinephrin
start
ci
ecri
institut
identifi
ed
alarm
fatigu
number
one
health
technolog
hazard
recent
studi
icu
patient
investig
alarm
total
annot
arrhythmia
alarm
fals
posit
fp
conclud
excess
number
alarm
complex
interplay
inappropri
user
set
patient
condit
algorithm
defi
cienci
nine
condit
caus
alarm
four
ecg
algorithm
relat
report
studi
investig
new
algorithm
improv
target
three
report
four
ecgrel
condit
implement
low
amplitud
qr
wide
qr
nonaction
ventricular
tachycardia
vt
method
fals
alarm
rate
new
algorithm
ge
carescap
compar
algorithm
evalu
studi
ge
solar
collect
ecg
waveform
data
user
set
qr
detect
sensit
highnorm
avail
therefor
normal
sensit
assum
version
old
algorithm
patient
low
qr
amplitud
gave
signifi
cantli
higher
number
fp
report
patient
sensit
mode
test
old
algorithm
sixtysix
percent
patient
pacemak
pacemak
mode
select
outlier
patient
fals
alarm
due
user
set
patient
pacemak
patient
condit
four
patient
bundl
branch
block
rather
algorithm
defi
cienci
exclud
result
improv
algorithm
result
reduct
fp
alarm
use
highsensit
mode
patient
low
qr
fp
reduct
compromis
regard
detect
true
event
found
introduct
cardiac
arrhythmia
may
observ
time
icu
stay
prognosi
may
suff
er
due
arrhythmia
studi
aim
evalu
incid
risk
factor
arrhythmia
occur
patient
icu
method
patient
treat
icu
includ
studi
fulfi
lled
follow
age
cardiac
valvular
diseas
cardiac
surgeri
recent
period
histori
myocardi
infarct
mi
need
mechan
ventil
one
organ
failur
demograph
hemodynam
laboratori
paramet
apach
ii
score
presenc
sepsi
acut
renal
failur
mi
vip
icu
stay
record
therapi
use
arrhythmia
respons
therapi
also
record
result
two
hundr
fourteen
patient
includ
studi
twentysix
percent
n
patient
arrhythmia
incid
higher
femal
p
averag
age
arrhythm
patient
older
nonarrhythm
patient
p
apach
ii
score
higher
arrhythm
patient
p
admiss
icu
cerebrovascular
event
cve
trauma
relat
arrhythmia
p
p
respect
signifi
cant
relationship
vip
sepsi
presenc
p
p
atrial
fi
brillat
frequent
type
arrhythmia
frequent
use
medic
diltiazem
patient
arrhythmia
longer
icu
stay
p
mortal
rate
patient
statist
signifi
cant
relationship
arrhythmia
mortal
p
conclus
older
age
higher
apach
ii
score
trauma
cve
vip
sepsi
increas
arrhythmia
risk
critic
ill
patient
atrial
fi
brillat
common
prefer
treatment
arrhythmia
diltiazem
introduct
pulmonari
hypertens
right
ventricular
dysfunct
rvd
frequent
encount
patient
acut
heart
failur
sought
better
understand
coupl
rvd
pulmonari
hypertens
set
acut
decompens
heart
failur
adhf
might
improv
prognost
stratifi
cation
infl
uenc
surviv
rate
method
echocardiographi
perform
patient
adhf
right
ventricular
function
assess
measur
right
ventricular
fraction
area
right
ventricular
eject
fraction
rvef
taken
cutoff
valu
rv
systol
dysfunct
systol
pulmonari
pressur
pasp
calcul
tricuspid
regurgit
signal
appli
modifi
ed
bernoulli
equat
method
total
patient
undergo
ppci
mih
compar
compar
consecut
patient
underw
ppci
mih
hypothes
combin
method
lead
better
surviv
rate
mih
induc
propofol
fentanyl
salin
mlkg
bw
maintain
hour
target
spontan
rewarm
allow
result
signifi
cant
diff
erenc
mih
control
group
gener
characterist
cardiac
arrest
circumst
angiograph
featur
except
decreas
heart
rate
mih
diff
erenc
mih
mih
group
arteri
pressur
peak
lactat
vs
mmoll
p
need
vasopressor
vs
p
aortic
balloon
counterpuls
vs
p
repeat
cardioversiondefi
brillat
vs
p
lower
incid
inotrop
use
vs
p
use
antiarrhythm
vs
p
diff
erenc
fio
mechan
ventil
renal
function
see
tabl
introduct
standard
electrocardiogram
ecg
biomark
accur
method
diagnosi
acut
coronari
syndrom
ac
howev
posterior
right
deriv
systemat
perform
due
timeconsum
procedur
involv
despit
major
therapeut
implic
fl
uid
load
instead
nitrat
use
right
ventricular
involv
publish
guidelin
recent
ecg
system
standard
ecg
six
addit
synthes
lead
assess
posterior
right
ventricular
area
one
record
procedur
develop
reliabl
materi
ecg
nihon
kohden
co
ltd
japan
alreadi
valid
indic
asian
popul
method
conduct
prospect
observ
studi
patient
admit
emerg
depart
ed
period
requir
ecg
guid
physician
discret
accord
patient
histori
patient
chest
pain
dyspnea
palpit
disturb
conscious
malais
abdomin
complaint
underw
synthes
ecg
within
minut
ed
arriv
aim
studi
evalu
eff
ectiv
synthes
ecg
ischemia
triag
tool
ed
particularli
abil
earli
detect
right
ventricular
involv
nontraumat
patient
treat
ed
adult
adult
popul
ecg
perform
patient
whose
symptom
suggest
ac
median
age
year
sex
ratio
clinic
present
chest
pain
dyspnea
palpit
disturb
conscious
other
fiftysix
diagnos
ac
includ
stelev
myocardi
infarct
stemi
nonstemi
eight
unstabl
angina
stemi
patient
eight
fi
diagnos
stemi
complic
right
ventricular
posterior
wall
ischemia
respect
mean
complic
could
miss
standard
ecg
conclus
eighteenlead
ecg
synthes
rightsid
posterior
precordi
lead
effi
cient
method
diagnos
ac
caucasian
popul
within
minut
ed
arriv
particularli
perform
detect
right
ventricular
ischemia
earli
modifi
acut
therapeut
strategi
introduct
acut
myocardi
infarct
stsegment
elev
stemi
treat
percutan
coronari
intervent
pci
left
ventricl
lv
undergo
neg
remodel
r
aim
investig
whether
global
longitudin
strain
sgl
left
ventricl
lv
predict
remodel
method
transthorac
echocardiographi
speckl
track
imag
ttesti
perform
day
primari
pci
month
later
patient
diagnosi
stemi
lv
rcriteria
lvef
increas
enddiastol
volum
increas
logist
regress
roc
curv
analysi
use
statist
analysi
result
eightythre
patient
year
stemi
lv
local
subject
primari
pci
studi
lv
figur
conclus
sgl
assess
fi
rst
day
primari
pci
use
predict
lv
rindepend
myocardi
infarct
local
vasopressor
manag
noradrenalin
dose
p
fl
uid
balanc
p
ee
p
independ
predictor
plasma
bnp
concentr
conclus
diastol
dysfunct
evalu
ee
e
constitut
major
independ
predictor
outcom
septic
shock
compar
cardiac
biomark
suggest
echocardiograph
techniqu
assess
diastol
dysfunct
sepsi
may
replac
cardiac
biomark
mortal
predict
fluid
balanc
vasopressor
manag
diastol
dysfunct
independ
predictor
bnp
elev
septic
shock
fi
nding
confi
rmed
extend
prospect
studi
introduct
depend
upon
medic
administ
accident
administr
medic
arteri
line
caus
devast
complic
wrongrout
inject
never
event
uk
may
underreport
especi
occur
unconsci
patient
may
notic
associ
pain
tempor
underreport
may
occur
result
complic
may
delay
number
hour
account
healthcar
worker
may
recognis
choos
report
error
uk
nation
patient
safeti
agenc
npsa
report
incid
relat
poor
sampl
techniqu
wrong
rout
arteri
inject
suff
ere
moder
sever
harm
npsa
suggest
train
use
clear
label
alongsid
red
arteri
tube
standard
red
lock
cap
use
prevent
arteri
sampl
error
method
conduct
nation
postal
survey
icu
uk
attempt
determin
rate
accident
intraarteri
inject
survey
sent
clinic
director
everi
icu
ask
whether
awar
unintent
arteri
line
inject
occur
hospit
last
year
icu
respond
report
person
seen
accident
inject
arteri
line
conclus
despit
arteri
line
safeti
recommend
made
npsa
demonstr
intraarteri
inject
still
problem
remain
underreport
incid
like
underestim
reli
recollect
singl
individu
institut
medic
error
mitig
consider
human
factor
system
engin
improv
patient
safeti
focu
clinic
awar
colour
code
train
may
lead
improv
howev
institut
clinic
director
also
bear
respons
prevent
never
event
number
engin
solut
avail
needlefre
noninject
arteri
sampl
devic
protect
healthcar
environ
make
error
imposs
introduct
use
icecold
salin
assum
provid
best
accuraci
tptd
obtain
cardiac
index
ci
global
enddiastol
volum
gedvi
extravascular
lungwat
evlwi
howev
roomtemperatur
inject
might
facilit
tptd
outsid
icu
recent
studi
show
accept
bia
percentag
error
pe
ciroom
deriv
tptd
ml
room
temperatur
salin
compar
cicold
use
ml
ice
salin
tptd
howev
gedviroom
evlwiroom
borderlin
pe
valu
close
bia
gedviroom
markedli
increas
higher
valu
gedvi
case
femor
cvc
sinc
imprecis
tptdroom
might
reduc
larger
volum
inject
aim
studi
compar
ci
gedvi
evlwi
deriv
tpdt
use
ml
room
temperatur
inject
standard
tptd
ml
ice
salin
introduct
method
cardiac
output
co
estim
valid
children
aim
studi
investig
reliabl
uncalibr
puls
contour
method
co
estim
pressur
record
analyt
method
pram
pediatr
patient
schedul
diagnost
right
left
heart
catheter
compar
oxygendirect
fick
method
method
cardiac
index
ci
simultan
estim
fick
pram
appli
pressur
signal
record
invas
femor
cathet
measur
perform
steadyst
condit
pram
ci
measur
obtain
consecut
beat
simultan
fick
ci
estim
agreement
fick
pram
assess
use
blandaltman
method
correl
coeffi
cient
bia
percentag
error
calcul
result
fortythre
ci
measur
perform
patient
data
show
good
agreement
cifick
cipram
r
bia
lminutem
limit
agreement
lminutem
percentag
error
figur
show
blandaltman
plot
introduct
although
recogn
question
indic
intravascular
volum
central
venou
pressur
cvp
integr
mani
therapeut
algorithm
hemodynam
resuscit
critic
ill
patient
attempt
simplifi
cvp
estim
sever
clinic
ultrasonograph
approach
suggest
nonetheless
extern
jugular
vein
ejv
circumfer
area
evalu
consid
role
ejv
visual
assess
clinic
estim
cvp
hypothes
ejv
ultrasound
evalu
could
use
reliabl
estim
cvp
method
patient
cvc
place
part
clinic
manag
evalu
ejv
intern
jugular
vein
ijv
measur
perform
left
cricoid
level
ijv
ejv
visual
short
axi
view
diamet
circumfer
area
obtain
end
expir
simultan
cvp
measur
measur
perform
singl
train
oper
blind
cvp
valu
result
fortyeight
patient
includ
poor
correl
found
cvp
ijv
ejv
circumfer
area
mechan
ventil
patient
strong
correl
found
cvp
ejv
circumfer
r
p
ci
area
r
p
ci
spontan
breath
patient
convent
receiveroper
characterist
curv
gener
assess
util
ejv
circumfer
area
predict
low
mmhg
versu
high
mmhg
cvp
valu
auc
ejv
circumfer
area
p
ci
p
ci
respect
figur
conclus
result
highlight
potenti
evolv
role
ejv
circumfer
area
hemodynam
manag
critic
care
volum
suppl
http
spontan
breath
patient
import
aspect
suggest
approach
simplic
requir
basic
technic
skill
make
suitabl
scenario
ultrasound
machin
avail
introduct
hypovolaemia
gener
believ
induc
centrali
sation
blood
volum
therefor
evalu
whether
hypovolaemia
hypervolaemia
result
chang
central
blood
volum
pulmonari
blood
volum
pbv
explor
eff
ect
distribut
pbv
circul
blood
volum
vd
circ
committe
approv
blood
volum
alter
direct
randomli
step
ml
mild
ml
moder
either
haemorrhag
retransfus
blood
infus
colloid
six
foxhound
dog
anaesthetis
dog
allow
breath
spontan
blood
volum
measur
use
dye
dilut
techniqu
pbv
measur
volum
blood
pulmonari
aortic
valv
vd
circ
twocompartment
curv
fi
tting
pbvvd
circ
ratio
use
measur
blood
volum
distribut
linear
mix
model
use
analys
infl
uenc
blood
volum
alter
measur
haemodynam
variabl
blood
volum
result
total
alter
blood
volum
result
chang
vd
circ
rang
figur
pbv
decreas
mild
moder
haemorrhag
retransfus
pbv
increas
moder
hypervolaemia
pbvvd
circ
ratio
remain
constant
stage
hypovolaemia
hypervolaemia
figur
mild
moder
alter
blood
volum
result
chang
pbv
vd
circ
howev
tradit
belief
centralis
could
show
cardiovascular
system
preserv
distribut
blood
central
circul
blood
volum
anaesthetis
dog
refer
introduct
permiss
hypotens
result
avoid
intravascular
overpressur
therebi
avoid
platelet
plug
dislodg
earli
clot
mechan
improv
result
trauma
hemorrhag
research
hypothesi
augment
neg
intrathorac
pressur
use
imped
threshold
devic
itd
improv
hemodynam
paramet
without
aff
ect
permiss
hypotens
caus
hemodilut
hand
aggress
resuscit
ringer
lactat
caus
hemodilut
intravascular
pressur
high
permiss
hypotens
capabl
platelet
plug
dislodg
method
twenti
anesthet
landracelargewhit
pig
kg
week
subject
fi
xed
hemorrhag
minut
pig
randomli
alloc
two
group
n
per
group
group
itd
treatment
hypotens
group
b
intraven
administr
l
ringer
lactat
appli
treatment
hypotens
hemodynam
paramet
continu
assess
fi
rst
minut
blood
loss
result
mean
systol
arteri
pressur
sap
minut
intervent
group
follow
group
mmhg
group
b
mmhg
maximum
sap
assess
period
group
mmhg
group
b
mmhg
mean
puls
pressur
higher
itd
group
versu
fl
uid
resuscit
group
p
assess
period
mean
hematocrit
group
group
b
p
conclus
studi
itd
increas
sap
puls
pressur
without
overcompens
hand
aggress
fl
uid
resuscit
led
signifi
cant
increas
sap
mmhg
capabl
clot
dislodg
addit
led
hemodilut
introduct
measur
global
enddiastol
volum
gedv
provid
cardiovascular
monitor
devic
use
thermodilut
procedur
aim
studi
assess
relat
clinic
avail
index
left
ventricular
enddiastol
volum
lvedv
typic
avail
patient
bedsid
method
measur
perform
six
anaesthetis
mechan
ventil
pig
volum
load
via
success
infus
salin
solut
fi
rst
perform
follow
dobutamin
infus
two
procedur
provid
wide
rang
lvedv
valu
experi
gedv
intermitt
measur
use
picco
monitor
pulsion
ag
germani
thermodilut
lvedv
continu
measur
use
admitt
cathet
transon
ny
usa
insert
left
ventricl
result
tabl
present
linear
correl
obtain
lvedv
gedv
correl
good
excel
r
valu
howev
coeffi
cient
linear
regress
present
larg
intersubject
variabl
prevent
precis
estim
lvedv
use
gedv
nevertheless
variat
lvedv
well
reproduc
gedv
index
variat
lvedv
actual
equal
gedv
coeffi
cient
b
alway
nonzero
indic
proport
gedv
index
actual
link
lvedv
result
show
gedv
lvedv
gener
well
correl
correl
coeffi
cient
subject
specifi
c
preliminari
calibr
step
instanc
use
echocardiographi
thu
necessari
infer
lvedv
gedv
perform
evalu
three
devic
use
assess
volum
statu
critic
ill
patient
institut
transthorac
echocardiographi
tte
philip
ultrasound
bio
reactanc
nicom
cheetah
medic
puls
contourbas
thermodilut
picco
pulsion
medic
method
ten
mechan
ventil
critic
ill
patient
picco
monitor
situ
good
qualiti
imag
transthorac
view
includ
studi
measur
made
triplic
singl
train
cardiologist
blind
result
monitor
perform
tte
studi
diff
erenc
among
three
method
assess
signifi
canc
use
oneway
anova
spearman
coeffi
cient
blandaltman
analysi
statist
analys
perform
use
graphpad
prism
p
taken
signifi
cant
result
nineti
measur
obtain
nicom
ttederiv
stroke
volum
appear
well
match
piccoderiv
valu
show
signifi
cant
variat
f
p
correl
tte
veloc
time
integ
vti
nicom
stroke
volum
variat
svv
r
p
figur
good
correl
small
bia
ttevti
piccosvv
r
p
figur
appli
follow
indic
volum
expans
picco
nicom
svv
tte
vti
variabl
found
agreement
case
tte
picco
case
echocardiographi
nicom
conclus
stroke
volum
produc
bioreact
appear
compar
measur
echocardiographi
picco
good
agreement
decisionmak
regard
fl
uid
administr
picco
echocardiographi
nicom
appear
unreli
set
bioreactancebas
passiv
leg
rais
test
predict
fl
uid
respons
patient
sepsi
c
hu
h
tong
g
cai
j
teboul
j
yan
x
lv
q
xu
j
chen
introduct
fluid
administr
alway
import
diffi
cult
therapi
patient
sepsi
accur
predict
fl
uid
respons
thu
estim
whether
patient
benefi
fl
uid
therapi
seem
particularli
import
present
studi
intend
predict
fl
uid
respons
patient
sepsi
use
bioreactancebas
passiv
leg
rais
test
compar
approach
commonli
use
central
venou
pressur
cvp
approach
method
prospect
singlecent
studi
includ
patient
sepsi
depart
critic
care
medicin
zhejiang
hospit
patient
randomli
assign
either
group
group
b
patient
group
fi
rst
take
passiv
leg
rais
test
take
fl
uid
infus
test
patient
group
b
follow
opposit
protocol
nicom
use
continu
record
hemodynam
paramet
cardiac
output
co
heart
rate
hr
central
venou
pressur
cvp
plr
volum
expans
fluid
respons
defi
ned
chang
co
result
co
increas
plr
l
minut
p
lminut
p
plrinduc
chang
co
veinduc
chang
co
highli
correl
r
cvp
uncorrel
r
area
roc
curv
predict
fl
uid
respons
respect
found
predict
fl
uid
respons
sensit
specifi
citi
conclus
bioreactancebas
plr
could
predict
fl
uid
respons
patient
sepsi
cvp
could
detect
heart
respons
fl
uid
administr
still
challeng
clinic
practic
chang
metabol
paramet
may
use
detect
chang
cardiac
output
co
fl
uid
expans
method
prospect
observ
studi
adult
critic
ill
patient
co
measur
either
echocardiographi
thermodilut
method
picco
swanganz
cathet
hemodynam
measur
blood
ga
analysi
obtain
fl
uid
challeng
either
ml
crystalloid
ml
colloid
arteri
central
venou
blood
ga
sampl
taken
simultan
oxygen
deliveri
oxygen
consumpt
vo
carbon
dioxid
product
vco
calcul
accord
wellknown
formula
patient
divid
three
group
high
respond
mild
respond
nonrespond
accord
chang
co
respect
result
evalu
patient
age
ci
apach
ii
score
ci
seven
patient
high
respond
eight
patient
moder
respond
nonrespond
signifi
cantli
increas
high
respond
p
compar
moder
respond
nonrespond
furthermor
nonrespond
decreas
p
moder
respond
show
chang
p
fl
uid
challeng
found
diff
erenc
chang
lactat
level
central
venou
oxygen
satur
scvo
high
respond
moder
respond
nonrespond
diff
erenc
chang
vco
vo
vco
ratio
found
high
respond
mild
respond
nonrespond
chang
vco
ratio
found
signifi
cantli
increas
high
respond
vs
p
mild
respond
vs
p
compar
nonrespond
conclus
signifi
cant
increas
co
fl
uid
administr
lead
improv
oxygen
deliveri
may
decreas
nonrespond
chang
scvo
lactat
level
track
chang
co
fl
uid
challeng
vco
ratio
may
use
index
identifi
signifi
cant
increas
co
fl
uid
challeng
case
co
measur
feasibl
introduct
aim
studi
assess
valu
global
enddiastol
volum
gedv
evalu
transpulmonari
thermodilut
indic
cardiac
preload
compar
stroke
volum
variat
svv
patient
septic
shock
method
prospect
observ
studi
perform
interdisciplinari
icu
includ
patient
septic
shock
hemodynam
monitor
perform
new
calibr
puls
wave
analysi
method
edward
lifesci
patient
group
uncalibr
method
flotrac
vigileo
edward
lifesci
patient
group
vigileo
fi
rst
hour
patient
receiv
mechan
ventil
vasopressor
measur
perform
immedi
volum
load
use
ml
ringer
solut
short
period
minut
result
total
fl
uid
challeng
studi
patient
observ
signifi
cant
relationship
gedv
index
volum
load
percentag
increas
gedv
index
group
chang
gedv
index
signifi
cantli
correl
chang
stroke
volum
index
r
p
insignifi
cant
relationship
svv
variat
cardiac
index
variat
p
vigileo
group
transpulmonari
thermodilut
gedv
better
indic
cardiac
preload
svv
patient
septic
shock
introduct
dynam
paramet
becom
standard
fl
uid
respons
assess
cutoff
valu
diff
erent
literatur
aim
assess
accuraci
diff
erent
preload
paramet
predict
fl
uid
respons
use
puls
power
analysi
compar
diff
erent
level
hemodynam
respons
due
passiv
leg
rais
plr
eff
ect
fl
uid
challeng
fc
method
prospect
studi
mix
icu
patient
fulli
ventil
co
monitor
underw
fc
due
hypotens
andor
hypoperfus
preload
depend
svv
andor
ppv
plr
perform
fc
hemodynam
data
record
preplr
postplr
postfc
l
crystalloid
compar
diff
erent
cutoff
valu
increas
co
sv
assess
abil
plr
svv
ppv
cvp
predict
respons
fc
statist
analysi
continu
variabl
express
mean
sd
comparison
done
use
pair
student
test
receiv
oper
characterist
roc
curv
gener
vari
discrimin
threshold
variabl
result
thirtyon
patient
includ
baselin
paramet
map
mmhg
sd
catecholamin
sv
ml
sd
co
l
sd
svv
sd
ppv
sd
hr
bpm
sd
cvp
mmhg
sd
total
patient
increas
co
fc
select
respond
plr
diff
erenc
respond
versu
nonrespond
patient
baselin
svv
vs
p
ppv
vs
p
diff
erenc
sv
co
statist
signifi
cant
best
paramet
predict
posit
respons
fc
plr
cutoff
co
increas
sensit
ci
specifi
citi
ci
au
roc
ci
roc
also
good
svv
ci
p
ppv
ci
p
cutoff
valu
sv
increas
plr
svv
ppv
p
wors
roc
addit
svv
identifi
ed
patient
increas
map
fc
sensit
ci
neg
predict
valu
ci
cvp
fail
distinguish
respond
nonrespond
conclus
result
support
idea
revers
fc
plr
co
cutoff
best
identifi
respond
patient
fc
dynam
paramet
svvppv
also
eff
ectiv
appropri
beattobeat
sv
co
use
puls
power
analysi
valid
tool
test
introduct
predict
fl
uid
respons
defi
ned
increas
stroke
volum
sv
least
volum
expans
dynam
static
esophag
doppler
od
paramet
propos
mechan
ventil
children
guid
fl
uid
therapi
studi
aim
compar
dynam
paramet
use
respiratori
variat
aortic
blood
fl
ow
static
paramet
use
doppler
correct
fl
ow
time
ftc
obtain
od
method
prospect
observ
intervent
studi
conduct
pediatr
icu
march
septemb
investig
mechan
ventil
children
acut
circulatori
failur
acf
tachycardia
hypotens
oliguria
delay
capillari
refi
lling
hemodynam
instabl
despit
vasopressor
drug
use
od
patient
intervent
standard
volum
expans
veinduc
increas
stroke
volum
patient
respond
four
patient
nonrespond
delta
vpeak
ao
respond
higher
nonrespond
vs
wherea
ftc
lower
respond
nonrespond
millisecond
vs
millisecond
predict
fl
uid
respons
higher
delta
vpeak
ao
roc
curv
area
ci
p
ftc
roc
curv
area
ci
p
best
cutoff
valu
delta
vpeak
ao
sensit
specifi
citi
predict
valu
respect
best
cutoff
valu
ftc
millisecond
sensit
specifi
citi
predict
valu
respect
conclus
studi
delta
vpeak
appropri
variabl
predict
fl
uid
respons
od
ventil
children
acf
pleth
variabl
index
pvi
new
dynam
index
obtain
automat
estim
respiratori
variat
puls
oximet
waveform
amplitud
noninvas
continu
hemodynam
monitor
recent
propos
mechan
ventil
patient
guid
fl
uid
therapi
recent
acquir
pvi
monitor
pvi
calcul
measur
chang
perfus
index
pi
respiratori
cycl
follow
pvi
pimax
pimin
pimax
studi
aim
investig
whether
pvi
baselin
predict
fl
uid
respons
method
pediatr
icu
start
prospect
observ
studi
januari
novemb
nine
mechan
ventil
children
investig
use
pvi
transthorac
echocardiographi
patient
acut
circulatori
failur
acf
tachycardia
hypotens
oliguria
delay
capillari
refi
lling
hemodynam
instabl
despit
vasopressor
drug
intervent
standard
volum
expans
result
signifi
cant
chang
stroke
volum
observ
volum
load
vl
eight
patient
respond
r
one
patient
nonrespond
nr
vl
pvi
signifi
cantli
higher
r
nr
baselin
vs
p
decreas
signifi
cantli
r
baselin
vl
vs
p
conclus
studi
pvi
seem
predict
fl
uid
respons
ventil
children
acf
accuraci
predict
fl
uid
respons
fr
use
ivc
collaps
high
patient
control
mechan
ventil
remain
unknown
spontan
breath
patient
mechan
ventil
also
adequ
ultrasound
imag
ivc
diffi
cult
obtain
substanti
number
patient
aim
current
studi
evalu
util
collaps
jugular
vein
ijv
subclavian
vein
scv
comparison
collaps
ivc
patient
pressur
support
ventil
method
patient
pressur
support
ventil
prospect
includ
fl
uid
challeng
clinic
indic
bilater
ijv
examin
level
cricoid
cartilag
bilater
scv
measur
vein
cross
clavicl
anteroposterior
diamet
crosssect
area
csa
ijv
scv
measur
use
frame
frame
analysi
ivc
measur
cm
right
atrial
border
long
axi
view
fluid
respons
defi
ned
increas
stroke
volum
calcul
vigileo
monitor
vigileo
flotrac
edward
lifesci
passiv
leg
rais
start
supin
posit
receiv
oper
characterist
roc
curv
gener
use
ezr
introduct
prevent
postsurg
complic
increasingli
recogn
major
healthcar
burden
recent
metaanalysi
show
decreas
complic
major
surgeri
periop
goaldirect
therapi
pgdt
assess
fi
nancial
consequ
postsurg
complic
larg
popul
us
hospit
order
predict
potenti
save
pgdt
method
data
adult
one
major
noncardiac
surgic
procedur
januari
june
select
premier
research
databas
twentysix
postsurg
complic
tabul
hospit
cost
length
stay
readmiss
rate
compar
patient
without
complic
risk
ratio
report
pears
metaanalysi
use
estim
expect
reduct
postsurg
morbid
pgdt
potenti
costsav
calcul
actual
anticip
morbid
rate
use
mean
diff
erenc
total
cost
introduct
studi
attempt
determin
vascular
pedicl
width
vpw
cutoff
valu
identifi
es
fl
uid
replet
state
defi
ned
ivc
diamet
cm
respiratori
variat
method
crosssect
design
consecut
critic
ill
patient
underw
simultan
chest
radiograph
ultrasound
research
ethic
committe
approv
studi
result
eightyfour
data
point
patient
collect
vpw
correl
ivc
diamet
r
p
ivc
variat
r
p
correl
observ
vpw
number
lung
comet
r
p
posit
fl
uid
balanc
r
p
multivari
linear
regress
standard
coeffi
cient
demonstr
mm
increas
ivc
diamet
correspond
mm
beta
increas
vpw
roc
curv
analysi
yield
auc
ci
p
provid
best
accuraci
cutoff
vpw
valu
mm
sensit
specifi
citi
ppv
npv
correct
classifi
cation
rate
see
figur
object
studi
determin
minimum
volum
intraven
fl
uid
requir
signifi
cantli
increas
pmsf
method
patient
follow
cardiac
surgeri
randomli
alloc
receiv
mlkg
bodi
weight
crystalloid
minut
use
ml
syring
pmsf
measur
use
arteri
pressur
stop
blood
fl
ow
arm
pneumat
tourniquet
infl
ate
minut
cardiac
output
co
also
record
baselin
immedi
fl
uid
infus
co
measur
lidco
pulmonari
arteri
cathet
posit
respons
consid
increas
baselin
previou
data
least
signifi
cant
chang
pmsf
median
compar
use
independ
sampl
media
test
proport
compar
use
chisquar
test
statist
signifi
canc
consid
p
result
fifti
patient
includ
respond
proport
respond
increas
increas
dose
fl
uid
tabl
regress
equat
chang
pmsf
dose
fl
uid
mlkg
ci
ci
r
f
p
predict
dose
fl
uid
requir
achiev
chang
pmsf
mlkg
crystalloid
minimum
volum
requir
perform
eff
ectiv
fl
uid
challeng
mlkg
infus
minut
howev
variat
chang
pmsf
explain
dose
iv
fl
uid
given
proport
respond
increas
volum
fl
uid
critic
care
volum
suppl
http
injuri
aki
develop
posit
fl
uid
balanc
describ
risk
factor
overal
mortal
delay
renal
recoveri
hypothes
fl
uid
overload
may
independ
risk
factor
aki
critic
ill
method
crosssect
design
collect
data
consecut
critic
ill
adult
patient
admit
period
medic
surgic
icu
singl
center
aki
defi
ned
accord
rifl
classifi
cation
logist
regress
analysi
perform
determin
predict
abil
variabl
aki
conclus
posit
fl
uid
balanc
cardiac
surgeri
independ
risk
factor
mortal
acut
kidney
injuri
patient
present
vasopleg
shock
conclus
postsurg
complic
signifi
cant
impact
hospit
margin
enhanc
recoveri
program
potenti
improv
qualiti
care
also
improv
hospit
margin
refer
categor
clinic
meaning
categori
mmoll
normal
mmoll
elev
mmoll
high
allow
nonlinear
eff
ect
unadjust
associ
lactat
group
length
stay
assess
kruskalw
test
post
hoc
wilcoxon
ranksum
test
assess
associ
postop
lactat
level
hospit
length
stay
perform
multivari
poisson
regress
robust
varianc
estim
adjust
variabl
includ
patient
demograph
comorbid
cardiac
characterist
exampl
new
york
heart
associ
class
eject
fraction
surgic
characterist
exampl
year
statu
elect
urgent
emerg
type
procedur
perfus
time
cross
clamp
time
includ
total
patient
median
age
quartil
femal
underw
coronari
arteri
bypass
graft
underw
valv
surgeri
median
length
hospit
stay
day
quartil
median
length
stay
normal
elev
high
lactat
group
day
quartil
day
quartil
day
quartil
p
comparison
multivari
analysi
patient
elev
lactat
time
ci
p
longer
length
stay
compar
normal
lactat
patient
high
lactat
time
ci
p
longer
length
stay
compar
normal
lactat
conclus
postop
lactat
level
associ
increas
length
hospit
stay
patient
undergo
major
cardiac
surgeri
intervent
aim
decreas
postop
lactat
level
may
decreas
hospit
length
stay
potenti
benefi
ts
protocol
intens
alveolar
recruit
may
outweigh
detriment
eff
ect
hemodynam
stabil
cardiac
surgeri
aim
studi
analyz
hemodynam
behavior
patient
includ
trial
intens
alveolar
recruit
cardiac
surgeri
method
random
trial
assign
adult
patient
pao
fio
peep
cmh
either
intens
alveolar
recruit
standard
protocol
use
lowtid
volum
ventil
ml
kgibw
adequ
volemia
statu
hypothesi
intens
alveolar
recruit
protocol
control
pressur
cmh
peep
cmh
minut
repeat
three
time
interv
maneuv
would
caus
hemodynam
instabl
result
total
patient
includ
standard
intens
group
patient
intens
group
signifi
cant
reduct
map
hour
hour
hour
protocol
return
baselin
figur
patient
sever
hypotens
map
mmhg
studi
stop
case
length
hospit
stay
shorter
among
patient
intens
group
vs
day
p
conclus
intens
alveolar
recruit
protocol
result
hemodynam
instabl
hypoxem
patient
cardiac
surgeri
introduct
nation
univers
hospit
singapor
recent
form
divis
critic
care
respiratori
therapi
servic
rapidli
expand
provid
respiratori
therapi
servic
cardiothorac
intens
care
unit
cticu
one
goal
servic
expans
reduct
durat
mechan
ventil
cardiac
surgeri
hypothes
introduct
teambas
extub
protocol
would
reduc
durat
mechan
ventil
ultim
aff
ect
icu
length
stay
method
multidisciplinari
group
creat
teambas
extub
protocol
protocol
appli
elect
postop
cardiac
surgeri
patient
assess
protocol
impact
data
collect
registri
month
month
protocol
initi
data
collect
includ
cardiopulmonari
bypass
time
mccormack
airway
assess
icu
admiss
time
initi
ph
lactat
inotrop
upon
arriv
cticu
blood
ga
analysi
prior
extub
time
extub
length
stay
patient
exclud
data
analysi
experienc
event
contraind
applic
protocol
signifi
cant
intraop
postop
complic
event
explicitli
state
extub
protocol
singapor
domainspecifi
c
review
board
grant
waiver
patient
consent
analyz
present
data
result
total
patient
undergo
elect
open
cardiac
surgeri
includ
patient
protocol
implement
preprotocol
patient
implement
postprotocol
signifi
cant
diff
erenc
mean
age
vs
p
gender
vs
p
euroscor
vs
p
proport
receiv
bypass
surgeri
vs
p
valv
surgeri
vs
p
two
group
median
extub
time
reduc
hour
minut
vs
minut
p
icu
length
stay
also
reduc
follow
introduct
preprotocol
hour
versu
hour
post
protocol
p
conclus
teambas
extub
protocol
signifi
cantli
reduc
durat
mechan
ventil
translat
reduc
icu
length
stay
patient
undergo
elect
openheart
surgeri
introduct
frailti
defi
ned
multidimension
syndrom
involv
loss
physic
cognit
reserv
lead
greater
vulner
advers
event
event
includ
suscept
unplan
hospit
admiss
death
frailti
associ
increas
icu
mortal
reduc
qualiti
life
aim
studi
investig
impact
baselin
frailti
postop
qualiti
life
indic
postop
frailti
follow
cardiothorac
surgeri
method
adult
patient
undergo
cardiac
surgeri
thorac
surgeri
involv
thoracotomi
includ
studi
baselin
measur
frailti
perform
statu
prospect
record
use
valid
tool
inform
consent
obtain
prior
inclus
outcom
measur
apach
ii
score
durat
ventil
length
icu
stay
mortal
record
followup
month
conduct
telephon
assess
recoveri
pattern
result
total
patient
includ
studi
includ
patient
underw
cardiac
surgeri
patient
underw
thorac
surgeri
eightyfi
patient
male
mean
age
year
rang
year
mean
baselin
frailti
score
also
vari
wide
within
cohort
four
patient
die
icu
follow
surgeri
icu
mortal
rate
mean
length
icu
stay
day
rang
day
mean
durat
ventil
hour
rang
hour
followup
patient
month
follow
surgeri
current
underway
conclus
owe
advanc
life
expect
health
periop
medicin
becom
diffi
cult
determin
fi
tness
major
surgeri
data
suggest
frailti
may
use
prognost
measur
help
inform
decis
refer
probabl
place
iabp
preoper
period
calcul
make
propens
analysi
obtain
two
homogen
group
treat
without
iabp
base
person
histori
function
statu
type
surgeri
seventyseven
patient
preoper
iabp
match
patient
without
bciao
nearest
propens
score
use
chisquar
test
student
test
need
binari
logist
regress
multivari
analysi
rule
possibl
confound
variabl
use
statist
packag
r
mac
result
total
record
iabp
insert
surgeri
perform
propens
score
analysi
pair
patient
without
bciao
base
epidemiolog
factor
type
surgeri
analysi
allcaus
mortal
patient
iabp
insert
prior
surgeri
die
versu
patient
without
iabp
preoper
implant
p
combin
endpoint
includ
need
prolong
mechan
ventil
hour
reoper
mediastin
stroke
surgeri
mortal
perform
occur
patient
preoper
iabp
versu
without
p
stratifi
ed
preoper
risk
analyz
euroscor
diff
erenc
group
observ
p
mortal
rate
p
combin
endpoint
patient
preoper
iabp
implant
higher
icu
length
stay
vs
p
diff
erenc
term
overal
hospit
stay
vs
ns
conclus
use
iabp
prior
cardiac
surgeri
patient
high
risk
reduc
mortal
rate
combin
endpoint
describ
icu
length
stay
greater
patient
iabp
implant
prior
surgeri
diff
erenc
overal
hospit
stay
intraort
balloon
pump
use
cardiac
surgeri
analysi
data
ariam
registri
cardiac
surgeri
j
md
delgadoamaya
e
curielbalsera
c
joyamontosa
g
besid
mortal
higher
later
iabp
implant
higher
mortal
rate
preoper
surgic
start
icu
p
icu
length
stay
day
hospit
length
stay
day
patient
need
iabp
icu
stay
higher
need
vs
day
p
wherea
diff
erenc
hospit
stay
vs
day
p
conclus
intraaort
balloon
pump
use
surgeri
perform
studi
period
patient
increas
risk
periop
complic
estim
euroscor
icu
length
stay
higher
patient
requir
iabp
diff
erenc
overal
hospit
stay
mortal
rate
higher
increas
delay
implant
hypothesis
pharyng
oxygen
concentr
would
maintain
higher
longer
transnas
humidifi
ed
rapid
insuffl
ation
ventilatori
exchang
thrive
convent
bagmask
preoxygen
cpo
cpo
requir
mask
remov
laryngoscopi
mean
air
may
enter
mouth
subsequ
apnoeic
oxygen
less
eff
ectiv
oral
suction
could
exacerb
process
howev
high
pharyng
oxygen
concentr
open
airway
maintain
apnoeic
oxygen
could
substanti
improv
method
use
includ
nodesat
recent
thrive
shown
extend
apnoea
time
hour
method
volunt
nasopharyng
sampl
cathet
underw
simul
emerg
airway
manag
eam
use
cpo
thrive
without
suction
follow
minut
preoxygen
cpo
fio
feo
thrive
lminut
optifl
ow
fisher
paykel
eam
simul
voluntari
apnoea
pharyngoscopi
laryngoscop
blade
tip
place
cm
posterior
pharyng
wall
capnographi
laryngoscop
tip
confi
rmed
apnoea
pharyng
ga
sampl
ml
collect
apnoea
second
oropharyng
suction
preoxygen
repeat
sampl
sampl
n
analys
use
calibr
fuel
cell
result
pharyng
oxygen
concentr
mean
sem
shown
figur
point
signifi
cant
p
conclus
pharyng
oxygen
concentr
rapidli
fall
follow
cpo
may
detriment
apnoeic
oxygen
con
vention
laryngoscopi
convers
thrive
maintain
high
pharyng
oxygen
concentr
time
suction
immedi
neg
eff
ect
pharyng
oxygen
concentr
attenu
thrive
assess
nodesat
lminut
abandon
due
discomfort
refer
critic
care
volum
suppl
http
locat
posit
light
sourc
standard
macintosh
blade
thu
provid
view
angl
usb
camera
connect
laptop
total
fi
rst
patient
present
emerg
depart
period
month
need
intub
includ
studi
everi
altern
patient
particip
evalu
assembl
video
laryngoscop
val
inform
patient
demograph
airway
characterist
cormacklehan
cl
view
eas
intub
use
val
collect
failur
defi
ned
one
attempt
intub
result
excel
good
laryng
exposur
obtain
patient
respect
patient
val
perform
compar
superior
view
intub
direct
laryngoscopi
success
patient
val
success
patient
three
patient
val
group
four
patient
direct
laryngoscopi
group
exclud
see
figur
conclus
new
assembl
val
cheapest
videoassist
laryngoscop
avail
cost
around
even
introduc
primari
healthcar
setup
develop
countri
val
consist
yield
compar
superior
glottic
view
compar
direct
laryngoscopi
despit
limit
lack
prior
experi
devic
devic
use
routin
well
diffi
cult
tracheal
intub
may
help
tool
intub
trauma
case
cspine
immobil
unavoid
present
videoassist
laryngoscop
use
tool
document
teach
monitor
tracheal
intub
introduct
airway
complic
common
outsid
oper
theatr
emerg
situat
capnographi
remain
gold
standard
confi
rming
correct
endotrach
tube
ett
placement
retain
high
sensit
specifi
citi
cardiac
arrest
european
resuscit
council
guidelin
adult
advanc
life
support
recommend
waveform
capnographi
set
failur
use
capnographi
also
identifi
ed
major
contributor
airwayrel
morbid
mortal
nation
uk
audit
sought
investig
current
practic
relat
avail
use
capnographi
equip
cardiac
arrest
within
uk
hospit
method
june
novemb
telephon
survey
conduct
uk
acut
hospit
adult
level
icu
emerg
depart
ed
hospit
identifi
ed
use
nation
avail
data
standardis
telephon
questionnair
develop
examin
practic
regard
intub
cardiac
arrest
avail
utilis
capnographi
within
ed
icu
gener
ward
question
direct
anaesthetist
intens
care
doctor
respond
cardiac
arrest
call
respond
given
option
declin
particip
data
anonymis
result
total
hospit
met
inclus
criteria
respons
rate
arrest
call
mainli
attend
anaesthesia
icu
doctor
around
physician
registrar
grade
abil
measur
etco
avail
four
ed
use
waveform
capnographi
similar
pattern
seen
seen
vast
major
icu
singl
institut
report
capnographi
avail
howev
hospit
survey
facil
measur
etco
present
gener
ward
avail
use
capnographi
confi
rm
ett
placement
less
use
etco
determin
cpr
eff
ectiv
prognost
conclus
believ
fi
rst
studi
kind
follow
investig
avail
capnographi
throughout
use
cardiac
arrest
whilst
equip
level
appear
adequ
albeit
perfect
resuscit
area
appear
lack
avail
suitabl
devic
gener
ward
introduct
nasogastr
ng
tube
insert
necessari
varieti
critic
ill
patient
intraabdomin
decompress
prevent
aspir
rout
medic
administr
nutrit
howev
often
fail
patient
show
sedat
comatos
mental
poor
cooper
procedur
although
mani
report
insert
ng
tube
diffi
cult
case
method
need
special
guid
wire
tube
nasoendoscop
report
case
ng
tube
insert
comatos
patient
use
laryngoscop
endotrach
tube
easili
avail
introduct
bantri
gener
hospit
bgh
small
rural
hospit
serv
larg
geograph
isol
part
southwest
ireland
follow
infl
uential
nation
review
adult
critic
care
servic
protocol
introduc
late
mandat
immedi
transfer
medic
patient
intub
emerg
basi
larg
critic
care
centr
km
away
similar
mandatori
transfer
protocol
introduc
time
throughout
island
ireland
data
avail
regard
patient
outcom
design
studi
look
outcom
patient
encompass
protocol
bgh
method
retrospect
review
chart
electron
data
medic
patient
requir
emerg
intub
bgh
novemb
decemb
record
follow
data
age
sex
admiss
diagnosi
comorbid
time
delay
transfer
intransit
mortal
length
stay
surviv
discharg
mortal
result
fortyfi
patient
male
includ
mean
age
year
commonest
admiss
diagnos
sepsi
cardiogen
shock
primari
respiratori
failur
nine
intracrani
haemorrhag
eight
median
transfer
delay
time
minut
patient
actual
transfer
signifi
cantli
younger
nontransf
patient
vs
year
p
intransit
mortal
zero
mean
length
stay
critic
care
centr
day
surviv
discharg
signifi
cantli
higher
transfer
compar
nontransf
patient
vs
p
overal
mortal
rate
month
respect
signifi
cantli
lower
transfer
group
p
conclus
overal
mortal
rate
medic
patient
intub
urgent
bgh
high
forti
per
cent
intub
patient
transfer
indic
signifi
cant
modifi
cation
protocol
time
patient
transfer
critic
care
centr
younger
signifi
cantli
better
outcom
patient
remain
bgh
probabl
due
decis
transfer
patient
poor
prognos
patient
surviv
discharg
still
aliv
month
later
refer
introduct
video
laryngoscopi
vl
known
improv
glottic
visual
fi
rstattempt
success
rate
compar
direct
laryngoscopi
dl
emerg
tracheal
intub
eti
sinc
vl
align
oral
pharyng
laryng
axe
upper
airway
sometim
lead
fail
intub
despit
good
glottic
visual
test
hypothesi
vl
lower
fi
rstattempt
success
rate
eti
dl
among
patient
good
glottic
visual
method
perform
prospect
observ
studi
examin
eti
tertiari
care
institut
juli
june
consecut
patient
underw
eti
emerg
depart
icu
includ
patient
year
age
intub
vl
use
cmac
exclud
eti
eff
ort
oper
complet
standard
data
collect
form
classifi
ed
glottic
visual
good
cl
grade
poor
cl
grade
primari
outcom
fi
rstattempt
success
rate
introduct
rapid
sequenc
induct
rsi
icu
emerg
depart
ed
oper
room
carri
risk
hypoxemia
laryngoscopi
prolong
especi
highrisk
patient
bag
mask
preoxygen
normal
use
extend
apnoea
time
howev
arteri
desatur
may
still
rapidli
occur
transnas
humidifi
ed
rapid
insuffl
ation
ventilatori
exchang
thrive
new
techniqu
provid
modest
cpap
preoxygen
crucial
also
continu
oxygen
pharyng
space
throughout
apnoeic
period
elect
surgeri
thrive
provid
apnoea
time
long
minut
due
apnoeic
oxygen
report
fi
rst
implement
thrive
emerg
patient
icu
ed
method
follow
train
thrive
system
instal
locat
either
fi
xed
system
anaesthet
machin
mobil
solut
wheel
stand
icu
er
simplifi
ed
optifl
ow
system
fisher
paykel
new
zealand
consist
highfl
ow
rotamet
reusabl
humidifi
er
reusabl
circuit
dispos
nasal
interfac
anaesthetist
grade
encourag
use
thrive
lminut
prior
highrisk
intub
introduct
agonist
increas
ciliari
beat
frequenc
experiment
model
rais
possibl
may
use
airway
hygien
salbutamol
increas
larg
airway
mucociliari
clearanc
although
may
true
smaller
airway
data
icu
patient
decid
test
eff
ectiv
transtrach
instil
mixtur
ipratropium
salbutamol
assess
reduct
number
aspir
hour
ventil
method
open
random
prospect
studi
held
admit
patient
altern
select
studi
control
group
includ
submit
invas
ventil
least
hour
four
patient
secondari
cardiac
rhythm
eff
ect
attribut
agonist
exclud
studi
group
ml
dilut
ml
ipratropium
mg
plu
salbutamol
mg
ml
distil
water
instil
aspir
secret
ventil
period
note
group
addit
demograph
data
number
tracheal
aspir
day
hour
ventil
conclus
preliminari
analysi
refer
fi
rst
month
studi
show
tendenc
reduct
ventil
hour
length
stay
studi
group
signifi
cant
diff
erenc
found
number
aspir
may
explain
icu
nurs
routin
studi
tri
fi
nd
whether
signifi
cant
diff
erenc
incid
vap
exist
allow
procedur
implement
icu
routin
hypothesis
simultan
use
heat
moistur
exchang
hme
heat
humidifi
er
hh
would
increas
incid
airway
occlus
period
comparison
devic
isol
bench
studi
compar
incid
airway
occlus
use
group
airway
humidifi
cation
group
hme
alon
group
hh
alon
group
hme
hh
combin
tracheal
intub
requir
use
artifi
cial
humidifi
cation
system
hme
less
effi
cient
conveni
especi
short
period
intub
hh
commonli
expens
devic
often
use
close
proxim
icu
depend
particular
clinic
scenario
clinic
practition
follow
critic
incid
hme
obstruct
due
waterlog
icu
realis
hh
hme
may
use
togeth
inadvert
airway
obstruct
resolv
remov
hme
patient
breath
circuit
introduct
ventilatorassoci
pneumonia
vap
common
complic
mechan
ventil
patient
frequent
pathogen
respons
deriv
aspir
secret
upper
respiratori
tract
stomach
order
prevent
aspir
two
mission
attain
good
tracheal
cuff
seal
welltoler
pressur
togeth
continu
evacu
secret
subglott
space
two
goal
achiev
use
anapnoguard
system
relat
endotrach
tube
ett
method
singlecent
openlabel
studi
gener
icu
control
group
retrospect
data
mechan
ventil
patient
standard
care
regular
ett
manual
suction
trachea
oralpharyng
space
nurs
staff
studi
group
prospect
data
connect
time
anapnoguard
system
ett
two
abovethecuff
suction
port
third
port
lumen
rins
co
measur
tripl
lumen
har
connect
control
system
design
measur
co
level
cuff
identifi
leak
infl
ate
cuff
accordingli
rins
suction
secret
cuff
includ
studi
patient
pneumonia
admiss
least
day
mechan
ventil
vap
diagnos
new
chest
xray
infi
ltrate
accompani
fever
leucocytosi
posit
sputum
cultur
sinc
introduct
develop
percutan
dilat
tracheostomi
pdt
procedur
accept
incorpor
icu
worldwid
spite
obviou
benefi
ts
patient
obtain
comfort
mobil
less
use
sed
procedur
also
impli
risk
sever
complic
may
lethal
sever
complic
includ
hemorrhag
displac
pneumothorax
diff
erent
method
pdt
describ
literatur
disadvantag
benefi
ts
aim
studi
analyz
complic
due
pdt
perform
without
use
bronchoscop
assist
method
studi
conduct
danish
eightb
nonunivers
icu
sinc
patient
admit
icu
regist
electron
patient
record
system
daili
vital
valu
diagnos
procedur
healthcar
provid
note
enter
search
percutan
dilat
tracheostomi
electron
system
found
patient
undergon
specifi
c
procedur
afterward
analyz
patient
hospit
record
look
periprocedur
postprocedur
complic
note
within
day
addit
regist
patient
age
sex
bmi
sofa
score
method
use
procedur
experi
oper
result
total
patient
admit
uci
undergon
pdt
two
exclud
due
pdt
perform
anoth
hospit
admiss
icu
pdt
perform
ciaglia
blue
rhino
method
pdt
perform
bronchoscop
guidanc
case
kind
complic
due
pdt
regist
six
case
need
surgic
hemostasi
three
case
bleed
need
transfus
blood
product
one
case
pdt
displac
one
case
ventilationrel
problem
procedur
fi
nalli
one
case
tracheal
cartilag
fractur
incid
pneumothorax
pdt
lethal
outcom
due
procedur
total
complic
rate
case
four
complic
occur
procedur
rest
occur
procedur
overal
periprocedur
complic
rate
conclus
studi
pdt
without
use
bronchoscop
guidanc
perform
safe
low
rate
complic
outlin
decision
algorithm
choos
appropri
techniqu
case
reduc
incid
complic
method
retrospect
review
perform
use
data
last
year
two
hundr
patient
select
patient
divid
two
group
one
includ
fi
rst
pdt
treat
without
algorithm
nagroup
includ
last
patient
treat
algorithm
agroup
valuat
clinic
anatom
featur
patient
neck
ultrasound
fi
brobronchoscopi
came
procedur
algorithm
formul
experi
pdt
techniqu
compar
specifi
c
characterist
one
physiopatholog
characterist
patient
record
complic
bleed
tracheoesophag
fi
stula
subglott
stenosi
tracheal
ring
fractur
diffi
culti
placement
chang
procedur
relat
pdt
perform
without
appli
algorithm
consid
complic
occur
experi
chang
modal
techniqu
choic
figur
compar
complic
report
nagroup
use
algorithm
guid
choos
kind
pdt
techniqu
seem
reduc
incid
complic
vs
p
chisquar
test
conclus
experi
applic
propos
algorithm
may
reduc
incid
complic
relat
pdt
icu
howev
random
control
multicent
studi
would
necessari
order
confi
rm
effi
cienci
valid
propos
algorithm
refer
introduct
percutan
bedsid
tracheostomi
pbt
frequent
done
procedur
icu
pbt
cleancontamin
procedur
durat
procedur
minut
depend
physician
procedur
skill
rate
infecti
complic
effi
caci
periop
therapi
reduc
infect
pbt
current
unknown
current
defi
nitiv
recommend
prophylact
antibiot
therapi
pbt
icu
method
clinic
microbiolog
data
retrospect
collect
analyz
icu
stay
pbt
perform
hour
pbt
procedur
patient
icu
control
defi
ned
patient
pbt
procedur
perform
icu
antibiot
administ
hour
prior
procedur
group
n
case
defi
ned
patient
pbt
procedur
perform
icu
without
antibiot
administ
hour
prior
procedur
group
n
secondari
bacteremia
line
sepsi
vap
hour
pbt
consid
infecti
complic
twotail
p
consid
signifi
cant
result
diff
erenc
found
age
gender
admiss
diagnos
length
icu
stay
inhospit
mortal
rate
two
studi
group
overal
gramneg
gramposit
fungal
fl
ora
similar
group
pbt
patient
receiv
antibiot
therapi
lower
incid
new
ventilatorassoci
pneumonia
vap
episod
group
vs
group
p
tabl
diff
erenc
incid
bacteremia
line
sepsi
tabl
conclus
fi
nding
highlight
import
conduct
prospect
random
control
trial
better
understand
role
antibiot
prophylaxi
pbt
introduct
respiratori
failur
wellknown
complic
aortic
aneurysm
surgeri
describ
impact
protocol
use
cpap
elect
surgeri
reduc
need
unplan
invas
ventil
method
introduc
cpap
protocol
patient
undergo
elect
aortic
aneurysm
surgeri
either
open
aaa
endovascular
repair
evar
accord
preexist
risk
factor
see
tabl
arteri
blood
ga
analysi
anaesthet
room
assign
two
altern
option
itu
prophylact
cpap
hour
fi
rst
two
postop
night
oxygen
via
face
mask
cpap
appli
time
patient
stay
pf
ratio
drop
criteria
stop
cpap
also
predefi
ned
previous
cpap
initi
discret
nurs
staff
pf
ratio
utilis
tabl
present
requir
invas
ventil
ippv
length
stay
lo
patient
group
conclus
clear
reduct
need
unplan
ippv
patient
group
audit
show
incomplet
protocol
adher
itu
therefor
benefi
ts
may
underestim
gastric
tube
burden
noninvas
ventil
although
niv
thought
comfort
patient
invas
mechan
ventil
failur
rate
icu
rang
except
interfacerel
problem
specifi
c
consider
patientventil
interact
appli
mechan
forc
niv
predisposit
stomach
infl
ate
ga
could
caus
sever
respiratori
complic
especi
copd
patient
thu
prolong
mechan
ventil
wean
process
remain
one
major
caus
niv
failur
although
lot
face
mask
diff
erent
interfac
avail
market
addit
port
ngt
character
higher
price
complex
setup
order
perform
niv
patient
requir
ngt
placement
without
addit
air
leak
abl
ensur
enter
nutrit
andor
stomach
drainag
instal
port
ngt
standard
face
mask
method
studi
six
copd
patient
admit
icu
requir
ngt
placement
ventil
draeger
evita
dura
modifi
ed
reusabl
silicon
face
mask
umdn
code
mm
id
connect
size
silicon
headgear
hook
ring
ngt
stay
icu
evalu
effi
caci
modifi
cation
compar
achiev
vt
modifi
ed
unmodifi
ed
face
mask
two
period
minut
mode
paramet
ventil
chang
assess
patient
comfort
visual
analogu
scale
averag
durat
niv
day
sd
examin
two
set
consequ
breath
cycl
everi
patient
mean
vt
ml
sd
ml
standard
face
mask
ml
sd
ml
modifi
ed
one
statist
signifi
cant
correl
two
dataset
p
addit
leak
detect
accord
va
evalu
fi
patient
comfort
improv
modifi
ed
mask
conclus
modifi
cation
face
mask
achiev
adequ
drainag
stomach
andor
enter
nutrit
patient
improv
comfort
niv
compar
ventil
standard
mask
without
addit
air
leak
low
cost
introduct
lung
ultrasound
lu
allow
semiquantifi
cation
lung
aerat
peep
trial
pneumonia
wean
lu
score
base
numbercoalesc
vertic
artifact
bline
longitudin
scan
long
pleura
identifi
ed
two
rib
visual
limit
intercost
space
ic
width
hypothes
transvers
scan
transv
align
ic
would
visual
longer
pleura
higher
number
artifact
better
assess
loss
aerat
loa
method
long
transv
perform
six
area
per
lung
anterior
later
posterior
divid
superior
inferior
long
perform
transv
obtain
probe
rotat
rib
disappear
consid
pleural
length
bline
numbercoalesc
subpleurallobar
consolid
lu
score
assign
normal
lung
moder
loa
wellspac
bline
sever
loa
coalesc
bline
complet
loa
tissuelik
pattern
result
enrol
patient
male
age
year
bmi
kgm
correspond
icss
icss
tissuelik
pattern
visual
techniqu
long
versu
transv
pleural
length
cm
rang
varianc
versu
cm
rang
varianc
p
bline
per
scan
versu
p
coalesc
bline
detect
versu
p
subpleur
consolid
versu
p
respect
lu
score
preval
signifi
cantli
diff
ere
long
versu
transv
figur
conclus
transv
visual
signifi
cantli
longer
pleura
greater
number
artifact
use
lung
diseas
assess
ultrasound
assess
extravascular
lung
water
patient
septic
shock
p
pirompanich
wattanathum
thammasat
univers
pathumthani
thailand
phramongkutklao
hospit
bangkok
thailand
critic
care
suppl
doi
introduct
extravascular
lung
water
evlw
refer
fl
uid
within
lung
outsid
vascular
compart
increment
evlw
associ
mortal
critic
ill
patient
extravascular
lung
water
index
evlwi
mlkg
found
patient
cardiogen
pulmonari
edema
correl
pulmonari
capillari
wedg
pressur
mmhg
measur
evlw
need
sophist
tool
invas
method
transpulmonari
thermodilut
tptd
techniqu
contrast
multipl
bline
lung
ultrasound
lu
recent
propos
correl
increas
evlw
patient
pulmonari
edema
studi
aim
compar
three
method
lu
evlwi
measur
tptd
assess
pulmonari
edema
patient
septic
shock
method
author
prospect
enrol
patient
septic
shock
admit
medic
icu
phramongkutklao
hospit
septemb
june
evlwi
measur
tptd
volumeview
set
edward
lifesci
method
accord
intern
evidencebas
recommend
pointofcar
lung
ultrasound
three
method
lu
logiq
e
ultrasound
ge
healthcar
compar
assess
evlw
daili
patient
indic
invas
blood
pressur
monitor
firstli
bline
measur
lung
zone
total
number
bline
seen
patient
count
total
bline
score
tb
secondli
upper
lower
blue
point
anterior
tworegion
scan
side
mark
physician
hand
pulmonari
edema
diagnos
three
bline
present
region
lastli
scan
eight
region
two
anterior
two
later
per
side
consid
abnorm
one
scan
per
side
three
bline
result
total
comparison
obtain
signifi
cant
posit
linear
correl
found
tb
evlwi
determin
tptd
r
p
tb
sensit
specifi
citi
defi
ne
evlwi
mlkg
low
sensit
respect
high
specifi
citi
respect
posit
blue
point
eight
region
defi
ne
evlwi
mlkg
conclus
tb
best
method
assess
evlw
compar
blue
point
eight
region
data
support
benefi
lu
summat
bline
score
rib
interspac
assess
increment
evlw
septic
shock
patient
refer
introduct
mechan
ventil
mv
induc
diaphragmat
muscl
atrophi
contractil
fi
bre
dysfunct
socal
ventilatorinduc
diaphragm
dysfunct
vidd
although
diaphragmat
atrophi
assess
use
ultrasound
biggest
trial
human
publish
far
includ
seven
patient
measur
thick
two
moment
diseas
process
aim
assess
time
cours
diaphragm
atrophi
larger
cohort
mv
patient
use
ultrasound
method
total
patient
adult
icu
includ
prospect
singlecentr
cohort
trial
patient
need
hour
mv
recent
admit
icu
exclud
patient
ventil
control
assist
andor
hybrid
ventil
mode
thick
diaphragm
assess
daili
fi
rst
record
within
hour
start
mechan
ventil
continu
measur
patient
extub
tracheotomis
measur
diaphragm
zone
apposit
describ
mccool
colleagu
use
linear
mhz
ultrasound
probe
figur
show
sampl
measur
success
abl
record
diaphragm
thick
includ
patient
median
time
ventil
day
iqr
day
mean
baselin
thick
mm
sd
mm
mean
nadir
mm
sd
mm
correspond
mean
chang
thick
sd
earli
hour
mv
alreadi
note
averag
drop
diaphragm
thick
illustr
rapid
progress
atrophi
vidd
conclus
averag
diaphragm
thick
decreas
cohort
decreas
occur
rapidli
twothird
maxim
thin
alreadi
present
hour
mv
refer
introduct
chestxray
recommend
routin
use
patient
suspect
pneumonia
use
emerg
set
limit
studi
diagnost
perform
new
method
quantit
analysi
lung
ultrasonographi
compar
bedsid
chest
xray
visual
lung
ultrasonographi
detect
communityacquir
pneumonia
use
thorac
comput
tomographi
gold
standard
method
thirtytwo
spontan
breath
patient
suspect
communityacquir
pneumonia
undergo
comput
tomographi
examin
consecut
enrol
hemithorax
evalu
presenc
absenc
abnorm
chest
xray
quantit
visual
ultrasonographi
result
quantit
ultrasonographi
show
higher
sensit
specifi
citi
diagnost
accuraci
chest
xray
respect
visual
ultrasonographi
respect
combin
respect
conclus
quantit
lung
ultrasonographi
consider
accur
either
chest
xray
visual
ultrasonographi
diagnosi
communityacquir
pneumonia
may
repres
use
fi
rstline
approach
confi
rmation
clinic
diagnosi
emerg
set
introduct
one
aim
lung
recruit
improv
oxygen
yet
investig
spontan
breath
patient
object
evalu
eff
ect
recruit
maneuv
oxygen
patient
ventil
cpap
pressur
support
cpapp
mode
method
prospect
observ
studi
patient
lung
injuri
score
recruit
follow
baselin
measur
peep
increas
cmh
recruit
maneuv
appli
second
cmh
ps
measur
taken
immedi
recruit
minut
minut
later
result
accord
diff
erenc
pao
fio
three
group
defi
ned
nonrespond
nr
diff
erenc
pao
fio
n
low
respond
lr
diff
erenc
pao
fio
n
high
respond
hr
diff
erenc
pao
fio
n
nrgroup
pao
fio
decreas
signifi
cantli
median
interquartil
pao
fio
versu
mmhg
lrgroup
hrgroup
signifi
cant
improv
versu
mmhg
versu
mmhg
p
respect
dynam
complianc
c
dyn
signifi
cantli
drop
compar
nrgroup
c
dyn
versu
mlcmh
signifi
cant
chang
lrand
hrgroup
p
time
point
dead
space
tidal
volum
ratio
vdsvte
signifi
cantli
increas
nrgroup
vdsvte
versu
lrand
hrgroup
p
conclus
recruit
maneuv
improv
pao
fio
major
patient
without
aff
ect
c
dyn
vdsvte
therefor
may
safe
approach
improv
oxygen
patient
ventil
cpapp
mode
refer
tradit
parametr
sampl
size
estim
depend
upon
restrict
assumpt
often
hold
real
data
studi
estim
n
detect
chang
length
mechan
ventil
lomv
use
montecarlo
simul
mc
mechan
ventil
mv
data
better
simul
cohort
method
data
mv
patient
admit
christchurch
hospit
icu
use
n
estim
use
mc
determin
sampl
size
power
compar
altman
nomogram
two
patient
group
patient
target
patient
lomv
day
mc
allow
rang
intervent
eff
ect
simul
studi
test
diff
erenc
lomv
day
mean
lomv
day
simul
lomv
intervent
group
compar
lomv
control
group
use
onesid
wilcoxon
ranksum
test
student
test
kolmogorovsmirnov
test
assess
central
tendenc
variat
result
distribut
lomv
heavili
skew
altman
nomogram
assum
normal
distribut
found
n
detect
lomv
chang
figur
panel
show
n
power
patient
includ
panel
target
patient
group
panel
show
imposs
achiev
power
intervent
eff
ect
eff
ect
msc
found
n
patient
n
target
cohort
conclus
tradit
parametr
sampl
size
estim
may
overestim
requir
patient
mc
estim
eff
ectiv
narm
evalu
specifi
c
patient
group
object
captur
local
clinic
practic
impact
lomv
import
consid
target
specifi
c
patient
group
appli
patient
select
criteria
easili
translat
trial
design
introduct
benzodiazepin
use
mani
set
induc
sedat
caus
reduct
respiratori
drive
object
monitor
eff
ect
benzodiazepin
respiratori
statu
nonintub
patient
diffi
cult
put
patient
safeti
risk
noninvas
respiratori
volum
monitor
rvm
provid
continu
measur
minut
ventil
mv
tidal
volum
tv
respiratori
rate
rr
use
quantifi
eff
ect
midazolam
respiratori
statu
spontan
breath
patient
method
impedancebas
rvm
exspiron
respiratori
motion
inc
waltham
usa
use
patient
receiv
mg
midazolam
prior
induct
anesthesia
sedat
spontan
breath
eleven
patient
year
averag
bmi
receiv
midazolam
least
minut
prior
induct
digit
rvm
data
collect
mv
tv
rr
calcul
evalu
segment
minut
fi
rst
dose
midazolam
ten
patient
analyz
group
one
patient
analyz
separ
due
idiosyncrat
reaction
result
follow
administr
midazolam
group
mv
tv
decreas
averag
respect
mean
sem
p
rr
remain
essenti
unchang
decreas
p
younger
half
cohort
year
decreas
mv
tv
signifi
cant
respect
older
half
cohort
year
display
fourfold
greater
mv
tv
decreas
p
p
compar
younger
cohort
p
figur
conclus
continu
monitor
rvm
provid
valuabl
depict
hypoventil
benzodiazepin
demonstr
methodolog
puls
oximetri
rr
alon
rvm
monitor
help
uncov
potenti
lifethreaten
hypoventil
older
patient
studi
ongo
quantifi
hypoventil
administr
anesthet
medic
introduct
mechan
ventil
potenti
induc
pulmonari
coagulopathi
local
treatment
nebul
heparin
could
benefi
cial
ventil
patient
aim
data
metaanalysi
determin
associ
nebul
heparin
outcom
mechan
ventil
critic
ill
patient
method
pubm
scopu
embas
web
scienc
search
relev
articl
articl
select
compar
nebul
heparin
standard
care
primari
endpoint
overal
mortal
secondari
endpoint
includ
occurr
pneumonia
number
ventilatorfre
day
aliv
day
result
six
articl
found
fi
retrospect
cohort
histor
control
one
random
control
trial
cover
patient
dosag
nebul
heparin
vari
iuday
fifti
patient
receiv
nebul
heparin
patient
receiv
standard
care
die
risk
ratio
rr
ci
see
figur
occurr
pneumonia
rr
ci
number
ventilatorfre
day
aliv
day
standard
mean
diff
erenc
ci
diff
erent
two
group
conclus
nebul
heparin
associ
improv
outcom
mechan
ventil
critic
ill
patient
metaanalysi
limit
methodolog
problem
includ
studi
one
random
control
trial
could
includ
also
patient
metaanalyz
studi
suff
ere
inhal
trauma
heparin
dosag
diff
ere
wide
frequent
reason
hypercapn
respiratori
failur
hrf
icu
copd
recent
year
obes
hypoventil
syndrom
oh
obstruct
sleep
apnea
osa
even
copd
patient
also
accompani
osa
due
increas
upper
airway
resist
patient
requir
higher
expiratori
pressur
epap
noninvas
ventil
niv
order
prescrib
optim
mode
pressur
icu
stay
discharg
intensivist
diagnos
underli
osa
portabl
record
devic
develop
approv
least
diagnosi
high
pretest
probabl
patient
result
equal
inlaboratori
polysomnographi
aim
studi
assess
whether
respiratori
polygraph
rplg
use
obtain
diagnost
inform
osa
hypercapn
icu
patient
method
patient
hrf
requir
niv
includ
studi
rplg
studi
conduct
nasal
oxygen
niv
use
philip
respiron
alic
devic
provid
record
puls
oximetri
deriv
heart
rate
snore
nasal
airfl
ow
nasal
pressur
transduc
nasal
thermistor
rib
cage
abdomin
motion
bodi
posit
abdomin
thorac
belt
american
academi
sleep
medicin
recommend
use
diagnosi
osa
oh
diagnost
diffi
culti
hypopnea
hypoxem
patient
evalu
obstruct
apnea
index
oai
instead
apnea
hypopnea
index
ahi
result
thirtyon
patient
mean
age
year
includ
studi
mean
apach
ii
score
bmi
kgm
admiss
arteri
blood
gase
follow
mean
sd
ph
pao
mmhg
paco
mmhg
hco
sat
admiss
diagnos
patient
oh
copd
mean
oai
patient
oai
eightyon
percent
n
record
interpret
clinic
rplg
data
support
new
diagnosi
osa
patient
epap
level
increas
laboratori
sleep
studi
recommend
patient
end
studi
copd
oh
patient
identifi
ed
osa
conclus
although
underestim
ahi
rplg
import
technic
feasibl
icu
patient
suggest
presenc
osa
provid
inform
appropri
niv
manag
introduct
respiratori
muscl
weak
common
mechan
ventil
patient
impair
liber
ventil
inspiratori
muscl
train
imt
might
acceler
liber
mechan
ventil
undertook
summar
previous
publish
imt
protocol
impact
imt
respiratori
muscl
function
clinic
outcom
method
search
multipl
databas
use
sensit
search
strategi
combin
mesh
head
keyword
studi
imt
mv
studi
adjud
inclus
data
abstract
independ
duplic
methodolog
qualiti
assess
use
grade
system
result
eleven
studi
met
inclus
criteria
six
random
control
trial
fi
observ
studi
critic
care
volum
suppl
http
varieti
imt
techniqu
employ
includ
inspiratori
threshold
load
eight
studi
biofeedback
increas
inspiratori
eff
ort
one
studi
chairsit
one
studi
diaphragmat
breath
pattern
train
one
studi
threshold
load
achiev
applic
extern
devic
six
studi
increas
inspiratori
pressur
trigger
set
two
studi
studi
implement
imt
wean
phase
n
diffi
cult
wean
n
one
studi
implement
imt
within
hour
intub
imt
associ
greater
increas
maxim
inspiratori
pressur
compar
control
six
studi
mean
diff
erenc
cmh
ci
signifi
cant
diff
erenc
durat
mv
six
studi
mean
diff
erenc
day
ci
rate
success
wean
figur
fi
studi
risk
ratio
ci
grade
qualiti
evid
low
outcom
risk
bia
high
studi
summari
eff
ect
imprecis
inconsist
seriou
advers
event
relat
imt
report
conclus
imt
mechan
ventil
patient
appear
safe
well
toler
improv
respiratori
muscl
function
imt
associ
acceler
liber
mechan
ventil
howev
includ
studi
import
methodolog
limit
employ
vari
method
imt
draw
fi
rm
conclus
eff
ect
imt
clinic
outcom
prospect
assess
abil
rapid
shallow
breath
index
comput
pressur
support
spontan
breath
trial
predict
extub
failur
icu
g
besch
j
revelli
p
jolliet
l
piquilloudimboden
chru
franc
chuv
lausann
switzerland
critic
care
suppl
doi
introduct
object
clinic
criteria
imperfect
assess
patient
extub
simpl
physiolog
paramet
use
tri
improv
extub
failur
ef
predict
rapid
shallow
breath
index
rsbi
respiratori
rate
rr
tidal
volum
vt
ratio
record
tpiec
spontan
breath
trial
sbt
known
reliabl
physiolog
predictor
howev
rsbi
nowaday
usual
comput
pressur
support
ps
sbt
use
valu
display
ventil
screen
base
spirometri
measur
without
assist
initi
publish
aim
present
studi
prospect
assess
abil
current
measur
rsbi
predict
ef
method
retrospect
analysi
prospect
collect
data
patient
intub
hour
admit
medicosurg
icu
lausann
switzerland
januari
decemb
ef
defi
ned
need
reintub
within
hour
extub
reintub
procedur
requir
gener
anesthesia
consid
ef
rr
vt
ps
sbt
record
ventil
rsbi
comput
accordingli
baselin
characterist
current
measur
rsbi
compar
patient
experienc
ef
versu
success
test
chisquar
test
appropri
abil
current
measur
rsbi
predict
ef
assess
use
roc
curv
analysi
result
total
extub
patient
includ
reintub
icu
mortal
icum
inhospit
mortal
hm
higher
reintub
patient
icum
versu
p
hm
versu
p
reason
ef
acut
lung
failur
n
congest
heart
failur
n
aspirationbronchi
congest
n
demograph
data
similar
patient
success
nonsuccess
extub
age
versu
year
p
male
gender
versu
p
sap
ii
score
higher
ef
group
versu
p
rsbi
signifi
cantli
higher
patient
experienc
ef
versu
p
area
roc
curv
current
measur
rsbi
ci
p
conclus
cohort
medicosurg
icu
patient
rsbi
measur
pressur
support
sbt
higher
patient
experienc
ef
imperfect
predict
ef
introduct
neutrophil
extracellular
trap
net
fi
brou
structur
produc
extracellularli
activ
neutrophil
trap
kill
variou
pathogen
releas
one
fi
rst
line
immun
system
meanwhil
recent
report
net
also
exert
advers
eff
ect
infl
ammatori
diseas
acut
respiratori
distress
syndrom
ard
acut
exacerb
idiopath
pulmonari
fi
brosi
acuteonset
respiratori
failur
character
excess
neutrophil
infi
ltration
alveolu
great
amount
neutrophil
elastas
releas
purpos
studi
evalu
whether
net
produc
bronchial
aspir
patient
ard
acut
exacerb
idiopath
pulmonari
fi
brosi
identifi
correl
respiratori
function
method
prospect
observ
studi
seven
patient
admit
icu
larg
urban
tertiari
referr
hospit
patient
mechan
ventil
time
admiss
bronchial
aspir
collect
serial
patient
suction
tracheal
tube
identifi
net
extracellular
compon
includ
dna
histon
citrullin
histon
simultan
detect
use
immunohistochemistri
respiratori
function
evalu
pao
fio
ratio
pf
ratio
result
studi
group
compris
four
men
three
women
median
age
iqr
year
old
reason
admiss
ard
n
acut
exacerb
idiopath
pulmonari
fi
brosi
n
reason
ard
bacteri
pneumonia
n
necrot
fasciiti
n
extens
burn
n
identifi
ed
net
bronchial
aspir
patient
net
format
persist
four
case
studi
period
pf
ratio
improv
patient
dead
due
respiratori
failur
hand
net
decreas
vanish
three
case
pf
ratio
improv
patient
recov
ard
conclus
net
format
observ
bronchial
aspir
patient
diagnos
ard
acut
exacerb
idiopath
pulmonari
fi
brosi
may
one
prognost
factor
ard
acut
exacerb
idiopath
pulmonari
fi
brosi
new
molecul
control
endotheli
barrier
jalkanen
univers
turku
finland
critic
care
suppl
doi
introduct
acut
lung
injuri
ali
hypoxem
form
acut
respiratori
distress
syndrom
ard
approv
pharma
colog
treatment
condit
high
mortal
vascular
leakag
one
earli
event
aliard
activ
maintain
endotheli
barrier
function
lung
capillari
via
enzymat
endproduct
adenosin
interferonbeta
increas
synthesi
eff
ectiv
mous
model
ali
method
therefor
conduct
phase
iii
trial
intraven
administ
human
recombin
use
studi
consist
dose
escal
phase
expans
phase
ii
part
test
safeti
toler
effi
caci
aliard
patient
mxa
marker
ifn
respons
biomark
measur
follow
pharmacokinet
dynam
intraven
administ
therapeut
effi
caci
result
optim
toler
dose
day
result
maxim
mxa
stimul
also
solubl
valu
increas
decreas
sera
aliard
patient
overal
mortal
patient
treat
introduct
mesenchym
stem
cell
msc
potent
stabil
eff
ect
vascular
endothelium
injuri
inhibit
endotheli
permeabl
lung
injuri
via
paracrin
hepatocyt
growth
factor
hgf
recent
indic
msc
secret
factor
mscendotheli
cell
mscec
interact
hypothes
mscec
interact
restor
endotheli
permeabl
induc
lipopolysaccharid
lp
via
paracrin
hgf
method
investig
endotheli
permeabl
induc
lp
two
cocultur
condit
transwel
hpmec
ad
upper
chamber
cellcultur
insert
two
diff
erent
cocultur
condit
lower
side
transwel
follow
mscec
interact
group
msc
hpmec
contact
cocultur
lower
chamber
msc
group
msc
lower
chamber
endotheli
permeabl
upper
side
transwel
detect
concentr
hgf
measur
cultur
medium
use
enzymelink
immunosorb
assay
kit
follow
neutral
hgf
antihgf
antibodi
cocultur
medium
addit
vecadherin
protein
express
measur
cocultur
condit
western
blot
adheren
junction
aj
protein
includ
factin
vecadherin
detect
immunofl
uoresc
techniqu
well
result
permeabl
signifi
cantli
increas
lp
stimul
dosedepend
timedepend
manner
p
meanwhil
mscec
interact
signifi
cantli
decreas
endotheli
permeabl
induc
lp
p
p
moreov
hgf
level
mscec
interact
group
much
higher
msc
group
p
howev
neutral
hgf
antihgf
antibodi
inhibit
role
mscec
interact
improv
endotheli
permeabl
p
compar
msc
group
mscec
interact
increas
vecadherin
protein
express
p
restor
remodel
factin
junction
local
vecadherin
howev
msc
eff
ect
signifi
cantli
block
antihgf
antibodi
p
p
conclus
data
suggest
mscec
interact
decreas
endotheli
permeabl
induc
lp
mainli
attribut
hgf
secret
hmsc
main
mechan
hgf
restor
integr
ec
monolay
remodel
endotheli
intercellular
aj
decreas
protein
express
transmembran
receptor
express
lung
primarili
locat
alveolar
type
cell
rage
implic
acut
respiratori
distress
syndrom
alveolar
infl
ammat
solubl
form
srage
assay
plasma
pulmonari
edema
fl
uid
marker
cell
injuri
function
activ
cell
assess
measur
alveolar
fl
uid
clearanc
afc
rate
relationship
srage
plasma
level
srage
afc
rate
never
investig
object
report
plasma
level
srage
mous
model
direct
acidinduc
epitheli
injuri
test
correl
afc
rate
method
fortyon
mice
divid
two
group
hcl
group
underw
orotrach
instil
hydrochlor
acid
day
group
control
mice
evalu
day
period
mechan
ventil
blood
lung
edema
fl
uid
ef
sampl
initi
mv
mice
receiv
tracheal
instil
bovin
serum
albumin
detect
chang
alveolar
protein
level
minut
plasma
level
srage
total
protein
level
measur
afc
rate
valu
correct
measur
mous
serum
albumin
ef
result
basal
afc
rate
minut
hclinjur
mice
signifi
cantli
depress
day
minut
p
time
afc
reach
basal
level
plasma
level
srage
higher
hcltreat
anim
control
anim
day
p
day
p
rate
afc
invers
correl
srage
level
plasma
spearman
p
see
figur
conclus
highest
impair
afc
report
day
srage
level
also
higher
injur
mice
may
good
surrog
marker
cell
injuri
newli
describ
relationship
afc
rate
srage
plasma
level
mous
model
direct
epitheli
injuri
result
support
translat
investig
role
rage
alveolar
injuri
recoveri
refer
introduct
cigarett
smoke
slowli
progress
damag
respiratori
system
surgic
critic
ill
patient
whether
activ
cigarett
smoke
admiss
surgic
intens
care
unit
sicu
associ
increas
risk
acut
respiratori
distress
syndrom
ard
clearli
identifi
ed
method
conduct
cohort
studi
use
thaisurg
intens
care
unit
thaisicu
studi
databas
recruit
thai
patient
admit
sicu
nine
universitybas
hospit
thailand
april
novemb
enrol
patient
divid
three
group
activ
smoker
exsmok
nonsmok
primari
outcom
incid
patient
diagnos
ard
secondari
outcom
includ
mortal
incid
system
infl
ammatori
respons
syndrom
sir
sicu
length
stay
lo
total
sicu
cost
result
patient
nonsmok
exsmok
activ
smoker
diff
erenc
apach
ii
score
three
group
patient
activ
smoker
exhibit
highest
incid
ard
activ
smoker
exsmok
nonsmok
p
diff
erenc
mortal
three
group
patient
activ
smoker
highest
incid
sir
activ
smoker
exsmok
nonsmok
p
compar
nonsmok
exsmok
activ
smoker
longer
sicu
lo
p
higher
total
sicu
cost
p
patient
smoke
packyear
time
like
develop
ard
patient
smoke
packyear
ci
p
multivari
analysi
found
everi
packyear
cigarett
smoke
admiss
sicu
associ
increas
risk
new
ard
hazard
ratio
ci
p
adjust
apach
ii
score
age
gender
chronic
obstruct
pulmonari
diseas
conclus
surgic
critic
ill
patient
activ
smoker
associ
increas
risk
new
ard
longer
sicu
lo
higher
total
icu
cost
compar
exsmok
nonsmok
fi
nding
emphas
essenti
need
smoke
cessat
program
refer
introduct
tradit
ard
obes
patient
ventil
higher
tidal
volum
higher
peep
due
expect
increas
pleural
pressur
howev
data
literatur
regard
infl
uenc
bodi
mass
lung
mechan
particularli
chest
wall
elast
univoc
failur
account
increas
bodi
weight
could
aff
ect
respiratori
function
result
injuri
mechan
ventil
onset
vili
aim
studi
evalu
role
bodi
weight
respiratori
mechan
ard
patient
method
group
deepli
sedat
paralyz
ard
patient
divid
three
class
accord
bodi
mass
index
normal
weight
kgm
overweight
kgm
obes
kgm
mechan
ventil
volumecontrol
mode
tidal
volum
mlkg
accord
predict
bodi
weight
respiratori
mechan
ga
exchang
assess
peep
level
cmh
result
total
ard
patient
enrol
patient
normal
weight
overweight
obes
lung
chest
wall
elast
diff
erent
group
peep
level
cmh
cmh
p
p
respect
endinspiratori
transpulmonari
pressur
also
similar
observ
diff
erenc
group
regard
pao
fio
ratio
p
peep
cmh
p
peep
cmh
paco
p
peep
cmh
p
peep
cmh
conclus
ard
obes
patient
chest
wall
elast
endinspiratori
transpulmonari
pressur
aff
ect
bodi
weight
suggest
normal
weight
obes
patient
present
similar
risk
lung
stress
vili
onset
sever
hypoxemia
diff
erent
group
method
observ
studi
icu
ventil
septic
patient
periton
pancreonecrosi
mediastin
done
ard
diagnos
stage
accord
va
negovski
research
institut
criteria
berlin
defi
nition
plasma
spd
measur
ard
diagnosi
day
day
immunoenzym
essay
biovendor
usa
patient
treat
accord
intern
guidelin
data
statist
analyz
statistica
anova
present
median
percentil
ngml
p
consid
statist
signifi
cant
area
receiv
oper
curv
calcul
result
sixtyfi
patient
screen
enrol
studi
accord
inclusionexclus
criteria
patient
assign
group
np
ard
n
year
old
mf
mortal
np
n
year
old
mf
mortal
group
compar
apach
ii
sofa
score
baselin
np
ard
group
spd
higher
point
np
group
plasma
spd
day
solubl
form
receptor
advanc
glycat
endproduct
srage
promis
marker
epitheli
dysfunct
fulli
character
biomark
ard
whether
srage
could
inform
respons
ventil
set
poorli
investig
whether
recruit
maneuv
rm
may
infl
uenc
plasma
srage
remain
unknown
method
twentyfour
patient
moderatesever
nonfoc
ard
enrol
prospect
monocentr
crossov
studi
random
rmsham
group
rm
sequenc
preced
sham
evalu
period
shamrm
group
invert
sequenc
protect
ventil
appli
rm
consist
applic
cmh
airway
pressur
second
arteri
blood
sampl
ga
analys
srage
measur
minut
pre
rm
sham
period
minut
minut
hour
hour
hour
rm
sham
period
result
mean
pao
fio
tidal
volum
peep
plateau
pressur
mmhg
mlkg
ideal
bodi
weight
cmh
respect
median
baselin
plasma
srage
level
pgml
rm
induc
signifi
cant
decreas
srage
pgml
hour
p
hour
post
rm
srage
level
increas
back
toward
baselin
valu
prerm
srage
associ
rminduc
oxygen
improv
auc
see
figur
conclus
report
fi
rst
kinet
studi
plasma
srage
rm
ard
fi
nding
could
help
design
futur
studi
srage
marker
respons
therapeut
intervent
ard
introduct
oesophag
pressur
increasingli
use
monitor
manag
mechan
ventil
patient
even
oesophag
balloon
cathet
correctli
posit
measur
aff
ect
inappropri
balloon
fi
lling
andor
oesophag
reaction
balloon
infl
ation
aim
assess
oesophag
reaction
oesophag
balloon
fi
lling
mechan
ventil
patient
method
oesophag
balloon
cathet
nutriv
sidam
mirandola
itali
introduc
middist
thorac
posit
patient
invas
mechan
ventil
acut
respiratori
failur
ambient
pressur
balloon
nutriv
cathet
infl
ate
ml
without
gener
recoil
pressur
balloon
progress
infl
ate
ml
step
ml
endexpiratori
valu
balloon
pressur
use
assembl
balloon
pressurevolum
curv
minimum
slope
section
curv
graphic
detect
infl
ation
volum
correspond
part
curv
consid
appropri
overdistens
balloon
exclud
defi
nition
section
curv
slope
attribut
oesophag
reaction
balloon
infl
ation
result
fortyfi
oesophag
balloon
pressurevolum
curv
obtain
patient
undergo
control
mechan
ventil
peep
cmh
fio
tidal
volumeid
bodi
weight
mlkg
accord
graphic
detect
minimum
slope
section
curv
minimum
maximum
appropri
balloon
volum
ml
ml
respect
two
volum
slope
curv
cmh
oml
rang
cmh
oml
conclus
oesophag
artefact
reaction
oesophag
wall
balloon
infl
ation
may
clinic
signifi
cant
averag
cmh
millilitr
volum
inject
cathet
reach
valu
high
cmh
oml
pressur
gener
oesophag
reaction
lead
overestim
pleural
pressur
therefor
oesophag
artefact
may
signifi
cantli
aff
ect
clinic
decisionmak
base
absolut
valu
oesophag
pressur
critic
care
volum
suppl
http
demonstr
recent
eff
ectiv
prognosi
extrapulmonari
etiolog
ard
includ
abdomin
emerg
case
sever
hypoxemia
earli
postop
period
intensivist
discuss
prone
posit
base
riskbenefi
ratio
method
conduct
retrospect
twocent
studi
year
aim
compar
preval
surgic
complic
potenti
relat
prone
posit
patient
least
one
prone
posit
session
patient
remain
supin
posit
abdomin
surgeri
patient
ard
context
recent
day
abdomin
surgeri
except
laparoscopi
includ
primari
outcom
number
patient
least
one
surgic
complic
potenti
relat
prone
posit
defi
ned
priori
complic
scar
dehisc
abdomin
compart
syndrom
stoma
leakag
stoma
necrosi
scar
necrosi
wound
infect
displac
drainag
system
remov
gastroor
jejunostomi
feed
digest
fi
stula
eviscer
result
identifi
ed
patient
postop
ard
year
sap
ii
among
emerg
surgeri
fifteen
patient
least
one
stoma
surgeri
nineteen
patient
least
one
prone
posit
session
number
session
baselin
prone
group
patient
minimum
pao
fio
ratio
lower
supin
group
vs
mmhg
p
plateau
pressur
higher
prone
group
vs
cmh
p
fi
rst
prone
posit
session
signifi
cantli
increas
pao
fio
ratio
vs
mmhg
p
mean
durat
fi
rst
prone
posit
session
hour
prone
group
patient
least
one
surgic
complic
comparison
nine
supin
group
p
complic
result
revis
surgeri
two
patient
prone
group
two
supin
group
p
mortal
icu
respect
prone
group
supin
group
p
conclus
preliminari
result
confi
rm
eff
ectiv
prone
posit
term
oxygen
ard
abdomin
surgeri
without
signifi
cant
increas
surgic
complic
eff
ect
need
surgic
revis
henc
necessari
clinician
refrain
prone
patient
postabdomin
surgeri
ard
introduct
ard
character
edema
diff
use
lung
fi
eld
distribut
excess
tissu
mass
studi
ct
scan
patient
singl
slice
compar
data
obtain
healthi
control
method
ard
patient
underw
ct
scan
imag
icu
stay
cmh
endinspiratori
pressur
hospit
discharg
patient
underw
followup
ct
scan
perform
end
inspir
lung
divid
three
section
along
apexbas
axi
three
section
along
sternumvertebr
axi
nine
region
per
lung
excess
tissu
mass
lung
region
defi
ned
diff
erenc
lung
tissu
gram
ct
scan
perform
ard
cours
followup
ct
scan
result
present
mean
sd
result
studi
eight
ard
patient
year
bmi
kgm
icu
admiss
patient
follow
clinic
paramet
pao
fio
peep
cmh
paco
mmhg
ph
averag
increas
lung
weight
ard
compar
followup
ct
scan
g
figur
present
tissu
volum
ard
white
bar
ard
resolut
black
bar
compar
ratio
two
p
vs
depend
region
conclus
excess
tissu
mass
diff
erent
apex
hilum
base
increas
depend
lung
region
apex
hilum
uniformli
distribut
lung
base
introduct
ard
wide
variabl
lung
morpholog
characterist
alveolar
collaps
airway
narrow
close
present
often
heterogen
despit
advanc
ard
imag
thu
far
unabl
distinguish
region
airway
open
airway
dilat
peepinduc
lung
recruit
demonstr
techniqu
function
respiratori
imag
fri
diff
erenti
two
entiti
method
six
patient
earlystag
ard
includ
prospect
singlecentr
cohort
trial
lower
infl
iction
point
pressurevolum
curv
consid
clinic
accept
minim
peep
valu
subsequ
four
distinct
peep
level
chosen
perform
ct
scan
cmh
median
valu
clinic
accept
minim
cmh
fri
method
describ
de
backer
colleagu
use
evalu
airway
open
airway
dilat
result
airway
stretch
bronchodilat
could
quantifi
ed
distinguish
airway
recruit
techniqu
higher
peep
pressur
recruit
also
expand
bronchi
ratio
dilationrecruit
bronchi
higher
upper
lobe
lower
lobe
illustr
figur
abl
phenotyp
patient
allow
predict
increas
peep
recruit
atelectasisbronchi
distend
certain
airway
region
conclus
novel
techniqu
fri
use
visualis
airway
structur
ard
distinguish
airway
stretch
critic
care
volum
suppl
http
airway
recruit
pilot
studi
show
ard
upper
lung
region
subject
airway
dilat
wherea
lower
atelectat
lung
lobe
airway
open
higher
peep
level
introduct
mechan
ventil
anesthesia
lead
develop
atelectasi
poor
oxygen
postop
pulmonari
complic
applic
peep
recruit
maneuv
rm
signifi
cantli
reduc
sever
atelectasi
improv
lung
function
applic
strategi
often
lead
hemodynam
instabl
may
associ
impair
reactiv
cardiovascular
system
purpos
studi
evalu
effi
caci
safeti
rm
patient
increas
sensit
peripher
chemoreceptor
spcr
refl
ect
decreas
reactiv
cardiovascular
system
method
conduct
prospect
studi
patient
high
spcr
evalu
use
breathhold
test
test
perform
measur
voluntari
breathhold
durat
bhd
twothird
maxim
inspir
end
breathhold
determin
palpat
contract
diaphragm
bhd
second
marker
high
spcr
patient
receiv
major
abdomin
surgeri
random
open
lung
ventil
group
peep
group
concept
open
lung
ventil
perform
follow
peep
increas
cmh
three
breath
cmh
three
breath
cmh
breath
peep
reduc
cmh
rm
repeat
everi
hour
peep
group
peep
maintain
cmh
whole
anesthesia
hemodynam
blood
gase
dynam
complianc
evalu
result
rm
improv
oxygen
compar
peep
group
mean
increas
oxygen
index
end
surgeri
mmhg
p
peep
group
increas
less
signifi
cant
amount
mmhg
p
dynam
complianc
increas
rm
group
chang
peep
group
hemodynam
chang
rm
pronounc
ci
averag
decreas
lminutem
compar
rm
p
svr
decreas
dyn
sec
cm
p
peep
group
chang
signifi
cant
diff
erenc
group
incid
complic
length
stay
icu
hospit
note
conclus
rm
patient
high
spcr
reduc
reactiv
cardiovascular
system
improv
lung
function
associ
risk
hemodynam
instabl
mechan
ventil
perform
breath
mechan
work
lung
parenchyma
part
energi
recov
part
dissip
respiratori
system
purpos
studi
assess
respect
role
three
known
determin
energi
dissip
lung
open
close
strain
lung
inhomogen
method
thirteen
femal
piglet
kg
ventil
strain
v
frc
greater
v
mlkg
hour
massiv
lung
edema
develop
piglet
divid
fi
group
character
diff
erent
energi
load
obtain
vari
respiratori
rate
breathsminut
n
n
n
n
n
everi
hour
two
ct
scan
perform
endexpir
endinspir
static
pressurevolum
curv
obtain
total
ct
scan
coupl
correspond
pressurevolum
curv
analyz
energi
dissip
lung
parenchyma
breath
determin
hysteresi
area
pressurevolum
curv
ct
scan
quantit
analyz
dedic
softwar
data
present
median
interquartil
rang
result
piglet
ventil
higher
energi
load
rr
develop
ventilatorinduc
lung
injuri
vili
piglet
ventil
lower
energi
load
rr
energi
dissip
lung
parenchyma
breath
j
dissip
energi
increas
time
piglet
develop
vili
remain
nearconst
piglet
recruit
lung
parenchyma
strain
lung
inhomogen
extent
percentag
lung
parenchyma
inhomogen
energi
dissip
lung
parenchyma
well
relat
lung
recruit
r
p
strain
r
p
lung
inhomogen
extent
r
p
multipl
linear
regress
show
dissip
energi
independ
relat
three
determin
energi
dissip
lung
open
close
p
strain
p
lung
inhomogen
p
conclus
energi
dissip
larg
depend
strain
obtain
high
tidal
volum
also
lung
inhomogen
lung
open
close
play
signifi
cant
role
refer
aim
preclin
studi
studi
timedepend
dosedepend
eff
ect
supplement
oxygen
prolong
ventilatori
support
pulmonari
infl
ammat
wellestablish
murin
model
ventil
compar
low
high
tidal
volum
method
healthi
male
mice
age
week
randomli
assign
experiment
group
n
appli
fraction
oxygen
fio
tidal
volum
either
mlkg
anesthet
mice
tracheotom
ventil
hour
infl
ammatori
cell
mediat
measur
bronchoalveolar
lavag
fl
uid
balf
result
mice
expos
higher
fio
signifi
cantli
higher
pao
level
end
experi
total
number
infl
ammatori
cell
balf
signifi
cantli
diff
erent
experiment
group
p
yet
increas
trend
percentag
neutrophil
observ
increas
fio
p
cytokin
chemokin
level
diff
er
fio
group
hour
ventil
mice
ventil
hour
signifi
cantli
increas
trend
fig
p
measur
increas
fio
wherea
kc
gmcsf
vegf
remain
virtual
unchang
diff
erenc
tidal
volum
group
small
markedli
infl
uenc
eff
ect
hyperoxia
see
figur
conclus
hyperoxia
induc
timedepend
diff
erenti
immun
respons
independ
tidal
volum
model
mechan
ventil
mice
presenc
cytokin
chemokin
pulmonari
compart
pronounc
prolong
sever
hyperoxia
introduct
electr
imped
tomographi
eit
function
imag
technolog
allow
one
region
monitor
aerat
lung
use
eit
increas
signal
qualiti
spatial
resolut
describ
quantifi
region
chang
aerat
caus
bodi
posit
spontan
breath
mechan
ventil
pulmonari
healthi
patient
undergo
laparoscop
prostatectomi
method
patient
perform
eit
measur
fi
point
time
tabl
swisstom
prototyp
thirtytwo
electrod
use
appli
weak
altern
current
thorax
measur
result
voltag
tomograph
imag
chang
region
imped
caus
ventil
creat
describ
ventil
distribut
use
novel
eit
lung
function
paramet
call
silent
space
provid
inform
area
receiv
much
air
tidal
breath
divid
nondepend
nss
depend
silent
space
dss
use
refer
line
run
perpendicular
graviti
vector
right
centr
ventil
nss
dss
express
percentag
total
lung
area
result
periop
chang
nss
dss
shown
tabl
mean
sd
statist
signifi
cant
diff
erenc
mark
compar
compar
p
conclus
describ
fi
rst
time
map
silent
space
spontan
breath
chang
ventil
condit
bodi
posit
patient
healthi
lung
use
eit
map
silent
space
might
prove
use
develop
periop
protect
ventil
strategi
still
unclear
mechan
caus
ventilatorinduc
diaphragm
dysfunct
vidd
consid
intrins
diaphragm
muscl
fi
ber
vidd
delay
complic
wean
mechan
ventil
mv
accordingli
contribut
prolong
icu
stay
older
patient
aff
ect
young
main
aim
studi
measur
eff
ect
age
day
mv
rat
diaphragm
muscl
fi
ber
structur
function
also
aim
investig
biolog
age
old
rat
obtain
data
use
design
futur
experiment
studi
focus
eff
ect
age
icu
set
method
use
uniqu
icu
rat
model
allow
us
maintain
vital
paramet
stabl
deep
sedat
mv
long
durat
sever
week
diaphragm
fi
ber
crosssect
area
csa
forcegener
capac
specifi
c
forc
absolut
forc
csa
measur
young
month
old
month
bn
hybrid
rat
respons
day
deep
sedat
volumecontrol
mv
investig
biolog
age
old
rat
perform
second
set
experi
compar
muscl
fi
ber
csa
specifi
c
forc
fast
slowtwitch
distal
hind
limb
muscl
three
diff
erent
age
group
young
adult
month
middl
age
month
old
rat
month
result
studi
demonstr
unexpect
increas
csa
p
diaphragm
fi
ber
respons
day
mv
young
old
anim
maximum
forc
decreas
p
young
old
anim
compar
control
result
dramat
loss
specifi
c
forc
increas
csa
concomit
decreas
specifi
c
forc
observ
young
old
diaphragm
fi
ber
compat
ineff
ectiv
compensatori
hypertrophi
respons
mv
comparison
limb
muscl
result
twentyeight
patient
includ
patient
signifi
cant
diff
erenc
patient
admiss
paramet
daili
niv
usag
time
paco
decreas
mmhg
patient
patient
fi
rst
hour
p
mmhg
reduct
paco
occur
patient
vs
p
shorter
time
vs
day
p
time
discharg
paco
level
mmhg
patient
p
group
show
similar
signifi
cant
improv
pao
paco
hco
level
within
fi
rst
day
patient
hco
level
decreas
rapidli
patient
p
durat
niv
vs
day
p
number
mode
pressur
chang
vs
time
p
signifi
cantli
less
mean
ipap
similar
group
maximum
minimum
epap
titrat
automat
signifi
cantli
diff
erent
mean
tidal
volum
amount
leakag
also
signifi
cantli
higher
conclus
result
suggest
avapsa
mode
may
provid
advantag
hypercapn
icu
patient
rapid
paco
reduct
less
niv
durat
workload
method
inpati
ccu
receiv
mechan
ventil
continu
day
octob
decemb
initi
includ
forti
patient
intub
prior
arriv
rcht
incomplet
note
extub
endoflif
care
exclud
patient
divid
group
fi
rst
airway
intervent
toe
tr
result
total
patient
toe
requir
airway
intervent
surviv
discharg
hospit
compar
tr
patient
four
patient
group
fail
fi
rst
intervent
die
prior
second
intervent
total
patient
second
intervent
fail
toe
surviv
discharg
hospit
one
patient
second
tr
die
discharg
gave
inhospit
mortal
rate
toe
group
tr
group
toe
perform
earlier
day
tr
perform
later
day
day
earli
tr
success
surviv
discharg
without
second
intervent
tr
day
compar
day
toe
success
perform
later
surviv
discharg
without
second
airway
intervent
toe
day
day
fi
rst
fail
toe
four
patient
success
second
toe
four
surviv
discharg
result
median
ccu
stay
day
median
hospit
stay
day
exclud
prior
ccu
admiss
seven
patient
tr
fi
rst
fail
toe
fi
surviv
discharg
ccu
four
discharg
hospit
group
shorter
median
stay
ccu
day
hospit
day
overal
median
durat
time
ventil
ccu
hospit
shorter
toe
group
day
respect
compar
day
tr
group
conclus
toe
common
associ
shorter
time
spent
ventil
ccu
hospit
tr
also
associ
lower
inhospit
mortal
rate
toe
success
perform
day
tr
success
perform
day
fail
toe
second
toe
associ
longer
time
hospit
better
mortal
rate
secondari
tracheostomi
introduct
bilevel
noninvas
ventil
niv
establish
therapi
chronic
obstruct
pulmonari
diseas
copd
confl
ict
evid
exist
use
patient
pneumonia
initi
arteri
ph
use
marker
sever
need
admiss
critic
care
cc
examin
impact
ph
condit
outcom
patient
acut
respiratori
failur
arf
mix
aetiolog
treat
niv
method
data
collect
retrospect
period
use
metavis
electron
patient
record
identifi
ed
patient
admit
arf
treat
bilevel
niv
patient
receiv
continu
posit
airway
pressur
primari
surgic
problem
exclud
record
primari
caus
respiratori
failur
arteri
blood
ga
valu
mortal
result
total
patient
identifi
ed
mean
age
male
primari
diagnosi
pneumonia
patient
exacerb
copd
overal
mortal
cc
year
patient
copd
infect
exacerb
higher
cc
mortal
compar
noninfect
howev
year
mortal
infect
noninfect
patient
pneumonia
higher
mortal
cc
year
patient
initi
ph
less
like
surviv
mortal
discharg
cc
ph
ph
narrow
year
subdivid
found
patient
infect
copd
ph
lowest
mortal
pneumonia
ph
highest
mortal
conclus
niv
use
unit
compar
success
rate
publish
seri
copd
patient
respond
well
niv
critic
care
volum
suppl
http
patient
pneumonia
treat
niv
highest
mortal
low
present
ph
associ
higher
mortal
patient
pneumonia
treat
niv
howev
copd
patient
ph
associ
higher
mortal
cc
year
work
defi
ning
precis
role
ph
prognost
indic
warrant
refer
introduct
larg
metaanalysi
suggest
use
low
tidal
volum
benefi
ts
patient
without
ard
studi
metaanalysi
includ
patient
receiv
ventil
gener
anesthesia
surgeri
aim
present
metaanalysi
determin
associ
tidal
volum
size
develop
pulmonari
complic
icu
patient
method
individu
patient
data
metaanalysi
studi
ventil
icu
patient
without
ard
correspond
author
retriev
studi
provid
individu
patient
data
primari
outcom
pulmonari
complic
composit
develop
ard
pneumonia
hospit
stay
secondari
outcom
includ
icu
hospit
length
stay
inhospit
mortal
patient
assign
three
group
base
tidal
volum
size
mlkg
predict
bodi
weight
pbw
mlkg
pbw
ml
kg
pbw
result
seven
investig
patient
metaanalyz
pulmonari
complic
occur
respect
mlkg
pbw
mlkg
pbw
mlkg
pbw
group
adjust
rr
ci
p
occurr
pulmonari
complic
associ
lower
number
icufre
day
aliv
day
lower
number
hospitalfre
day
aliv
day
increas
inhospit
mortal
conclus
ventil
low
tidal
volum
associ
lower
risk
develop
pulmonari
complic
occurr
pulmonari
complic
associ
increas
icu
hospit
length
stay
inhospit
mortal
icu
patient
without
ard
refer
combin
global
demograph
shift
increas
surviv
follow
critic
ill
led
increas
number
patient
requir
prolong
mechan
ventil
pmv
longer
critic
care
stay
prospect
observ
studi
evalu
characterist
specialitybas
outcom
critic
ill
patient
undergo
prolong
mechan
ventil
north
england
critic
care
network
noeccn
method
weekli
survey
conduct
period
screen
patient
older
year
age
requir
pmv
adult
critic
care
unit
within
noeccn
patient
data
collect
includ
patient
demograph
admiss
diagnosi
special
hospit
length
stay
lo
pre
post
critic
care
admiss
sever
ill
score
critic
care
lo
statu
hospit
discharg
result
studi
period
patient
met
criteria
pmv
repres
annual
admiss
noeccn
bedday
major
patient
receiv
pmv
medic
follow
emerg
surgeri
elect
surgeri
specialist
servic
spinal
cord
injuri
cardiothorac
transplant
commonest
admiss
diagnosi
medic
popul
pulmonari
infect
follow
acut
neurolog
disord
surgic
patient
admit
critic
care
periop
period
end
studi
period
highest
hospit
mortal
observ
nonspecialist
surgic
popul
contrast
medic
popul
one
lowest
hospit
mortal
rate
lower
predict
use
intens
care
nation
audit
research
network
ill
sever
score
compar
rate
hospit
discharg
found
medic
nonspecialist
surgic
patient
conclus
result
studi
highlight
expand
proport
noeccn
critic
care
bedday
occupi
stabl
patient
undergo
pmv
keep
publish
uk
data
elev
hospit
mortal
observ
nonspecialist
surgic
subpopul
although
literatur
suggest
medic
cohort
patient
poorer
prognosi
within
region
liber
mechan
ventil
discharg
hospit
refer
introduct
estim
respiratori
mechan
mechan
venti
late
patient
unreli
patient
exhibit
spontan
breath
sb
eff
ort
top
ventil
support
revers
trigger
eff
ect
result
mwave
shape
pressur
wave
modelbas
method
reconstruct
aff
ect
airway
pressur
curv
present
enabl
estim
true
underli
respiratori
mechan
patient
method
airway
pressur
fl
ow
data
breath
pneumonia
patient
use
proof
concept
pressur
wave
reconstruct
method
fi
ll
part
miss
area
caus
sb
eff
ort
revers
trigger
connect
peak
pressur
endinspir
slope
figur
timevari
elast
model
use
identifi
underli
respiratori
elast
auc
dr
introduct
modelbas
respiratori
mechan
use
guid
mechan
ventil
therapi
howev
identifi
ed
mechan
properti
vari
breath
breath
lead
potenti
treatment
error
use
modelbas
care
requir
accuraci
studi
investig
quantifi
es
variabl
improv
applic
guid
clinic
intervent
method
retrospect
data
acut
respiratori
distress
syndrom
ard
patient
use
patient
sedat
prevent
spontan
breath
eff
ort
ventil
use
volum
control
mode
squar
fl
ow
profi
le
vari
peep
level
maintain
minut
minut
data
collect
analysi
dataset
provid
wide
rang
respiratori
mechan
valu
clinic
protocol
detail
clinic
proven
singl
compart
model
respiratori
system
elast
er
identifi
ed
data
everi
breath
cycl
peep
level
use
linear
regress
method
dynam
elast
edynam
peak
airway
pressur
posit
endexpiratori
pressur
tidal
volum
correspond
breath
cycl
calcul
comparison
coeffi
cient
variat
cv
identifi
ed
er
across
patient
low
expect
period
allow
timedepend
alveolar
recruit
fulli
occur
stabilis
howev
even
substanti
stabilis
period
remain
diff
erenc
minimum
maximum
estim
er
within
period
analys
data
introduct
maintain
appropri
tidal
volum
vt
import
success
lung
protect
ventil
howev
neonat
presenc
airway
leak
may
increas
error
deliveri
tini
vt
rais
concern
ventilatorinduc
lung
injuri
studi
investig
accuraci
vt
deliveri
noninvas
ventil
niv
modern
neonat
ventil
method
use
lung
simul
patient
bodi
weight
kg
measur
actual
deliv
vt
lung
compar
valu
display
ventil
six
ventil
test
condit
variou
combin
respiratori
mechan
normal
restrict
obstruct
leak
level
lminut
peep
set
cmh
condit
test
niv
mode
pressur
level
set
achiev
vt
lung
mlkg
set
f
time
second
f
default
rise
time
calcul
mean
error
ventilatordisplay
vt
variou
level
airway
leak
vt
mean
error
valu
present
tabl
leak
exist
mean
error
less
ventil
except
one
show
mean
error
leak
level
increas
three
ventil
show
mark
diff
erenc
deliv
display
vt
particular
could
oper
larg
leak
condit
three
ventil
servo
show
accept
vt
accuraci
across
condit
test
conclus
tidal
volum
accuraci
neonat
niv
vari
greatli
among
diff
erent
ventil
leak
condit
must
consid
neonat
ventil
manag
avoid
overventil
underventil
method
hat
cap
devis
icu
use
train
teach
capnographi
trace
left
signifi
airway
function
contrast
trace
right
indic
immedi
attent
requir
figur
present
staff
work
icu
individu
bedsid
teach
session
feedback
obtain
evalu
introduct
wean
mechan
ventil
import
concern
icu
clinic
practic
surfac
electromyographi
semg
noninvas
tool
assess
activ
diff
erent
muscl
describ
semg
pattern
respiratori
muscl
cpap
trial
patient
undergo
pressur
support
ventil
method
twentyon
adult
clinic
stabl
patient
undergo
assist
mechan
ventil
hour
investig
pressur
support
baselin
cpap
trial
semg
diaphragm
costmar
intercost
sternocleid
accessori
muscl
record
dedic
devic
inbiolab
groningen
netherland
simultan
airway
waveform
express
ratio
signal
baselin
diaphragmat
electr
activ
nasogastr
tube
eadi
patient
also
measur
rapid
shallow
breath
index
lower
patient
one
patient
fail
trial
observ
mean
inspiratori
valu
costmar
increas
immedi
switch
cpap
signifi
cantli
vari
cpap
trial
anova
p
hand
activ
accessori
muscl
increas
signifi
cantli
period
p
strongli
correl
respiratori
rate
r
p
invers
tabl
introduct
aim
studi
determin
type
incid
risk
factor
earli
postop
pulmonari
complic
heart
transplant
recipi
method
retrospect
collect
data
record
consecut
heart
transplant
januari
decemb
total
patient
underw
heart
transplant
patient
younger
year
n
patient
die
intraop
n
fi
rst
postop
day
n
includ
analys
data
collect
case
demograph
featur
durat
mechan
ventil
respiratori
problem
develop
icu
stay
earli
postop
mortal
day
respiratori
complic
sought
pleural
eff
usion
pneumonia
pulmonari
atelectasi
pulmonari
edema
pneumothorax
acut
respiratori
failur
method
includ
patient
receiv
ila
due
hypercapn
respiratori
failur
bridgetotranspl
obstruct
lung
diseas
sweep
ga
fl
ow
increas
step
l
minut
constant
blood
fl
ow
phase
similarli
blood
fl
ow
gradual
increas
constant
sweep
ga
fl
ow
phase
step
ga
transfer
via
membran
well
arteri
blood
ga
sampl
obtain
vt
reduct
mlkg
attenu
overdistens
associ
hypercarbia
thought
combin
extracorpor
co
remov
ecco
r
continu
renal
replac
therapi
crrt
insert
oxygen
membran
within
hemofi
ltration
circuit
patient
present
ard
acut
kidney
injuri
aki
method
fi
rst
set
measur
perform
mlkg
ecco
r
twenti
minut
later
vt
reduc
mlkg
remaind
studi
period
hour
ventil
set
arma
trial
crrt
mode
hemofi
ltration
predilut
ultrafi
ltration
adjust
achiev
fi
ltration
fraction
sweep
ga
fl
ow
constant
lminut
primari
endpoint
reduct
paco
minut
initi
ecco
r
result
eight
patient
studi
age
year
sap
ii
sofa
score
inclus
blood
fl
ow
inlet
oxygen
membran
mlminut
co
remov
rate
mlminut
initi
ecco
r
mlkg
induc
mean
paco
reduct
mmhg
p
experi
complic
transfer
ecmo
patient
even
longer
trip
wide
thorough
clinic
evalu
multidisciplinari
ecmo
team
allow
optim
clinic
paramet
transport
safe
transfer
start
ecmo
treatment
peripher
hospit
transfer
patient
ecmo
may
viabl
option
compar
convent
ventil
data
suggest
ecmo
set
safe
peripher
hospit
multidisciplinari
highli
special
ecmo
team
introduct
cerebr
microhemorrhag
mh
diminut
focal
bleed
detect
best
mri
use
susceptibilityweight
imag
sequenc
swi
found
varieti
neurolog
diseas
pattern
distribut
lead
underli
pathomechan
survivor
highaltitud
cerebr
edema
hace
show
multipl
mh
predominantli
splenium
corpu
callosum
mountain
lack
acclimat
high
altitud
tend
suff
er
hace
hypoxemia
great
height
discuss
main
trigger
hace
acut
respiratori
distress
syndrom
adr
character
oxygen
failur
mechan
ventil
patient
sever
classifi
ed
ratio
arteri
oxygen
tension
fraction
inspir
oxygen
patient
suff
ere
sever
ard
refractori
convent
therapi
venoven
extracorpor
membran
oxygen
therapi
therapeut
option
ensur
oxygen
method
retrospect
examin
patient
cerebr
mri
includ
swi
suff
ere
sever
ard
receiv
ecmo
therapi
mri
slide
anonym
analyz
two
experienc
neuroradiologist
base
distribut
pattern
characterist
modifi
ed
hace
score
mhc
survey
result
six
patient
show
multipl
mh
emphasi
splenium
corpu
callosum
eight
patient
sporad
mh
parenchyma
brain
corpu
callosum
remain
six
patient
intracerebr
alter
distribut
mh
involv
splenium
resembl
seen
hace
survivor
conclus
base
result
postul
hypoxemia
one
main
player
develop
spleniumassoci
mh
hace
also
sever
ard
diseas
accompani
sever
hypoxemia
investig
examin
potenti
trigger
special
circumst
concern
ard
treatment
lead
mh
distinct
pattern
diff
erenti
venou
oxygen
return
key
factor
diff
erenti
hypoxia
venoarteri
extracorpor
membran
oxygen
x
hou
x
less
diff
erenc
venou
oxygen
return
attenu
diff
erenti
hypoxia
also
observ
ivcca
faijv
see
figur
conclus
diff
erenti
venou
oxygen
return
key
factor
diff
erenti
hypoxia
va
ecmo
take
advantag
notion
diff
erenti
venou
oxygen
return
choos
better
cannula
confi
gurat
clinic
practic
helpecmo
pilot
studi
heparin
low
dose
protocol
versu
standard
care
critic
ill
patient
undergo
ecmo
randomis
control
phase
ii
studi
evalu
two
level
heparin
anticoagul
patient
requir
full
anticoagul
work
substudi
helpecmo
trial
describ
consent
process
parent
studi
site
consent
research
often
obtain
research
coordin
littl
involv
investig
howev
natur
ecmo
popul
requir
modifi
ed
consent
approach
implement
given
ecmo
often
insert
emerg
requir
model
would
success
hour
could
deliv
member
treat
team
helpecmo
pilot
studi
enrol
patient
admit
larg
metropolitan
icu
requir
ecmo
educ
elig
criteria
studi
process
given
icu
senior
medic
staff
consent
must
perform
prior
commenc
anticoagul
often
short
time
ecmo
cannul
facilit
recruit
hour
helpecmo
studi
box
locat
icu
within
box
instruct
page
outlin
screen
consent
randomis
process
well
administr
task
plain
languag
statement
randomis
envelop
consent
document
sticker
provid
consent
script
provid
ensur
consist
across
consent
personnel
process
review
research
coordin
follow
day
confi
rm
local
govern
complianc
result
april
decemb
patient
screen
fourteen
met
elig
criteria
approach
consent
twelv
patient
enrol
randomis
receiv
either
standard
anticoagul
lowdos
heparin
per
studi
protocol
consent
provid
person
respons
patient
one
patient
compet
consent
one
enrol
legisl
allow
enrol
research
absenc
person
respons
two
refus
seventyon
per
cent
particip
approach
hour
eightysix
per
cent
consent
clinician
twentyon
per
cent
patient
consent
noninvestig
conclus
model
consent
describ
proven
success
challeng
patient
popul
abil
staff
perform
consent
studi
signifi
cant
factor
success
pilot
review
studi
process
research
coordin
support
model
conclus
vaecmo
eff
ectiv
treatment
tool
refractori
cs
patient
acut
lifethreaten
heart
failur
patient
aff
ect
acut
decompens
ccm
poorer
outcom
character
multipl
organ
dysfunct
alreadi
known
literatur
rhabdomyolysi
condit
result
releas
mainli
creatin
kinas
ck
myoglobin
breakdown
myocyt
myoglobin
known
caus
renal
failur
rf
ck
level
routin
use
indic
ck
level
ul
found
associ
risk
rf
howev
data
lack
level
ck
predict
rf
especi
gener
trauma
patient
purpos
studi
determin
initi
ck
level
predict
markedli
elev
ck
characterist
trauma
patient
elev
ck
clinic
diagnosi
rhabdomyolysi
confi
rmed
creatin
kinas
ck
level
iul
local
therapeut
protocol
trigger
aggress
renoprotect
treatment
patient
ck
iul
evalu
local
practic
refi
ne
ck
threshold
instig
renoprotect
treatment
studi
correl
ck
time
trend
advers
outcom
acut
kidney
injuri
aki
need
emerg
renal
replac
therapi
rrt
mortal
also
evalu
mcmahon
score
risk
predict
model
base
demograph
clinic
laboratori
variabl
avail
admiss
conclus
sever
aki
rrt
need
highli
associ
previou
htn
number
previou
medic
relat
sever
aki
htn
describ
risk
factor
develop
aki
critic
ill
patient
acei
arb
use
associ
aki
develop
septic
patient
knowledg
fi
rst
studi
investig
risk
factor
associ
aki
surgic
septic
patient
ciai
introduct
acut
kidney
injuri
aki
associ
increas
morbid
mortal
critic
ill
patient
earli
detect
treatment
may
improv
outcom
method
retrospect
analysi
prospect
collect
data
patient
without
endstag
renal
diseas
epan
trial
earli
detect
aki
defi
ned
accord
creatininebas
kdigo
guidelin
three
multivari
logist
regress
model
lr
develop
use
data
avail
baselin
lrb
upon
icu
admiss
lrba
end
fi
rst
day
icu
subpopul
n
plasma
neutrophil
gelatinaseassoci
lipocalin
pngal
earli
biomark
aki
measur
icu
admiss
valu
ad
pngal
lrba
assess
model
evalu
via
bootstrap
compar
receiv
oper
characterist
roc
decis
curv
critic
care
volum
suppl
http
result
tabl
present
perform
model
admiss
pngal
perform
improv
predict
made
later
time
point
highest
similar
result
obtain
subgroup
septic
cardiac
surgeri
patient
independ
predictor
pngal
alon
perform
better
model
use
routin
clinic
data
avail
upon
admiss
howev
combin
pngal
lrba
predict
perform
improv
perform
improv
includ
pngal
conclus
studi
show
potenti
datadriven
model
base
routin
collect
patient
inform
earli
detect
aki
fi
rst
week
icu
stay
although
ad
admiss
pngal
admiss
data
improv
earli
detect
aki
ad
valu
lost
upon
inclus
data
fi
rst
day
icu
introduct
studi
test
hypothesi
cellular
respons
kidney
sepsi
character
earli
activ
amp
activ
protein
kinas
ampk
activ
tempor
associ
downregul
epitheli
sodium
channel
benac
method
fifteen
wildtyp
wt
mice
subject
cecal
ligat
punctur
clp
sacrifi
ced
hour
addit
pretreat
three
wt
three
ampk
beta
knockout
mice
ampk
activ
aicar
mgkg
intraperiton
hour
clp
sacrifi
ced
hour
clp
blood
tissu
sampl
collect
anim
ampk
activ
benac
mitophagi
iii
examin
western
blot
kidney
lysat
plasma
creatinin
scr
assess
use
elisa
acut
respons
sepsi
character
earli
activ
ampk
increas
hour
peak
hour
decreas
hour
figur
activ
associ
consist
decreas
benac
express
aicar
pretreat
anim
ampk
activ
wt
mice
associ
decreas
express
benac
compar
ampk
ko
mice
figur
conclus
ampk
activ
earli
induct
sepsi
associ
consist
decreas
betaenac
express
apic
membran
tubular
epitheli
cell
addit
absenc
ampk
activ
ko
anim
associ
increas
express
betaenac
hour
clp
data
support
hypothesi
earli
activ
ampk
decreas
energi
consumpt
ion
channel
downregul
figur
conclus
predict
aki
septic
nonsept
critic
ill
patient
pragmat
randomis
control
trial
need
prove
role
clinic
basi
refer
introduct
gold
standard
routin
evalu
kidney
function
measur
serum
creatinin
concentr
scr
icu
patient
muscl
loss
dilut
lead
decreas
scr
scr
distribut
total
bodi
water
result
delay
scr
chang
glomerular
fi
ltration
rate
gfr
chang
lag
time
cystatin
c
cysc
protein
produc
cell
nucleu
therefor
less
aff
ect
muscl
mass
also
lag
time
may
shorter
volum
distribut
extracellular
fl
uid
object
studi
evalu
whether
singl
point
measur
cysc
adequ
scr
monitor
kidney
function
icu
patient
method
data
collect
two
prospect
singlecent
studi
conveni
sampl
icu
patient
studi
period
measur
cysc
scr
urinari
inulin
clearanc
cinu
introduct
current
accur
method
measur
glomerular
fi
ltration
rate
gfr
acut
kidney
injuri
aki
fourhour
creatinin
clearanc
often
use
previous
valid
method
measur
gfr
use
continu
infus
lowdos
iohexol
cildi
patient
stabl
renal
function
gfr
normal
steadi
state
achiev
hour
subject
calcul
variat
suggest
aki
studi
compar
gfr
measur
cildi
creatinin
clearanc
method
critic
ill
patient
evolv
aki
patient
follow
nephrectomi
recruit
demograph
compar
use
test
cidli
connect
hour
plasma
renal
iohexol
creatinin
concentr
measur
tandem
mass
spectrometri
four
time
daili
iohexol
renal
clearanc
irc
calcul
compar
use
blandaltman
analysi
result
baselin
estim
gfr
similar
postnephrectomi
evolv
aki
group
p
evolv
aki
group
higher
apach
score
vs
p
compar
irc
bia
sd
limit
agreement
pearson
r
observ
evolv
aki
group
wherea
bia
sd
limit
agreement
pearson
r
postnephrectomi
group
compar
irc
bia
sd
limit
agreement
pearson
r
establish
aki
group
bia
sd
limit
agreement
pearson
r
postnephrectomi
group
conclus
data
suggest
accur
precis
patient
aki
follow
nephrectomi
irc
appear
accur
precis
patient
predict
aki
risk
outcom
post
nephrectomi
patient
evolv
aki
hypothesis
irc
use
altern
creatininebas
measur
aki
introduct
acut
kidney
injuri
aki
follow
coronari
arteri
bypass
graft
cabg
result
signifi
cant
morbid
mortal
prolong
stay
cardiothorac
icu
sought
determin
incid
aki
cardiothorac
centr
hypothes
higher
occurr
patient
undergo
cabg
use
cardiopulmonari
bypass
oncab
compar
pump
opcab
surgeri
method
retrospect
data
nondialys
patient
undergo
isol
cabg
institut
collect
year
propens
score
use
softwar
platform
use
match
subject
oncab
opcab
group
regard
preoper
variabl
logist
euroscor
creatinin
clearanc
crcl
gender
oper
urgenc
postop
aki
defi
ned
rise
baselin
serum
creatinin
chisquar
analysi
use
determin
statist
signifi
cant
diff
erenc
result
case
opcab
oncab
subject
includ
fi
nal
analysi
group
higher
incid
aki
renal
replac
therapi
rrt
oncab
group
although
signifi
cantli
greater
opcab
group
tabl
mortal
rate
ident
three
death
group
averag
length
icu
stay
opcab
group
day
versu
day
oncab
group
increas
total
foki
score
associ
increas
mortal
increas
oi
tabl
foki
control
prism
independ
predictor
oi
p
conclus
picu
patient
admiss
day
aki
alon
predict
maxfo
composit
score
includ
aki
fo
paramet
correl
oi
discrimin
survivor
nonsurvivor
fo
seem
result
combin
increas
fl
uid
exposur
underli
aki
fulli
explain
oliguria
pediatr
patient
introduct
tissu
inhibitor
insulinlik
growth
factor
bind
protein
specifi
c
urinari
biomark
predict
acut
kidney
injuri
aki
critic
ill
patient
within
hour
result
ngml
associ
seven
time
risk
aki
compar
test
result
aim
studi
explor
use
potenti
nephrotox
medic
within
window
posit
biomark
test
diagnosi
aki
stage
method
identifi
ed
patient
enrol
sapphir
studi
receiv
least
one
potenti
nephrotox
drug
day
aki
defi
ned
stage
per
kdigo
classifi
cation
littl
known
loss
rrt
whether
diff
er
type
rrt
studi
aim
quantifi
micronutri
loss
rrt
patient
aki
compar
three
diff
erent
rrt
modal
continu
venoven
haemofi
ltration
cvvh
intermitt
haemodialysi
ihd
sustain
loweffi
cienci
diafi
ltration
sledf
method
prospect
observ
studi
conduct
nuh
thirtythre
adult
patient
aki
requir
rrt
ihd
sledf
cvvh
recruit
sampl
blood
rrt
effl
uent
obtain
baselin
mid
endsess
particip
fi
rst
rrt
treatment
sampl
process
store
subsequ
analysi
amino
acid
highperform
liquid
chromatographi
trace
element
induct
coupl
mass
spectrometri
derivat
physiolog
fl
uid
micronutri
loss
calcul
multipli
masscorrect
concentr
total
volum
rrt
effl
uent
adjust
baselin
plasma
concentr
rrt
dose
data
analys
restrict
maximum
likelihood
estim
equat
total
baselin
plasma
concentr
standard
amino
acid
similar
ihd
versu
sledf
group
vs
respect
higher
cvvh
group
rrt
reduc
plasma
concentr
amino
acid
sledf
group
p
eff
ect
ihd
cvvh
group
ihd
cvvh
introduct
venoven
extracorpor
membran
oxygen
vvecmo
novel
therapi
sever
respiratori
failur
srf
introduct
reduc
mortal
howev
patient
requir
substanti
blood
product
support
case
develop
lifethreaten
haemorrhag
method
contact
practition
centr
examin
haematolog
manag
result
total
practition
contact
respond
attend
physician
predominantli
base
north
america
europ
respect
ninetysix
per
cent
unit
use
polymethylpenten
membran
oxygen
use
centrifug
pump
thirtyfour
per
cent
respond
manag
case
year
work
unit
handl
annual
saw
patient
one
centr
use
unfraction
heparin
monitor
anticoagul
vari
use
aptt
act
apttr
sixti
per
cent
routin
measur
antithrombin
scenario
base
patient
practition
target
haemoglobin
hb
gl
howev
target
hb
outsid
rang
favour
transfus
threshold
gl
patient
improv
compar
patient
start
ecmo
seventeen
per
cent
practition
transfus
platelet
count
l
whilst
maintain
platelet
count
l
scenario
describ
patient
srf
secondari
hospitalacquir
pneumonia
patient
develop
haemothorax
persist
blood
loss
mlhour
practition
target
higher
haemoglobin
concentr
gl
target
higher
platelet
count
l
compar
patient
scenario
neither
diff
erenc
statist
signifi
cant
seventyon
per
cent
state
would
manag
patient
anticoagul
agreement
length
time
anticoagul
restart
anticoagul
hour
compar
advis
anticoagul
day
scenario
examin
manag
incident
intracrani
haemorrhag
lack
consensu
regard
durat
anticoagul
respond
held
anticoagul
less
hour
whilst
held
anticoagul
day
tranexam
consid
use
conclus
wide
variat
use
blood
product
intens
anticoagul
surpris
given
current
lack
evid
work
requir
provid
standardis
approach
five
patient
discharg
icu
surviv
hdischarg
discharg
icu
patient
similar
hsurvivor
sofa
score
heart
rate
mean
arteri
pressur
lactat
show
lower
sto
downslop
minut
vs
minut
p
literatur
durat
mechan
ventil
dmv
often
consid
import
risk
factor
rf
vap
critic
patient
gener
whole
durat
mv
taken
method
team
studi
vru
crash
occur
urban
area
clinic
data
includ
injuri
assess
use
total
bodi
ct
scan
injuri
sever
score
iss
abbrevi
injuri
score
ai
icu
hospit
length
stay
outcom
score
engin
collect
data
onsit
partnership
polic
assess
dynam
vehicl
advanc
reconstruct
techniqu
medic
engin
data
crossmatch
correl
process
injuri
suff
ere
person
relat
specifi
c
impact
object
averag
iss
sd
car
involv
seriou
urban
vru
crash
cartopedestrian
crash
frequent
impact
speed
alway
kmhour
tabl
head
face
frequent
injur
part
injuri
collect
follow
lower
extrem
term
maximum
ai
mai
head
sever
injur
region
mai
figur
head
still
frequent
sever
injur
region
sever
injuri
increas
rigid
part
car
improv
vru
safeti
devic
activ
passiv
reduc
impact
speed
sever
primari
impact
next
step
introduct
variou
damp
alarmin
releas
trauma
solubl
receptor
advanc
glycat
endproduct
srage
report
associ
acut
renal
failur
durat
ventil
cellfre
dna
cfdna
associ
prognosi
trauma
patient
studi
kinet
two
biomark
fi
rst
day
cohort
sever
ill
trauma
patient
method
patient
sustain
seriou
traumat
injuri
within
hour
trauma
recruit
level
trauma
center
collect
iss
baselin
demograph
characterist
resuscit
inform
daili
organ
dysfunct
mod
score
day
blood
sampl
collect
within
hour
trauma
day
day
srage
measur
elisa
cfdna
measur
uv
absorb
plasma
isol
collect
data
patient
characterist
injuri
profi
le
neurolog
fi
nding
result
radiolog
examin
medic
cours
analyz
sensit
specifi
citi
mrcdr
detect
intramedullari
lesion
mri
conduct
analysi
conclus
use
curv
dilat
twg
techniqu
thorac
drainag
procedur
found
statist
signifi
cant
advantag
twg
techniqu
comparison
cs
techniqu
regard
precis
chest
tube
placement
within
pleural
caviti
introduct
outcom
multipl
trauma
patient
relat
number
diagnost
therapeut
intervent
hospit
icu
patient
sever
trauma
suscept
sepsi
lead
poor
outcom
factor
associ
occurr
sepsi
outcom
patient
investig
method
studi
retrospect
trauma
patient
admit
icu
kat
gener
hospit
athen
last
year
treat
day
age
gender
type
injuri
sever
injuri
injuri
sever
score
length
icu
stay
sever
sepsi
coexist
diseas
outcom
caus
death
record
logist
regress
chisquar
test
use
statist
analysi
normobar
oxygen
paradox
nop
postul
period
normobar
hyperoxia
follow
rapid
return
normoxia
creat
condit
rel
hypoxia
act
turn
stimulu
erythropoietin
epo
product
variat
gsh
oxygen
free
radic
ro
level
may
involv
process
test
nop
critic
ill
patient
method
prospect
observ
studi
mechan
ventil
fio
patient
activ
bleed
blood
transfus
need
kidney
failur
eighteen
patient
underw
period
normobar
hyperoxia
fio
patient
evalu
control
fio
variat
epo
assay
baselin
hour
hour
serum
gsh
ro
assay
baselin
fio
return
normoxia
patient
hyperoxia
group
result
epo
tend
increas
hyperoxia
group
time
p
remain
stabl
control
group
p
figur
ro
level
increas
decreas
gsh
tend
decreas
increas
hyperoxia
group
therefor
use
round
cutoff
valu
mgl
examin
diagnost
accuraci
pathfast
ddimer
exclud
pe
correl
pathfast
vida
result
particularli
close
concentr
around
critic
cutoff
valu
mgl
correl
pathfast
stratu
result
particularli
close
patient
group
vte
r
wherea
slightli
lower
result
obtain
stratu
control
group
wide
use
cutoff
valu
mgl
pathfast
demonstr
suitabl
sensit
stratu
roc
analysi
indic
optim
cutoff
valu
could
set
either
mgl
mgl
pathfast
stratu
respect
conclus
use
pathfast
ddimer
assay
six
diagnos
miss
time
fi
rst
present
compar
diagnos
miss
vida
ddimer
exclus
assay
yield
higher
sensit
pathfast
ddimer
assay
compar
vida
assay
vs
stratu
assay
show
compar
perform
appear
suitabl
exclus
vte
emerg
room
set
wherea
pathfast
demonstr
superior
sensit
moreov
pathfast
analyz
allow
simultan
determin
ddimer
cardiac
troponin
within
minut
whole
blood
sampl
therefor
method
might
use
point
care
earli
diagnost
assess
patient
symptom
pe
chest
pain
admit
er
chest
pain
unit
introduct
despit
prevent
anticoagul
therapi
measur
venou
thromboembol
diseas
major
caus
morbid
mortal
among
patient
hospit
icu
fact
pulmonari
embol
seriou
manifest
diseas
also
one
primari
caus
sudden
death
aim
studi
investig
frequenc
thromboembol
pulmonari
embol
icu
hospit
trauma
neurosurg
patient
method
one
hundr
icu
patient
postop
neurosurg
trauma
includ
studi
patient
demograph
data
well
medic
histori
temperatur
white
blood
cell
platelet
count
record
admiss
day
thrombosi
diagnosi
fi
nal
outcom
treatment
statist
perform
p
consid
signifi
cant
result
thirtyeight
patient
present
thrombosi
trauma
neurosurg
examin
correl
thrombosi
develop
hospit
diagnosi
treatment
alloc
time
overal
patient
outcom
found
neurosurg
patient
develop
thrombosi
frequent
trauma
patient
p
relat
diagnosi
thrombosi
preval
among
patient
brain
lesion
p
regard
type
thrombosi
pulmonari
embol
also
commonli
appar
among
individu
brain
lesion
p
addit
statist
signifi
cant
correl
thrombosi
occurr
hospit
day
p
patient
outcom
discharg
p
type
thrombosi
directli
associ
poor
outcom
especi
one
result
central
cathet
p
pulmonari
embol
p
howev
correl
found
temperatur
white
blood
cell
platelet
count
admiss
p
conclus
thrombosi
aff
ect
icu
patient
fi
nal
outcom
type
thrombosi
contribut
poor
outcom
mainli
occurr
pulmonari
embol
signifi
cantli
increas
mortal
rate
dvt
diagnos
use
compress
ultrasonographi
color
doppler
imag
interpret
two
independ
investig
train
ultrasonographi
patient
receiv
intermitt
pneumat
compress
unfraction
heparin
twice
daili
iuc
stay
dvt
detect
therapeut
anticoagul
initi
contrastenhanc
ct
perform
patient
suspect
pulmonari
embol
primari
outcom
incid
dvt
icu
stay
patient
follow
hospit
discharg
result
total
patient
includ
median
age
bmi
year
kgm
respect
femal
surgic
critic
care
patient
median
apach
ii
sofa
score
respect
risk
factor
associ
dvt
presenc
central
venou
cathet
malign
hemodialysi
rate
dvt
rate
crt
asymptomat
seen
neck
upper
extrem
dvtassoci
advers
event
pulmonari
embol
bleed
hospit
stay
allcaus
mortal
rate
conclus
incid
asymptomat
dvt
rel
high
adult
critic
ill
patient
found
neck
upper
extrem
without
advers
event
research
need
evalu
clinic
signifi
canc
type
dvt
introduct
comput
tomograph
pulmonari
angiographi
ctpa
use
standard
tool
diagnos
acut
pulmonari
embol
ape
right
ventricular
rv
strain
sign
may
use
predict
advers
outcom
howev
result
still
controversi
primari
object
studi
evalu
relationship
rv
strain
sign
respiratori
failur
requir
mechan
ventil
death
ape
secondari
object
identifi
clinic
factor
relat
outcom
altern
paramet
chang
unabl
detect
region
hypoxia
aim
evalu
quotient
central
venoustoarteri
carbon
dioxid
gradient
arterioven
oxygen
content
diff
erenc
cacvo
valid
transfus
trigger
paramet
hemodynam
stabl
anem
patient
reduc
amount
potenti
counterproduct
erythrocyt
transfus
method
fortyfi
postop
patient
admit
cardiac
icu
enrol
januari
septemb
three
group
defi
ned
accord
trend
blood
loss
surgic
drain
fi
rst
postop
hour
mild
blood
loss
defi
ned
hour
moder
hour
sever
hour
addit
follow
paramet
monitor
ci
co
svr
serum
lactat
scvo
hemoglobin
cacvo
calcul
cacvo
quotient
assess
total
pair
blood
sampl
enrol
patient
hemodynam
stabl
retrospect
analysi
data
perform
result
cacvo
show
signifi
cant
correl
moder
sever
blood
loss
group
p
signifi
cant
correl
detect
mild
blood
loss
group
abnorm
cacvo
easi
detect
refl
ect
intracapillari
hemoglobin
capac
declin
signifi
cantli
improv
erythrocyt
transfus
p
conclus
blood
transfus
carri
risk
advers
eff
ect
carri
respons
fi
nding
suggest
addit
easi
detect
transfus
trigger
paramet
cacvo
provid
physiolog
inform
anemiarel
alter
oxygen
extract
condit
henc
indic
erythrocyt
transfus
howev
addit
studi
warrant
confi
rm
fi
nding
refer
introduct
aim
evalu
frequenc
red
blood
cell
rbc
transfus
patient
traumat
brain
injuri
tbi
well
determin
outcom
associ
rbc
transfus
popul
method
conduct
systemat
review
cohort
studi
trial
patient
tbi
search
medlin
embas
cochran
librari
biosi
databas
incept
june
select
cohort
studi
rct
adult
patient
tbi
report
data
rbc
transfus
extract
data
relat
demograph
baselin
characterist
blood
product
use
relev
clinic
patientori
outcom
cumul
incid
transfus
pool
random
eff
ect
model
dersimonian
approach
freemantukey
transform
stabil
varianc
evalu
associ
rbc
transfus
potenti
determin
well
outcom
pool
risk
ratio
mean
diff
erenc
random
eff
ect
model
mantelhaenszel
method
sensit
subgroup
analysi
plan
priori
aim
studi
explor
associ
red
blood
cell
transfus
rbct
mortal
thai
critic
ill
surgic
patient
method
studi
part
multicent
prospect
observ
studi
perform
nine
surgic
intens
care
unit
sicu
across
nation
april
novemb
studi
includ
adult
patient
admit
sicu
surgeri
patient
categor
transfus
transfus
group
accord
whether
receiv
rbct
time
sicu
stay
demograph
data
clinic
outcom
well
sicu
hospit
length
stay
lo
sicu
hospit
mortal
collect
patient
follow
day
discharg
sicu
primari
endpoint
hospit
mortal
data
compar
group
logist
regress
analysi
perform
determin
whether
rbct
independ
risk
factor
hospit
mortal
addit
patient
match
group
base
propens
score
requir
rbct
compar
introduct
anaemia
patient
sever
traumat
brain
injuri
tbi
may
worsen
neurolog
outcom
aim
studi
determin
associ
haemoglobin
level
hb
neurolog
outcom
determin
transfus
threshold
may
use
futur
transfus
trial
aim
improv
neurolog
outcom
tbi
patient
method
substudi
prospect
multicentr
activ
coagul
infl
ammat
trauma
acit
ii
studi
perform
subject
recruit
januari
decemb
adult
trauma
patient
admit
level
trauma
centr
sever
traumat
brain
injuri
ai
head
icu
admiss
avail
hb
level
admiss
select
analysi
primari
outcom
cognit
function
patient
determin
estim
glasgow
outcom
scale
go
discharg
anaemia
defi
ned
hb
level
gdl
sever
anaemia
gdl
moder
anaemia
within
fi
rst
hour
post
injuri
multivari
logist
regress
model
use
determin
associ
anaemia
neurolog
outcom
receiv
oper
characterist
curv
youden
index
use
determin
optim
transfus
threshold
introduct
subsaharan
africa
suff
er
acut
lifethreaten
indic
blood
transfus
compar
highincom
countri
commonest
system
failur
contribut
periop
death
lowresourc
set
time
avail
correctli
crossmatch
blood
product
often
result
absolut
shortag
blood
product
failur
chain
suppli
distribut
audit
earli
step
chain
qualiti
blood
request
univers
teach
hospit
uth
lusaka
zambia
uth
formal
blood
request
form
cancer
diseas
hospit
cdh
blood
request
form
develop
blood
bank
perform
retrospect
review
june
blood
request
form
submit
crossmatch
laboratori
follow
prospect
review
septemb
group
save
request
exclud
form
audit
american
associ
blood
bank
aabb
minimum
standard
content
blood
request
form
analysi
perform
fisher
exact
test
nomin
data
test
continu
data
result
total
blood
request
review
cdh
ward
eighteen
form
cdh
ward
met
minimum
aabb
standard
p
mean
number
standard
met
request
cdh
rest
sd
sd
respect
p
consid
blood
request
standard
met
order
least
signatur
request
doctor
urgenc
request
hospit
number
indic
transfus
type
product
request
request
doctor
name
age
date
birth
patient
gender
patient
quantiti
product
request
date
form
complet
patient
ward
patient
full
name
conclus
audit
reveal
import
system
failur
impact
effi
caci
safeti
transfus
practic
uth
full
patient
identifi
er
well
vital
inform
indic
urgenc
rare
fi
lled
crucial
blood
bank
prioritis
releas
blood
product
audit
show
practic
may
signifi
cantli
improv
cheap
intervent
standardis
blood
request
form
meet
intern
standard
introduct
zambia
suppli
blood
insuffi
cient
meet
clinic
need
nation
level
paradox
blood
also
often
transfus
unnecessarili
set
zambian
nation
blood
transfus
servic
current
scale
voluntari
blood
donat
suppli
system
requir
hospit
improv
blood
transfus
safeti
rural
district
hospit
zambia
audit
practic
survey
knowledg
amongst
staff
use
standard
establish
nation
guidelin
method
retrospect
audit
month
blood
transfus
form
st
franci
hospit
eastern
provinc
zambia
respect
patient
note
review
record
observ
transfus
patient
demograph
length
stay
survey
nurs
attitud
confi
denc
knowledg
relat
blood
transfus
standard
result
may
june
request
made
blood
receiv
blood
transfus
record
observ
avail
audit
demonstr
request
mostli
complet
urgenc
indic
match
blood
patient
one
nurs
record
amongst
case
transfus
met
minim
requir
transfus
reaction
monitor
nurs
survey
n
experienc
post
mean
year
rang
week
year
nurs
rate
highli
confi
dent
handl
blood
transfus
identifi
deal
transfus
reaction
howev
believ
could
identifi
transfus
reaction
measur
temperatur
alon
would
measur
temperatur
paramet
monitor
transfus
even
ideal
set
knew
check
observ
minut
start
transfus
hourli
thereaft
would
check
start
complet
hour
complet
transfus
frequent
report
reason
observ
time
pressur
ward
set
current
practic
evid
inadequ
identifi
prevent
blood
transfus
reaction
survey
reveal
high
confi
denc
patchi
knowledg
amongst
nurs
requir
safe
blood
transfus
better
time
transfus
time
nurs
staff
number
higher
alongsid
compulsori
train
may
togeth
repres
potenti
lowcost
intervent
improv
blood
transfus
safeti
introduct
earli
sepsi
activ
infl
ammatori
respons
coagul
occur
extracorpor
therapi
use
adsorb
mediat
coagul
fi
lter
drawback
aim
studi
evalu
whether
thromboelastographi
teg
may
detect
hypercoagul
may
improv
anticoagul
extracorpor
treatment
method
twentyfour
patient
earli
sever
sepsi
teg
monitor
basal
time
three
diff
erent
extracorpor
treatment
coupl
plasma
fi
ltration
cpfa
heparin
infus
group
cpfa
citrat
infus
group
b
rrt
oxiri
fi
lter
heparin
coat
heparin
infus
group
c
anova
test
use
statist
analysi
result
tabl
present
teg
valu
earli
septic
patient
angl
decreas
r
increas
group
diff
erenc
group
b
group
c
p
group
c
ly
higher
group
b
p
result
initi
kept
refer
total
articl
mortal
keyword
read
abstract
paper
analys
three
articl
evalu
mortal
two
group
patient
use
use
vht
identifi
ed
among
three
studi
one
raw
data
avail
succeed
get
inform
two
author
ask
main
author
select
paper
renown
author
fi
eld
studi
new
data
could
includ
review
answer
neg
three
studi
johansson
stensbal
total
case
trauma
raw
data
unavail
trauma
messeng
colleagu
prospect
studi
case
mortal
similar
raw
data
unavail
kashuk
colleagu
prospect
studi
case
mortal
control
group
vht
group
conclus
studi
avail
end
imposs
conclud
whether
use
vht
emerg
depart
decreas
mortal
studi
need
aim
analysi
explor
evalu
role
thromboelastographi
teg
aid
manag
patient
admit
haemorrhag
icu
teg
shown
rationalis
reduc
transfus
requir
precis
role
teg
assess
manag
haemostasi
bleed
patient
uncertain
previous
demonstr
method
prospect
audit
teg
analys
perform
patient
gener
medic
surgic
icu
record
period
oper
document
reason
admiss
demograph
data
indic
teg
laboratori
result
blood
ga
analysi
teg
result
diagnosi
subsequ
action
teg
result
patient
admit
haemorrhag
includ
analysi
result
seventyeight
audit
sheet
complet
identifi
ed
haemorrhag
reason
admiss
mean
age
rang
mean
apach
ii
score
rang
main
indic
teg
analysi
includ
coagulopathi
ongo
haemorrhag
result
perform
teg
analysi
patient
document
chang
manag
ten
patient
requir
administr
blood
product
would
receiv
base
convent
laboratori
result
inform
gain
teg
also
result
omiss
anticoagul
three
patient
two
patient
anticoagul
increas
conclus
teg
aid
prompt
rationalis
blood
product
titrat
anticoagul
bleed
patient
teg
identifi
es
number
patient
requir
administr
platelet
procoagul
would
identifi
ed
convent
method
sever
patient
would
also
receiv
inappropri
transfus
cost
resourc
implic
alongsid
potenti
advers
eff
ect
patient
recognis
research
need
clarifi
overal
effi
caci
teg
bleed
patient
introduct
review
aim
assess
valu
thromboelastographi
teg
gener
icu
previous
demonstr
teg
nearpati
assess
whole
blood
coagul
fi
brinolysi
reduc
transfus
requir
cardiothorac
surgeri
liver
transplant
method
prospect
audit
teg
test
perform
patient
treat
gener
icu
conduct
month
result
total
teg
test
perform
failur
rate
seventyeight
audit
sheet
collect
mean
patient
age
year
mean
apach
ii
score
admiss
includ
trauma
periop
haemorrhag
sepsi
standard
test
coagul
demonstr
defi
cit
coagul
identifi
ed
function
signifi
cant
teg
abnorm
clot
factor
activ
measur
inrapttr
patient
thrombocytopen
total
document
teg
result
chang
manag
patient
case
blood
product
requir
document
see
tabl
figur
aim
assess
hemostasi
use
rotem
patient
endstag
liver
diseas
esld
undergo
liver
transplant
lt
develop
predict
model
patient
prone
high
intraop
blood
loss
method
retrospect
analyz
patient
underw
lt
januari
decemb
singl
nation
center
patient
acut
liver
failur
incomplet
data
exclud
demograph
data
sever
liver
diseas
assess
meld
score
model
esld
presenc
portal
vein
thrombosi
laboratori
data
record
preoper
perform
concomit
rotem
assay
standard
coagul
test
prothrombin
time
pt
intern
normal
ratio
inr
fi
brinogen
hour
surgeri
minut
neohepat
phase
intraop
blood
loss
record
high
blood
loss
defi
ned
loss
one
blood
volum
surgeri
correl
record
data
standard
rotem
paramet
deriv
thrombodynam
rotem
paramet
potenti
index
tpi
maximum
veloc
clot
format
maxv
time
maxv
maxvt
auc
analyz
use
spss
result
appli
exclus
criteria
patient
analyz
mean
age
year
sd
median
meld
score
preoper
mce
correl
age
p
ci
meld
score
p
ci
pt
p
inr
p
maxv
correl
fi
brinogen
level
p
ci
auc
correl
age
p
ci
meld
score
p
ci
patient
portal
vein
thrombosi
increas
intem
cft
p
ci
maxvt
p
ci
correl
found
preoper
rotem
paramet
intraop
blood
loss
calcul
mathemat
diff
erenc
preoper
intraop
maxv
maxvt
auc
high
blood
loss
correl
p
ci
p
ci
p
ci
conclus
meld
score
correl
decreas
maxv
auc
preoper
rotem
inr
patient
portal
vein
thrombosi
increas
intem
cft
maxvt
high
blood
loss
associ
decreas
thrombodynam
paramet
correl
found
blood
loss
standard
rotem
paramet
figur
abstract
chang
manag
due
teg
result
introduct
fdaapprov
dose
fourfactor
prothrombin
complex
concentr
usa
base
inr
weight
howev
data
suggest
fi
xed
dose
may
suffi
cient
inr
revers
hemostasi
object
studi
assess
effi
caci
safeti
fi
xed
dose
unit
histor
warfarin
revers
includ
combin
factor
ix
complex
vitamin
k
fresh
frozen
plasma
ffp
introduct
studi
conduct
headtohead
comparison
fourfactor
prothrombin
complex
concentr
two
diff
erent
threefactor
pcc
eff
ectiv
revers
vitamin
k
antagonist
vka
induc
anticoagul
use
establish
rat
model
acut
bleed
contain
human
coagul
factor
ii
vii
ix
x
indic
urgent
revers
acquir
coagul
factor
defi
cienci
induc
vka
therapi
adult
patient
acut
major
bleed
contrast
contain
factor
ii
ix
x
minim
vii
indic
prevent
control
hemorrhag
episod
hemophilia
b
patient
nevertheless
use
correct
hemostasi
follow
warfarin
overdos
discuss
lack
factor
vii
product
rais
question
effi
caci
method
rat
receiv
oral
dose
mgkg
phenprocoumon
hour
post
dose
anim
treat
singl
intraven
dose
salin
pn
csl
behr
vh
baxter
profi
sd
grifol
studi
endpoint
includ
bleed
follow
tail
clip
activ
partial
thromboplastin
time
aptt
prothrombin
time
pt
addit
plasma
level
vitamin
kdepend
coagul
factor
determin
result
acut
coumarin
anticoagul
rat
induc
rise
median
bleed
time
averag
second
maximum
observ
period
compar
untreat
anim
parallel
pt
aptt
prolong
second
second
respect
treatment
abl
fulli
statist
signifi
cantli
revers
bleed
achiev
averag
bleed
time
second
parallel
elev
pt
reduc
second
contrast
two
product
partial
abl
reduc
coumarininduc
bleed
averag
bleed
time
second
post
treatment
respect
also
correl
inferior
reduct
pt
achiev
minimum
level
second
respect
reduct
aptt
seen
treatment
option
anticoagul
eff
ect
dabigatran
revers
idarucizumab
pcc
porcin
blood
vitro
howev
impact
clinic
paramet
blood
loss
known
thu
studi
assess
effi
caci
idarucizumab
comparison
pcc
apcc
dabigatrananticoagul
swine
follow
polytrauma
clinic
relev
endpoint
method
ethic
approv
male
pig
administ
dabigatran
etexil
mgkg
twice
daili
po
day
dabigatran
administ
intraven
anaesthetis
anim
day
achiev
consist
high
concentr
anim
randomis
receiv
idarucizumab
mgkg
n
pcc
ukg
n
apcc
ukg
n
placebo
n
intervent
start
minut
bilater
femur
fractur
standardis
blunt
liver
injuri
primari
endpoint
blood
loss
observ
period
minut
histopatholog
haemodynam
sever
coagul
variabl
also
assess
data
analys
repeatedmeasur
anova
mean
sd
result
dabigatran
level
compar
group
ngml
result
alter
coagul
variabl
blood
loss
compar
minut
post
trauma
group
ml
increas
ml
anticoagul
control
anim
post
injuri
idarucizumab
treatment
reduc
total
blood
loss
ml
p
vs
apcc
ml
p
vs
control
pcc
ml
p
vs
control
hour
anim
intervent
group
surviv
wherea
control
anim
die
within
observ
period
mean
surviv
minut
rang
minut
histopatholog
sign
thromboembol
event
present
alter
coagul
variabl
return
baselin
level
idarucizumab
applic
also
signifi
cantli
although
inconsist
lesser
extent
amelior
follow
pcc
conclus
medic
intervent
associ
reduc
blood
loss
increas
surviv
howev
idarucizumab
specifi
c
antidot
dabigatran
reduc
total
blood
loss
promin
normalis
coagul
paramet
greater
degre
compar
either
pcc
apcc
refer
result
twentythre
patient
kteg
csa
group
compar
time
avail
result
shorter
use
csa
protocol
comparison
kteg
tabl
diff
erenc
statist
p
clinic
mean
reduct
time
minut
signifi
cant
sct
need
longest
time
obtain
fi
nal
result
conclus
implement
csa
includ
rteg
ff
teg
could
shorten
time
target
treatment
critic
bleed
patient
introduct
assess
costeff
ectiv
therapeut
intervent
increasingli
crucial
health
decisionmak
spontan
bacteri
periton
sbp
one
major
complic
liver
cirrhosi
use
albumin
conjunct
antibiot
shown
eff
ectiv
clinic
trial
method
decis
tree
figur
popul
publish
sourc
clinic
cost
epidemiolog
variabl
perspect
taken
us
payer
robust
model
check
use
oneway
probabilist
sensit
analys
clinic
cours
follow
month
death
total
medic
cost
qualityadjust
life
year
qali
calcul
result
total
cost
decreas
use
albumin
improv
surviv
result
addit
qali
patient
albumin
decreas
cost
per
qali
see
tabl
figur
conclus
use
albumin
treatment
spb
costeff
ectiv
introduct
use
albumin
therapeut
controversi
sever
area
requir
assess
base
evid
eff
ectiv
resourc
alloc
support
indic
includ
sepsi
area
hepat
diseas
coronari
arteri
bypass
graft
cabg
latent
therapeut
demand
ltd
underli
evidencebas
demand
ensur
ampl
suppli
drug
avail
aff
ordabl
estim
ltd
would
assist
decisionmak
resourc
critic
care
volum
suppl
http
alloc
mani
clinic
epidemiolog
variabl
subject
uncertainti
decis
analysi
may
assist
gener
assess
demand
albumin
method
decis
analysi
model
construct
use
excel
model
base
relationship
epidemiolog
clinic
factor
shown
infl
uenc
diagram
exemplifi
ed
figur
sepsi
data
individu
factor
obtain
literatur
oneway
sensit
analysi
use
gener
tornado
diagram
exemplifi
ed
figur
albumin
use
sepsi
determin
rel
contribut
diff
erent
factor
ltd
probabilist
sensit
analysi
use
gener
probabl
distribut
calcul
mean
level
ltd
indic
result
averag
albumin
use
calcul
g
per
inhabit
sever
sepsi
g
per
inhabit
liver
diseas
g
per
inhabit
cabg
show
total
ltd
g
per
use
albumin
us
annual
conclus
albumin
consumpt
usa
current
averag
g
per
popul
henc
ltd
three
evidencebas
indic
repres
current
usag
work
need
assess
ltd
albumin
less
welldefi
ned
area
refer
induct
ecmo
may
result
metabol
acidosi
due
circuit
prime
chloriderich
fl
uid
sudden
decreas
plasma
strong
ion
diff
erenc
sid
eff
ect
attenu
use
balanc
solut
sid
equal
patient
plasma
bicarbon
concentr
hco
aim
compar
eff
ect
novel
balanc
solut
sid
equal
patient
hco
commonli
employ
crystalloid
circuit
prime
patient
undergo
venoven
ecmo
method
randomli
assign
patient
acut
respiratori
failur
need
ecmo
receiv
either
nacl
ns
sid
ringer
lactat
rl
sid
novel
balanc
solut
solut
x
sid
equal
patient
hco
circuit
prime
solut
arteri
blood
gase
laboratori
paramet
collect
result
enrol
patient
prime
procedur
rl
n
ns
n
solut
x
n
ecmo
initi
ard
bridg
lung
transplant
acut
graft
failur
transplant
acut
chronic
respiratori
failur
averag
prime
volum
mlkg
patient
baselin
hco
meql
fi
rst
hour
ecmo
initi
arteri
ph
rais
similarli
group
p
due
co
remov
contrast
decreas
start
minut
ns
rl
group
variat
meql
p
vs
baselin
p
interact
twoway
anova
period
chang
observ
solut
x
group
meql
ns
group
reduct
associ
reduct
sid
meql
minut
p
entir
due
increas
cl
vs
meql
p
rl
group
sid
reduct
vs
meql
p
associ
increas
cl
vs
meql
p
lactat
vs
meql
p
chang
observ
electrolyt
concentr
dilut
diff
er
group
p
atot
variat
acidifi
eff
ect
ns
rl
amplifi
ed
patient
higher
baselin
hco
conclus
compar
ns
rl
use
novel
balanc
solut
sid
equal
patient
hco
level
ecmo
prime
uniqu
avoid
addit
metabol
acidosi
patient
uncompens
hypercapnia
aim
studi
investig
eff
ect
intraop
use
gelatin
live
donor
liver
transplant
postop
acut
kidney
injuri
aki
demonstr
ischemia
chlorideliber
fl
uid
manag
caus
aki
liver
transplant
gelatin
minim
side
eff
ect
renal
function
howev
might
reason
postop
aki
method
total
liver
transplant
patient
retrospect
evalu
septemb
septemb
among
patient
includ
studi
patient
year
old
transplant
cadaver
donor
need
preoper
renal
replac
therapi
exclud
patient
divid
two
group
gi
without
gelatin
administr
gii
gelatin
administr
patient
age
gender
actual
bodi
weight
diagnos
meld
score
apach
ii
score
durat
oper
total
clamp
time
noradrenalin
infus
rate
amount
erythrocyt
suspens
fresh
frozen
plasma
ffp
thrombocyt
suspens
use
intraop
fl
uid
balanc
intraop
total
clamp
diuresi
serum
creatinin
level
postop
day
durat
mechan
ventil
length
icu
hospit
stay
hospit
mortal
rate
record
chang
creatinin
level
day
evalu
accord
kdigo
guidelin
aki
result
total
patient
categor
gi
gii
total
clamp
time
intraop
diuresi
intraop
crystalloid
use
intraop
fl
uid
balanc
oper
bleed
erythrocyt
suspens
ffp
thrombocyt
suspens
use
postop
lactat
level
gii
statist
signifi
cantli
higher
gi
p
accord
kdigo
guidelin
aki
gii
day
statist
signifi
cantli
higher
gi
p
conclus
patient
receiv
gelatin
kidney
dysfunct
postop
period
observ
frequent
also
group
total
clamp
time
longer
amount
blood
product
use
surgeri
group
factor
associ
aki
reveal
studi
purpos
studi
incid
acut
kidney
injuri
aki
accord
rifl
akin
criteria
critic
ill
burn
patient
resuscit
ringer
solut
supplement
lower
molecular
weight
hydroxyethyl
starch
he
determin
relationship
rrt
indic
mortal
method
studi
consecut
patient
admit
critic
care
burn
unit
resuscit
perform
use
lactat
ringer
solut
he
low
dose
achiev
urin
output
lactat
level
transpulmonari
thermodilut
paramet
contribut
colloid
crystalloid
measur
renal
function
evalu
statist
analysi
perform
use
spearman
test
result
averag
total
bodi
surfac
area
tbsa
burn
median
total
volum
need
fi
rst
hour
mlkg
tbsa
burn
accord
rifl
criteria
patient
present
risk
present
injuri
present
failur
accord
akin
criteria
present
stage
stage
ii
stage
iii
replac
therapi
rrt
perform
patient
six
patient
rrt
employ
fi
nal
stage
multiorgan
failur
remain
nine
patient
variou
reason
one
surviv
conclus
resuscit
phase
burn
patient
use
he
low
dose
seem
caus
risk
injuri
accord
rifl
akin
criteria
report
studi
burn
patient
resuscit
without
he
howev
need
rrt
associ
high
mortal
although
mani
case
display
termin
introduct
graft
failur
major
caus
morbid
patient
burn
result
increas
length
hospit
stay
increas
number
oper
region
burn
unit
collat
data
anaesthet
chart
patient
admit
burn
icu
requir
skin
graft
aim
analys
whether
anaesthet
variabl
contribut
graft
failur
method
thirtyfi
patient
includ
analysi
total
oper
combin
debrid
split
skin
graft
ssg
chang
dress
patient
admit
burn
icu
januari
octob
exclus
criteria
death
prior
discharg
initi
surgeri
diff
erent
hospit
sixteen
patient
good
graft
viabil
group
patient
poor
graft
viabil
group
b
logist
regress
perform
use
spss
version
hosmer
lemeshow
test
use
confi
rm
good
fi
independ
variabl
age
sex
preoper
haemoglobin
intraop
fl
uid
resuscit
blood
product
inotrop
volatil
agent
temperatur
poor
graft
viabil
defi
ned
requir
least
one
addit
skin
graft
analysi
perform
oper
subtyp
oper
ssg
debrid
ssg
signifi
cant
diff
erenc
age
total
burn
surfac
area
belgian
outcom
burn
injuri
score
group
oper
data
use
colloid
found
signifi
cantli
contribut
toward
poor
graft
viabil
p
ci
analysi
perform
ssg
debrid
oper
colloid
remain
signifi
cant
p
ci
metarminol
use
found
signifi
cantli
contribut
p
ci
poor
graft
viabil
overal
use
inotrop
signifi
cant
two
group
variabl
includ
minimum
maximum
temperatur
preoper
haemoglobin
blood
transfus
found
signifi
cant
conclus
result
suggest
use
colloid
contributor
poor
graft
viabil
burn
found
independ
temperatur
overal
inotrop
use
howev
use
metarminol
may
contribut
factor
introduct
long
time
mani
investig
tri
demonstr
increas
mortal
associ
acidbas
distur
banc
studi
sought
determin
associ
hyperchloremia
measur
icu
admiss
whether
electrolyt
disturb
associ
increas
morbid
mortal
method
data
retrospect
collect
consecut
adult
patient
admit
agustin
ohoran
hospit
icu
januari
juli
underw
inpati
medic
treatment
use
electron
fi
le
result
dataset
consist
medic
fi
le
serum
chlorid
concentr
valu
admiss
elig
hyperchloremia
serum
chlorid
mmoll
quit
common
incid
patient
propens
match
base
associ
death
hyperchloremia
patient
collect
patient
hyperchloremia
admiss
n
patient
match
patient
normal
serum
chlorid
level
admiss
two
group
well
balanc
respect
variabl
collect
hyperchlorem
group
increas
risk
mortal
icu
discharg
rel
risk
ratio
confi
denc
interv
risk
increas
admiss
hyperchloremia
associ
increas
morbid
mortal
higher
score
sever
scale
associ
statist
import
see
figur
conclus
retrospect
cohort
trial
demonstr
associ
hyperchloremia
poor
icu
admiss
outcom
death
addit
studi
requir
demonstr
causal
relationship
variabl
kidney
play
crucial
role
regul
electrolyt
acidbas
homeostasi
impair
renal
function
associ
greater
urinari
strong
ion
diff
erenc
sidu
patient
metabol
acidosi
critic
ill
patient
sever
factor
infus
fl
uid
acid
endogen
product
would
lead
chang
plasma
sid
acidbas
homeostasi
without
renal
regul
urinari
electrolyt
sidu
henc
aki
highlight
inabl
address
acidbas
metabol
disturb
may
detect
major
increas
creatinin
decreas
urin
output
evalu
eff
ect
renal
function
urinari
strong
ion
excret
use
stewart
approach
acidbas
critic
ill
patient
aki
method
retrospect
studi
conduct
patient
diagnosi
aki
accord
kdigo
creatinin
criteria
avail
urinari
chemistri
one
point
icu
stay
evalu
day
defi
ned
day
sidu
calcul
urinari
spot
analysi
sidu
nau
ku
clu
patient
follow
stage
aki
next
day
aki
revers
defi
ned
accord
lack
criteria
aki
result
total
critic
ill
patient
diagnosi
aki
includ
sidu
day
diff
er
diff
erent
aki
stage
day
sidu
day
statist
diff
erent
diff
erent
aki
stage
day
tabl
sidu
day
statist
diff
erent
revers
revers
aki
day
tabl
convent
receiveroper
curv
gener
assess
accuraci
sidu
predict
aki
revers
day
auc
sidu
p
ci
conclus
sidu
identifi
ed
patient
revers
aki
good
accuraci
sidu
promis
simpl
costeff
ectiv
tool
aki
patient
evalu
research
need
assess
sidu
capabl
earli
detect
patient
renal
dysfunct
increas
creatinin
decreas
urin
output
figur
abstract
group
mortal
high
low
chlorin
introduct
care
icu
patient
benefi
ted
medic
devic
bisphenol
bpa
phthalat
leach
plastic
matrix
hypothes
icu
patient
expos
bpa
phthalat
medic
devic
method
serum
n
urinari
n
sampl
adult
n
icu
patient
analyz
total
bpa
di
phthalat
dehp
phthalat
metabolit
pm
also
enrol
patient
preoper
schedul
thorac
surgeri
repeat
sampl
taken
day
icu
stay
control
data
came
healthi
control
referenc
literatur
result
show
adult
icu
patient
continu
expos
phthalat
dehp
well
bpa
albeit
lesser
extent
result
detect
serum
urinari
level
almost
everi
patient
everi
studi
time
point
moreov
level
signifi
cantli
higher
control
compar
referenc
literatur
chronolog
exposur
demonstr
preoper
urin
serum
level
dehp
metabolit
often
detect
limit
medic
devic
sourc
chemic
patient
hemofi
ltration
extracorpor
membran
oxygen
show
serum
level
higher
gener
popul
worker
plastic
industri
serum
urinari
level
dehp
metabolit
highest
ever
report
human
biolog
highli
relev
concentr
even
conclus
adult
icu
patient
expos
plastic
soften
particular
pm
despit
continu
tighten
regul
bpa
dehp
still
present
medic
devic
patient
safeti
concern
icu
research
possibl
toxic
clinic
eff
ect
chemic
releas
medic
devic
undertaken
introduct
vitamin
defi
cienci
may
frequent
occur
critic
ill
patient
may
associ
sepsi
increas
mortal
therefor
evalu
preval
defi
cienci
dutch
icu
relationship
sepsi
morbid
mortal
method
conduct
prospect
observ
studi
mix
icu
total
patient
admit
juli
june
includ
readmiss
patient
studi
level
determin
within
hour
admiss
level
judg
suffi
cienci
nmoll
insuffi
cienci
nmoll
defi
cienci
nmoll
result
preval
defi
cienci
insuffi
cienci
respect
patient
suffi
cient
vitamin
level
vitamin
defi
cienci
associ
sepsi
p
icu
admiss
patient
defi
cient
level
higher
mean
apach
iv
score
versu
p
longer
length
hospit
stay
versu
day
p
respect
compar
patient
suffi
cient
level
patient
defi
cient
vitamin
level
odd
ratio
inhospit
mortal
confi
denc
interv
p
rel
patient
suffi
cient
vitamin
level
conclus
defi
cienci
frequent
occur
dutch
critic
ill
patient
although
relat
sepsi
diseas
sever
morbid
vitamin
defi
cienci
independ
predictor
mortal
patient
otherwis
rel
low
introduct
stress
hyperglycaemia
sh
commonli
observ
hospitalis
icu
advers
infl
uenc
outcom
sh
occur
previous
nondiabet
patient
might
refl
ect
latent
disturb
glucos
metabol
predict
futur
risk
diabet
want
assess
incid
disturb
glucos
metabol
dgm
identifi
predictor
futur
diabet
risk
could
support
time
diagnosi
prevent
earli
treatment
impend
diabet
mellitu
dm
method
prospect
observ
studi
enrol
patient
without
known
dm
admit
least
hour
icu
antwerp
univers
hospit
septemb
march
g
oral
glucos
toler
test
perform
month
post
icu
admiss
screen
disturb
glucos
metabol
furthermor
examin
whether
postdischarg
glucos
disturb
could
predict
findrisc
questionnair
patient
demograph
comorbid
icu
admiss
paramet
relat
icu
stay
glucos
paramet
insulin
need
calor
intak
diseas
sever
result
total
patient
experienc
sh
icu
stay
eight
month
post
icu
admiss
glucos
metabol
disturb
subject
impair
fast
glucos
impair
glucos
toler
impair
fast
glucos
impair
glucos
toler
diagnos
dm
disturb
glucos
metabol
tend
preval
subject
experienc
sh
icu
stay
compar
without
sh
vs
p
admiss
correl
degre
sh
r
p
findrisc
score
vs
p
sap
score
median
group
p
daili
calor
intak
icu
stay
vs
p
associ
dgm
conclus
stress
hyperglycaemia
frequent
nondiabet
patient
tendenc
toward
futur
disturb
glucos
metabol
dm
glucos
metabol
disturb
subject
month
post
icu
admiss
diagnos
diabet
mellitu
predictor
elev
risk
includ
high
findrisc
score
high
sap
score
lower
daili
calor
intak
icu
stay
refer
introduct
conjectur
transit
hypoglycemia
hyperglycemia
may
harm
hypoglycemia
investig
associ
degre
correct
hypoglycemia
icu
mortal
patient
moder
strict
strict
glycem
control
method
retrospect
analysi
pool
cohort
seven
icu
netherland
year
icu
patient
develop
hypoglycemia
mgdl
includ
exclud
patient
readmit
patient
hypoglycemia
followup
blood
glucos
measur
perform
within
hour
determin
associ
three
measur
correct
hypoglycemia
within
hour
hypoglycemia
icu
mortal
predefi
ned
rang
highest
blood
glucos
level
mgdl
mgdl
mgdl
refer
categori
mg
dl
mgdl
quartil
delta
glucos
defi
ned
diff
erenc
minimum
maximum
blood
glucos
level
third
quartil
refer
categori
quartil
standard
deviat
blood
glucos
level
third
quartil
refer
categori
result
total
icu
patient
develop
least
one
episod
hypoglycemia
three
separ
multivari
analys
three
measur
adjust
respect
confound
categori
mgdl
highest
blood
glucos
level
associ
increas
mortal
compar
refer
categori
odd
ratio
confi
denc
interv
ci
lowest
quartil
delta
glucos
ci
lowest
quartil
standard
deviat
ci
associ
higher
icu
mortal
refer
categori
transit
hyperglycemia
insuffi
cient
recoveri
hypoglycemia
associ
increas
icu
mortal
patient
moder
strict
strict
glucos
control
insulin
introduct
purpos
studi
compar
comput
protocol
paper
protocol
manag
three
domain
glucos
control
hyperglycemia
common
critic
ill
patient
risk
death
associ
hyperglycemia
hypoglycemia
glucos
variabl
safe
eff
ectiv
insulin
protocol
must
minim
hyperglycemia
glucos
variabl
also
avoid
hypoglycemia
computerbas
insulin
protocol
promis
better
perform
adjust
individu
sensit
insulin
method
histor
cohort
studi
patient
admit
three
icu
medicalcardiac
trauma
neurosci
academ
tertiari
care
hospit
adult
patient
januari
octob
one
two
continu
insulin
protocol
least
hour
includ
start
studi
period
paper
protocol
use
adult
icu
target
glucos
mgdl
use
patient
glucos
higher
mgdl
june
replac
computerbas
insulin
protocol
endotool
criteria
initi
target
glucos
mgdl
primari
exposur
insulin
protocol
primari
outcom
perform
maintain
glucos
control
result
median
glucos
endotool
group
mgdl
lower
adult
icu
group
mgdl
p
standard
deviat
glucos
endotool
group
mg
dl
lower
adult
icu
group
mgdl
p
proport
patient
group
higher
measur
sever
hyperglycemia
level
mgdl
endotool
group
lower
adult
icu
group
p
proport
patient
least
one
moder
hypoglycem
measur
mgdl
signifi
cantli
diff
erent
endotool
group
versu
adult
icu
group
vs
respect
p
howev
higher
overal
incid
hypoglycemia
endotool
group
hypoglycem
personprotocol
day
compar
adult
icu
group
personprotocol
day
rr
ci
p
sever
hypoglycemia
mgdl
rare
occur
endotool
group
adult
icu
group
conclus
patient
comput
protocol
lower
median
glucos
less
variabl
less
hyperglycemia
patient
paper
protocol
higher
risk
moder
sever
hypoglycemia
comput
group
glucos
data
prove
routin
use
use
actual
case
data
shown
compar
mean
absolut
rel
diff
erenc
mard
integr
area
curv
auc
continu
glucos
monitor
intermitt
measur
use
measur
patient
risk
method
analysi
use
aggreg
case
data
gener
recent
clinic
trial
glysur
steril
singleus
sensor
dedic
monitor
system
use
measur
blood
glucos
concentr
patient
continu
real
time
measur
risk
compar
use
mard
accept
error
calcul
tool
auc
calcul
use
auc
analysi
softwar
program
result
mard
glysur
sensor
intermitt
measur
use
hospit
exist
protocol
compar
measur
risk
patient
uncertainti
regard
patient
absolut
blood
glucos
statu
glysur
sensor
lower
intermitt
measur
result
also
show
variabl
bg
data
increas
benefi
continu
monitor
increas
signifi
cantli
reduc
patient
risk
continu
monitor
reduc
patient
risk
respect
high
medium
low
variabl
situat
conclus
evid
continu
glucos
technolog
instrument
drive
safe
eff
ectiv
glucos
manag
protocol
support
consist
glycem
manag
standard
within
icu
across
institut
refer
introduct
need
continu
glucos
monitor
critic
ill
patient
object
trial
determin
point
accuraci
reliabl
devic
design
continu
monitor
interstiti
glucos
level
icu
patient
sentrino
medtron
minim
northridg
ca
usa
method
critic
ill
patient
anticip
life
expect
hour
elig
particip
platelet
count
ml
devic
read
compar
glucos
measur
arteri
blood
use
blood
ga
analyz
rapidlab
siemen
healthcar
diagnost
hagu
netherland
use
linear
mix
model
determin
factor
aff
ect
point
accuraci
addit
determin
reliabl
includ
durat
devic
startup
calibr
skip
data
acquisit
prematur
disconnect
sensor
result
includ
patient
age
year
apach
ii
score
admiss
type
medic
elect
surgeri
emerg
surgeri
diabet
accuraci
analys
compar
sampl
sensor
patient
sampl
per
patient
hour
hour
per
patient
hour
per
sensor
blandaltman
plot
show
bia
mgdl
limit
agreement
mgdl
glucos
predict
error
analysi
show
glucos
valu
mgdl
within
mgdl
glucos
valu
mgdl
within
compar
rapidlab
result
clark
error
grid
analysi
show
zone
pair
measur
zone
b
pair
measur
zone
c
pair
measur
zone
point
accuraci
meet
standard
dose
accuraci
improv
increas
number
calibr
better
patient
diabet
mellitu
sixti
sensor
remov
prematur
varieti
reason
devic
startup
time
minut
number
skip
data
acquisit
low
result
avail
realtim
data
connect
time
per
sensor
conclus
point
accuraci
devic
rel
low
critic
ill
patient
devic
reliabl
rel
good
although
sensor
remov
prematur
varieti
reason
introduct
hyperglycemia
common
often
multifactori
critic
ill
patient
associ
hyperglycemia
advers
outcom
repeatedli
establish
varieti
set
object
studi
investig
whether
hyperglycemia
admiss
icu
impact
present
outcom
sepsi
patient
whether
eff
ect
diff
erent
patient
histori
diabet
mellitu
method
twocent
prospect
observ
cohort
studi
conduct
includ
consecut
critic
ill
patient
admit
icu
januari
juli
sepsi
patient
identifi
ed
use
strict
clinic
diagnost
criteria
fi
rst
glucos
measur
within
time
window
hour
hour
icu
admiss
categor
euglycemia
mgdl
mild
hyperglycemia
mgdl
sever
hyperglycemia
mg
dl
patient
hypoglycemia
exclud
multivari
cox
proport
hazard
model
use
determin
eff
ect
admiss
hyperglycemia
mortal
correct
covari
result
patient
admit
sepsi
admiss
glucos
level
within
normal
rang
mild
hyperglycemia
sever
hyperglycemia
patient
sever
hyperglycemia
older
higher
apach
iv
score
often
diabet
compar
euglycem
patient
shock
admiss
common
patient
admit
euglycemia
crude
mortal
increas
increas
admiss
glucos
cox
regress
analysi
show
increas
risk
hr
ci
hr
ci
ci
mortal
patient
admit
sever
hyperglycemia
compar
euglycemia
associ
mortal
sever
hyperglycemia
admiss
present
patient
without
known
diabet
patient
histori
diabet
mortal
hr
ci
vs
ci
sever
hyperglycemia
associ
blunt
proinfl
ammatori
cytokin
respons
admiss
patient
without
patient
diabet
conclus
sever
hyperglycemia
admiss
associ
increas
mortal
sepsi
patient
without
histori
diabet
mellitu
microdialysisbas
continu
glucos
monitor
cgm
maquet
critic
care
ab
solna
sweden
method
patient
expect
stay
icu
hour
need
arteri
cathet
central
venou
cathet
cvc
elig
maximum
day
hour
per
day
blood
drawn
arteri
line
everi
minut
point
accuraci
express
use
clark
error
grid
blandaltman
plot
glucos
predict
error
analysi
trend
accuraci
express
use
continu
glucos
error
grid
analysi
result
threehundr
fi
ftyfour
pair
sampl
obtain
seven
patient
year
old
apach
ii
score
sampl
per
patient
point
accuraci
pair
valu
zone
remain
valu
zone
b
clark
error
grid
blandaltman
bia
mgdl
upper
limit
agreement
mgdl
lower
level
agreement
mgdl
glucos
predict
error
analysi
show
valu
mgdl
within
valu
measur
blood
ga
analyz
within
rang
trend
accuraci
rate
error
grid
continu
glucos
error
grid
analysi
pair
valu
zone
zone
b
zone
c
conclus
point
trend
accuraci
test
microdialysisbas
cgm
good
critic
ill
patient
introduct
hyperglycemia
occur
patient
admit
medic
icu
micu
associ
poor
prognosi
whether
appli
intens
insulin
therapi
achiev
tight
glycem
control
critic
ill
patient
benefi
cial
remain
controversi
anoth
import
observ
link
glycem
variabl
mortal
perform
pilot
studi
hypothes
implement
intens
insulin
therapi
realtim
continu
glucos
monitor
rtcgm
may
help
safe
achiev
tight
glucos
control
avoid
hypoglycemia
reduc
glycem
variabl
micu
patient
method
twocent
random
control
pilot
studi
perform
period
includ
patient
sever
ill
apach
ii
score
cgm
monitor
start
within
hour
admiss
micu
thirtyfi
patient
age
year
nondiabeticdiabet
patient
apach
ii
score
randomli
assign
rtcgm
n
blind
cgm
group
microdialysisbas
glucos
sensor
use
period
glucos
monitor
insulin
infus
perform
use
modifi
ed
yale
protocol
outcom
measur
percentag
time
normoglycemia
hypoglycemia
glycem
variabl
cgm
accuraci
result
rtcgm
group
percentag
time
target
glycemia
mgdl
versu
control
group
ns
glycemia
averag
mgdl
versu
mg
dl
respect
ns
time
spent
hypoglycemia
mgdl
statist
diff
erent
group
assign
rtcgm
time
versu
blind
cgm
registr
time
paramet
glucos
variabl
standard
deviat
mean
glucos
valu
coeffi
cient
variat
mean
amplitud
glucos
excurs
diff
er
group
valu
arteri
glycemia
correl
well
data
fall
region
b
error
grid
analysi
conclus
studi
use
rtcgm
neither
improv
glucos
control
variabl
reduc
hypoglycem
event
hand
state
insulin
infus
protocol
alreadi
led
overal
tight
glucos
control
without
signifi
cant
hypoglycemia
risk
leav
littl
space
improv
introduct
faecal
periton
fp
common
caus
sepsi
admiss
icu
report
review
patient
admit
icu
year
fp
aim
defi
ne
clinic
characterist
outcom
risk
factor
mortal
icu
patient
fp
method
data
extract
retrospect
electron
case
fi
le
primari
outcom
icu
mortal
secondari
outcom
hospit
mortal
logist
regress
analysi
use
identifi
independ
risk
factor
mortal
result
ninetynin
fp
patient
admit
april
januari
median
age
iqr
femal
preponder
median
icu
length
stay
lo
day
iqr
admiss
critic
care
clinic
data
includ
median
temperatur
iqr
systol
blood
pressur
bp
mmhg
iqr
diastol
bp
mmhg
iqr
lactat
mmoll
iqr
bilirubin
iqr
haemoglobin
gl
iqr
haematocrit
iqr
creatinin
iqr
prothrombin
time
second
iqr
patient
initi
oper
emerg
laparotomi
primari
perfor
case
subsequ
anastomot
dehisc
need
relaparotomi
happen
case
respect
forti
per
cent
patient
underw
one
surgic
abdomin
intervent
common
antibiot
use
tazobactam
fl
uconazol
commonest
antifung
percentag
patient
receiv
mechan
ventil
renal
replac
therapi
inotropicvasopressor
support
icu
stay
respect
icu
hospit
mortal
rate
respect
increas
day
day
year
none
surgic
factor
diabet
infl
uenc
surviv
strongest
independ
risk
factor
associ
icu
mortal
systol
bp
icu
admiss
ci
p
acut
kidney
injuri
aki
within
fi
rst
hour
icu
admiss
ci
p
lactat
icu
admiss
ci
p
conclus
cohort
critic
ill
fp
patient
icu
mortal
rate
respect
consist
predictor
mortal
across
time
point
aki
within
hour
icu
admiss
admiss
lactat
method
singlecentr
observ
studi
prospect
enrol
patient
undergo
elect
cardiac
surgeri
primari
output
time
faec
ttfe
repres
postop
ileu
secondari
output
occurr
ischaem
coliti
pneumonia
quantit
variabl
compar
anova
wilcoxon
test
qualit
variabl
chisquar
test
multivari
analys
perform
logist
regress
p
input
p
output
result
includ
patient
age
year
mf
sex
ratio
preoper
left
ventricl
eject
fraction
bypassvalv
ratio
number
graft
mammal
arteri
univari
analys
bypass
receiv
anaesthet
drug
p
shorter
extracorpor
circul
durat
versu
minut
p
receiv
less
blood
product
p
bypass
lower
postop
level
troponin
vs
pgml
p
ldh
vs
pg
ml
contrast
intraabdomin
pressur
iap
higher
relat
number
graft
day
figur
day
p
respect
number
mammal
graft
day
day
p
respect
ttfe
longer
reach
signifi
canc
p
well
occurr
abdomin
ischaemia
p
occurr
pneumonia
higher
p
multivari
analysi
iap
day
day
relat
propofol
quantiti
predictor
pneumonia
durat
mechan
ventil
peak
lactat
postop
hour
coronari
bypass
respect
conclus
number
coronari
graft
mammal
arteri
use
cardiac
surgeri
associ
higher
iap
higher
risk
pneumonia
howev
whether
due
direct
bowel
ischaemia
longer
anaesthesia
remain
studi
larger
trial
result
eightyseven
patient
femal
mean
age
year
primari
cancer
colorect
patient
ovarian
appendic
other
averag
oper
time
hour
averag
intraop
crystalloid
given
ml
pack
rbc
unit
colloid
ml
averag
blood
loss
ml
patient
admit
icu
post
procedur
averag
fl
uid
balanc
ml
patient
stay
icu
averag
day
patient
surviv
icu
stay
durat
mechan
ventil
hour
total
fl
uid
balanc
icu
ml
hypomagnesemia
frequent
electrolyt
abnorm
pleural
eff
usion
three
patient
requir
drainag
seven
patient
develop
pneumonia
patient
requir
renal
replac
therapi
averag
hospit
lo
day
two
patient
die
hospit
fi
rst
patient
compar
last
patient
durat
mv
icu
lo
hospit
lo
signifi
cantli
shorter
latter
group
vs
hour
vs
vs
day
respect
p
conclus
proper
select
patient
cr
hipec
done
safe
major
complic
signifi
cant
reduct
icu
util
shorter
hospit
lo
experi
procedur
suggest
learn
curv
well
better
util
resourc
refer
patient
highvolum
center
dissemin
intravascular
coagul
dic
score
predictor
outcom
critic
ill
patient
yet
disturb
coagul
hemostasi
refl
ect
dic
score
common
fi
nding
patient
liver
cirrhosi
thu
unclear
whether
dic
score
prognost
valu
critic
ill
patient
liver
cirrhosi
aim
studi
assess
applic
prognost
impact
dic
score
critic
ill
patient
liver
cirrhosi
method
patient
liver
cirrhosi
admit
medic
icu
analyz
studi
detail
laboratori
analys
includ
platelet
count
ddimer
fi
brinogen
prothrombin
index
perform
admiss
dic
score
calcul
surviv
assess
site
contact
patient
attend
physician
result
total
admiss
icu
liver
cirrhosi
analyz
thirtynin
percent
femal
median
age
iqr
year
median
sofa
score
admiss
median
meld
score
iqr
twentyeightday
mortal
median
dic
score
admiss
iqr
overt
dic
dic
score
found
dic
score
signifi
cantli
higher
nonsurvivor
compar
survivor
iqr
vs
iqr
p
auroc
dic
score
predict
mortal
ci
overt
dic
admiss
signifi
cantli
associ
mortal
ci
p
mortal
rate
admiss
cirrhosi
overt
dic
compar
dic
score
conclus
disturb
coagul
hemostasi
found
major
cirrhot
patient
admit
icu
dic
score
suitabl
predictor
mortal
critic
ill
patient
liver
cirrhosi
refer
introduct
factor
associ
initi
poor
graft
function
ipgf
liver
transplant
still
debat
although
initi
insult
graft
begin
cold
ischemia
time
cit
recent
studi
show
injuri
occur
rewarm
ischemicreperfus
ir
injuri
present
graft
may
respons
postop
graft
dysfunct
along
factor
ir
injuri
may
also
play
role
develop
postreperfus
syndrom
pr
revascular
liver
graft
aim
studi
assess
whether
longer
warm
ischemia
time
wit
associ
pr
ipgf
liver
transplant
secondari
aim
investig
whether
patient
intraop
pr
higher
risk
postop
ipgf
method
retrospect
observ
studi
includ
liver
transplant
patient
exclud
studi
group
patient
retranspl
procedur
recipi
divid
graft
graft
extend
criteria
donor
record
demograph
data
intraop
pr
cit
wit
alt
ast
level
standard
coagul
test
postop
day
pod
statist
analysi
perform
use
spss
statist
signifi
cant
p
valu
use
criteria
nanashima
colleagu
diagnosi
ipgf
alt
andor
ast
level
iul
within
hour
olt
studi
group
includ
men
women
mean
age
year
wit
longer
minut
correl
signifi
cantli
alt
ast
level
pod
p
alt
pod
p
ast
pod
p
ast
pod
prothrombin
time
p
pod
p
pod
p
pod
could
fi
nd
correl
pr
wit
p
cit
p
transaminas
level
pod
correl
wit
minut
ipgf
confi
rmed
use
pearson
chisquar
test
p
test
use
correl
ipgf
pr
nonsignifi
cant
result
p
conclus
studi
show
pr
risk
factor
ipgf
liver
transplant
wit
minut
infl
uenc
develop
pr
associ
ipgf
liver
transplant
close
monitor
liver
test
earli
postop
period
import
especi
recipi
graft
wit
minut
eff
ort
decreas
wit
may
prove
use
reduct
ipgf
liver
transplant
patient
result
patient
could
reach
patient
evalu
studi
among
patient
femal
male
mean
age
hbsag
posit
nine
patient
nine
male
antihcv
posit
four
patient
among
three
male
one
femal
one
patient
posit
antihiv
present
studi
observ
seropreval
hbsag
antihcv
antihiv
higher
citi
popul
howev
take
safeti
precaut
healthcar
worker
surgic
invas
procedur
catheter
intub
tracheostomi
without
inform
serolog
test
result
patient
reduc
contamin
agent
patient
decompens
cirrhosi
admit
icu
histor
high
mortal
rate
suggest
improv
patient
select
improv
icu
outcom
patient
cirrhosi
aim
studi
determin
mortal
evalu
risk
factor
may
infl
uenc
outcom
group
patient
larg
uk
district
gener
hospit
view
introduc
select
criteria
futur
icu
admiss
patient
decompens
liver
diseas
method
retrospect
analysi
perform
adult
patient
decompens
chronic
liver
diseas
admit
gener
nontranspl
critic
care
unit
januari
decemb
data
collect
regard
demograph
icu
mortal
hospit
mortal
aetiolog
chronic
liver
diseas
sever
score
acut
diagnos
organ
support
requir
result
thirtyseven
patient
identifi
ed
median
age
year
predominantli
male
seventysix
per
cent
alcoholrel
cirrhosi
overal
icu
mortal
hospit
mortal
valu
higher
alcohol
group
respect
icu
death
alcohol
liver
diseas
median
score
apach
iii
sofa
day
childpugh
meld
seventi
per
cent
treat
sepsi
gi
bleed
encephalopathi
suspect
confi
rmed
spontan
bacteri
periton
acut
kidney
injuri
organ
support
requir
respiratori
noninvas
invas
ventil
vasoact
agent
support
renal
replac
therapi
rrt
alcohol
liver
diseas
patient
requir
respiratori
cardiovascular
support
icu
mortal
requir
rrt
mortal
alcohol
liver
diseas
patient
requir
combin
respiratori
cardiovascular
rrt
support
mortal
conclus
decompens
chronic
liver
diseas
admit
icu
signifi
cant
icuhospit
mortal
increas
alcohol
liver
diseas
sepsi
aki
common
acut
diagnos
cohort
alcohol
liver
diseas
patient
requir
organ
support
high
mortal
outlook
multiorgan
failur
requir
rrt
group
dismal
refer
support
therapi
bridg
transplant
recoveri
adult
liver
failur
system
er
specifi
c
challeng
appli
children
due
larg
extracorpor
volum
ml
therefor
develop
adapt
protocol
applic
children
method
prime
blood
circuit
perform
use
l
isoton
salin
wherea
plasma
circuit
contain
adsorpt
devic
fi
lled
u
fresh
frozen
plasma
ml
stabil
solut
human
plasma
protein
next
children
bodi
weight
bw
kg
solut
pack
cell
pc
infus
inlet
blood
line
mlminut
volum
pc
need
calcul
base
circuit
prime
volum
maximum
allow
extracorpor
blood
volum
child
mlkg
bw
prime
phase
blood
plasma
fl
ow
increas
least
ml
minut
mlminut
respect
dialys
fl
ow
set
mlminut
region
citrat
anticoagul
done
calciumfre
dialys
eventu
heparin
ad
prime
solut
post
treatment
circuit
volum
either
reinfus
bw
kg
reinfus
use
isoton
salin
bw
kg
volum
depend
hydrat
statu
origin
infus
volum
pc
reduct
ratio
rr
urea
creatinin
crea
bilirubin
bili
ammonia
nh
calcul
pretreat
posttreat
serum
concentr
primari
secondari
patient
outcom
evalu
result
eight
children
fi
malethre
femal
year
old
rang
year
bw
kg
gfr
uncuff
ed
doubl
lumen
dialysi
cathet
fr
femorali
n
fr
jugulari
n
treat
accord
protocol
total
session
execut
use
n
n
n
dialys
hour
blood
fl
ow
mlminut
albumin
fl
ow
mlminut
ultrafi
ltration
fl
ow
ml
rr
urea
crea
bili
nh
primari
surviv
rate
four
patient
transplant
bridg
transplant
howev
one
die
within
day
discharg
icu
fi
fth
patient
die
due
primari
diseas
month
treatment
remain
three
patient
fulli
recov
bridg
recoveri
conclus
adapt
protocol
promis
treatment
children
liver
failur
molecular
adsorb
recircul
system
mar
use
remov
circul
albuminbound
toxin
patient
liver
failur
howev
applic
mar
demonstr
improv
surviv
random
clinic
trial
clinic
util
fi
nalli
establish
depart
use
mar
restrict
critic
ill
patient
acut
acut
chronic
liver
failur
aim
explor
mar
effi
caci
remov
toxic
paramet
safeti
system
method
sinc
treat
patient
femal
median
age
year
rang
month
year
list
liver
transplant
mar
median
model
end
stage
liver
diseas
meld
score
patient
older
year
age
n
interquartil
rang
fl
ow
rate
ml
kghour
treatment
kit
chang
everi
hour
patient
treat
median
hour
rang
hour
result
fiftyfi
patient
success
bridg
transplant
nine
die
could
transplant
fi
patient
recov
without
liver
transplant
fortyfour
transplant
patient
aliv
day
transplant
ammonium
decreas
modestli
median
p
mar
treatment
detect
worsen
coagulopathi
signifi
cant
decreas
platelet
count
fi
brinogen
concentr
increas
intern
normal
ratio
phosphat
magnesium
decreas
signifi
cantli
mar
treatment
conclus
close
observ
treatment
coagulopathi
electrolyt
disturb
essenti
treat
patient
mar
mar
reduc
stabil
ammonium
biomed
marker
patient
list
urgent
liver
transplant
high
meld
score
liver
encephalopathi
seem
case
set
detoxifi
cation
properti
mar
may
insuffi
cient
first
clinic
experi
new
type
albumin
dialysi
introduct
liver
failur
lf
associ
prolong
hospit
stay
increas
cost
substanti
mortal
regard
limit
number
donor
organ
extracorpor
liver
support
appeal
concept
bridg
transplant
avoid
transplant
case
recoveri
new
type
albumin
dialysi
system
recent
introduc
system
provid
rapid
regener
toxinbind
albumin
secondari
circuit
alter
bind
capac
albumin
biochem
chang
ph
physic
chang
temperatur
modul
dialys
method
evalu
fi
rst
patient
treat
system
regard
safeti
effi
caci
seven
patient
treat
context
runin
phase
studi
hepaticu
hepaticu
seven
patient
treat
sinc
system
receiv
ce
certifi
cate
juli
patient
treat
suff
ere
acut
chronic
lf
n
secondari
lf
result
nonhepat
diseas
sepsi
n
conclus
far
system
proven
safe
feasibl
procedur
eff
ectiv
elimin
water
proteinbound
toxin
human
lf
introduct
hospit
admiss
mortal
rate
patient
cirrhosi
uk
rise
cirrhot
patient
physiolog
challeng
increas
risk
sepsi
death
mortal
rate
cirrhosi
nontranspl
icu
increas
avail
medic
therapi
public
expect
place
pressur
limit
intens
care
resourc
lack
research
factor
use
decid
patient
admit
refer
icu
method
prospect
survey
sent
consult
gastroenterologist
consult
intensivist
scotland
recipi
rate
signifi
canc
physiolog
social
criteria
decis
refer
admit
patient
intens
care
infl
uenc
denot
signifi
cant
impact
decis
recipi
list
addit
criteria
use
practic
ask
whether
would
admit
refer
individu
grade
childpugh
cirrhosi
either
gastrointestin
bleed
sepsi
result
thirtyfi
consult
gastroenterologist
intens
care
consult
respond
repres
respons
rate
respect
criterion
given
averag
rate
gastroenterologist
intensivist
childpugh
score
stabl
presenc
transplant
list
referr
secondari
bleed
varic
recent
discharg
icu
abstin
alcohol
nutrit
statu
age
one
addit
organ
failur
score
group
sex
employ
smoke
drug
use
depriv
posit
virolog
statu
infl
uenc
decis
refer
admit
patient
clinician
report
complianc
medic
outpati
appoint
plu
obviou
precipit
factor
import
featur
decis
major
respond
would
refer
admit
grade
childpugh
cirrhosi
gastrointestin
bleed
would
refer
admit
childpugh
b
sepsi
total
gastroenterologist
would
refer
childpugh
c
cirrhosi
sepsi
intensivist
would
accept
conclus
referr
admiss
decis
patient
cirrhosi
multifactori
childpugh
statu
stabl
appear
greatest
signifi
canc
diff
erenc
opinion
admiss
patient
childpugh
c
sepsi
requir
evalu
introduct
cirrhot
patient
admit
icu
usual
regard
particularli
poor
prognosi
compar
group
critic
ill
patient
aim
studi
evalu
preval
case
mix
outcom
patient
cirrhosi
admit
gener
icu
nontranspl
center
method
data
collect
run
icu
databas
studi
cirrhot
patient
admit
icu
januari
novemb
result
total
patient
cirrhosi
admit
account
total
icu
admiss
mean
age
year
male
preponder
main
caus
cirrhosi
alcohol
follow
alcohol
plu
chronic
hepat
c
viru
hcv
infect
hcv
viru
infect
alon
common
caus
admiss
sepsissept
shock
surgic
gastrointestin
bleed
hepat
encephalopathi
admiss
patient
present
averag
model
endstag
liver
diseas
score
classifi
ed
grade
c
childpugh
score
mean
acut
physiolog
chronic
health
evalu
apach
ii
new
simplifi
ed
acut
physiolog
score
sap
ii
regard
organ
failur
admiss
mean
sequenti
organ
failur
assess
score
icu
mortal
patient
hospit
mortal
variabl
admiss
relat
signifi
cantli
icu
mortal
score
describ
except
childpugh
score
bilirubin
intern
normal
ratio
creatinin
bicarbon
lactat
ph
use
renal
replac
therapi
icu
stay
p
mortal
rate
cirrhot
patient
superior
gener
icu
mortal
vs
howev
patient
cirrhosi
present
signifi
cantli
higher
sever
score
system
apach
ii
sap
ii
admiss
compar
noncirrhot
high
preval
organ
dysfunct
assess
sofa
score
conclus
high
sever
diseas
conjunct
high
mortal
rate
observ
group
patient
make
us
consid
possibl
benefi
ts
earlier
referringadmiss
icu
ideal
multiorgan
failur
aris
hand
nontranspl
center
cirrhot
patient
constitut
small
percentag
total
icu
admiss
complex
peculiar
manag
patient
prompt
earli
transfer
special
center
aim
studi
evolut
incid
intraabdomin
hypertens
critic
burn
patient
use
slightli
restrict
fl
uid
therapi
protocol
base
monitor
transpulmonari
thermodilut
lactic
acid
method
prospect
studi
consecut
patient
admit
critic
burn
unit
octob
octob
resuscit
perform
object
blood
pressur
mmhg
hourli
diuresi
cm
kg
lactic
acid
clearanc
thermodilut
transpulmonari
paramet
ci
lminutem
itbi
mlm
perform
measur
iap
bladder
cathet
everi
hour
fi
rst
hour
result
ninetyeight
men
women
studi
mean
age
year
tbsa
fl
uid
provid
tbsa
fi
rst
hour
less
predict
parkland
mlkg
although
total
contribut
fi
rst
hour
similar
evolut
intraabdomin
pressur
admiss
mmhg
conclus
iah
incid
slightli
restrict
fl
uid
protocol
use
less
expect
introduct
intraabdomin
hypertens
iah
frequent
icu
associ
advers
outcom
wors
prognosi
purpos
studi
assess
risk
factor
iah
prognosi
major
injur
patient
burn
resuscit
method
adult
burn
patient
burn
injuri
exceed
total
bodi
surfac
area
april
novemb
includ
iap
measur
iah
suspect
accord
kron
method
via
foley
cathet
monitor
iap
perform
everi
hour
day
normal
result
twenti
patient
enrol
studi
mean
age
year
male
six
femal
averag
tbsa
screen
monitor
iap
appli
oliguria
abdomin
distens
gastrointestin
troubl
iah
occur
day
day
earli
burn
resuscit
respect
iah
observ
case
patient
admit
icu
delay
day
post
burn
injuri
iah
note
patient
fi
patient
develop
abdomin
compart
syndrom
mean
iap
mmhg
patient
assign
two
group
iah
n
iah
n
compar
studi
two
group
show
hia
increas
signifi
cantli
bodi
weight
gain
within
fi
rst
day
injuri
kg
versu
kg
p
occurr
ard
vs
p
respiratori
failur
vs
p
shock
vs
p
mortal
vs
conclus
iah
frequent
earli
burn
resuscit
major
injur
patient
seem
associ
fl
uid
overload
burn
contribut
organ
damag
aim
studi
investig
eff
ect
sepsi
respiratori
mechan
porcin
model
intraabdomin
hypertens
iah
method
sixteen
pig
divid
two
group
eight
ga
gb
anim
receiv
gener
anesthesia
mechan
ventil
paramet
record
includ
respiratori
system
chest
wall
lung
complianc
cr
ccw
cl
respiratori
system
chest
wall
inspiratori
expiratori
resist
rrsisp
rrsexp
rcwisp
rcwexp
baselin
measur
minut
intraabdomin
pressur
iap
rais
helium
insuffl
ation
mmhg
group
remain
level
whole
studi
gb
sepsi
induc
minut
iap
increas
iv
administr
escherichia
coli
endotoxin
paramet
record
everi
minut
last
measur
made
minut
right
deinsuffl
ation
iap
return
baselin
level
result
cr
decreas
statist
signifi
cantli
group
iap
increas
increas
deinsuffl
ation
ga
similarli
ccw
decreas
group
return
baselin
valu
group
deinsuffl
ation
cl
decreas
signifi
cantli
gb
return
baselin
valu
ga
rrsisp
increas
gb
decreas
deinsuffl
ation
wherea
rrsexp
increas
group
signifi
cant
manner
gb
decreas
ga
deinsuffl
ation
rcwisp
rcsesp
show
alter
studi
period
result
depict
mean
valu
sd
tabl
conclus
sepsi
iah
neg
eff
ect
respiratori
mechan
howev
combin
even
detriment
eff
ect
amelior
deinsuffl
ation
introduct
enzym
gener
adenosin
dampen
infl
ammat
improv
vascular
barrier
function
sever
diseas
model
also
circul
solubl
form
blood
studi
whether
level
solubl
form
cytokineschemokin
predict
develop
organ
failur
acut
pancreat
method
altogeth
patient
acut
pancreat
subclassifi
ed
accord
revis
atlanta
criteria
mild
moder
sever
sever
form
studi
serum
blood
cell
sampl
collect
admiss
protein
level
solubl
form
serum
determin
use
novel
enzymelink
immunosorb
assay
activ
solubl
form
use
radioact
enzym
assay
messeng
rna
level
leukocyt
use
quantit
pcr
serum
level
cytokin
growth
factor
determin
use
bioplex
pro
human
cytokin
assay
magnet
bead
suspens
panel
result
activ
protein
concentr
solubl
form
messeng
rna
level
decreas
along
diseas
sever
p
activ
solubl
form
admiss
predict
develop
sever
pancreat
diff
erent
group
patient
especi
activ
solubl
form
better
creactiv
protein
creatinin
predict
sever
pancreat
group
patient
without
sign
organ
failur
admiss
subgroup
analys
patient
sever
pancreat
without
organ
dysfunct
upon
admiss
hepatocyt
growth
factor
granulocyt
colonystimul
factor
gcsf
level
predict
develop
sever
pancreat
gcsf
accur
cytokin
conclus
activ
solubl
form
level
certain
cytokin
admiss
hospit
prognost
valu
predict
develop
sever
form
acut
pancreat
possibl
combin
prognost
marker
might
improv
prognost
accuraci
requir
studi
introduct
heterogen
publish
result
led
us
conduct
clinic
trial
assess
effi
caci
new
formul
four
probiot
p
prophylaxi
complic
colorect
surgeri
method
doubleblind
placebocontrol
random
studi
conduct
enrol
patient
undergo
colorect
cancer
surgeri
placebo
formul
l
acidophilu
l
plantarum
b
lacti
boulardii
administ
start
day
oper
continu
day
post
oper
patient
followedup
day
develop
postop
complic
primari
outcom
paxgen
tube
serum
collect
postop
day
measur
gene
express
serum
cytokin
clinicaltrialsgov
result
administr
p
signifi
cantli
decreas
rate
postop
major
complic
vs
placebo
p
odd
ratio
major
benefi
found
reduct
postop
pneumonia
rate
vs
p
wound
infect
vs
p
anastomot
leakag
vs
p
need
mechan
ventil
vs
p
time
hospit
discharg
shorten
critic
care
volum
suppl
http
well
gene
express
posit
relat
circul
p
group
placebo
group
figur
conclus
studi
p
formul
signifi
cantli
decreas
risk
postop
complic
name
mechan
ventil
infect
anastomot
leakag
modul
gene
express
one
suggest
mechan
introduct
studi
aim
determin
success
rate
nasoenter
tube
net
insert
postpylor
area
ultrasonographi
usg
compar
commonli
use
method
direct
abdomin
radiographi
method
patient
admit
adult
icu
april
juli
indic
net
insert
enter
feed
includ
studi
inform
consent
given
patient
rel
nasoenter
feed
tube
place
use
blind
bedsid
method
singl
anesthesiologist
motil
stimul
agent
use
outsid
polyurethran
f
unweight
net
bexen
spain
guid
wire
lubric
gel
net
insert
nostril
determin
mouthposterior
earxiphoid
distanc
push
least
distanc
follow
auscult
gastric
area
air
infus
ml
tube
patient
posit
right
side
tube
advanc
cm
guid
wire
insid
net
remov
patient
brought
supin
posit
net
visual
two
radiologist
simultan
portabl
usg
mindray
prc
mhz
convex
probe
whether
pass
postpylor
area
local
tube
confi
rmed
abdomin
radiographi
patient
fi
rst
insert
net
ratio
inaccur
local
correct
placement
postpylor
area
record
result
compar
abdomin
radiographi
result
studi
bedsid
blind
method
use
net
insert
patient
eleven
tube
detect
pass
postpylor
area
usg
one
case
net
could
seen
postpylor
area
usg
detect
postpylor
area
control
abdomin
radiographi
patient
net
detect
stomach
control
abdomin
radiographi
success
net
placement
bedsid
blind
method
usg
imag
versu
respect
conclus
success
rate
bedsid
blind
method
net
placement
low
clear
placement
techniqu
high
success
rate
appli
usg
use
higher
number
patient
reduc
need
abdomin
radiographi
object
determin
whether
administr
thiamin
mitig
elev
lactat
level
patient
septic
shock
thiamin
essenti
aerob
metabol
found
thiamin
level
low
invers
correl
lactat
level
patient
sepsi
method
perform
random
doubleblind
placebocontrol
twocent
trial
januari
octob
enrol
patient
septic
shock
elev
lactat
mmoll
obviou
compet
caus
lactat
elev
patient
receiv
thiamin
mg
placebo
iv
twiceday
day
primari
outcom
lactat
level
hour
secondari
outcom
includ
sofa
score
hour
mortal
lactat
level
hour
compar
group
use
wilcoxon
ranksum
test
categor
variabl
compar
use
fisher
exact
test
lactat
valu
hour
die
hour
imput
accord
predefi
ned
plan
perform
preplan
analysi
baselin
thiamin
defi
cienci
nmoll
result
enrol
patient
receiv
thiamin
placebo
baselin
characterist
similar
group
found
overal
statist
signifi
cant
diff
erenc
lactat
level
thiamin
placebo
group
iqr
vs
iqr
p
fewer
patient
thiamin
group
lactat
level
mmoll
hour
vs
p
statist
signifi
cant
evalu
survivor
hour
vs
p
although
preplan
analysi
imput
data
found
diff
erenc
sofa
score
mortal
total
patient
thiamin
defi
cient
defi
cient
patient
receiv
thiamin
statist
signifi
cant
lower
lactat
level
hour
iqr
vs
iqr
p
patient
placebo
group
lactat
mmoll
vs
p
mortal
thiamin
placebo
group
respect
p
conclus
thiamin
defi
cienci
preval
septic
shock
thiamin
decreas
overal
median
lactat
level
hour
patient
thiamin
defi
cienci
statist
signifi
cant
lower
lactat
level
hour
thiamin
group
larg
although
nonsignifi
cant
diff
erenc
mortal
introduct
malnutrit
common
hospit
medic
patient
associ
poor
clinic
outcom
whether
malnutrit
direct
link
advers
outcom
rather
mirror
sever
patient
condit
remain
debat
aim
studi
associ
acut
chronic
malnutrit
statu
blood
biomark
diff
erent
pathophysiolog
concept
better
understand
underli
mechan
malnutrit
method
prospect
follow
consecut
adult
medic
inpati
hospit
februari
octob
tertiari
care
swiss
hospit
nutrit
risk
assess
use
nutrit
risk
screen
nr
score
incorpor
acut
chronic
measur
malnutrit
multiadjust
regress
model
use
investig
associ
acut
chronic
nutrit
risk
biomark
mirror
infl
ammat
crp
pct
proadm
leucocyt
stress
copeptin
renal
dysfunct
creatinin
urea
nutrit
statu
vitamin
albumin
calcium
glucos
hematolog
function
platelet
inr
hb
rdw
biomark
level
transform
decil
due
skew
distribut
result
total
patient
mean
age
year
male
includ
overal
signifi
cant
associ
nr
biomark
infl
ammat
stress
renal
function
nutrit
hematolog
system
coeffi
cient
ci
crp
p
pct
p
proadm
p
copeptin
p
urea
p
vitamin
p
albumin
p
hemoglobin
p
rdw
p
associ
remain
robust
adjust
sociodemograph
model
comorbid
model
main
medic
diagnosi
model
subgroup
analysi
suggest
mainli
acut
part
malnutrit
chronic
malnutrit
associ
increas
biomark
level
conclus
acut
malnutrit
associ
pronounc
infl
ammatori
respons
increas
biomark
diff
erent
pathophysiolog
system
may
partli
explain
link
malnutrit
advers
medic
outcom
howev
intervent
trial
need
prove
causal
relationship
provis
nutrit
critic
care
unit
ccu
shift
nutrit
support
nutrit
therapi
potenti
benefi
ts
deriv
recoveri
critic
ill
explor
audit
manag
nutrit
ccu
south
african
hospit
american
societi
parenter
enter
nutrit
guidelin
furthermor
review
knowledg
confi
denc
healthcar
provid
manag
nutrit
ccu
method
retrospect
data
collect
patient
admit
fourb
ccu
period
survey
distribut
diff
erent
disciplin
involv
patient
nutrit
ccu
result
seventytwo
patient
admit
ccu
time
period
note
abl
three
paediatr
patient
exclud
twentynin
patient
stay
day
audit
popul
median
age
audit
popul
femal
sixteen
postop
admiss
median
apach
ii
score
patient
suffi
cient
avail
data
n
rang
audit
found
patient
nutrit
start
ccu
nutrit
start
within
hour
eight
patient
nutrit
assess
done
total
respond
survey
eight
anaesthetist
surgic
disciplin
seven
ccu
nurs
fi
dietician
agre
nutrit
start
fi
rst
hour
except
surgeon
agre
averag
selfrat
knowledg
nutrit
manag
ccu
lowest
highest
dietician
ccu
nurs
show
highest
confi
denc
respect
anaesthetist
rate
knowledg
surgeon
rate
found
poor
manag
nutrit
ccu
pair
limit
knowledg
low
confi
denc
manag
amongst
attend
staff
evid
would
suggest
develop
dissemin
clear
hospit
guidelin
could
improv
rate
correct
manag
howev
lack
uniform
guidanc
base
strong
evid
lead
global
author
nutrit
suggest
order
improv
implement
adequ
nutrit
research
urgent
requir
introduct
optim
enter
nutrit
earli
shown
benefi
cial
critic
ill
patient
howev
underfeed
still
common
problem
critic
ill
surgic
patient
often
present
addit
challeng
optim
enter
feed
object
studi
improv
enter
feed
practic
surgic
icu
method
clinic
practic
improv
programm
local
qualiti
improv
initi
involv
multidisciplinari
team
aim
identifi
improv
defi
cienci
process
deliveri
care
team
led
intensivist
consist
doctor
surgeon
nurs
pharmacist
form
improv
enter
feed
practic
surgic
icu
qualiti
improv
methodolog
employ
audit
carri
determin
problem
underfeed
unit
root
caus
analys
conduct
team
member
identifi
ed
key
barrier
optim
feed
area
improv
protocol
develop
standard
encourag
earli
enter
feed
well
reduc
time
feed
interrupt
patient
go
surgeri
variou
reason
educ
intervent
conduct
lectur
physician
nurs
visual
aid
form
screensav
bedsid
comput
serv
remind
team
optim
feed
subsequ
audit
conduct
determin
improv
achiev
desir
outcom
name
amount
calori
protein
receiv
well
proport
patient
achiev
target
calori
protein
consid
target
calori
kcalkgday
target
protein
gkgday
result
patient
receiv
calori
vs
protein
vs
post
implement
mean
percentag
patient
post
group
achiev
requir
calori
versu
pre
group
mean
percentag
patient
achiev
requir
protein
versu
pre
group
conclus
multiprong
approach
qualiti
improv
methodolog
help
increas
provis
calori
protein
popul
critic
ill
surgic
patient
howev
still
room
improv
term
achiev
optim
enter
nutrit
target
earli
popul
also
need
look
sustain
result
nutric
score
tool
design
quantifi
risk
critic
ill
patient
develop
advers
event
may
modifi
ed
aggress
nutrit
therapi
gener
popul
icu
cancer
patient
prone
nutrit
risk
due
diseas
treatment
complic
aim
character
nutric
score
behavior
popul
patient
admit
oncolog
icu
method
januari
june
appli
nutric
score
patient
age
year
without
cerebr
death
criteria
length
stay
lo
hour
data
collect
analyz
use
spss
evalu
impact
mortal
use
logist
regress
result
sixtynin
patient
includ
women
men
patient
age
year
normal
rang
weight
n
mean
lo
minimum
maximum
common
motiv
admiss
sepsi
n
apach
ii
score
patient
n
sofa
score
superior
n
nutric
score
low
risk
n
patient
high
n
twentyeightday
mortal
n
high
nutric
score
correspond
increas
odd
die
fi
rst
day
p
apach
ii
sofa
mortal
predictor
alon
increas
point
apach
score
correspond
increas
p
increas
point
sofa
correspond
increas
odd
dead
day
p
bodi
mass
index
age
number
comorbid
day
icu
correl
mortal
conclus
nutric
score
good
tool
cancer
patient
predict
mortal
nevertheless
compound
nutric
score
correl
independ
mortal
apach
ii
sofa
score
investig
toward
inclus
categori
tumor
stage
type
tumor
could
use
develop
specifi
c
prognost
tool
popul
introduct
critic
ill
patient
experi
hypermetabol
increa
ing
substrat
util
especi
glucos
oxid
glycogen
main
sourc
glucos
bodi
store
skelet
muscl
liver
respect
sinc
glycogen
store
limit
evalu
hypothesi
critic
ill
could
associ
glycogen
deplet
lead
skelet
muscl
catabol
gluconeogenesi
eventu
result
cachexia
import
determin
futur
icu
surviv
icuacquir
weak
method
nine
critic
ill
patient
year
old
icu
stay
day
week
evalu
skelet
muscl
glycogen
content
use
rapid
noninvas
highfrequ
ultrasound
methodolog
denver
co
usa
scan
obtain
rectu
femori
vastu
laterali
muscl
glycogen
content
measur
score
accord
scale
patient
varieti
primari
diagnos
includ
septic
shock
n
hemorrhag
shockabdomin
hypertens
n
hypovolem
shockpost
major
oncolog
surgeri
n
trauma
n
burn
injuri
n
result
six
nine
patient
glycogen
present
muscl
score
three
patient
glycogen
score
well
score
healthi
individu
refer
comparison
collect
postcompetit
level
competit
athlet
decreas
glycogen
store
score
well
critic
ill
patient
studi
conclus
fi
rst
time
muscl
glycogen
store
evalu
critic
ill
data
show
sever
glycogen
deplet
icu
patient
probabl
lead
muscl
catabol
necessari
gluconeogenesi
eventu
result
cachexia
fi
nding
pose
sever
metabol
challeng
icu
patient
interf
recoveri
contribut
poor
surviv
light
fi
nding
reevalu
nutrit
protocol
potenti
anabolicanticatabol
therapi
decreas
muscl
catabol
may
improv
surviv
diff
erent
therapeut
may
prevent
hypermetabol
betablock
reevalu
along
anabol
agent
oxandrolon
could
counteract
sever
catabol
respons
critic
ill
monitor
muscl
glycogen
replet
could
signal
transit
catabol
anabol
phase
introduct
low
plasma
glutamin
concentr
associ
unfavour
outcom
acut
icu
admiss
question
whether
diff
erenc
plasma
glutamin
level
acut
elect
icu
admiss
method
perform
singlecentr
prospect
observ
studi
mix
icu
exclus
criteria
age
year
total
parent
nutrit
admiss
patient
divid
two
group
elect
surgeri
acut
admiss
blood
sampl
taken
icu
admiss
daili
glutamin
level
measur
use
bioprofi
le
plu
analys
nova
biomed
uk
cheshir
uk
mannwhitney
u
test
use
detect
diff
erenc
group
bonferroni
method
correct
multipl
comparison
includ
patient
elect
surgeri
cardiac
gener
surgeri
patient
acut
admiss
sepsi
acut
surgeri
two
trauma
medic
baselin
characterist
present
tabl
plasma
glutamin
level
admiss
signifi
cantli
lower
acut
patient
compar
elect
surgeri
mmoll
iqr
versu
moll
iqr
figur
abstract
indirect
calorimetri
measur
signifi
cantli
higher
rest
energi
expenditur
p
appear
signifi
cant
correl
apach
iv
score
glutamin
level
r
p
moreov
backward
linear
regress
analysi
correl
independ
associ
apach
iv
score
presenc
infect
type
admiss
conclus
plasma
glutamin
level
signifi
cantli
lower
acut
admiss
compar
elect
surgeri
group
consider
amount
patient
decreas
glutamin
level
independ
associ
type
admiss
contrast
previou
studi
found
glutamin
level
determin
sever
ill
presenc
infect
introduct
intraven
fi
sh
oil
fo
lipid
emuls
le
rich
polyunsatur
fatti
acid
exhibit
antiinfl
ammatori
immunomodulatori
eff
ect
previous
demonstr
focontain
emuls
may
abl
decreas
mortal
ventil
day
critic
ill
last
year
sever
addit
random
control
trial
rct
fobas
le
publish
therefor
purpos
metaanalysi
updat
systemat
review
aim
elucid
effi
caci
fobas
le
clinic
outcom
critic
ill
method
search
computer
databas
overal
mortal
primari
outcom
secondari
outcom
infect
icu
hospit
length
stay
lo
mechan
ventil
mv
day
includ
rct
conduct
critic
ill
adult
patient
evalu
fobas
le
parenter
nutrit
pn
enter
fed
patient
analyz
data
use
revman
introduct
studi
aim
describ
patient
characterist
prehospit
factor
associ
icu
admiss
ed
pauciti
inform
earli
recognit
critic
ill
paramed
especi
australian
prehospit
set
method
retrospect
cohort
studi
juli
june
conduct
perth
metropolitan
area
serv
singl
ambul
servic
adult
patient
includ
transport
public
hospit
ed
use
ed
inform
system
edi
seven
eight
ed
admit
icu
ed
edicu
group
patient
age
year
rural
area
transfer
exclud
use
exist
ambul
clinic
data
link
edi
data
prehospit
cohort
characterist
describ
use
univari
statist
techniqu
logist
regress
conduct
admiss
icu
ed
critic
ill
surrog
outcom
variabl
variabl
includ
regress
model
age
sex
paramedicidentifi
ed
urgenc
time
patient
seen
doctor
base
australasian
triag
scale
paramedicidentifi
ed
patient
problem
time
taken
ambul
servic
receiv
call
hospit
arriv
physiolog
variabl
systol
blood
pressur
sbp
heart
rate
hr
respiratori
rate
rr
temperatur
oxygen
satur
gc
includ
logist
model
introduct
aim
identifi
adequaci
assist
provid
assess
correct
anaesthet
equip
drug
avail
emerg
call
made
icu
remot
area
hospit
emerg
call
often
involv
manag
critic
ill
patient
highest
mortal
result
import
clinic
team
necessari
compet
right
level
resourc
paramount
method
undertook
prospect
survey
adult
patient
emerg
call
put
anaesthet
team
london
district
gener
hospit
period
perform
snapshot
audit
equip
resuscit
trolley
across
ward
radiolog
depart
compar
data
collect
avail
equip
standard
set
resuscit
council
uk
recommend
minimum
equip
checklist
survey
address
avail
clinic
compet
appropri
durat
stay
anaesthet
assist
emerg
call
qualit
data
collect
avail
requir
emerg
drug
result
studi
period
emerg
call
attend
twentythre
call
accid
emerg
depart
four
icu
survey
result
demonstr
two
case
anaesthet
assist
arriv
emerg
call
put
case
time
assist
avail
assist
adequ
clinic
anaesthet
skill
requir
attend
physician
case
skill
assist
requir
n
felt
assist
stay
clinic
requir
length
time
emerg
drug
requir
found
avail
case
n
case
n
necessari
emerg
equip
avail
data
collect
equip
resuscit
trolley
inadequaci
identifi
ed
oxygen
cylind
fi
lled
less
full
case
n
endtid
capnographi
identifi
ed
absent
conclus
emerg
call
requir
standard
met
involv
compet
respond
team
member
adequ
resourc
lead
us
question
whether
guidelin
exist
regard
clinic
compet
timeli
assist
avail
physician
emerg
call
refer
introduct
widespread
concern
regard
excess
mortal
patient
admit
hospit
hour
introduc
electron
track
trigger
system
patientrack
autom
alert
larg
univers
teach
hospit
system
comput
patient
earli
warn
score
alert
medic
staff
via
pager
oper
hour
day
day
week
could
eff
ectiv
tool
reduc
variat
mortal
throughout
work
week
base
analysi
respons
focus
threeprong
intervent
formul
implement
hospit
wide
arm
intervent
identifi
cation
name
role
staff
member
use
highli
visibl
label
role
alloc
accord
polici
written
multidisciplinari
work
group
time
respons
allow
structur
synopsi
patient
current
statu
commun
team
intervent
preced
extens
staff
educ
staff
complet
survey
month
later
assess
success
intervent
signifi
cantli
increas
satisfact
amongst
staff
regard
identifi
cation
team
leader
key
staff
member
respons
time
eff
ectiv
reduc
repetit
improv
staff
understand
patient
statu
medic
issu
found
signifi
cant
chang
staff
percept
regard
clariti
ongo
treatment
plan
end
met
call
respons
conclus
utilis
lowcost
intervent
region
set
success
improv
staff
percept
role
alloc
commun
within
met
call
respons
intervent
also
led
signifi
cantli
increas
overal
satisfact
met
call
system
survey
identifi
ed
facet
met
call
respons
also
requir
attent
given
encourag
result
design
followup
intervent
incorpor
structur
multidisciplinari
train
met
call
scenario
introduct
medic
emerg
team
met
introduc
institut
januari
provid
time
respons
need
acut
ill
inpati
cardiac
arrest
call
met
assess
patient
prescrib
manag
plan
respons
team
follow
promptli
stabilis
transfer
patient
place
safeti
requir
aim
evalu
eff
ect
introduc
met
clinic
relev
process
outcom
method
prospect
data
analys
use
stata
primari
outcom
measur
immedi
mortal
defi
ned
mortal
cardiovascular
ill
predomin
baselin
morbid
none
baselin
ill
show
increas
risk
mortal
group
among
true
cardiac
arrest
event
due
pulseless
electr
activityasystol
due
ventricular
fi
brillat
vf
pulseless
ventricular
tachycardia
vt
diff
erenc
initi
outcom
initi
rhythm
vfpulseless
vt
chanc
discharg
hospit
p
although
arriv
time
cbt
infl
uenc
fi
nal
outcom
durat
resuscit
minut
odd
ratio
p
favor
return
spontan
circul
death
control
age
patient
true
cardiac
arrest
event
discharg
hospit
good
neurolog
outcom
discharg
seen
among
patient
base
cerebr
perform
categori
score
conclus
experi
show
everi
patient
admit
hospit
fi
sustain
cardiac
arrest
surviv
hospit
discharg
good
neurolog
recoveri
variat
eff
ectiv
cardiopulmonari
resuscit
qualiti
comparison
world
data
could
due
inher
diff
erenc
sever
primari
ill
patient
divers
report
data
refer
practic
relat
cpr
a
train
london
secondari
school
method
conduct
regist
audit
cpr
a
train
london
school
secondari
school
identifi
ed
via
web
link
london
borough
council
telephon
interview
school
staff
familiar
cpr
a
train
practic
conduct
prospect
use
standard
webbas
survey
survey
respons
data
captur
electron
defi
ned
univers
train
programm
deliv
cpr
a
train
student
school
use
simpl
descript
statist
summaris
result
result
total
school
complet
survey
cover
estim
student
popul
four
school
provid
univers
train
programm
addit
er
option
train
programm
student
school
a
avail
school
premis
common
reason
univers
cpr
train
programm
requir
addit
class
time
fund
unavail
programm
three
student
die
sudden
cardiac
arrest
period
past
year
anesthet
domest
pig
induct
anim
random
receiv
either
ml
mlkg
group
n
ml
mlkg
group
b
n
balanc
crystalloid
solut
undergo
fl
uid
load
cpr
group
c
n
spontan
circul
rosc
restor
anim
observ
minut
result
group
signifi
cant
increas
intracrani
pressur
follow
decreas
rosc
observ
group
b
mmhg
p
c
mmhg
p
compar
p
rise
intracrani
pressur
group
signifi
cantli
higher
mmhg
p
wherea
coronari
perfus
pressur
lower
group
control
group
c
volum
load
fl
uid
infus
induc
mild
increas
group
b
group
conclus
icu
survivor
like
shockabl
rhythm
cathlab
receiv
ppci
th
less
sick
nonsurvivor
may
simpli
refl
ect
select
bias
benefi
factor
confer
cardiac
patient
may
set
liber
icu
admiss
polici
ohca
nonshock
rhythm
howev
access
ppci
may
determin
surviv
suggest
ohca
patient
taken
directli
region
heart
attack
centr
introduct
mild
hypothermia
fever
control
shown
improv
neurolog
outcom
post
cardiac
arrest
common
method
induc
hypothermia
includ
bodi
surfac
cool
intravascular
cool
howev
new
approach
use
cathet
place
esophagu
recent
becom
avail
method
report
fi
rst
three
case
temperatur
control
use
esophag
cool
devic
ecd
ecd
place
oral
similar
fashion
orogastr
tube
temperatur
reduct
achiev
connect
ecd
commerci
avail
heat
exchang
unit
blanketrol
ii
iii
fi
rst
patient
male
kg
admit
success
resuscit
protract
outof
hospit
cardiac
arrest
initi
temperatur
within
current
institut
protocol
sever
hour
arriv
temperatur
slowli
increas
despit
applic
cool
blanket
ice
pack
groin
axilla
ecd
insert
reduct
temperatur
achiev
within
hour
patient
expir
day
second
patient
femal
kg
admit
resuscit
outofhospit
pea
arrest
despit
initi
cool
protocol
surfacecool
blanket
cold
intraven
salin
mount
fever
peak
shortli
admiss
ecd
insert
confi
rming
extern
heat
exchang
connect
temperatur
gradual
drop
period
hour
subsequ
made
favor
neurolog
recoveri
discharg
home
day
third
patient
male
patient
kg
present
ongo
fever
secondari
necrot
pneumonia
postop
period
coronari
arteri
bypass
graft
fever
unrespons
empir
antibiot
therapi
antipyret
cool
blanket
ice
pack
ecd
insert
result
decreas
temperatur
less
hour
patient
eventu
made
full
recoveri
discharg
home
day
three
patient
placement
devic
occur
less
minut
eas
use
report
excel
nurs
staff
physician
conclus
ecd
novel
technolog
use
temperatur
manag
post
cardiac
arrest
fever
control
critic
ill
patient
despit
patient
mount
febril
respons
temperatur
control
achiev
maintain
success
devic
report
easi
use
physician
nurs
introduct
clinic
outcom
vari
depend
method
use
induc
therapeut
hypothermia
follow
stroke
cardiac
arrest
swine
test
hypothesi
select
nasopharyng
brain
cool
snbc
contrast
system
hypothermia
advers
impact
cerebr
perfus
method
two
group
anim
kg
blood
fl
ow
right
middl
cerebr
arteri
mca
measur
use
transcrani
doppler
tcd
group
snbc
initi
use
perfl
uorohexan
aerosol
mlkgminut
oxygen
lkgminut
nasopharyng
cathet
atom
group
anim
bodi
surfac
cool
use
watercircul
blanket
group
brain
temperatur
intracrani
pressur
icp
core
temperatur
vital
sign
continu
record
cool
termin
brain
reach
anim
allow
passiv
rewarm
snbc
group
brain
target
temperatur
reach
minut
mean
icp
drop
precipit
nadir
mmhg
tcd
show
signifi
cant
vasospasm
mca
compar
intern
carotid
arteri
ica
entir
cool
phase
tabl
upon
termin
cool
brain
temperatur
spontan
rewarm
core
temperatur
minut
rewarm
associ
hyperemia
elev
icp
group
cerebr
vasospasm
hyperemia
cool
rewarm
respect
conclus
snbc
associ
signifi
cant
vasospasm
mca
addit
spontan
rapid
rewarm
brain
vasodil
rapid
reperfus
rebound
elev
icp
occur
minut
termin
snbc
like
detriment
alreadi
ischem
brain
introduct
uncontrol
shiver
may
neg
consequ
increas
metabol
demand
subsequ
neutral
benefi
ts
therapeut
normothermia
previou
antishiv
protocol
util
least
sedat
describ
therapeut
temperatur
modul
ttm
aim
describ
evalu
antishiv
protocol
emphas
least
sedat
regimen
least
number
pharmacolog
agent
patient
undergo
therapeut
normothermia
twentyseven
patient
nonsurvivor
rosc
minut
one
patient
cpc
hospit
discharg
observ
signifi
cant
diff
erenc
group
age
p
time
emerg
call
start
al
p
durat
basic
life
support
perform
bystand
gener
practition
paramed
p
initi
rhythm
asystol
one
survivor
nonsurvivor
p
ventricular
fi
brillat
six
survivor
nonsurvivor
p
pulseless
electr
activ
one
survivor
nonsurvivor
p
cardiac
arrest
wit
survivor
nonsurvivor
p
first
measur
rso
survivor
group
compar
nonsurvivor
group
p
also
signifi
cant
diff
erenc
found
mean
rso
minut
rosc
survivor
nonsurvivor
respect
observ
signifi
cant
diff
erenc
increas
rso
minut
rosc
survivor
nonsurvivor
p
conclus
observ
signifi
cant
diff
erenc
fi
rst
measur
rso
mean
rso
minut
rosc
patient
good
neurolog
outcom
cpc
hospit
discharg
patient
wors
neurolog
outcom
nonsurvivor
cpc
howev
signifi
cant
diff
erenc
observ
increas
group
larger
studi
necessari
confi
rm
result
studi
investig
associ
hemoglobin
cerebr
oxygen
scto
outcom
postca
patient
method
prospect
observ
studi
postca
patient
hypothermia
fi
rst
hour
icu
stay
hemoglobin
determin
hourli
togeth
correspond
scto
nir
svo
patient
pulmonari
arteri
cathet
n
result
base
pair
data
found
strong
linear
relationship
hemoglobin
averag
scto
scto
hemoglobin
r
p
given
previous
suggest
scto
target
hemoglobin
level
gdl
gener
result
suboptim
brain
oxygen
fortythre
patient
good
neurolog
outcom
cpc
day
post
ca
signifi
cant
associ
averag
hemoglobin
introduct
purpos
studi
determin
rate
magnitud
respons
hypoxia
three
diff
erent
region
oxygen
satur
rso
devic
rso
technolog
focus
absolut
accuraci
without
consider
respons
characterist
current
rso
technolog
assum
oxygen
satur
fi
xed
ratio
arteri
venou
blood
cerebr
arteri
oxygenationrel
vasoact
may
chang
arterialven
ratio
hypoxia
thu
absolut
rso
accuraci
may
less
import
compar
sensit
chang
cerebr
rso
method
ten
subject
complet
studi
includ
analysi
one
invo
sensor
safbsm
place
left
side
one
equanox
foresight
juli
juli
sensor
altern
subject
place
right
side
forehead
bilater
monitor
desatur
induc
adjust
inspiratori
ga
mixtur
n
desatur
titrat
room
air
achiev
plateau
arteri
oxygen
satur
spo
resatur
induc
rapid
chang
fio
minut
spo
process
repeat
desatur
spo
rapid
return
spo
cerebr
puls
oximetri
data
record
studi
time
fio
chang
plateau
record
rso
level
total
spo
respons
calcul
devic
assess
rate
rso
chang
rate
rso
chang
second
total
rso
chang
compar
nse
serum
concentr
threshold
predict
poor
outcom
posit
predict
valu
sensit
three
patient
surviv
good
outcom
despit
nse
serum
concentr
two
patient
nse
elev
document
prior
cardiac
arrest
one
patient
neuroendocrin
tumor
pancrea
patient
suff
ere
enceph
unknown
etiolog
osteomyelofi
brosi
potenti
confound
third
patient
ovarian
carcinoma
use
intraaort
balloon
pump
blood
transfus
shortli
cardiac
arrest
patient
nse
poor
outcom
major
patient
die
caus
hypox
encephalopathi
conclus
patient
cardiac
arrest
target
temperatur
manag
nse
serum
concentr
strongli
indic
poor
outcom
nse
produc
tumor
acut
brain
diseas
sever
hematolog
diseas
use
intraaort
balloon
pump
blood
transfus
need
consid
potenti
confound
nse
serum
concentr
larg
exclud
hypox
encephalopathi
incompat
reawaken
frequent
suff
ere
cardiogen
shock
organ
dysfunct
die
frequent
respect
hospit
mortal
versu
p
see
also
figur
conclus
patient
hospit
acut
heart
failur
prehospit
postadmiss
resuscit
cardiac
arrest
sever
complic
associ
signifi
cantli
morbid
mortal
conclus
ten
percent
patient
resuscit
ca
admit
icu
becom
od
consist
total
number
od
center
patient
resuscit
ca
suff
er
sever
irrevers
brain
damag
brain
dead
thu
substanti
expand
donor
pool
justifi
es
extens
resuscit
eff
ort
save
live
save
organ
might
reassur
famili
staff
commun
method
retrospect
studi
polytraumat
patient
head
injuri
intub
treat
prehospit
unit
transport
trauma
center
patient
group
accord
bal
bal
mgl
bal
mgl
inclus
criteria
age
injuri
sever
score
head
abbrevi
injuri
scale
ai
physiolog
paramet
outcom
respect
surviv
hospit
discharg
sthd
function
outcom
analyz
sever
injuri
measur
use
traumainjuri
sever
score
triss
head
injuri
use
ai
function
outcom
measur
use
glasgow
outcom
scale
go
cerebr
perform
categori
cpc
glasgow
coma
confi
denc
level
p
gc
discharg
border
statist
signifi
canc
vs
confi
denc
level
p
variabl
triss
ai
sthd
cpc
show
statist
signifi
cant
diff
erenc
among
group
conclus
presenc
alcohol
blood
posit
eff
ect
neurolog
outcom
signifi
cant
diff
erenc
surviv
howev
posit
result
neurolog
outcom
bal
group
may
also
due
fact
group
younger
small
number
patient
studi
anoth
limit
factor
interpret
therefor
neuroprotect
role
alcohol
need
clarifi
cation
introduct
cerebr
ischemia
cei
major
complic
event
acut
brain
injuri
abi
endotheli
dysfunct
key
player
method
studi
cellular
marker
endotheli
dysfunct
peripher
reactiv
hyperemia
index
rhi
patient
abi
admiss
day
compar
healthi
volunt
n
cei
determin
clinic
use
comput
tomographi
patient
abi
rhi
admiss
signifi
cantli
reduc
compar
healthi
subject
p
coincid
decreas
circul
endotheli
progenitor
cell
epc
p
tabl
rhi
recov
eight
patient
without
develop
cei
figur
black
fail
fulli
recov
day
three
four
patient
develop
cei
figur
red
despit
recoveri
rhi
within
day
patient
p
epc
count
remain
signifi
cantli
lower
day
patient
abi
p
introduct
sinc
patient
acut
brain
injuri
treat
headup
height
diff
erenc
cm
heart
ear
canal
caus
diff
erenc
mathemat
cpp
true
cpp
mmhg
depend
zero
refer
level
use
bodi
length
patient
figur
conduct
survey
analyz
current
practic
cpp
target
zero
refer
level
diff
erent
icu
method
neuroicu
physician
invit
particip
survey
icp
cpp
target
level
measur
result
center
summar
tabl
center
use
headup
elev
consid
icp
mmhg
threshold
start
treat
icp
variat
note
minim
maxim
cpp
threshold
center
measur
icp
ear
canal
twentyseven
center
measur
map
heart
three
center
measur
map
ear
canal
three
center
use
mmhg
minim
cpp
rais
bed
two
center
use
minim
cpp
mmhg
appli
upper
limit
conclus
consid
infl
uenc
posit
cpp
variat
among
center
narrow
rang
cpp
threshold
futur
studi
guidelin
describ
map
measur
altern
propos
new
formula
cpp
true
cpp
map
heart
icp
ear
height
diff
erenc
heart
ear
canal
cm
introduct
purpos
studi
assess
rate
confi
rmed
infect
antibiot
exposur
monitor
practic
normothermia
protocol
util
traumat
brain
injuri
patient
treatment
prevent
fever
focu
therapi
patient
sever
neurolog
injuri
fever
identifi
ed
independ
risk
factor
morbid
mortal
introduct
osmotherapi
mannitol
man
hyperton
salin
ht
current
use
treat
elev
intracrani
pressur
sever
acut
brain
injuri
sabi
howev
eff
ect
cerebr
oxygen
metabol
extens
evalu
method
retrospect
analysi
cohort
patient
sabi
traumat
brain
injuri
tbi
subarachnoid
hemorrhag
sah
monitor
cerebr
microdialysi
cmd
brain
oxygen
pbto
icp
treat
man
gkg
ht
ml
icp
mmhg
osmotherapi
administ
minut
patient
individu
respons
intervent
analyz
minut
follow
infus
episod
hyperton
solut
administ
within
hour
treatment
select
variabl
analyz
includ
cmd
lactat
pyruv
glucos
glutam
lactatepyruv
ratio
main
brain
physiolog
variabl
icp
pbto
cpp
analysi
conduct
use
mixedeff
ect
multilevel
regress
patient
acut
brain
injuri
abi
increas
cerebr
energi
demand
frequent
potenti
lead
cerebr
glucos
deplet
gd
poor
outcom
set
lactat
may
act
supplement
fuel
examin
dynam
cerebr
lactat
suppli
prolong
gd
abi
method
retrospect
analyz
sever
abi
tbi
eight
sah
monitor
brain
oxygen
cerebr
microdialysi
cmd
measur
hourli
level
cerebr
extracellular
glucos
lactat
pyruv
lactatepyruv
ratio
lpr
variat
cmd
variabl
analyz
function
gd
defi
ned
spontan
decreas
cmd
glucos
normal
low
mm
least
hour
increas
cerebr
energi
demand
lpr
result
gd
episod
patient
found
increas
cmd
lactat
vs
mm
lpr
vs
p
brain
oxygen
blood
lactat
remain
normal
dynam
lactat
glucos
suppli
studi
analyz
relationship
blood
cmd
sampl
correl
blood
brain
lactat
found
brain
glucos
lpr
normal
r
p
figur
correl
becam
linear
gd
progress
rise
r
p
energi
demand
increas
suggest
increas
cerebr
lactat
avail
correl
blood
brain
glucos
chang
opposit
direct
decreas
r
p
gd
lpr
conclus
energi
dysfunct
associ
increas
suppli
nonhypox
cerebr
lactat
data
suggest
lactat
may
act
altern
substrat
abi
avail
cerebr
glucos
reduc
introduct
studi
design
see
whether
correl
transcrani
doppler
tcd
paramet
ccp
intracrani
pressur
icp
monitor
cerebr
hemodynam
chang
evalu
icp
indirectli
tcd
method
prospect
descript
studi
conduct
picu
june
decemb
investig
children
sever
trauma
brain
injuri
tbi
tcd
measur
routin
perform
bilater
middl
cerebr
arteri
parallel
icp
registr
icp
cpp
data
correl
pi
correl
coeffi
cient
calcul
control
linear
correl
residu
test
normal
distribut
around
regress
line
introduct
improv
recoveri
challeng
process
case
vari
degre
sever
brain
injuri
bi
requir
intens
care
amantadin
sulfat
recommend
use
case
brain
injuri
coma
remiss
scale
jfkcr
consist
auditoryvisualmotormouthtongu
function
commun
awar
scale
provid
score
show
numer
recoveri
coma
aim
studi
evalu
outcom
eff
ect
use
neurorecoveri
glasgow
coma
scale
gc
jfkcr
icu
last
month
method
approv
ethic
committe
recruit
patient
brain
injuri
result
trauma
hemorrhag
initi
gc
receiv
mg
twice
daili
day
recoveri
period
subject
age
gender
diagnosi
initi
apach
ii
score
time
initi
therapi
jfkcr
gc
score
aspart
aminotransferas
alanin
aminotransferas
bun
creatinin
platelet
count
electrocardiographi
fi
nding
electrolyt
valu
arteri
blood
ga
valu
day
record
result
patient
diagnos
includ
two
postcpr
fi
intracrani
one
subdur
hematoma
one
cva
one
postop
aneurysm
one
subarachnoid
hemorrhag
one
brain
contus
tabl
overleaf
present
fi
nding
therapi
initi
day
admiss
patient
patient
dramat
improv
observ
patient
gc
jfkcr
score
therapi
initi
month
patient
discharg
home
care
patient
therapi
withdrawn
day
due
persist
thrombocytopenia
tp
despit
exclus
reason
subsequ
improv
observ
tp
complic
rel
less
sever
averag
accept
conclus
suggest
dose
mgday
day
seem
improv
neurorecoveri
bi
patient
good
toler
prospect
control
studi
larg
homogen
bi
popul
better
defi
ne
role
recoveri
complic
biomark
longterm
outcom
among
ubiquitin
carboxytermin
hydrolas
current
investig
defi
ne
potenti
prognost
valu
object
systemat
review
determin
abil
predict
prognosi
follow
moder
sever
tbi
method
medlin
embas
cochran
librari
biosi
electron
databas
confer
abstract
exist
narr
review
search
incept
juli
cohort
studi
includ
patient
moder
sever
tbi
evalu
prognost
valu
accord
mortal
glasgow
outcom
scale
go
consid
data
concern
patient
outcom
studi
method
laboratori
method
abstract
pool
result
plan
present
use
mean
diff
erenc
analyz
use
random
eff
ect
model
well
sensit
analys
explain
potenti
heterogen
result
search
strategi
yield
articl
fi
studi
correspond
inclus
criteria
n
studi
perform
group
research
five
studi
report
mortal
n
two
studi
report
go
n
result
includ
studi
observ
signifi
cant
predictor
mortal
howev
two
studi
repres
uniqu
studi
popul
thu
preclud
metaanalysi
conclus
systemat
review
observ
publish
studi
conduct
group
investig
present
result
intersect
cohort
patient
due
pauciti
data
could
perform
pool
analysi
conclud
associ
biomark
longterm
prognosi
assay
use
recent
develop
studi
done
diff
erent
research
team
need
determin
reproduc
valid
potenti
prognost
tool
introduct
icu
patient
may
remain
comatos
resolut
critic
ill
frequent
due
delay
sed
clearanc
may
also
result
increas
intracrani
pressur
icp
cerebr
edema
propos
measur
optic
nerv
sheath
diamet
onsd
rapid
bedsid
screen
test
use
quickli
identifi
patient
cerebr
edema
increas
icp
method
prospect
observ
studi
carri
consecut
patient
admit
multidisciplinari
medic
surgic
icu
stabl
patient
unexplain
coma
schedul
brain
imag
includ
patient
obviou
ocular
trauma
sed
narcot
infus
exclud
onsd
measur
use
mhz
linear
array
ultrasound
transduc
probe
place
close
eye
transvers
axi
onsd
measur
predefi
ned
point
mm
posterior
globe
eye
measur
mean
valu
use
introduct
increas
intracrani
pressur
icp
advers
aff
ect
anesthesia
due
disturb
cerebr
blood
fl
ow
older
patient
disturb
may
increas
incid
postop
delirium
pod
may
lead
poor
outcom
standard
hemodynam
protocol
involv
maintain
mean
arteri
blood
pressur
map
patient
intracrani
hypertens
may
enough
maintain
adequ
cerebr
perfus
purpos
studi
evalu
protocol
maintain
cerebr
perfus
pressur
cpp
prevent
postop
delirium
older
patient
abdomin
surgeri
method
total
asa
patient
undergo
major
abdomin
surgeri
durat
hour
icp
mmhg
evalu
venou
ophthalmodynamometri
includ
research
patient
random
two
group
map
group
map
maintain
mmhg
within
baselin
n
cpp
group
cpp
maintain
mmhg
within
baselin
n
icp
map
cpp
assess
everi
hour
anesthesia
time
recoveri
conscious
incid
pod
length
stay
icu
hospit
also
evalu
result
initi
icp
mmhg
map
group
mmhg
cpp
group
anesthesia
stabl
without
signifi
cant
chang
decreas
map
induct
anesthesia
similar
two
group
stabl
anesthesia
frequenc
use
vasopressor
infus
rate
higher
cpp
group
time
recoveri
conscious
map
group
higher
minut
vs
minut
p
incid
postop
delirium
higher
map
group
vs
cpp
group
p
signifi
cant
diff
erenc
two
group
complic
total
length
stay
icu
hospit
higher
map
group
day
vs
p
day
vs
n
group
p
introduct
critic
ill
patient
blood
lactat
admiss
associ
outcom
patient
aneurysm
subarachnoid
hemorrhag
sah
investig
studi
associ
earli
circul
lactat
glucos
unfavor
diseas
cours
prognost
role
lactat
glucos
studi
hypothes
may
increas
due
sympathet
activ
sah
result
studi
attempt
assess
risk
ischem
stroke
patient
burn
injuri
confl
ict
investig
risk
ischem
stroke
hospit
burn
injuri
patient
taiwan
evalu
whether
risk
higher
compar
gener
popul
method
data
million
nation
health
insur
bene
fi
ciari
util
adult
benefi
ciari
follow
januari
decemb
identifi
develop
ischem
stroke
meanwhil
identifi
ed
patient
burn
injuri
match
unexpos
patient
base
highdimension
propens
score
cox
regress
model
appli
compar
hazard
ischem
stroke
match
cohort
introduct
muscl
wast
common
consequ
longterm
stay
critic
care
environ
may
slow
rehabilit
survivor
previou
ultrasound
studi
demonstr
loss
crosssect
area
lower
limb
muscl
intens
care
stay
studi
look
marker
muscl
architectur
muscl
thick
pennat
angl
fascicl
length
chang
lower
limb
well
look
chang
muscl
thick
upper
limb
method
follow
ethic
approv
patient
intub
ventil
one
two
critic
care
depart
assent
take
part
studi
next
kin
bmode
ultrasound
scan
right
bicep
vastu
laterali
medial
head
gastrocnemiu
perform
day
scan
perform
patient
free
sedat
muscl
thick
mt
measur
three
muscl
pennat
angl
pa
measur
lower
limb
muscl
fascicl
length
fl
deriv
pa
mt
result
twenti
patient
recruit
scan
day
eight
scan
day
bicep
alter
mt
day
mt
vastu
laterali
signifi
cantli
decreas
day
mm
muscl
loss
p
day
mm
muscl
loss
p
also
signifi
cant
loss
pa
day
p
day
presenc
delirium
critic
care
independ
risk
factor
mortal
everi
day
delirium
addit
rel
risk
death
year
delirium
predict
tool
predelir
recent
develop
calibr
multin
project
studi
aim
determin
util
predelir
icu
method
studi
prospect
investig
patient
medic
surgic
gener
icu
patient
includ
hour
sedat
mechan
ventil
research
calcul
predelir
score
patient
predelir
involv
record
variabl
submit
onlin
algorithm
estim
percentag
risk
delirium
diagnos
delirium
camicu
perform
hourli
predelir
score
predict
mean
rate
delirium
predelir
risk
score
rang
figur
six
patient
develop
delirium
fi
rst
hour
follow
extub
fifteen
patient
predict
less
probabl
delirium
twelv
patient
develop
delirium
point
icu
stay
result
total
delirium
bedday
conclus
observ
patient
experienc
delirium
less
report
preval
similar
set
audit
studi
demonstr
agreement
record
rate
delirium
predict
rate
use
predelir
suggest
predelir
use
qualityaudit
work
uk
icu
order
assess
attempt
improv
manag
delirium
work
requir
assess
util
predelir
risk
assess
tool
individu
patient
introduct
propofol
infus
syndrom
pri
rare
propofol
complic
lead
cardiac
failur
fi
rst
describ
critic
ill
children
adult
traumat
brain
injuri
pathophysiolog
unknown
although
common
factor
prolong
hour
use
highdos
mgkghour
propofol
combin
elev
level
catecholamin
corticosteroid
recent
case
report
earlyonset
pri
anesthesia
earli
postop
set
publish
mani
lactic
acidosi
interpret
onset
pri
critic
er
might
concern
poor
diff
erenti
diagnost
approach
observ
bia
also
lactic
acidosi
oblig
pri
symptom
incid
lactic
acidosi
propofol
sedat
unknown
gain
insight
incid
characterist
earli
pri
perform
systemat
review
earli
pri
case
introduct
among
drug
use
sedat
propofol
primari
role
despit
propofol
describ
exert
relax
eff
ect
skelet
muscl
data
show
action
diaphragm
report
aim
observ
studi
human
appli
ultrasound
assess
propofol
eff
ect
diaphragmat
contract
motion
endoscop
procedur
method
investig
seven
consecut
patient
undergo
gastroscopi
colonoscopi
endoscopi
unit
hospit
patient
receiv
propofol
dose
abl
induc
maintain
sedat
level
ramsay
sedat
scale
procedur
measur
obtain
right
side
thorax
millimet
diaphragmat
motion
dm
diaphragmat
motion
maxim
inspir
dm
forc
measur
mmode
mhz
array
convex
probe
place
midclavicular
line
use
liver
acoust
window
thick
end
inspir
tei
thick
end
expir
tee
measur
mmode
mhz
vascular
probe
thicken
fraction
tf
calcul
tei
tee
tee
time
point
measur
taken
patient
arriv
surgeri
room
baselin
minut
level
ramsey
sedat
scale
obtain
sedat
minut
patient
recoveri
level
ramsey
sedat
scale
awaken
data
analyz
report
tabl
express
mean
sd
anova
use
compar
data
repeat
measur
post
hoc
statist
comparison
bonferroni
test
use
identifi
signifi
cant
variat
result
propofol
administr
tei
reduc
wherea
awaken
increas
reach
baselin
convers
tee
chang
studi
propofol
sedat
tf
decreas
return
baselin
recoveri
dm
show
reduct
propofol
administr
wherea
forc
diaphragmat
motion
test
patient
consciou
forc
dm
evid
chang
conclus
observ
studi
ultrasound
assess
propofol
caus
reduct
diaphragmat
contract
motion
endoscop
procedur
refer
introduct
delirium
recognit
critic
ill
patient
consid
import
take
account
poor
outcom
associ
occurr
purpos
studi
evalu
knowledg
pertain
delirium
well
implement
screen
practic
studi
constitut
compon
survey
explor
current
sedationrel
practic
south
african
icu
method
follow
approv
univers
human
research
ethic
committe
valid
questionnair
distribut
electron
physician
member
variou
medic
databas
south
africa
south
africa
formal
registri
critic
care
practition
result
one
hundr
twentysix
respond
indic
practic
icu
set
sixtysix
per
cent
specialist
mainli
anaesthesiologist
whilst
critic
care
subspecialist
respond
indic
averag
patient
experi
delirium
eighti
per
cent
respond
indic
delirium
impact
signifi
cantli
neg
patient
outcom
whilst
indic
associ
delirium
screen
achiev
mainli
clinic
assess
twentyfour
per
cent
utilis
object
tool
screen
delirium
amongst
camicu
utilis
amongst
deliri
patient
sed
choic
dexmedetomidin
major
howev
prescrib
midazolam
fi
rst
choic
set
conclus
fi
nding
compar
report
similar
survey
conduct
region
delirium
screen
method
inadequ
vast
major
utilis
object
method
loxapin
control
agit
wean
mechan
ventil
random
control
trial
gaudri
b
sztrymf
r
sonnevil
b
megarbann
c
clec
h
introduct
wean
prolong
mechan
ventil
mv
icu
may
imped
occurr
agit
loxapin
abil
control
agit
without
aff
ect
effi
caci
spontan
ventil
observ
studi
justifi
implement
random
control
trial
method
conduct
multicent
placebocontrol
parallel
group
random
trial
fi
french
icu
novemb
novemb
patient
age
year
mv
hour
potenti
candid
wean
ventil
exhibit
agit
defi
ned
richmond
agit
sedat
scale
rass
sedat
withdraw
randomli
assign
receiv
either
loxapin
placebo
particip
mask
group
alloc
random
patient
receiv
mg
loxapin
placebo
nasogastr
tube
rass
monitor
everi
hour
second
dose
loxapin
placebo
administ
agit
persist
worsen
case
sever
agit
usual
sedat
benzodiazepin
morphin
agent
immedi
resum
extub
contempl
patient
consciou
calm
primari
endpoint
time
fi
rst
administr
loxapin
placebo
success
extub
reintub
follow
hour
three
hundr
patient
necessari
power
detect
reduct
wean
time
loxapin
group
onesid
type
error
rate
result
trial
discontinu
patient
random
insuffi
cient
enrol
fifteen
patient
withdrew
consent
leav
patient
analysi
fortyseven
patient
assign
loxapin
group
placebo
group
median
time
success
extub
day
loxapin
group
day
placebo
group
rr
ci
p
fi
rst
hour
sedat
frequent
resum
placebo
group
vs
p
one
patient
transient
seizur
loxapin
group
conclus
result
consist
hypothesi
day
reduct
median
wean
time
loxapin
group
diff
erenc
statist
signifi
cant
loxapin
reduc
need
resum
sedat
wean
mv
given
qualiti
data
methodolog
result
may
use
futur
metaanalys
investig
incid
symptom
risk
factor
withdraw
associ
prolong
dexmedetomidin
use
dexmedetomidin
adrenerg
receptor
agonist
anxiolyt
analges
sed
properti
intend
shortterm
use
increas
literatur
describ
prolong
use
sedat
howev
rais
potenti
withdraw
syndrom
recommend
discontinu
dexmedetomidin
goal
includ
determin
hemodynam
eff
ect
discontinu
dexmedetomidin
role
clonidin
patient
prolong
dexmedetomidin
use
method
retrospect
review
patient
admit
critic
care
unit
exposur
dexmedetomidin
longer
hour
januari
juli
data
includ
patient
demograph
dexmedetomidin
exposur
bolu
dose
total
cumul
dose
durat
sed
exposur
withdraw
symptom
measur
score
nurs
subject
assess
treatment
given
withdraw
potenti
withdraw
episod
review
two
review
hemodynam
paramet
analyz
assess
hemodynam
chang
associ
discontinu
dexmedetomidin
descript
statist
use
test
chisquar
test
median
interquartil
rang
iqr
report
result
total
patient
account
uniqu
dexmedetomidin
treatment
cours
median
age
time
dexmedetomidin
infus
month
rang
day
year
dexmedetomidin
dose
rang
median
cumul
dose
iqr
median
durat
exposur
dexmedetomidin
hour
iqr
maximum
durat
hour
identifi
ed
separ
episod
withdraw
incid
common
symptom
agit
fever
vomitingretch
loos
stool
decreas
sleep
statist
analysi
show
factor
signifi
cantli
associ
critic
care
volum
suppl
http
withdraw
cumul
dose
p
durat
use
dexmedetomidin
p
durat
opioid
exposur
prior
dexmedetomidin
wean
also
risk
factor
withdraw
p
use
clonidin
transit
dexmedetomidin
protect
withdraw
p
conclus
studi
show
withdraw
syndrom
associ
prolong
infus
dexmedetomidin
patient
higher
cumul
dose
longer
durat
exposur
risk
result
suggest
clonidin
use
protect
withdraw
dexmedetomidin
introduct
sedat
icu
basic
therapeut
procedur
increas
toler
invas
treatment
reduc
discomfort
extracorpor
membran
oxygen
ecmo
highli
invas
treatment
prolong
sedat
may
requir
patient
undergo
ecmo
repres
challeng
respect
sedat
initi
deep
sedat
may
requir
optim
ventil
circuitpati
fl
ow
minim
oxygen
consumpt
critic
phase
repres
wean
ecmo
support
optim
sedat
clearli
defi
ned
moreov
data
sedat
practic
dexmedetomidin
dex
adult
patient
undergo
ecmo
contrast
sed
dex
analgosed
eff
ect
without
respiratori
depress
could
use
facilit
spontan
respiratori
activ
recoveri
sedat
method
investig
role
dex
sed
agent
use
recoveri
deep
sedat
wean
extracorpor
support
patient
vvecmo
may
octob
prospect
enrol
seven
patient
aff
ect
ard
diff
erent
etiolog
treat
vvecmo
mean
age
year
mean
icu
stay
day
initi
patient
sedat
associ
opioid
gaba
receptor
agonist
follow
intern
protocol
time
wean
ecmo
rule
cardiovascular
instabl
start
administr
dex
without
initi
bolu
progress
decreas
dose
sed
drug
result
mean
durat
dex
infus
day
except
one
patient
receiv
dex
singl
drug
suspens
sed
lowdos
infus
anoth
sed
compar
initi
dose
maintain
three
patient
present
advers
event
two
bradycardia
one
hypotens
four
patient
dex
discontinu
recoveri
respiratori
function
two
patient
deeper
sedat
ventilatori
dyssynchroni
need
sed
drug
start
one
patient
drug
suspend
extrem
bradycardia
resolv
suspens
conclus
studi
dex
allow
reduct
dose
sed
drug
wean
vvecmo
may
lead
cooper
sedat
promot
spontan
breath
side
eff
ect
describ
costbenefi
ratio
must
still
verifi
ed
extens
patient
wean
ecmo
introduct
sedat
icu
crucial
reduct
patient
discomfort
particular
patient
undergo
mechan
ventil
help
toler
intub
reduc
pain
anxieti
propofol
pr
wide
use
option
viabl
altern
shortterm
sedat
st
hour
includ
benzodiazepin
bdz
dexmedetomidin
dx
aim
pool
avail
evid
compar
eff
ect
pr
term
awaken
recoveri
time
st
mechan
ventil
icu
patient
method
plan
systemat
literatur
review
search
medlin
scopu
perform
metaanalysi
direct
comparison
report
wean
time
tw
durat
mechan
ventil
tmv
time
extub
tex
length
stay
icu
ticu
primari
analysi
consid
data
rct
secondari
analysi
observ
studi
also
includ
result
literatur
search
identifi
ed
relev
rct
versu
bdz
fi
observ
studi
one
versu
bdz
compar
bdz
pr
associ
signifi
cantli
reduc
tw
hour
ci
tmv
hour
ci
ticu
hour
ci
statist
signifi
cant
diff
erenc
result
compar
pr
dx
nonrandom
evid
includ
result
chang
signifi
cantli
conclus
conclus
pr
associ
shorter
awaken
recoveri
time
st
bdz
diff
erenc
could
shown
pr
compar
dx
recent
sever
anim
studi
observ
dexmedetomidin
dex
new
sed
adrenoceptor
agonist
inhibit
infl
ammatori
respons
moreov
dex
report
antiinfl
ammatori
eff
ect
patient
howev
studi
smallsiz
studi
studi
eff
ect
longterm
administr
dex
sever
septic
patient
present
studi
evalu
eff
ect
longterm
administr
dex
infl
ammatori
respons
sever
sever
septic
patient
hypothes
administr
dex
benefi
cial
eff
ect
sever
septic
patient
method
patient
mf
mean
age
year
sever
sepsi
administ
propofol
mgkghour
sedat
patient
mf
mean
age
year
administ
dex
hour
addit
propofol
dex
group
twentyfour
patient
administ
dex
control
group
primari
outcom
chang
infl
ammatori
respons
hour
administr
dex
none
secondari
outcom
chang
apach
ii
sofa
score
hour
administr
dex
none
result
administr
dex
occur
mean
hour
hour
dex
group
white
blood
cell
count
creactiv
protein
crp
procalcitonin
pct
group
signifi
cantli
decreas
administr
dex
none
howev
crp
pct
dex
group
signifi
cantli
lower
control
group
crp
versu
mgdl
p
pct
versu
ngml
p
mean
sd
apach
ii
sofa
score
group
decreas
administr
dex
none
apach
ii
sofa
score
dex
group
lower
control
group
apach
ii
versu
p
sofa
versu
p
mean
sd
conclus
present
studi
longterm
administr
dex
benefi
cial
eff
ect
infl
ammatori
respons
sever
sever
septic
patient
describ
main
indic
dose
infus
length
side
eff
ect
dexmedetomidin
dex
administ
children
adolesc
admit
pediatr
icu
picu
method
retrospect
observ
studi
includ
children
year
admit
brazilian
picu
receiv
dex
novemb
june
demograph
data
indic
initi
dose
maximum
dose
time
infus
dex
side
eff
ect
impact
heart
rate
hr
mean
arteri
pressur
map
hour
start
infus
result
total
children
median
age
month
weight
kg
length
icu
stay
day
receiv
dex
mortal
rate
indic
wean
mechan
ventil
neurosurg
postop
nci
upper
airway
surgeri
va
noninvas
ventil
refractori
tachycardia
indic
diff
erenc
initi
maximum
dose
infus
length
signifi
cant
decreas
map
hr
hour
infus
dex
total
group
howev
signifi
cant
diff
erenc
occur
group
analyz
map
hr
hour
start
infus
p
oneway
anova
respect
six
patient
dex
suspend
possibl
side
eff
ect
conclus
increas
dex
indic
observ
pediatr
popul
studi
dex
demonstr
safe
toler
drug
side
eff
ect
especi
relat
cardiovascular
system
refer
introduct
pain
assess
associ
import
ome
icu
patient
remain
challeng
particularli
non
commun
patient
use
reliabl
tool
paramount
allow
implement
sedationanalgesia
protocol
multidisciplinari
team
studi
compar
psychometr
properti
interrat
agreement
primarili
valid
respons
feasibl
secondarili
three
pain
scale
behaviour
pain
scale
bpsbpsni
bp
nonintub
patient
critic
care
pain
observ
tool
cpot
nonverb
pain
scale
nvp
pain
tool
routin
use
medic
icu
method
prospect
observ
studi
ed
polytraumat
patient
n
mean
acut
physiolog
chronic
health
evalu
ii
apach
ii
score
measur
fi
rst
hour
plasma
tac
ferric
reduc
activityantioxid
power
frap
control
subject
use
agematch
gendermatch
volunt
n
also
evalu
contribut
antioxid
molecul
uric
acid
bilirubin
albumin
valu
result
polytraumat
patient
show
diff
erenc
tac
refer
control
subject
ed
polytraumat
patient
show
high
frap
valu
found
frap
valu
invers
correl
apach
ii
score
r
p
suggest
trauma
patient
increas
antioxid
respons
measur
frap
assay
could
pathophysiolog
respons
stress
albumin
uric
acid
concentr
reproduc
frap
trend
sever
conclus
frap
valu
trauma
ed
patient
independ
infl
uenc
age
p
apach
ii
score
p
head
trauma
p
result
accentu
infl
uenc
trauma
locat
sever
tac
chang
tac
respons
ed
patient
reinforc
need
adequ
tailor
treatment
aim
recoveri
antioxid
therapi
determin
three
method
pain
manag
provid
best
pain
control
sever
asa
iii
older
patient
surgic
icu
sicu
technolog
improv
older
patient
benefi
surgeri
need
sicu
care
older
surgeri
patient
frequent
present
two
medic
problem
first
unspecifi
c
symptom
decreas
pain
sensat
result
delay
diagnosi
second
usual
given
enough
periop
pain
relief
optim
pain
manag
result
periop
stabl
hemodynam
statu
decreas
morbid
mortal
length
stay
medic
cost
method
retrospect
cohort
studi
chart
review
allcaus
patient
sicu
april
septemb
unconsci
uncoop
asa
iii
patient
exclud
primari
point
compar
eff
ectiv
three
diff
erent
method
pain
manag
prn
iv
demerolnsaid
dn
iv
patientcontrol
analgesia
pca
patientcontrol
epidur
analgesia
pcea
three
diff
erent
condit
rest
movement
cough
visual
analogu
scale
va
secondari
point
patient
satisfact
result
total
patient
exclud
va
result
present
tabl
mean
sd
rest
pcea
group
signifi
cantli
better
two
group
movement
diff
erenc
pcea
group
dn
group
better
pca
group
cough
pcea
group
wors
dn
group
although
diff
erenc
pcea
group
pca
group
pcea
group
get
best
grade
patient
satisfact
conclus
pcea
provid
better
pain
control
rest
two
method
wherea
prn
demerolnsaid
pcea
somewhat
better
pca
patient
move
cough
prn
demerolnsaid
provid
best
pain
control
howev
patient
satisfact
signifi
cantli
better
pcea
suppos
trigger
product
subsequ
erythropoietin
subsequ
research
clinician
start
scientifi
c
discuss
potenti
clinic
benefi
support
human
expos
high
demand
critic
ill
patient
object
studi
therefor
evalu
eff
ect
xenon
serum
level
erythropoietin
healthi
volunt
method
monocent
random
blind
crossov
trial
regist
clinicaltrialsgov
healthi
studi
test
person
spontan
breath
randomli
hour
xenon
xeo
control
ga
n
primari
outcom
paramet
erythropoietin
level
hour
exposur
secondari
outcom
paramet
xenon
elimin
kinet
measur
blood
exhal
sampl
applic
xenon
increas
erythropoietin
level
maximum
hour
exposur
p
compar
baselin
valu
compar
control
valu
p
figur
xenon
ga
chromatograph
traceabl
blood
exhal
probe
hour
exposur
figur
conclus
etomid
use
associ
lower
postop
svri
increas
presenc
g
homozygos
polymorph
introduct
oper
therapi
invas
medic
therapi
operationrel
medic
error
me
might
signifi
cant
impact
medic
error
assess
incid
characterist
operationrel
me
improv
patient
safeti
patient
method
japan
advers
event
jet
studi
prospect
cohort
studi
evalu
ae
me
two
tertiari
care
hospit
includ
adult
patient
age
year
old
oper
period
primari
outcom
studi
operationrel
me
defi
ned
deviat
appropri
process
oper
periop
care
train
nurs
place
particip
hospit
review
chart
daili
weekday
along
laboratori
incid
report
prescript
queri
collect
potenti
event
also
collect
characterist
patient
cohort
operationrel
me
associ
operationrel
ae
operationrel
prevent
ae
suspect
event
collect
physician
review
independ
evalu
classifi
ed
oper
conclus
machin
learn
tool
er
appeal
mathemat
framework
model
complex
medic
situat
proof
concept
demonstr
applic
comput
scienc
highqual
data
mimicii
databas
potenti
lead
develop
meaning
tool
ultim
capabl
assist
physician
make
right
decis
right
time
individu
patient
tight
cooper
clinician
data
scientist
help
close
gap
current
separ
two
world
ultim
benefi
patient
introduct
surrog
consent
timesensit
recruit
critic
care
research
challeng
yet
low
enrol
number
omit
ethnic
group
skew
result
conclus
patient
diff
erent
ethnic
group
may
respond
diff
erent
therapeut
data
eff
ect
ethnic
recruit
icu
trial
icu
recruit
nation
trial
serv
increasingli
nonwhit
british
popul
popul
undertook
studi
determin
whether
ethnic
aff
ect
icu
consent
rate
method
perform
retrospect
review
screen
log
three
nation
uk
trial
promis
baltip
gain
one
local
trial
nociceptin
sepsi
analys
consent
rate
elig
patient
ethnic
age
sex
intervent
observ
trial
ethnic
research
seek
consent
perform
chisquar
analysi
enter
signifi
cant
valu
logist
regress
model
use
spss
result
identifi
ed
elig
patient
across
trial
white
british
nwb
analysi
demonstr
consentass
refus
signifi
cantli
associ
nwb
p
intervent
trial
p
diff
erent
researcherpati
ethnic
p
logist
regress
analysi
confi
rmed
independ
factor
nwb
ci
p
intervent
trial
ci
p
data
point
miss
researcherpati
ethnic
variabl
exclud
conclus
initi
studi
suggest
ethnic
may
aff
ect
assent
consent
icu
research
patient
diff
erent
ethnic
four
time
less
like
recruit
whilst
data
incomplet
researcherpati
ethnic
data
suggest
may
import
factor
may
infl
uenc
futur
consent
process
believ
role
ethnic
warrant
investig
clinic
trial
also
area
organ
donat
introduct
decis
tree
analysi
use
algorithm
classifi
data
item
recurs
pose
seri
question
item
within
dataset
question
lead
anoth
node
potenti
question
predefi
ned
end
condit
reach
question
ask
figur
hypothes
score
gener
use
decis
tree
method
improv
upon
exist
hamilton
earli
warn
score
hew
composit
endpoint
cardiac
arrest
unplan
icu
admiss
death
method
databas
electron
captur
vital
sign
consecut
admit
patient
eight
medic
surgic
ward
use
train
test
decis
tree
earli
warn
score
onethird
data
withheld
algorithm
use
test
set
algorithm
look
signifi
cant
chang
vital
hour
prior
outcom
develop
score
base
upon
result
rel
risk
composit
endpoint
happen
given
certain
vital
sign
score
predict
gener
decis
tree
analysi
compar
incept
hew
cohort
plan
analysi
determin
discriminatori
predict
abil
decis
tree
hew
conduct
area
receiv
oper
characterist
curv
test
whether
current
hew
appropri
sensit
specifi
citi
compar
decis
tree
score
auroc
calcul
train
set
data
well
separ
popul
addit
medic
surgic
patient
two
score
also
plot
along
effi
cienci
curv
compar
percentag
vital
preced
critic
event
percentag
vital
produc
ew
valu
greater
equal
given
ew
valu
conclus
decis
tree
analysi
methodolog
reallif
vital
sign
produc
ew
superior
previou
observ
studi
use
decis
tree
especi
one
composit
vital
may
show
certain
vital
predict
critic
event
other
data
use
improv
current
hew
score
electron
icu
support
time
renal
replac
therapi
resourcelimit
area
develop
world
gupta
introduct
time
avail
kidney
specialist
pose
formid
challeng
icu
locat
tier
ii
tier
iii
citi
develop
world
renal
replac
therapi
rrt
often
requir
icu
acut
renal
failur
patient
avail
nephrologist
specialist
scarc
lead
unnecessari
riski
transfer
higher
center
metropolitan
even
wors
death
explor
whether
remot
monitor
icu
electron
icu
eicu
would
help
mitig
demandsuppli
gap
method
retrospect
studi
conduct
four
critinext
affi
liat
eicu
use
provid
support
icu
bed
remot
command
center
intensivist
requisit
staff
eicu
complet
access
patient
realtim
vital
hemodynam
paramet
imag
laboratori
valu
audiovisu
appropri
engin
smart
alert
eicu
model
extend
initi
get
rrt
done
patient
whenev
deem
necessari
time
unavail
specialist
site
patient
baselin
demograph
includ
risk
factor
sever
score
allcaus
mortal
day
transfer
higher
center
rrt
prevent
record
descript
analysi
perform
betweengroup
comparison
perform
appli
chisquar
statist
signifi
canc
assum
valu
p
total
admiss
inpati
fi
le
acut
kidney
injuryacut
renal
failur
review
januari
juli
n
juli
januari
n
pre
post
eicu
implement
respect
result
baselin
demograph
patient
profi
le
two
group
show
statist
signifi
cant
diff
erenc
mean
apach
ii
score
pre
post
eicu
respect
statist
signifi
cant
diff
erenc
allcaus
mortal
day
decreas
pre
post
eicu
respect
reduct
p
transfer
rrt
came
two
post
eicu
implement
p
conclus
year
broad
consensu
benefi
ts
eicu
intervent
depriv
area
need
paradigm
shift
elev
special
care
improv
outcom
small
studi
clearli
indic
benefi
ts
outcom
econom
even
provid
intervent
remot
area
eicu
bridg
demandsuppli
gap
need
explor
util
full
potenti
emerg
world
figur
abstract
sampl
heart
rate
decis
tree
aim
evalu
outcom
resourc
use
investig
associ
organiz
factor
effi
cient
resourc
use
larg
sampl
brazilian
icu
method
retrospect
cohort
studi
patient
medic
admiss
admit
icu
privat
hospit
n
medic
medicalsurg
n
retriev
demograph
clinic
outcom
data
electron
icu
qualiti
registri
epim
monitor
system
survey
icu
use
standard
questionnair
regard
hospit
icu
structur
organ
staffi
ng
pattern
process
care
famili
care
polici
effi
cient
resourc
use
assess
estim
standard
mortal
rate
smr
standard
resourc
use
sru
adjust
sever
ill
accord
sap
score
propos
rothen
colleagu
result
median
admiss
per
center
iqr
sap
score
point
median
icu
length
stay
day
icu
hospit
mortal
rate
respect
estim
smr
sru
respect
effi
cient
icu
smr
sru
median
least
effi
cient
icu
smr
sru
median
overachiev
icu
low
smr
high
sru
underachiev
icu
high
smr
low
sru
icu
effi
cient
icu
usual
locat
privat
accredit
hospit
stepdown
unit
train
program
critic
care
univari
analys
compar
least
effi
cient
icu
clinic
protocol
ci
graduat
nurseb
ratio
associ
effi
cient
resourc
use
daili
checklist
also
tend
associ
effi
cient
resourc
use
p
conclus
observ
great
variabl
outcom
resourc
larg
sampl
brazilian
icu
implement
clinic
protocol
nurs
staffi
ng
pattern
target
improv
effi
cienci
resourc
use
emerg
countri
brazil
introduct
aim
studi
assess
blood
pressur
bp
heart
rate
hr
chang
shift
icu
nurs
relat
work
experi
hypothesi
less
experienc
nurs
comparison
experienc
one
would
subject
work
stress
could
demonstr
higher
chang
bp
hr
shift
method
enrol
nurs
work
shift
schedul
gener
adult
icu
demograph
clinic
data
obtain
complet
short
questionnair
nurs
invit
measur
bp
hr
begin
middl
end
shift
eshbshcertifi
ed
automat
devic
use
bp
hr
measur
surviv
patient
transport
ambul
emerg
depart
ed
depend
clinic
condit
patientrel
factor
organis
prehospit
set
data
inform
concern
patient
prehospit
system
could
form
valuabl
resourc
assess
potenti
risk
factor
associ
advers
outcom
mortal
aim
describ
ambul
transport
ed
identifi
prognost
factor
access
prehospit
phase
associ
mortal
method
includ
adult
patient
year
fi
rsttime
ambul
transport
ed
odens
univers
hospit
period
april
septemb
ambul
personnel
record
vital
sign
clinic
fi
nding
structur
form
paper
ambul
transport
contact
link
inform
populationbas
healthcar
regist
order
identifi
comorbid
condit
inform
mortal
demograph
factor
fi
rst
regist
vital
sign
analys
univari
logist
regress
analysi
mortal
outcom
result
total
fi
rsttime
ambul
contact
identifi
ed
period
inclus
overal
mortal
ci
univari
analysi
show
increas
age
charlson
comorbid
index
vital
paramet
outsid
normal
refer
rang
summon
physicianassist
mobil
emerg
care
unit
associ
mortal
analys
current
carri
conclus
found
sever
prehospitalregist
vital
sign
record
ambul
personnel
fi
rst
contact
patient
prognost
factor
mortal
introduct
critic
ill
patient
may
requir
interhospit
transfer
specialist
care
lack
local
icu
capac
harm
assum
delay
result
clear
whether
delay
due
transfer
distanc
defi
cienci
organis
care
method
total
deterior
ward
patient
spot
light
studi
transfer
rather
admit
local
defi
ned
delay
time
critic
care
assess
fi
rst
hospit
arriv
critic
care
second
hospit
use
hospit
postcod
deriv
latitud
longitud
calcul
geodes
straightlin
distanc
figur
road
distanc
site
use
r
version
compar
daytim
versu
overnight
pm
transfer
durat
assum
traffi
c
would
contribut
less
delay
overnight
map
visualis
perform
quantum
gi
version
median
delay
admiss
hour
rang
hour
median
geodes
distanc
km
rang
km
road
distanc
km
rang
km
correl
time
delay
geodesicroad
distanc
weak
figur
r
respect
transfer
delay
daytim
overnight
similar
wilcoxon
rank
sum
p
conclus
interhospit
transfer
subject
clinic
signifi
cant
delay
substanti
travel
distanc
delay
weakli
correl
distanc
travel
may
refl
ect
delay
result
organis
ineffi
cienci
infer
eff
ort
improv
effi
cienci
transfer
focu
local
organis
issu
diff
erenc
durat
taken
overnight
versu
daytim
transfer
introduct
discharg
intens
care
potenti
vulner
time
patient
recov
critic
ill
recent
data
anzic
group
highlight
mortal
diff
erenc
patient
discharg
hour
nearli
twice
discharg
day
result
replic
institut
mortal
discharg
versu
discharg
uk
nice
advis
transfer
critic
care
ward
hour
avoid
document
advers
event
postul
one
import
factor
hospit
decreas
medic
nurs
cover
overnight
look
delay
discharg
fi
rst
medic
review
outreach
review
method
case
note
consecut
patient
discharg
ward
septemb
octob
examin
identifi
time
discharg
icu
subsequ
fi
rst
review
receiv
medic
team
critic
care
outreach
team
grade
doctor
review
patient
record
result
patient
discharg
case
note
request
avail
examin
forti
patient
discharg
ward
document
medic
review
note
patient
review
consult
follow
intens
care
patient
wait
hour
medic
review
time
patient
receiv
review
nursel
outreach
team
see
figur
conclus
clear
highli
vulner
group
patient
recov
critic
ill
receiv
inadequ
earli
followup
within
hospit
postul
delay
medic
review
lack
senior
review
may
caus
discharg
overnight
contribut
increas
mortal
seen
institut
anzic
studi
nighttim
discharg
introduct
wild
mushroom
poison
mp
import
medic
emerg
may
bad
clinic
outcom
aim
evalu
clinic
laboratori
featur
patient
wild
mp
admit
emerg
depart
central
black
sea
region
inform
emerg
depart
physician
earli
diagnosi
manag
wild
mp
light
obtain
data
method
studi
design
retrospect
examin
fi
le
patient
wild
mp
admit
ondokuz
mayi
univers
emerg
depart
januari
decemb
patient
older
year
includ
studi
patient
evalu
accord
gender
age
locat
durat
mushroom
intak
start
clinic
symptom
time
applic
hospit
clinic
featur
fi
nding
treatment
method
number
patient
compar
region
distribut
popul
monthli
temperatur
averag
annual
rainfal
critic
care
volum
suppl
http
result
total
patient
poison
wild
mushroom
studi
malefemal
ratio
age
patient
chang
mean
age
year
mp
constitut
intox
case
time
fi
rst
symptom
occur
mushroom
intak
mean
hour
patient
live
villag
town
citi
center
admiss
mostli
made
autumn
eightysix
percent
intox
happen
wild
mushroom
collect
natur
frequent
symptom
nausea
vomit
increas
liver
function
test
patient
observ
two
patient
die
patient
transfer
center
liver
transplant
remain
patient
discharg
hospit
conclus
wild
mp
caus
bad
clinic
outcom
public
inform
probabl
hazard
wild
mushroom
ingest
collect
consumpt
wild
mushroom
natur
common
public
health
unit
take
protect
precaut
wild
mp
educ
health
person
regard
mp
lead
success
result
patient
manag
introduct
mani
patient
drug
overdos
sedat
medic
reason
warrant
icu
admiss
histor
monitor
behavior
suicid
risk
done
icu
patient
awak
enough
psychiatr
consult
method
medic
psychiatri
unit
mpu
institut
part
depart
clinic
psychiatri
patient
drug
overdos
emerg
depart
risk
assess
made
intensivist
without
icu
indic
cardiac
respiratori
monitor
admit
mpu
altern
awak
enough
seen
psychiatrist
immedi
perform
analysi
patient
drug
overdos
admit
icu
mpu
n
mpu
n
use
welch
test
comparison
result
institut
mpu
reduct
number
patient
drug
overdos
per
month
admit
icu
also
patient
admit
icu
sicker
stay
longer
see
tabl
patient
admit
icu
initi
mpu
admiss
estim
one
patient
may
harm
advers
event
hospit
stay
transform
organiz
cultur
improv
patient
safeti
cultur
consid
import
conduct
prospect
control
studi
assess
impact
standard
patient
safeti
cours
icu
patient
safeti
cultur
use
valid
patient
safeti
cultur
assess
tool
method
staff
two
icu
tertiari
referr
hospit
district
hospit
hong
kong
recruit
compar
chang
measur
safeti
cultur
patient
safeti
cours
basic
patient
safeti
cours
administ
staff
safeti
cultur
assess
unit
use
survey
base
hospit
survey
patient
safeti
cultur
rel
risk
ci
improv
baselin
followup
hospit
patient
safeti
domain
adjust
durat
work
unit
year
vs
year
calcul
audit
look
whether
icu
document
investig
involv
ionis
radiat
could
improv
anticip
benefi
ts
would
improv
commun
multidisciplinari
team
betterinform
decisionmak
method
patient
admit
icu
septemb
octob
includ
investig
involv
ionis
radiat
request
intens
care
clinician
exclud
indic
imag
note
patient
note
analys
less
hour
imag
report
result
shown
figur
imag
request
gener
poorli
document
total
chest
xray
cxr
document
total
ct
scan
document
despit
one
show
acut
chang
total
cxr
request
follow
procedur
carri
itu
insert
central
venou
cathet
document
three
document
signifi
cant
fi
nding
six
cxr
request
investig
worsen
respiratori
function
none
document
five
signifi
cant
fi
nding
conclus
investig
follow
procedur
gener
well
document
investig
seek
patholog
document
regardless
fi
nding
may
infl
uenc
manag
patient
compromis
patient
safeti
audit
present
department
meet
emphasis
import
imag
document
place
investig
introduct
icu
workfl
ow
physician
nurs
healthcar
provid
often
complic
distract
interrupt
diffi
culti
concentr
multitask
need
frequent
chang
prioriti
patient
carerel
procedur
therefor
continu
challeng
commun
implement
plan
earli
effi
cient
reliabl
way
within
team
constantli
keep
track
task
complet
postpon
forgotten
facilit
everi
caregiv
workfl
ow
earli
effi
cientli
commun
implement
round
comprehens
plan
summari
arcop
tool
method
patient
carerel
therapeut
diagnost
decis
made
morn
round
consist
intensivist
nurs
team
surgeon
respiratori
therapist
dietician
clinic
pharmacist
physiotherapist
immedi
thereaft
plan
next
period
discuss
summar
confi
rmed
priorit
organ
multidisciplinari
team
aspect
optim
patient
care
workfl
ow
effi
cienci
enter
plan
data
fl
screen
visual
templat
connect
intranet
immedi
access
everi
physician
nurs
caregiv
workstat
result
twelv
month
implement
arcop
tool
conduct
caregiv
interview
identifi
ed
follow
eff
ect
increas
treatment
confi
denc
standard
multidisciplinari
decisionmak
reduc
loss
inform
immedi
plan
summar
whole
team
reduct
ambigu
misunderstand
care
plan
earli
written
document
higher
level
secur
forget
procedur
task
posit
accept
tool
fl
exibl
chang
prioriti
care
procedur
posit
accept
tool
mark
accomplish
task
provid
visual
feedback
care
plan
statu
individu
caregiv
workfl
ow
econom
perman
treatment
plan
avail
higher
job
satisfact
throughout
caregiv
team
conclus
arcop
tool
util
becom
daili
routin
icu
function
eff
ectiv
commun
workfl
ow
tool
help
us
reduc
patient
carerel
misunderstand
delay
also
enhanc
econom
work
sequenc
also
highli
contribut
better
level
patient
safeti
furthermor
markedli
contribut
improv
level
qualiti
work
caregiv
aim
thaisicu
studi
incid
outcom
advers
event
nine
sicu
universitybas
hospit
thailand
method
multicent
prospect
observ
studi
done
year
old
admiss
hour
surgic
patient
admit
larg
postgradu
medic
train
universitybas
sicu
april
januari
patient
data
divid
three
main
phase
admiss
discharg
data
daili
crf
icu
stay
patient
follow
discharg
icu
day
icu
admiss
day
follow
discharg
icu
surviv
result
follow
recruit
period
total
patient
icuday
includ
analysi
process
admit
patient
median
age
year
patient
admit
directli
postop
monitor
median
apach
ii
score
admit
prioriti
need
aggress
hemodynam
resuscit
respiratori
support
icu
mortal
mortal
day
icu
increment
associ
conclus
largest
system
surveil
observ
sicu
studi
result
refer
futur
research
also
provid
inform
patient
rel
advic
confront
advers
event
sicu
admiss
retrospect
observ
cohort
studi
mortal
length
stay
surgic
icu
admiss
hame
maruthappu
marshal
pimentel
l
celi
j
salciccioli
j
shalhoub
aim
know
frequenc
criteria
implic
reject
icu
admiss
icu
unit
secondlevel
hospit
bed
method
observ
retrospect
studi
time
interv
month
januari
june
retrospect
regist
patient
reject
admiss
unit
analyz
clinic
reject
report
use
hospit
report
extract
diff
erent
variabl
demograph
age
sex
proven
emerg
room
hospit
clinic
comorbid
function
situat
diagnosi
reason
request
admiss
reject
motiv
good
bad
futil
lack
bed
patient
reject
whether
defi
nitiv
condit
whether
patient
admit
afterward
state
hospit
discharg
realiz
descript
analysi
frequenc
multivari
analysi
factor
relat
futil
reject
result
reject
repres
total
icu
patient
evalu
admiss
total
male
mean
age
year
total
two
comorbid
pluripatholog
moder
sever
function
disabl
caus
reject
situat
patient
good
relat
qualit
futil
bad
mix
lack
space
bed
patient
reject
multivari
analysi
signifi
cant
variabl
relat
futil
reject
age
year
sever
function
disabl
hospit
proven
conclus
reject
admiss
icu
unit
frequent
medic
activ
daytoday
job
type
patient
reject
cardiolog
mostli
evalu
thorac
pain
probabl
ischem
low
risk
second
place
found
patient
decid
reject
base
subject
qualit
futil
relat
mostli
age
prior
function
disabl
proven
prospect
servic
review
assess
impact
age
apach
ii
score
function
score
toward
admiss
accept
refus
itu
tertiarylevel
facil
method
design
plan
prospect
review
referr
period
data
collect
review
lt
dp
sp
case
note
patient
refer
itu
follow
variabl
collect
age
sex
apach
ii
score
function
statu
score
grade
referr
sourc
referr
data
collect
patient
accept
itu
refus
admiss
statist
data
analyz
use
graphpad
categor
variabl
express
mean
standard
error
mean
unpair
variabl
statist
signifi
canc
determin
use
unpair
test
p
consid
statist
signifi
cant
function
statu
signifi
cant
variabl
aff
ect
admiss
p
apach
score
patient
admit
itu
signifi
cantli
lower
refus
patient
p
patient
age
aff
ect
admiss
statu
p
see
tabl
introduct
six
sigma
project
initi
evalu
improv
transfer
care
patient
icu
medic
error
respons
billion
dollar
increas
healthcar
spend
miscommun
among
healthcar
provid
major
contributor
error
handoff
particularli
vulner
period
care
process
institut
surgic
patient
schedul
admiss
icu
fi
rst
recov
postanesthesia
care
unit
pacu
process
multipl
unstructur
individu
handoff
occur
parallel
provid
may
lead
commun
error
diff
erenti
inform
share
content
variabl
care
delay
ineffi
cienci
method
multidisciplinari
qi
project
initi
input
icu
anesthesia
surgic
servic
seri
pdsa
cycl
conduct
began
defi
ning
current
process
via
direct
observ
valu
stream
map
orthoped
neurosurg
patient
new
process
introduc
includ
direct
transfer
patient
icu
singl
structur
bedsid
report
care
provid
standard
handoff
tool
implement
use
process
time
wait
time
inform
content
process
measur
handoff
error
outcom
measur
satisfact
score
also
measur
result
follow
implement
new
transfer
process
averag
wait
time
decreas
minut
process
time
decreas
minut
lead
time
decreas
minut
handoff
error
rate
decreas
errorspati
fi
rsttime
qualiti
rate
increas
staff
satisfact
improv
elimin
pacu
stay
cost
involv
admiss
pacu
defer
conclus
singl
multidisciplinari
bedsid
handoff
process
icu
lead
cost
time
save
elimin
redund
nonvaluead
process
less
opportun
medic
error
occur
substanti
improv
fi
rsttime
qualiti
process
success
attain
aff
ect
staff
satisfact
posit
introduct
prolong
hospit
stay
prior
admiss
icu
previous
shown
independ
associ
poorer
outcom
probabl
due
slow
deterior
physiolog
function
hospit
infl
uenc
process
lead
critic
care
admiss
investig
whether
commonli
measur
sever
score
system
acut
physiolog
chronic
health
evalu
apach
ii
intens
care
nation
audit
research
centr
icnarc
sequenti
organ
failur
assess
sofa
score
signifi
cantli
diff
erent
patient
admit
prolong
preicu
hospit
length
stay
describ
mortal
hospit
length
stay
method
retrospect
analysi
prospect
collect
data
emerg
admiss
icnarc
databas
adult
critic
care
unit
within
major
trauma
centr
period
demograph
data
apach
ii
score
sofa
score
icnarc
model
score
mortal
length
hospit
stay
prior
icu
admiss
collect
five
group
patient
defi
ned
follow
admit
icu
within
week
hospit
group
within
day
group
within
day
group
within
day
group
day
group
chisquar
anova
test
perform
use
sofa
statist
packag
result
total
emerg
admiss
analys
major
patient
admit
within
week
hospit
admiss
n
younger
lower
apach
ii
score
vs
p
apach
ii
score
group
group
patient
admit
icu
week
follow
hospit
admiss
signifi
cantli
higher
hospit
mortal
p
icu
length
stay
vs
day
p
icu
mortal
remain
group
icnarc
sofa
score
equal
group
posticu
length
stay
signifi
cantli
longer
group
inhospit
cpr
prior
admiss
icu
lower
patient
group
probabl
signifi
appropri
dnar
decis
made
ward
conclus
prolong
preicu
hospit
admiss
associ
higher
hospit
icu
mortal
commonli
measur
score
refl
ect
higher
mortal
patient
admit
prolong
stay
hospit
research
paramet
may
refl
ect
chang
physiolog
reserv
may
strengthen
score
patient
introduct
hospit
cost
constant
concern
within
health
especi
icu
hospit
admiss
averag
life
expect
grow
gradual
mainli
older
critic
patient
studi
aim
observ
direct
cost
patient
admit
icu
relat
sap
length
stay
icu
fi
nal
outcom
method
retrospect
observ
studi
direct
cost
studi
materi
medicin
oxygen
therapi
hospit
fee
icu
patient
novemb
novemb
readmiss
within
hour
exclud
also
patient
highest
lowest
cost
remain
patient
divid
age
group
patient
studi
male
averag
age
year
year
biggest
icu
averag
cost
group
patient
year
old
us
well
longest
icu
stay
day
highest
sap
higher
icu
inhospit
mortal
respect
studi
show
direct
cost
icu
stay
older
patient
higher
younger
patient
diff
erenc
explain
higher
sever
measur
sap
older
age
group
figur
requir
greater
length
stay
icu
figur
might
expect
mortal
group
older
patient
also
signifi
cantli
higher
conclus
studi
show
greater
age
associ
higher
sever
measur
sap
higher
direct
cost
higher
mortal
icu
inhospit
environ
introduct
pregnanc
labour
usual
progress
unev
howev
seriou
complic
occur
develop
rapidli
necessit
critic
care
admiss
support
success
confi
dential
enquir
highlight
defi
cienci
area
suboptim
care
lead
increas
morbid
mortal
nation
matern
hospit
largest
matern
hospit
republ
ireland
total
babi
deliv
standalon
institut
onsit
facil
includ
twobe
dedic
anaesthesia
lead
highdepend
unit
method
retrospect
observ
studi
carri
januari
januari
especi
look
follow
paramet
admit
diagnosi
demograph
length
stay
number
admiss
requir
transfer
tertiarylevel
care
total
deliveri
occur
total
hdu
admiss
record
period
repres
admiss
averag
age
patient
admit
hdu
year
predomin
reason
admiss
hypertens
diseas
pregnanc
haemorrhag
antepartumpostpartum
sepsi
reason
includ
cardiac
rhythm
disturb
neurolog
complic
preexist
medic
diseas
averag
length
stay
day
total
admit
hdu
requir
transfer
tertiarylevel
icu
care
centr
studi
period
repres
deliveri
conclus
signifi
cant
demand
within
institut
hdu
care
patient
number
admiss
increas
main
admit
diagnos
hypertens
diseas
pregnanc
haemorrhag
increas
number
patient
admit
manag
sepsi
highlight
increas
awar
recognit
manag
condit
pregnanc
increas
number
hdu
admiss
could
also
explain
recent
introduct
earli
warn
score
deterior
patient
hospit
would
requir
evalu
low
number
transfer
patient
tertiari
centr
underpin
import
anaesthesia
lead
servic
introduct
object
survey
establish
preval
symptom
posttraumat
stress
mix
staff
group
work
adult
paediatr
intens
care
set
examin
main
theme
staff
descript
traumat
event
experienc
work
method
total
health
profession
work
three
adult
four
paediatr
unit
two
centr
ask
rate
current
level
posttraumat
stress
symptom
trauma
screen
questionnair
tsq
result
paediatricneonat
intens
care
staff
like
score
clinic
cutoff
point
posttraumat
stress
symptom
tsq
relat
incid
work
adult
intens
care
staff
sampl
picu
n
vs
aicu
n
p
staff
provid
descript
traumat
event
experienc
follow
theme
case
mortal
rate
follow
factor
associ
mortal
univari
logist
regress
age
bodi
mass
index
past
medic
histori
tbsa
ftbsa
intox
co
cn
inhal
injuri
fl
ame
burn
selfinfl
ict
burn
p
sex
p
admiss
date
p
simpl
period
regress
show
biannual
season
eff
ect
mortal
document
period
p
period
p
depend
multivari
analysi
without
period
term
identifi
ed
age
past
medic
histori
tbsa
ftbsa
inhal
intox
admiss
date
factor
independ
associ
mortal
method
twentytwo
patient
suff
ere
gp
admit
icu
januari
decemb
includ
acut
physiolog
chronic
health
evalu
apach
ii
prognost
score
scale
use
order
assess
sever
ill
fi
rst
icu
day
sequenti
organ
failur
assess
sofa
score
use
measur
organ
dysfunct
birmingham
vascul
activ
score
wegen
granulomatosi
bvaswg
use
assess
vascul
activ
outcom
measur
taken
account
icu
mortal
icu
length
stay
result
one
patient
admit
twice
period
sampl
compris
male
femal
respect
featur
averag
age
year
admit
icu
respiratori
failur
due
diff
use
alveoli
hemorrhag
due
sepsi
hypovolem
shock
fi
nalli
tuberculosi
accord
bvaswg
patient
correspond
sever
diseas
one
limit
diseas
one
persist
diseas
averag
icu
length
stay
day
inpati
day
compar
sofa
score
aliv
deceas
patient
diff
erenc
p
aliv
patient
diagnos
icu
plasmapheresi
found
protector
factor
p
conclus
bvaswg
score
signifi
cantli
diff
erent
aliv
deceas
patient
plasmapheresi
found
surviv
predictor
studi
shown
sofa
apach
ii
score
prognost
valu
patient
increas
demand
revis
hip
surgeri
older
patient
poor
frailti
previous
submit
work
demonstr
frailti
predict
need
medic
review
review
patient
month
see
whether
frailti
impact
care
largest
report
studi
review
frailti
need
organ
support
outcom
complex
orthopaed
surgeri
method
retrospect
note
review
patient
januari
april
undergo
revis
hip
surgeri
data
collect
includ
frailti
comorbid
oper
blood
loss
anaesthet
techniqu
level
organ
support
patient
locat
day
total
patient
mean
age
year
identifi
ed
frail
patient
signifi
cantli
like
need
vasopressor
postop
p
increas
frailti
score
associ
increas
length
stay
hdu
p
analysi
patient
locat
day
show
frail
patient
stay
hospit
longer
p
frail
patient
also
bleed
intraop
p
coeffi
cient
valu
everi
point
increas
frailti
averag
blood
loss
increas
ml
increas
unit
blood
transfus
length
stay
increas
day
p
use
epidur
associ
increas
need
postop
vasopressor
p
see
figur
conclus
frailti
associ
increas
intraop
resourc
use
postop
care
requir
independ
choic
anaesthet
techniqu
type
surgeri
subject
health
econom
analysi
demand
amongst
frailer
surgic
popul
increas
refer
demograph
physiolog
measur
coexist
condit
use
evalu
icu
perform
stratifi
patient
clinic
trial
assist
inhospit
healthcar
decis
resourc
alloc
aim
project
determin
whether
gener
score
deriv
routin
laboratori
paramet
could
use
predict
mortal
rate
patient
admit
icu
uk
method
p
valu
calcul
use
test
mannwhitney
u
test
chisquar
test
depend
distribut
data
order
determin
variabl
signifi
cantli
diff
erent
survivor
nonsurvivor
critic
ill
signifi
cant
variabl
categoris
subgroup
accord
medic
relev
landmark
univari
analys
assess
correl
mortal
forward
logist
regress
model
use
choos
paramet
includ
score
roc
curv
illustr
sensit
specifi
citi
select
variabl
via
auc
result
age
platelet
alt
apach
ii
select
includ
new
laboratorybas
score
auc
score
higher
individu
laboratori
paramet
auc
increas
includ
variabl
age
lactat
fio
urea
creatinin
alt
apach
ii
platelet
bicarbon
haemoglobin
ph
ionis
ca
carboxyhaemoglobin
albumin
although
improv
consid
signifi
cant
confi
denc
interv
two
score
variabl
overlap
conclus
laboratorybas
score
success
establish
icu
patient
reveal
auc
compar
establish
score
similar
popul
compil
variabl
produc
laboratorybas
score
show
greater
prognost
power
individu
variabl
model
develop
requir
auc
term
use
howev
order
use
clinic
set
auc
must
least
research
includ
intern
extern
valid
studi
must
perform
optimis
model
clinic
implement
among
icu
patient
high
level
trait
anxieti
rel
common
associ
intrus
symptom
ptsd
independ
childhood
trauma
stress
exposur
throughout
life
associ
depress
cardiac
surgeri
patient
admit
icu
postop
eff
ect
trait
anxieti
relationship
cumul
life
stress
stressrel
psychopatholog
remain
unknown
therefor
aim
assess
mediat
moder
role
trait
anxieti
atrisk
patient
popul
method
multicent
followup
studi
dexamethason
cardiac
surgeri
dec
trial
valid
selfreport
questionnair
sent
year
cardiac
surgeri
icu
treatment
assess
symptom
ptsd
depress
relat
cumul
life
stress
childhood
trauma
major
stress
life
event
trait
anxieti
determin
psychopatholog
data
avail
elig
particip
mediat
moder
analys
perform
multivari
linear
regress
assess
eff
ect
trait
anxieti
subgroup
analys
perform
sex
result
trait
anxieti
partial
mediat
relationship
cumul
life
stress
ptsd
reduct
p
p
fulli
mediat
associ
cumul
life
stress
depress
reduct
p
p
trait
anxieti
moder
factor
cumul
life
stress
psychopatholog
full
mediat
trait
anxieti
found
femal
patient
n
wherea
partial
mediat
seen
male
patient
n
regard
ptsd
symptom
depress
full
mediat
present
femal
male
patient
conclus
cardiac
icu
patient
trait
anxieti
mediat
infl
uenc
cumul
life
stress
occurr
ptsd
depress
symptom
prospect
research
necessari
establish
factor
reliabl
measur
earli
identifi
cation
icu
patient
risk
stressrel
psychopatholog
introduct
although
icu
surviv
rate
increas
last
decad
neg
eff
ect
mental
health
relat
qualiti
life
becom
clear
literatur
preval
anxieti
depress
symptom
post
icu
rang
earli
recognit
treatment
anxieti
depress
symptom
import
depress
cari
risk
suicid
limit
qualiti
life
delay
return
work
studi
hospit
anxieti
depress
symptom
icu
discharg
method
patient
treat
icu
januari
decemb
day
invit
visit
posticu
aftercar
clinic
six
week
discharg
receiv
letter
invit
togeth
healthrel
questionnair
hospit
anxieti
depress
scale
had
questionnair
patient
ask
return
questionnair
prior
visit
data
analyz
had
score
indic
clinic
signifi
cant
anxieti
depress
patient
refer
psychologist
analys
treatment
patient
data
analyz
retrospect
result
seventynin
patient
men
women
mean
age
year
median
apach
ii
iv
respect
median
icu
hospit
day
respect
seventysix
percent
mechan
ventil
median
day
median
time
icu
discharg
aftercar
visit
day
patient
divid
three
categori
possibl
clinic
signifi
cant
women
compar
men
show
signifi
cantli
symptom
vs
p
patient
subarachnoid
hemorrhag
neurotrauma
multitrauma
patient
show
symptom
pain
fatigu
muscl
weak
impair
daili
activ
dyspnea
hoars
signifi
cantli
associ
clinic
signifi
cant
associ
age
found
diagnosi
icu
admiss
length
stay
sever
ill
delirium
use
sed
associ
conclus
preval
clinic
signifi
cant
posticu
femal
sex
posticu
physic
complaint
pain
fatigu
muscl
weak
impair
daili
activ
hoars
dyspneawer
signifi
cantli
associ
effi
caci
intervent
previou
work
shown
intens
care
patient
undergo
mani
stress
experi
aff
ect
longterm
psycholog
wellb
studi
demonstr
high
preval
depress
anxieti
posttraumat
stress
disord
intens
care
admiss
method
systemat
review
carri
accord
prisma
statement
search
conduct
medlin
embas
psychinfo
databas
inclus
criteria
includ
studi
popul
adult
patient
mix
gener
icu
studi
design
exclud
studi
focus
specifi
c
diseas
state
exclud
includ
studi
assess
risk
bia
use
qualiti
checklist
result
total
paper
retriev
studi
elig
inclus
review
studi
combin
popul
patient
admit
icu
europ
asia
north
america
eleven
studi
random
control
trial
rct
intervent
classifi
ed
four
group
music
therapeut
touch
diari
psychotherapeut
intervent
ten
studi
found
music
intervent
eff
ectiv
short
term
howev
followup
result
limit
studi
low
qualiti
moder
qualiti
evid
three
studi
eff
ectiv
diari
intervent
mediumterm
followup
result
mixedqu
evid
therapeut
touch
intervent
short
term
three
studi
two
psychotherapeut
intervent
studi
moder
qualiti
one
show
promis
result
followup
evid
effi
caci
nonpharmacolog
intervent
reduc
shortterm
longterm
stress
intens
care
patient
low
moder
qualiti
studi
includ
mainli
shortterm
mediumterm
followup
highlight
need
largerscal
betterqu
rct
longerterm
outcom
measur
howev
result
indic
nonpharmacolog
includ
psycholog
approach
like
benefi
cial
reduc
shortterm
longterm
stress
intens
care
patient
introduct
patient
recov
critic
ill
suff
er
mani
physic
psycholog
problem
recoveri
includ
muscl
weak
fatigu
sign
symptom
ptsd
anxieti
depress
present
specialist
intens
care
followup
rehabilit
inconsist
mani
geograph
area
nonexist
result
mani
survivor
critic
ill
requir
use
exist
commun
rehabilit
servic
aim
present
servic
evalu
understand
utilis
commun
rehabilit
servic
critic
care
survivor
method
databas
acut
referr
commun
rehabilit
servic
retrospect
analys
may
octob
age
refer
specialti
reason
referr
rehabilit
document
databas
crosscheck
critic
care
databas
glasgow
royal
infi
rmari
identifi
individu
admit
critic
care
admiss
result
period
patient
refer
parent
specialti
commun
rehabilit
north
east
glasgow
thirtythre
patient
refer
critic
care
stay
admiss
eight
patient
refer
rehabilit
orthopaed
eight
medicin
older
patient
acut
medicin
remain
six
specialti
six
patient
critic
care
admiss
work
age
two
individu
admit
critic
care
follow
trauma
whilst
four
complex
social
need
prior
critic
care
admiss
includ
individu
high
bodi
mass
index
none
individu
work
age
refer
consequ
critic
care
stay
conclus
servic
evalu
demonstr
critic
care
survivor
refer
commun
rehabilit
servic
particularli
work
age
work
requir
understand
optim
rehabilit
pathway
patient
group
brazil
earli
mobil
protocol
consist
fi
phase
exercis
unconsci
patient
activ
exercis
associ
respiratori
exercis
patient
lie
bed
exercis
patient
sit
bed
phase
exercis
patient
sit
chair
stand
posit
phase
exercis
plu
walk
hospit
record
patient
septemb
august
includ
studi
data
extract
hospit
record
age
gender
diagnosi
arrhythmia
coronariopathi
congest
heart
failur
patholog
length
stay
number
discharg
number
phase
earli
mobil
protocol
pearson
chisquar
test
use
compar
number
mobil
phase
per
group
diagnos
odd
ratio
calcul
comparison
found
statist
signifi
cant
p
result
total
hospit
record
analyz
patient
averag
sd
year
major
male
result
reveal
patient
cicu
receiv
phase
patient
cicu
receiv
phase
earli
mobil
protocol
diff
erenc
proport
patient
receiv
phase
found
among
arrhythmia
coronariopathi
congest
heart
failur
group
diff
erenc
found
congest
heart
failur
group
cardiovascular
patholog
p
congest
heart
failur
group
mobil
time
ci
time
ci
cardiovascular
patholog
group
phase
respect
conclus
consider
proport
patient
mobil
without
seriou
complic
cicu
fi
nding
suggest
patient
diagnos
arrhythmia
coronariopathi
congest
heart
failur
equal
mobil
icu
introduct
variou
therapeut
intervent
need
critic
care
may
refl
ect
high
risk
death
evalu
associ
commonli
use
intervent
hospit
mortal
finnish
icu
patient
method
retriev
data
adult
patient
treat
finnish
icu
finnish
intens
care
consortium
databas
use
therapeut
intervent
score
system
categor
icu
intervent
simplifi
ed
acut
physiolog
score
sap
ii
quantifi
sever
ill
exclud
readmiss
patient
miss
outcom
sap
ii
tiss
data
also
exclud
common
intervent
arteri
line
bolu
intraven
medic
rare
one
preval
intervent
applic
specifi
c
popul
intracrani
pressur
monitor
intraaort
balloon
assist
group
sever
tiss
categori
applic
perform
backward
stepwis
binari
logist
regress
analysi
tiss
item
assess
impact
intervent
hospit
mortal
express
odd
ratio
confi
denc
interv
ci
age
admiss
type
sap
score
minu
age
admiss
type
score
adjust
multivari
analysi
conclus
larg
retrospect
multicent
studi
tiss
item
associ
highest
risk
death
cardiac
arrest
andor
countershock
unexpectedli
independ
eff
ect
emerg
admiss
compar
magnitud
term
impact
hospit
mortal
inicu
cardiac
arrest
might
amen
prevent
measur
studi
correct
natur
declin
hrqol
mean
score
four
dimens
physic
function
p
physic
role
p
gener
health
p
social
function
p
still
signifi
cantli
lower
year
icu
discharg
compar
preadmiss
level
although
eff
ect
size
small
conclus
five
year
icu
discharg
survivor
still
perceiv
signifi
cantli
lower
hrqol
preadmiss
hrqol
proxi
agematch
gener
popul
importantli
howev
correct
natur
declin
eff
ect
size
small
suggest
patient
regain
agespecifi
c
hrqol
year
icu
stay
introduct
ecmo
support
ard
emerg
strategi
convent
treatment
modal
fail
ecmo
advantag
oxygen
circul
also
unfavor
eff
ect
seriou
complic
brain
death
due
cerebrovascular
hemorrhag
apnea
test
import
compon
confi
rming
brain
death
patient
support
ecmo
apnea
test
remain
challeng
braindeath
diagnosi
often
made
without
apnea
test
method
present
two
case
receiv
vv
ecmo
support
progress
ard
initi
ecmo
use
sedat
prevent
movement
improv
adapt
mechan
ventil
also
use
anticoagul
heparin
prevent
thromboembol
event
ecmo
circuit
occlus
daili
followup
notic
patient
lost
pupil
reaction
light
sedat
ceas
comput
brain
tomographi
perform
patient
intracerebr
hemorrhag
decid
determin
brain
death
apnea
test
increas
ecmo
blood
fl
ow
fi
decreas
sweep
ga
fl
ow
disconnect
patient
mechan
ventil
respect
one
patient
see
spontan
breath
eff
ort
carbon
dioxid
retent
conclud
apnea
test
success
confi
rmed
brain
death
hand
confi
rmed
brain
death
patient
cerebr
angiographi
due
occurr
hypoxia
hypotens
apnea
test
result
experienc
challeng
determin
brain
death
patient
ecmo
support
ard
challeng
conduct
apnea
test
ecmo
support
auxiliari
test
requir
patient
toler
chang
need
conduct
apnea
test
increas
use
ecmo
therapi
clinician
may
come
face
face
complic
lifeend
decis
conclus
current
guidelin
includ
brain
death
criteria
use
support
therapi
ecmo
therefor
updat
one
main
goal
intens
care
medicin
reduc
mortal
critic
ill
patient
howev
essenti
recogn
endoflif
care
integr
compon
critic
care
besid
surviv
success
intens
care
also
includ
qualiti
live
preserv
qualiti
die
object
studi
evalu
incid
type
endoflif
decis
eld
critic
patient
die
icu
method
analysi
patient
includ
icu
run
databas
die
novemb
octob
follow
variabl
evalu
age
gender
reason
admiss
sap
ii
length
icu
stay
type
eld
classifi
eld
four
concept
defi
ned
comfort
care
chang
cur
therapi
comfort
care
therapi
limit
therapi
mainten
cur
therapi
without
escal
exampl
renal
substitut
decis
resuscit
perform
advanc
life
support
cardiac
arrest
occur
without
previou
endoflif
decis
prior
decis
regard
eld
result
total
patient
admit
icu
die
reason
admiss
die
septic
shock
post
cardiac
arrest
cardiogen
shock
nontraumat
brain
bleed
fiftythre
patient
die
comfort
care
decis
patient
decis
resuscit
limit
therapi
decis
thirtyseven
patient
die
without
previou
endoflif
decis
howev
specifi
calli
group
look
individu
record
patient
die
fi
rst
hour
admiss
four
evid
brain
death
organ
donor
leav
one
patient
eld
conclus
studi
comfort
care
main
eld
line
concept
eld
essenti
ensur
care
provid
critic
care
volum
suppl
http
consist
qualiti
life
death
appar
larg
proport
patient
without
previou
endoflif
decis
due
patient
die
fi
rst
hour
icu
admiss
correspond
condit
refractori
treatment
addit
studi
also
draw
attent
better
plan
icu
admiss
hospit
outreach
order
reduc
earli
icu
mortal
pauciti
data
whether
treatment
philosophi
diff
erent
patient
compar
would
want
act
surrog
decisionmak
love
one
method
anonym
survey
sent
member
australia
new
zealand
intens
care
societi
colleg
intens
care
medicin
cicm
fi
rst
section
compris
hypothet
case
scenario
span
week
icu
stay
patient
four
diff
erent
stage
icu
stay
respond
request
answer
multiplechoic
question
regard
philosophi
treatment
base
perceiv
prognosi
patient
particular
time
follow
two
section
contain
set
question
hypothet
scenario
respond
act
surrog
decisionmak
patient
respond
patient
situat
respons
compar
amongst
three
section
stage
use
chisquar
test
result
total
respons
receiv
fellow
cicm
result
present
tabl
conclus
icu
physician
would
withdraw
care
patient
major
would
also
want
dispar
decis
continu
treat
patient
versu
treat
self
famili
increas
increas
length
stay
refer
introduct
analyz
percept
parent
regard
return
hospit
children
die
particip
convers
doctor
analyz
feel
parent
particip
studi
evalu
care
provid
moment
lead
death
children
method
descript
exploratori
qualit
studi
studi
site
pediatr
icu
hospit
luca
hospit
de
clinica
de
porto
alegr
fifteen
parent
children
die
picu
studi
particip
studi
data
collect
occur
conduct
semistructur
interview
data
analyz
use
themat
content
analysi
research
approv
research
ethic
committe
hospit
abil
return
hospit
talk
medic
assist
consid
parent
posit
enlighten
opportun
parent
particip
studi
understood
moment
opportun
heard
demonstr
intent
contribut
experi
order
improv
care
hospit
studi
conclus
conclud
need
implement
measur
provid
palli
care
parent
death
children
necessari
consid
possibl
provid
famili
followup
meet
multidisciplinari
team
death
children
prioriti
improv
provid
famili
guidenavig
educ
provid
fragil
famili
trust
improv
provid
commun
skill
inform
patient
longterm
eff
ect
critic
ill
develop
strategi
facilit
continu
care
provid
conclus
patient
famili
member
untap
resourc
engag
research
viabl
strategi
identifi
opportun
qualiti
improv
patient
famili
centr
introduct
purpos
studi
assess
visit
restrict
place
famili
visit
adult
patient
critic
care
unit
within
trauma
hospit
england
whilst
well
recognis
highqual
care
patient
paramount
import
also
awar
support
patient
famili
er
longterm
benefi
ts
patient
famili
hospit
unit
review
whether
could
adopt
fl
exibl
attitud
visit
time
assess
provid
welcom
environ
rel
inform
review
order
develop
best
practis
approach
survey
major
trauma
centr
england
method
telephon
survey
visit
time
conduct
adult
critic
care
unit
trauma
centr
england
list
trauma
centr
obtain
nh
england
websit
critic
care
unit
obstetr
high
depend
unit
coronari
care
unit
unless
part
cardiothorac
critic
care
unit
within
hospit
survey
respond
ask
visit
hour
whether
children
allow
visit
mani
visitor
bed
space
result
fiftythre
unit
four
bed
cover
whole
england
survey
respons
rate
visit
hour
vari
hospit
unit
within
hospit
nine
unit
open
visit
hour
although
gave
advic
time
avoid
nurs
handov
major
unit
oper
restrict
visit
median
rang
hour
unit
allow
maximum
two
visitor
bedspac
children
allow
nine
unit
without
restrict
remain
unit
advis
may
appropri
children
visit
discret
parent
medic
staff
conclus
major
adult
critic
care
unit
england
includ
restrict
visit
polici
visit
polici
sourc
debat
amongst
staff
intens
care
concern
open
visit
includ
increas
workload
interrupt
normal
routin
consist
view
staff
unit
appreci
enquiri
express
mix
opinion
extend
visit
time
extend
visit
time
part
wider
project
improv
way
rel
experi
intens
care
whilst
ensur
medic
nurs
staff
feel
support
creat
environ
optim
commun
follow
introduct
fwr
audit
famili
satisfact
use
valid
fsicu
questionnair
method
prospect
studi
rel
satisfact
patient
complet
critic
care
episod
questionnair
complet
anonym
data
collect
pragmat
studi
chang
made
commun
strategi
result
high
degre
satisfact
across
domain
fsicu
includ
treatment
famili
provis
inform
figur
one
hundr
per
cent
found
fwr
help
anticip
fifteen
per
cent
chang
percept
critic
care
enabl
rais
new
concern
one
hundr
per
cent
abl
question
answer
satisfactorili
link
fsicu
seen
mark
improv
decisionmak
satisfact
conclus
shown
progress
improv
year
across
domain
mark
improv
inform
provis
decisionmak
support
year
sinc
introduc
fwr
correl
improv
overal
satisfact
figur
interestingli
fwr
help
rel
anticip
fwr
well
receiv
result
suggest
unrecognis
need
met
pragmat
studi
feel
true
represent
famili
satisfact
encourag
commun
inform
decisionmak
support
continu
improv
becom
embed
fabric
critic
care
practic
lead
mark
improv
satisfact
famili
refer
introduct
famili
critic
ill
patient
death
love
one
icu
often
unexpect
traumat
event
characteris
diffi
cult
decis
regard
withhold
withdraw
lifesustain
therapi
increasingli
import
bereav
care
bc
icu
acknowledg
although
report
continu
highlight
inadequaci
around
endof
life
care
critic
care
environ
intens
care
societi
ic
publish
guidelin
map
bc
icu
aim
compar
bc
icu
across
england
recommend
set
ic
method
adult
icu
england
contact
period
use
standardis
questionnair
base
nine
domain
identifi
ed
ic
answer
collect
anonym
use
complianc
rate
deem
accept
result
icu
identifi
ed
answer
questionnair
fortythre
per
cent
respond
access
train
bc
commun
skill
name
member
staff
respons
train
write
audit
develop
bc
polici
ask
presenc
written
bc
polici
respond
posit
even
less
provis
audit
develop
servic
inform
staff
cultur
religi
rite
around
time
death
rel
death
avail
respect
gener
practition
inform
death
take
place
icu
case
particip
icu
eff
ort
made
ensur
privaci
griev
rel
dedic
followup
facil
bereav
even
though
staff
support
programm
recognis
paramount
icu
formal
one
set
conclus
fi
rst
nation
audit
bc
icu
sinc
initi
ic
guidelin
public
even
though
icu
provid
rel
inform
around
time
death
train
audit
adequ
facil
meet
recommend
standard
lack
adher
defi
nite
multifactori
requir
research
meantim
vigor
implement
guidelin
warrant
order
ensur
optim
care
bereav
famili
refer
